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Abstract
The thesis describes synthetic approaches towards chiral aromatic aminodiols, an 
important structural m otif that can also potentially be prepared via the sequential use of 
transketolase (TK) and transaminase (TA). Syntheses of aminopyruvates and analogues 
as novel TK donors are also described.
Initially, the aims of this Ph. D. are laid out in Chapter 1; a literature review of the uses 
o f enzymes in chemoenzymatic syntheses is covered. In particular, carbon-carbon bond 
forming enzymes (TK) from a family of thiamine pyrophosphate enzymes are 
discussed. The latter part of Chapter 1 explores the use o f TAs to convert ketone groups 
to amino groups stereoselectively. Chapter 2 is concerned with current synthetic 
strategies towards the synthesis of aminodiols and the Sharpless asymmetric 
aminohydroxylation (AA). This is a key reaction in establishing chiral aminoalcohol 
functionalities.
The results and discussion are described in Chapter 3 to Chapter 5. Chapter 3 outlines a 
systematic approach towards nitrogen containing pyruvate donors, via a number of 
synthetic protocols, for potential use with TK and TK mutants. Finally, a TK mimetic 
reaction is presented with the successful synthesis o f 3-phthalimidopyruvate. Synthetic 
approaches towards aromatic aminodiols via a short reaction sequence for use as HPLC 
standards are outlined in Chapter 4. Initially, one-pot methodologies were explored to 
access both syn and tf«r/-diastereomers and are described. Using ‘masked’ aromatic syn- 
aminodiols, the methodology for producing aromatic 5 7 /7-aminodiols via a short reaction 
sequence is described along with the synthesis o f cinnamate precursors for the Sharpless 
asymmetric aminohydroxylation (AA) reaction. Finally, the results o f Sharpless AA 
reactions via homogeneous and heterogeneous catalytic conditions with cinnamate 
precursors are presented in Chapter 5.
An overall summary and future areas o f research in the future are discussed in Chapter 
6, whilst a formal description of the experimental methods and procedures employed in 
this thesis are presented in Chapter 7.
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Aims & Objectives
The UCL-based Bioconversion-Chemistry-Engineering Interface Programme (BiCE) is 
interested in using transketolase (TK) to access enantiopure ketodiols for conversion 
into enantiopure aminodiols by transaminase (TA ) . 1 The project was split into two main 
themes (Scheme 1.1.1): transketolase and transaminase.
Asymmetric I 
synthesis I
OH
ketone 4 x  = o h  nh2 
7a X = N3 
7b X = NH2 
7c X = CN 
7d X = Phth
Scheme 1.1.1: Overall Project Scheme
An enantioselective carbon-carbon bond forming reaction (Scheme 1.1.1) is performed 
by transketolase (TK). A key constraint identified with the TK enzyme route is the lack 
of substituted pyruvate donors 1. Hydroxypyruvate (1, X = OH) is the only pyruvate 
donor accepted by TK currently. TK, however, functions with many aldehyde acceptors 
2, where R can be alkyl, hydroxyalkyl and potentially aryl groups to give chiral 
ketodiols 3. These are substrates for transamination using transaminases (TA) and 
could allow access to chiral aromatic aminodiols 4.
Reaction o f ketodiols 3 with transaminases (TAs) will generate aminodiols 4. TAs are 
known to work with a number o f aryl substrates . 1'2'3'4'5 In order to study the 
chemoselectivity of this reaction, synthetic routes to enantiopure aryl aminodiols were 
sought after for structural elucidation o f the biocatalytic process by chiral HPLC and 
also to assess the efficacy of synthetic approaches versus biocatalytic strategies.
To further enhance the synthetic utility o f this important C-C bond forming reaction, the 
aim was to investigate the chemoselectivity o f TK mutants by synthesising nitrogen- 
containing pyruvates, where X contained an azide (5a), amino (5b), cyano (5c) or 
phthalimido group (5d). From this we aimed to generate enantiopure a-hydroxyketones
Chemical
1 X=OH 
5a X = N-
OH
5b X = NH2 
5cX = CN 
5d X = Phth
TK, Mg2+, TPP
Y 3 X = OH 6a X = N3 6b X = NH2 
6c  X = CN 
6d X = Phth
TA
r
am ine donor
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(6a-d) and the subsequent aminoalcohols (7a-d) by transamination or a chemical 
method.
If no chemoselectivity was expressed towards the nitrogen containing pyruvates 5a-d by 
TK or its mutants, a recently discovered a mimetic TK reaction6 could be used to study 
the formation o f racemic products (6a-d), and still allow access, through transaminase 
(TA), or by reductive amination, to an interesting pool of synthons 7a-d. In particular, 
if  X contained an amino group (6b), reaction with TA could provide chiral diamino 
alcohols (7b). These are structural motifs found in a number of natural products and 
anti depressant and anti psychotic drugs.
There are several synthetic methods that could have been explored, however, we were 
keen to establish a general approach with a broad substrate range and versatility. 
Investigations into the Sharpless aminohydroxylation (Sharpless AA) were carried out, 
as the literature predominantly reported the syntheses o f syn aminoalcohol moieties 
where, aryl p-hydroxy-a-amino esters resulted {i.e. undesired 3-phenylisoserine 
enantiomers). We aimed to carry out an in-depth study, using homogeneous and 
heterogeneous Sharpless AA conditions with A-bromoacetamide and A-chloro, A-sodio- 
carbamate salts to allow rapid access to syn aryl a-hydroxy-P-amino esters {i.e. 3- 
phenylserine enantiomers) . 7,8 These 3-phenylserine enantiomers could be then readily 
converted into enantiopure aryl aminodiols (4, X = OH). To enhance this study, we 
aimed to make the process more environmentally benign, by extending the study to 
include the use o f solid supported catalysts. This was to minimise the danger o f using 
osmium tetroxide and to investigate the effects o f catalyst structure on the regio- and 
enantioselectivities of this reaction.
Within this study, we aimed to synthesise cinnamate substrates by aqueous Wittig 
reactions and by conventional organic syntheses in organic solvents. These cinnamate 
substrates would then be used for subsequent Sharpless AA reactions, initially to 
investigate the ease o f forming enantiopure aryl sjw-aminodiols 4, before potentially 
considering alkyl substrates.
We aimed to also explore other one-pot syntheses towards aryl p-hydroxy-a-amino 
esters (3-phenylserine enantiomers), providing HPLC standards for both syn and/or anti 
P-hydroxy-a-amino esters.
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Introduction
Chapter 1
1.1 Enzymatic and Chemoenzymatic 
syntheses
“Biotransformations involve the use o f biological systems to bring about chemical 
changes on systems that would not otherwise occur in nature .” 9 These reactions are 
performed using enzymes, which help to satisfy the increasingly stringent 
environmental constraints placed upon industry to replace ‘harmful' chemical reagents 
and avoid the generation of harmful waste.
Enzymes have been used in organic synthesis for several decades. Since the 1960s, 
glucoamylase has been used for the hydrolysis o f starch and the use o f encapsulated 
enzymes for detergents was introduced in the 1970s.10 Recently, the use o f enzymes in 
chemical synthesis has increased due to advances in recombinant DNA technology, 
protein engineering and metabolic engineering. The enzyme itself may only represent 
one part o f an overall synthesis as a biocatalytic conversion, but when coupled with 
other chemical steps, the whole process is referred to as a chemoenzymatic synthesis.
The main advantages o f using enzymes in organic syntheses are that they usually 
operate at ambient temperatures and under neutral aqueous conditions. Furthermore, 
conversions can normally occur in the absence of functional group protection . 11 
Although this is potentially beneficial, there is a disadvantage: enzymes have a tendency 
to denature in organic solvents due to the removal of water molecules from around the 
enzyme structure. This can limit their usefulness in organic synthesis where a large 
number of reactions are performed exclusively in organic solvents. For enzymes, water 
can act like a “molecular lubricant” keeping the enzyme in a rigid conformation and 
allowing them to catalyse reactions. 12,13 Despite this, studies over the past 15 years have 
shown that enzymes can function in organic solvents with surprisingly high catalytic 
efficiencies. 14,15 The use of hydrophobic solvents can be more effective than the use of
16
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hydrophilic solvents due to the former removing tightly bound water molecules from 
the enzymes active site. Additional advantages of using organic solvents with enzymes 
include increased solubility of substrates in hydrophobic solvents and a favourable shift 
o f equilibrium to favour the formation of the desired product. 16
Enantiopure 2-chloro- and 2-bromo propionic acids (entries 1-4, Table 1.1.1) are used 
as intermediates in the synthesis o f the phenoxypropionic herbicides. They have been 
successfully generated from a yeast-lipase (<Candida cylindracea) catalysed
• 1 7 *enantioselective butanolysis in solvents containing as little as 0.1% water. This 
reaction is o f interest as it is thermodynamically impractical in water. This is because 
water promotes racemisation and hinders resolution o f the acid.
OH + R2OH o r 2Candida cylindracea
X
(R)
Ri
OH
X
(S)
Entry Ri X r2oh solvent Reaction 
time, h
Yield
(%)
isomer Ee, %
1 c h 3 Br n-butyl
alcohol
H exane 14.5 96 S 99
2 c h 3 Cl n-butyl
alcohol
H exane 14.5 96 S 95
3 CH3(CH2)3 Br n-butyl
alcohol
H ex an e1 48 89 s 73
4 c h 3( c h 2)13 Br n-butyl
alcohol
H ex an e1 32 67 s Unknown
Table 1.1.1: Production of optically active acids from racemates via yeast lipase in organic solvents1'
As shown in Table 1.1.1, good yields and enantioselectivities were attained (entries 1- 
4), making this bioconversion an attractive strategy for the generation o f 2-chloro- and 
2 -bromo propionic acids.
The advantages of enzymes over traditional chemical synthesis and the disadvantage of 
using enzymes exclusively in aqueous media have been addressed by some enzymes 
being able to function in organic solvents. Despite this, however, genetic manipulation 
o f the enzyme itself is a far more valuable tool as it allows a deeper understanding of 
enzyme mechanism (through site-directed mutagenesis) and the acceptance of unnatural 
substrates (through directed evolution). In addition, enzymes can be genetically 
engineered to increase their structural and thermostability.
17
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1.2 Genetic manipulation of enzymes
Once an enzyme is identified as having potential catalytic ability, cloning and over­
expression allows for its production on a multi-gram scale, which before the advent of 
recombinant DNA technology was not possible. There are two methods for improving 
enzymes turnover o f substrate or for broadening the enzymes substrate specificity. 
Firstly, site-directed mutagenesis (1980s), a forerunner to directed evolution (1990s) 
succeeds in providing a good understanding of protein structure and function. Whilst 
this is a successful method, previous knowledge of the enzymes structure is required, 
which is not always easily obtained. Despite this, site-directed mutagenesis is a 
valuable tool, particularly when successful mutants are identified and can then be 
implemented in analysing the enzymes function, however this technique is much too 
time-intensive for the development of high throughput protocols . 19
The second method is directed evolution, which was designed to generate enzymes with 
specific characteristics in a random, selection-driven manner. The main advantage of 
directed evolution over site-directed mutagenesis, is that prior knowledge of the 
enzymes structure is not required and its compatibility with high throughput protocols. 
Directed evolution involves two independent but powerful technologies: methods for 
the generation of random genetic libraries, and strategies for the selection of variant 
enzymes that possesses specific characteristics. Such characteristics include increased
catalytic activity, enhanced selectivity for a substrate, or an improved stability of the
20enzyme. The genetic libraries are then run through a high-throughput screen that is 
capable o f dealing with large numbers of variants based on in vivo selection ( 1 0 8- 1 0 10 
variants) or in vitro selection (105-106 variants). This is achieved by detection of 
colonies on agar plates using, for example, fluorescence or colorimetric product 
formation. Alternatively, individual clones can be assayed on 96-well microtitre plates 
(103-104 variants) for a more accurate determination of activity (Scheme 1.2.1) . 21
18
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alDirected evolution of enzymes 
Generation of variant gene libararies
Random mutation
parent gene error prone PCR 
mutator strains 
recombination
Bacterial
transformation
cellDNA
mutant library 
bl Library evaluation
Colorimetric, fluorescent or 
chemisluminescent screens
life or deathselection
petri dish
Whole Cell biotransformations
o o
microowell plate
10 -1 0  variants
108 - 10 0 variants
|  103-104 variants
Analysis
Scheme 1.2.1: Strategies for the directed evolution of enzymes involving (a) generation of libraries of 
variant genes and (b) high-throughput screening of the libraries using different analytical methods21
One example o f the development o f directed evolution using enzymes was to allow ease 
o f access to enantiopure amines by deracemisation. This was based on initial work 
involving the deracemisation o f natural and unnatural DL-amino acids, using a 
chemoenzymatic process (Scheme 1.2.2). L-Amino acid oxidases promote 
stereoinversion by enantioselective oxidation o f a DL-amino acid (L-8 ) to imino acid (9), 
followed by reduction with non-selective reducing agent. An array o f non-selective 
chemical reducing agents (sodium cyanoborohydride; sodium borohydride; amine- 
boranes and Pd/C-ammonium formate) was considered. Alternatively, keto acid 10 
could be obtained through hydrolysis of the imine. Various experiments by Turner et 
al., showed reducing agents, such as amine-boranes could be implemented for use in 
water, whereas sodium cyanoborohydride and sodium borohydride were less 
successful.22'23
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NH,
Oxidation
D and L-amine oxidase 
(D and L-AO)L-8
Reduction
NH +H20
nh2
NH4
R" 'C 0 2H 
10
D-8
Scheme 1.2.2: Deracemisation o f a-amino acids using an enantioselective d  and L-amine oxidases in 
combination with a non-selective chemical reducing agents22
Based on this platform methodology, directed evolution techniques were then used with 
the amine oxidase {Aspergillus niger) to catalyse the enantioselective oxidation of a- 
methylbenzylamine (Scheme 1.2.3), starting with (S)-a-methylbenzylamine (11a) to 
imine (12), which was converted to (i?)-a-methylbenzylamine ( l ib )  by ammonia- 
borane. From approximately 150,000 clones, one mutant (Asn336Ser), showed 50-fold 
greater activity with (S )-lla  and a six fold greater enantioselectivity compared with the 
wild-type enzyme, resulting in (i?)-llb  formation in 77 % yield and 93 % ee.242*
NH?
A. niger amino oxidase (Asn336Ser mutant)
Scheme 1.2.3: Deracemisation of a-methylbenzylamine using an Asn336Ser mutant of A. niger amine 
oxidase2425
Newman et al., reported a further example o f the use of directed evolution in the 
production of furanone flavour compounds (Scheme 1.2.4). Microorganisms containing 
aryl dioxygenases converted aromatic hydrocarbons to the corresponding cA-diols, 
important fragments for the manufacture o f a wide range of fine chemicals.26 Multigene 
DNA shuffling was applied to toluene dioxygenase (tod) and tetrachlorobenzene 
dioxygenase (tec) operons to improve the biotransformation of cA-dihydroxylated 
aromatic compounds. Four gene operons, todC lC IB A  and tecAlA2A3A4 were 
shuffled and were pre-screened. A high-throughput screen was then developed where
20
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slow release o f the substrate circumvented substrate toxicity to the bacterial host. As a 
result, nine clones were selected and tested. Clone CIO was found to have the best 
activity and accepted a number o f substrates including /7-xylene, m-xylene, 1,2,3- 
trimethylbenzene and naphthalene.
Exploiting the use of the inexpensive starting material (Scheme 1.2.4) /7-xylene (13) 
underwent a whole cell biotransformation with “directly evolved” bacterial toluene 
dioxygenase (E. coli JM 109 (pTrocdNKl)), which led to cA-l,2-dihydroxy-3,6- 
dimethyl-cyclohexa-3,5-diene (14) on an 88 g scale. Ozonolysis of this meso diol 14 
gave a 1:1 diastereomeric mixture of diketone (15) and o-methylketal-hemiketal (16). 
These diastereoisomers were dissolved in 77-butyl acetate containing a phosphate buffer 
and heated at 95 °C for 5 h. The reaction mixture was then left to stand for 12 h and 
gave furanone (17). This compound is normally synthesized from the expensive 2,5- 
hex-3-ynediol, so using /7-xylene 13 made this process more economically feasible on 
an industrial scale.26'27
13 14 15 16 17
Scheme 1.2.4: (a) E. coli JM109 (pTrcodNKl); (b) 0 3, MeOH; then aq. Na2S20 3, NaHC03 (84-92%); (c) 
wBuOAc, H20 , phosphate buffer, 95 °C, 5 h (39-40%)26
Directed evolution can also be used to enhance the thermostability o f enzymes. For 
example, a newly isolated enantioselective esterase from Pseudomonas fluorescens 
KCTC 1767 had been identified as a possible biocatalyst, which converted racemic 
ketoprofen ethyl ester (18) to (R)-ketoprofen ethyl ester (18a) and (S)-ketoprofen (19). 
The only problem was that Pseudomonas fluorescens KCTC 1767 was reported to have 
low structural and thermal stability.28 In order to overcome this, Kim et al., performed 
directed evolution on this enantioselective esterase by successive steps o f error prone 
and staggered extension polymerase chain reactions (PCR). After two rounds of in vitro 
directed evolution, a mutant 6-52 that had 5-point mutations was identified. Three of 
these mutations were found to affect the amino acid residues (L120P, 1208V and 
T249A) whilst the other two mutations were silent. Mutant 6-52 was identified with 
enhanced thermal stability (12.8 % conversion c .f  wild type 0.2%).29
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Scheme 1.2.5: Schematic representation for the enzymatic resolution of ketoprofen ethyl ester (18) to 
(/?)-ketoprofen ethyl ester (18a) and (5)- ketoprofen (19) using an esterase
This general preamble o f genetic manipulation techniques used to improve the enzymes 
chemoselectivity towards unnatural substrates introduced some of the methods that are 
currently employed by the BiCE collaboration. The BiCE collaborators are interested in 
two enzymes as part o f a dual enzymatic or chemoenzymatic pathway (Scheme 1.2.6). 
These are transketolase (TK), a thiamine pyrophosphate dependentenzyme and 
transaminase (TA) to access enantiopure aminodiols 4.
Chemical
Asymmetric
synthesis
OH OH
TK, Mg2+, TPP TA
OH f  \  R
am ine donor ketone
Scheme 1.2.6: Overall Project Scheme
1.3 Thiamine pyrophosphate dependent(TPP) enzymes
Thiamine pyrophosphate dependentenzymes include many enzymes, but for this 
section, the focus was on pyruvate decarboxylase (PDC), benzoyl formate decarboxylase 
(BFD) and transketolase (TK). Thiamine (vitamin Bj) is required for the production of 
thiamine pyrophosphate (TPP) (20). TPP dependent enzymes can catalyse either the 
cleavage or formation of bonds to the carbon atom of a carbonyl group. The mechanism 
shown (Scheme 1.3.1) is pyruvate decarboxylation to give acetaldehyde (26).
22
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V-conformation
28 R = H
29 R = P2Of
OR
Scheme 1.3.1: Structure of TPP (20), mechanism of PDC and inactive analogues deazaTPP (27-29)
Deprotonation of the C-2 in the thiazolium ring 20 gives the ylid (21). The ylid 
subsequently attacks the carbonyl group of pyruvate (22) and gives the 2-lactylTPP 
species (23). The positively charged thiazolium ring then facilitates decarboxylation 
and affords the enamine intermediate (24). The mechanisms o f TPP dependent 
enzymes are very similar, going through the enamine intermediate 24 (Scheme 1.3.1), 
whether for C-C bond formation or bond cleavage. In the case o f PDC, protonation of 
the enamine 23 yields 2-(l-hydroxyethyl) TPP (25). Release of acetaldehyde 26 from 
the catalytic cycle regenerates the ylid 21 and thus completes the catalytic cycle.30
How the substrate binds to TPP-dependent enzymes and which acid or base groups are 
involved in the C-2 deprotonation at the C-2 o f the thiazolium ring, remains unknown. 
This is in spite of the number of crystal structures solved for TPP-dependent enzymes.31 
It is suggested that mobile loops close over the active site when the substrate binds and 
masks the essential catalytic groups. The only exception to this is transketolase (TK), 
which is known to catalyse the formation of enamine intermediate 24 and was 
characterised by X-ray crystallography.32
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Invariably, many TPP-dependent enzymes exist as dimers, with the active sites at the 
interfaces between the two subunits.31 TPP is usually bound in the V-conformation 20 
(Scheme 1.3.1), which is not the lowest energy state. This conformation was 
characterised by the close proximity o f the 4'-amino groups on the pyrimidine ring to 
the hydrogen atom on the C-2 atom of the thiazolium ring heading to form ylid 21. At 
the centre of much controversy is the deprotonation of the hydrogen atom at C-2 of the 
thiazolium ring. It is believed the aminopyrimidine unit is responsible for this 
deprotonation. In its usual form, the amino group exists with its lone pairs in 
conjugation with the 7i-system of the pyrimidine ring. Tautomerisation to the less stable 
imino group (20a) (Scheme 1.3.1) allows the iminopyrimidine nitrogen to act as the 
base. Evidence for this hypothesis came from the studies on oxythamine diphosphate 
(27) (Scheme 1.3.1). This was completely inactive when bound instead of TPP 20. 
TPP hydrogen exchange at C-2 was measured using NMR experiments with PDC and 
was 105 times faster than when oxythiamine diphosphate 27 was bound, which retarded 
the exchange of hydrogen.33
One method to overcome the problem of masking essential catalytic groups was 
explored by combining an inhibitor and crystallographic studies. Deazathiamine 
(Deaza) (28) (Scheme 1.3.1) was converted into DeazaTPP (29) using concentrated 
phosphoric acid and is isoelectronic with TPP 20.30 The lack o f a positive charge on 
DeazaTPP 29 was expected to prevent the formation of C-2 ylid 21. A deazaTPP 
crystal structure had been solved, but in proteolysis studies with chymotrypsin, where 
29 existed in an identical position to TPP. The Enz-deazaTPP complex was observed to 
protect both the a-chains of the tetramer (enzyme subunit is an a jfii tetramer) from 
proteolysis. The similarity between the ylid 21 and deazaTPP 29 complex suggested 
that the loop closed once the ylid was formed. Therefore in the Enz-TPP complex, one 
o f the two TPP molecules was present as the ylid 21, whilst the other was the protonated 
TPP 20.
TK is known not to accept pyruvate 22, but will accept hydroxypyruvate 1. Whereas 
conversely, PDC does not accept hydroxypyruvate 1, but accepts pyruvate 22. If 
successful amino pyruvate analogues 5a-d were synthesised there is a possibility of 
testing these substrates with a-keto decarboxylases, TK and TK mutants. Furthermore, 
the possibility of novel biotransformations could enable the production o f novel and 
interesting chiral synthons through carbon-carbon bond forming reactions.
24
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1.3.1 Pyruvate decarboxylase (PDC)
As discussed, pyruvate decarboxylase (PDC) can undergo two reaction pathways 
(Scheme 1.3.2). One allows the formation of acetaldehyde 26 and ethanol, whilst 
Neuberg et ah, discovered the other was a carboligation reaction that occurred during 
‘phytochemical reductions’ o f aldehydes using fermenting yeast.34,35
cof N+-
23©ON+-
HO,
24
OH
OR
H+
N+-
H—O
CH3 R- = CH2CH2OPP
R' =
Scheme 13.2: Reaction pathways of enzymatic a-keto decarboxylase (red arrows) and formation of a- 
hydroxyketones by PDC (blue arrows)
The mechanism of decarboxylation depends on two properties o f the thiazolium ring. 
The first is its capacity to ionise and form a nucleophilic anion and thus bind the a- 
carbonyl group o f a-keto acids; and second was its ability to stabilize the negative 
charge upon decarboxylation of the substrate. The reaction cycle is initiated by the 
activation o f TPP 20 by the enzyme. The C2-TPP ylid 21 then performs a nucleophilic 
attack on pyruvate 22. Proton transfer gives 2-lactylTPP 23, which through 
decarboxylation stabilizes the resulting doubly negatively charged species 24. This 
‘active aldehyde 24’ leads to the formation o f chiral a-hydroxy ketones via a reversible 
reaction. This is achieved by addition o f a second aldehyde, such as benzaldehyde (30) 
and gives (K)-phenylacetylcarbinol (PAC) (31) through an acyloin-type condensation 
reaction. Unequivocal proof of the ability o f PDC to undergo both reaction pathways 
was discovered by Hanc and Kakac36, who incubated an enriched fraction o f PDC from 
yeast with pyruvate 22 and benzaldehyde 30 and afforded (^)-phenylacetylcarbinol 
(PAC) 31.
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Following this work, a wide range of aldehydes (aliphatic, aromatic, heteroaromatic and 
a,p-unsaturated aldehydes) have been condensed with pyruvate 22 (Table 1.3.1 A and 
B). The majority of these reactions were reported using fermenting yeasts and only a 
few with isolated enzymes.34
Table 13.1: a-Hydroxyketones obtained by (A) decarboxylative incorporation of pyruvate and (B) 
decarboxylative introduction of various aliphatic a-keto acid, using fermenting yeast (Saccharomyces sp.) 
(1), or isolated enzymes PDC Sacch. sp. (2) and PDC Z. mobilis. P )34
A liphatic
k e to n e s
a -h y d ro x y
o -  1 ' 2 ' 3
V
-co2
R -  CnH2n+i
CH,
R e sid u e  R C a ta ly s t R e fe ren ce
n = 1 -12 1 [37]
n = 1,2 2 [38]
n = 1,2 3 [39]
A ro m atic  a -h y d ro x y  k e to n e s S X
R =  x
—z
(B e n z a ld e h y d e  d e r iv a tiv e s)
R e s id u e C a ta ly s t R e fe re n c e
X, Y, Z = -H 1 [40]
2 [41]
3 [39]
M o n o su b s titu te d  d e riv a tiv e s
X, Y, Z = -F, -Cl, -Br 1 [42]
2 [41]
3 [38]
X, Y, Z = -OH, CH3, OCH3, -CF3 1 [37]
Z = -CH(CH3)2, -N(CH3)2, -C6H5 1 [37]
D isu b s titu te d  d e riv a tiv e s
X, Y = -di-F 1.2 [41]
X, X' = - di-F 1.2 [41]
26
Introduction: Chapter 1
A ro m atic  a n d  h e te ro c y c lic  a -h y d ro x y  k e to n e s
R e s id u e C a ta ly s t R e fe re n c e
R = Ph(CH2)n, n = 1,2 
X = H, -CH3
‘X ' X = 0 ,  S
/ X
x  = o , s
\  7
1 [37]
1 [43]
2 [38]
3 [39]
1 [37]
2 [38]
3 [39]
1 [37]
1 [37]
[37]
Despite reports o f PDC’s chemoselectivity to a broad range o f substrates, allowing the 
introduction of a C2 unit via decarboxylative incorporation o f pyruvate 22, only a few 
examples o f decarboxylative incorporation of alternative pyruvate donors have been 
reported (Table 1.3.1, B).
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D decarboxylative introduction of various aliphatic a-keto acid, using fermenting yeast 
{Saccharomyces sp.) (1), or isolated enzymes PDC Sacch. sp. (2) and PDC Z. mobilis. P )34
Ri r 2 C ata ly s t R e fe re n c e
Ph -c h 3 1 [43]
-C2H5
- c 3H7
-c h 3 & -C2H5 1 [43]
-CH3 & -C2 H5 1 [43]
-CH3 &C2 H5 -c h 3 & -c 2 h 5 1 [44]
2 [38]
-C2 H5 -c h 3 & -C 2 H5 3 [39]
It is notable that the majority o f the a-hydroxy ketones shown in Table 1.3.1 (A and B) 
were synthesized on an analytical scale, rather than preparative. The most extensively 
studied reaction with regards to improvement in yields and stability o f the microbial 
catalyst, particularly in the presence of benzaldehyde 30, was the formation of (R)- 
phenylacetylcarbinol (PAC) 31. Various yeasts from Saccharomyces sp. and Candida 
sp. were at the forefront o f these investigations.
One o f the main problems encountered was that whole cell reactions with yeasts also 
contained alcohol dehydrogenases, which converted benzaldehyde-like substrates to 
benzylic alcohols, lowering the efficacy o f the reaction. Other by-products included 
acetoin, 2-hydroxypropiophenone (2-HPP), benzoin, benzoic acid, butane-2,3-dione 
(diketone), 1-phenyl-propan-2,3-dione (acetylbenzoyl) and fra/zs-cinnamaldehyde. 
Additionally (J?)-PAC 31 could be reduced to (\R ,25)-1 -phenyl- 1,2-propanediol.34
The best way of counteracting these unwanted by-products was to use isolated pyruvate 
decarboxylases for the production o f fft)-PAC-31. Although benzaldehyde 30 had the 
ability to inhibit PDC, concentrations o f up to 70 mM have been achieved with PDC 
from Z. mobilis. A comparison o f S. cerevisiae and C. utilis PDC to PDC from Z. 
mobilis showed the former were used at ambient temperatures, whereas the latter would
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only function at 4 °C. Although, wild-type Z. mobilis enzymes had lower carboligase 
activity, this was significantly improved by site directed mutagenesis.
Mutants PDCW3921 and PDCW392M were selected as the most active enzymes in a 
series. The initial rate o f (7?)-PAC-31 formation increased by a factor o f 5-6 compared 
with the wild-type enzyme. Another enzyme capable of producing (R)-PAC 31 was 
benzyl formate decarboxylase.
1.3.2 Benzylformate decarboxylase (BFD)
Wilcocks, et al., first described the formation o f a-hydroxyketones using benzylformate 
decarboxylase (BFD) from Pseudomonas putida  whole cells and cell extracts. In 
particular, the formation of a tautomer o f (R)-PAC 31, (S)-2-hydroxypropiophenone (2- 
HPP) 32, was obtained from acetaldehyde 26 and benzoylformate (Scheme 1.3.3).45 The 
enantiomeric excess o f the reaction was determined to be 91-92%. Initially, it was 
found that benzaldehyde 30 was produced at a higher rate than (5)-2-HPP 32, but this 
rate declined after reaching a maximum. This was attributed to the reversibility in the 
last step o f the catalytic cycle, (which was also the case with the PDC catalytic cycle) 
(Scheme 1.3.2), and allowed the binding of the released aldehyde to TPP 20, to form the 
‘active aldehyde’ 24 and subsequent reaction with acetaldehyde 26.
Several investigations have revealed similar reaction conditions (pH 6; 30°C) are 
required for the synthesis o f (i?)-PAC-31, as are required for the synthesis of (S)-2-HPP- 
32. BFD (Ps. p .) biotransformations were investigated by Wilcocks and Ward, and 
BFD tolerated a broad pH range (5-8) and temperature optima (20-40°C)43 BFD (Ps. 
p.) was also identified to produce (jR)-benzoin (33) in high enantiomeric excess. Ideally. 
BFD and PDC could complement each other as biocatalysts for the production of 
symmetric and mixed a-hydroxy ketones as seen (Scheme 1.3.3).
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o
O (R)-PAC 31
A H
26 OH
O
Acetoin 34
(S)-2-HPP 32
(f?)-bezoin 33
Scheme 1.3.3: Reaction products of the biotransformation using pyruvate 22 and benzaldehyde 30 with 
PDC and benzoylformate and acetaldehyde 26 with BFD, respectively
Pyruvate 22 and acetaldehyde 26, when incubated with PDC formed acetoin (34) as a 
racemate. In the presence of acetaldehyde 26 and benzaldehyde 30, however, formation 
o f symmetric acetoin 34 was reduced and formation o f (R)-PAC-30 was predominant.
In the case of BFD, the formation o f (i?)-benzoin 33 occurred either in the presence of 
benzylformate or benzaldehyde 30 as substrates. Whereas, the mixed product (S)-2- 
HPP 32, resulted by generating an “active benzaldehyde” at TPP (Scheme 1.3.2), which 
was followed by the addition of acetaldehyde 26.34
The last carboligation study considered with TK is shown next and its mechanistic 
details are illustrated, complete with an analysis o f which amino acid residues within 
TKs active site are responsible for these inferences.
1.3.3 Transketolase (TK)
Transketolase (TK) catalyses (Scheme 1.3.4) the asymmetric transfer o f a two-carbon 
unit from, typically, 3-hydroxypyruvate 1 to an aldehyde acceptor 2 in the presence of 
thiamine pyrophosphate (TPP 20) and magnesium (II) ions. This reaction was made 
irreversible through the loss o f carbon dioxide.46,47 One o f the aims of the 
Bioconversion Chemistry Engineering Interface Programme (BiCE) was to use TK to 
access enantiopure ketodiols (3) for conversion into enantiopure aminodiols 4 by 
transaminase (TA).1
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o
Scheme 1.3.4: Formation of ketodiol 3
TK was first identified by Racker et al., in 195348 in Saccharomyces cerevisiae (yeast) 
and later in spinach leaves.46 Investigations into the use o f TK in synthesis have, 
however, mainly been reported using over-expressed TK from Escherichia coli49 and S. 
cerevisiae.50
TK catalysed condensation can occur with a wide range of aldehydes, particularly those 
having (^)-stereogenic hydroxyl centres at C2 (2, R = AlkylCH(OH)) and this was seen 
as particularly useful for synthesising novel carbohydrates.49 The ketol pyruvate donors 
(Scheme 1.3.5), 2,3-dioxopropionoic acid (35), 2-oxo-3-hydroxybutyric acid (36) and 2- 
oxomalonic acid (37) were known, but did not to undergo conversion to a- 
hydroxyketones using TK.51 This meant, P-hydroxypyruvic acid (la  = H) or salts of P- 
hydroxypyruvate (lb  = K+ or lc  = Li+) were the only known pyruvate donors for this 
reaction currently known.
Scheme 1.3.5: Other potential pyruvate donors for TK51
In vivo TK catalyses a step in the non-oxidative pentose phosphate pathway and this 
involved the coenzyme, TPP 20 (Scheme 1.3.6).
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Scheme 1.3.6: Ketol transfer reactions in the non oxidative pentose phosphate pathway catalysed by TK52
TPP was deprotonated at C-2 to give carbanion 21. From there, attack on the carbonyl 
unit o f D-xylulose-5-phosphate (38), afforded the activated TPP-D-xylulose-5-phosphate 
complex (39). Subsequent release of glyceraldehyde phosphate (40) gave species (41) 
and (41a), which reacted with R-substituted glycolaldehydes (42) and formed complex 
(43). Subsequent rearrangement promoted by the positive charge o f the thiazolium ring, 
gave ketose 44 and released the TPP ylid 21, thus completing the catalytic cycle.52
An understanding of this mechanism, along with the known crystal structures o f TK (E. 
coli and S. cerevisiae) has identified the amino acid residues involved in catalysis of this 
reaction. In particular, the X-ray crystallographic study on S. cerevisiae TK (Figure 
1.3.1), by Schneider and Lindqvist showed the enzyme subunit consisted of three 
domains, all o f the a /p  type.53
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Figure 13.1: Schematic view of the dimer of transketolase. The subunits are coloured in blue and red,
respectively41
The amino-terminal or PP domain (Figure 1.3.2) consisted o f 320 amino acids and a 
five-stranded parallel p-sheet with helices on both sides. The second domain, the Pyr 
domain (residues 323-538) contained a six-stranded parallel p-sheet, sandwiched 
between a-helices. The third domain, the C-domain (omitted from Figure 1.3.2) was 
the carboxy-terminal domain (residues 539-680); and though it was far away from the 
active site o f the enzyme, its catalytic function, if  any, was unresolved. The TK dimer 
was formed through tight interactions between the PP- and Pyr domains, where the 
cofactor was bound at the interface between the subunits and the Pyr domain o f the 
second subunit (Figure 1.3.2).53
33
Introduction: Chapter 1
PP-domain Pyr-domain
PP-domain
Pyr-domain
Figure 13.2: TPP bound at the subunit-subunit interfaces of TK. The two TPP molecules are shown as 
ball and stick molecules. The subunits are coloured in blue and red, respectively41
The cofactor TPP was deeply buried within the active site o f TK with the only atom 
accessible being the C-2 atom of the thiazolium ring. The conformation o f TPP binding 
with TK haloenzyme differed from that in of the free crystal structure o f TPP 20, which 
existed in a high-energy conformation (the V-conformation (Scheme 1.3.1)). In this 
conformation the C-2 carbon atom of the thiazolium ring was brought close (3.1 A) to 
the 4-amino group of the pyrimidine ring.53 Yet, in the crystal structure o f TK, there 
was no enzymic base suitably located to abstract the proton at C-2 o f the thiazolium ring 
o f TPP 20. It was believed that TPP assisted deprotonation occurred through the 
observed hydrogen bond between the side chain o f the conserved residue Glu418 and 
Nl'-nitrogen of TPP 20 (Figure 1.3.3).
The molecular basis o f substrate binding in TK was identified using a crystallographic 
structure with the acceptor substrate erythrose-4-phosphate (Figure 1.3.3). Figure 1.3.3 
highlighted the possible functions o f the conserved amino acids in substrate 
binding/recognition and in catalysis, as deduced from various crystallographic and 
mutagenesis studies.53
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Figure 1 3 3 : Proposed model of the covalent donor substrate-TPP adduct in the active site of TK. The 
function of the conserved residues in the active site channel is indicated41
This model (Figure 1.3.3) determined how other donors interacted with the enzyme’s 
active site. In particular, p-HPA (1), a pyruvate donor accepted by TK, and the 
recognition o f the C l hydroxyl group of this donor could be attributed to the two 
histidine residues (H69 and H I03). This provided some explanation as to why 
pyruvate, which does not possess a C l hydroxyl group, was not accepted by TK. 
Substitution of these two conserved histidine residues with more hydrophobic residues 
(not detailed by the author), meant that TK mutants were able to accept pyruvate, 
though at lower rates o f conversion.53
Residues R359, R528 and H469 were highly conserved in TK sequences and were 
associated with the phosphate binding of phosphorylated substrates. Replacement of 
any o f these three residues with alanine yielded mutant enzymes with considerable 
residual activities, but large Km values for phosphorylated substrates. This provided a 
molecular explanation as to why non-phosphorylated sugars were poor substrates for
With regards to acceptor chain length, TK had a broad substrate range o f between a 3 
and 7-carbon skeleton. This was associated with the architecture of the substrate 
channel and the phosphate binding area (Figure 1.3.3). The ‘business’ end of the 
substrate was always anchored in the right place by the phosphate-binding site, allowing 
the a-carbon of the acceptor to always come into contact with the C-2 carbon atom of 
the thiazolium ring or the a-carbon atom of the dihydroxy-ethyl TPP intermediate 25, 
respectively. Phosphate binding was via two arginine residues, which through flexible
TK.53
35
Introduction: Chapter 1
side chains can adjust to variations in the position of phosphate groups on chain 
extended substrates .53
The D-threo stereochemistry attributed to TK reactions and preferred C2-D 
configurations o f substrates can be attributed to a hydrogen bond (Figure 1.3.3) between 
the side chain of D477 and the C2-hydroxyl group of the acceptor aldehyde. Site- 
directed mutagenesis studies have been key in establishing this fact by replacement of 
D477 with alanine .53
Finally, the histidine residues located in the active site in addition to H69 and H I03 are 
believed to play a role in transition state stabilisation and various proton transfers. In 
Scheme 1.3.7, a reaction mechanism refers to three histidine bases (B1-B3).
+DONOR
N+ CH2OH CH2OH■PRODUCT 1
a-carbanion enamine
+ACCEPTOR
Scheme 1.3.7: Reaction mechanism of TK. The identity of bases Br B3 were discussed in the text
During the first half of the catalytic cycle, two proton transfer steps occur; the C-2 
carbon atom of the TPP 20 is deprotonated and upon cleavage of the TPP-donor 
product, the C-3 hydroxyl group is deprotonated to yield the aldose product. Also the 
negative charge developing at C-2 o f the carbonyl oxygen was stabilised 
electrostatically. It was thought that 4' imino group could act as a sufficiently strong 
enough base at Bi to abstract the C-2 atom of the thiazolium ring, as previously 
discussed.
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The C-2 carbanion of TPP nucleophilically attacked the carbonyl carbon o f the donor 
substrate. For covalent bond formation to occur, stabilisation of the developing 
negative charge at the carbonyl oxygen was required. B2 had two candidates (from the 
model shown in Figure 1.3.2), His481 and the charged 4'-imino group o f TPP. Through 
various site directed mutagenesis studies, it was concluded that the charged 4'-imino 
group o f TPP might act as both Bi and B2 in the reaction mechanism (Scheme 1.3.7). 
The groups involved in steps 1 and 2 cannot catalyse proton abstraction at the C-3 atom 
of the acceptor substrate. Two conserved residues; H30 and H263 were both within 
hydrogen bonding distance to the carbonyl oxygen of the acceptor substrate and the C-3 
hydroxyl group of the reaction intermediate (Scheme 1.3.7). Both residues were 
candidates for the acid/base catalyst in this reaction, referred to as B3 .
In an attempt to assess the viability o f TK as a preparative biocatalyst for the synthesis 
of carbohydrates, Whitesides et al., produced ketoses in yields comparable to ketoses 
formed typically from fructose-1,6 -bisphosphate aldolase (FB aldolase)
biotransformations.31 TK, however, had several advantages over FB aldolase, in its 
ability to resolve racemic aldehyde substrates without requiring the phosphorylated 
substrates, unlike FB-aldolase. This enabled more straightforward monitoring of the 
progress of TK reactions, as well as the ease in isolation of the products.
TK-catalysed carbon-carbon bond formation was both enantiospecific, in that the new 
chiral centre formed in the product had the (^-configuration (the same configuration as 
C-3 o f the natural donor substances), and stereoselective in that the enzyme has a 
preference for a-hydroxyaldehydes with an (^-configuration at C-2. A number of 
reports described the use o f non-natural aldehydes substrates with TK from spinach 
leaves, yeast (S. cerevisiae) and E. Coli. Generally, TK from yeast and E. Coli generated 
products with an (S)-chiral centre, though with spinach TK, some loss of 
enantiospecificity was observed with certain substrates, notably a-unsubstituted 
aldehydes.54 The (S)-stereochemistry with racemic aldehyde substrates can be proved by 
derivatization to a known standard and can be compared by chiral gas chromatography 
(GC), or from existing optical rotation data .49
Fewer reports detailed the use o f spinach TK due to the loss of some enantioselectivity. 
Yet, in understanding heptulose synthesis in higher plant metabolism, Villafranca et al., 
reported the use of spinach TK46 with non-phosphorylated pentoses. Despite the ability
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of TK to accept unnatural non-phosphorylated ketol donors, the rate o f heptulose 
formation was reported to be 150 times greater with D-ribose-5-phosphate than with D- 
ribose as a donor.46
Changes in the R\ group of glycolaldehydes 42a-l, (Scheme 1.3.4) resulted in [3S,4R] or 
d-threo ketotriols (44a-l).54 Early studies included chemoselectivity investigations and 
carbohydrate syntheses with yeast TK on 1-to 5-mmol scale. These results are 
presented below in Table 1.3.2.
OH OH
Li-HPA 1c 
TK
OH
O 42a-l OH 44a-l
Adduct Recovered aldehydes
Ri Aldehyde VRi/VRl =h Ketotriol Yield
(%)1
Yield
(%)1
Ee (%)*
H 42a 100 44a 60 n/a n/a
c h 3 42b 20 44b 44 21 >95
CH3CH2 42c 33 44c 45 23 95
C H 3(CH2)2 42d 22 44d 39 21 77
M eOCH2 42e 27 44e 38 9 94
M eSC H 2 42f 33 44f - - -
H2C=CH 42g 56 44g 30 - -
h 2c = c h c h 2 42h 28 44h 45 20 95
(S)-H 2C=CH CH O H 3 42i 36 441 60 n/a n/a
(R)-H2C=CHCHOH4 42j 32 44j 63 n/a n/a
(c h 3)3c 42k 11 44k - - -
HO(CH2)2 42I <10 441
T “---- 7 ^ — — — - 7 - -
corresponding diol (obtained by reduction of the aldehydes with sodium borohydride). 
derived from D-xylose. 4Optically active aldehydes derived from D-ribose.
3Optically active aldehyde
Table 1.3.2: Substrates for yeast TK51
A number o f conclusions were drawn from the results in Table 1.3.2. Yeast TK was 
shown to be chemoselective to a broad range o f aldehydes provided they had an (R)- 
configuration at C-2. Size effects exemplified by branching at C-3 (aldehyde 42c, R = 
Et to aldehyde 42k, R = /-butyl) were indicated by moderate yields of the corresponding 
ketotriols 44c-k and low yields of the corresponding aldehydes recovered. Hindered 
aldehydes also decreased the relative rates of reaction. The stereochemistry at the (5- 
carbons of aldehyde entries (S)-42i and (7?)-42j showed no particular effect on their 
rates o f reaction.
TK-catalysed syntheses of carbohydrates were compared with the comparable FB- 
aldolase reaction. Adduct 44g can only be synthesised readily from TK, using aldehyde 
42g. FB-Aldolase does not accept acrolein as a substrate, but other alkene-containing
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aldehydes (42g-j) may act as substrates for FB-aldolase. These would result in 
diastereomeric adducts (44g-j), whereas the TK adducts would result in single 
enantiomers (44g-j). Enzymatic reduction o f these adducts (44g-j) by iditol 
dehydrogenase (E.C. 1.1.1.14), coupled with formate dehydrogenase (E.C. 1.1.1.27) and 
sodium formate (Scheme 1.3.8) would generate NADH furnished alkene-polyols (45- 
48). Oxidative cleavage of these alkenes with ozone, followed by reductive workup 
with sodium sulfite afforded 2-deoxy-L-gulose (49), L-gulose (50) and L-idose (51), 
respectively.
HO-
0=
H 0-
HO------ HO------
----- OH ----- OH
HO------ HO-----
a b
------OH -------► ----- OH ------- ► ------OH
C < <
= c h 2
Io
J
O
J
= CH2 45 X = CH2 46 X = CH2 49
= L-CH(OH) X = L-CH(OH) 47 X = L-CH(OH) 50
= D-CH(OH) X = D-CH(OH) 48 X = L-CH(OH) 51
Scheme 1.3.8: Aldose synthesis: a) iditol dehydrogenase (EC 1.1.1.14), FDH (EC 1.1.1.14), NADH,
NaH-C02; b) 1. 0 3, 2. Na2S 0 3
Yeast TK can additionally be used for the kinetic resolution of Ri-substituted l-2- 
glyceraldehydes from racemic Ri-substituted glycoaldehydes (52a-g),55 which allowed 
access to ketotriols (44m-s) in good chemical yields and in excellent optical purity 
(Table 1.3.3).
OH OH
H Li-HPA (1c), 
 TK Ri
O 52a-g
OH
OH 44 m-s
Ri Aldehydes Ketotriol Adduct 
Yield (%)
Aldehyde 
Yield (%)
Aldehyde
PhC H 20 52a 44m 79 75 98
c h 3o 52b 44n 72 72 99
SH 52c 44o 80 - -
EtS 52d 44p 74 52 99
F 52e 44q 79 71 96
c h 3 52f 44r 80 50 99
CN 52g 44s 82 78 97
using chiral gas chromatography.
Table 1.3.3: Yeast TK-catalysed reaction of racemic R-substituted 2-glycolaldehydes with equimolar 
amounts o f lithium HPA lc
In a further study, 3-O-benzylglyceraldehyde (52a) was used as a substrate for an E. coli 
transketolase, which was later used in a chemoenzymatic synthesis o f a novel
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glycosidase inhibitor, JV-hydroxypyrrolidine.56 A range of other R-substituted 
glycolaldehydes (Table 1.3.4) were assessed in unbuffered media by the controlled 
addition o f 1M HC1 through the use of an autotitrator, and also in O.IM-glycylglycine 
buffer (pH 7.0). The authors supplied no ee values, but it is assumed that chiral
derivatization was used to assign the D-threo or (S)-stereochemistry observed. 49
Entry Substrate Products Yield (%)
1 OH
o 42a
OH "" O
oh 44a
74 (43)
2 Me if"
I, 42c
0
Jl OH
I  44c
29 (23)
3 OH<<
------- ---- V 42*!------------
OH O
oh 44gO OfT
2 3 (1 2 ) '
42m
Ptv .0. Ph a
52a
OH O
V
(26)
76
44m
Table 1.3.4: Results of E. coli TK catalysed couplings in unbuffered medium ('yields in brackets are for 
corresponding reactions in 0.1 M glycylglycine buffer, pH 7.0)
p-HPA (1) and (±)-3-0-benzylgylceraldehyde (52a) are subjected to E. coli TK (entry 
5, Table 1.3.4) to give 5-0-benzyl-D-xylulose (44m) in 76% yield on a 2-3g scale 
(Scheme 1.3.9). This is used as a convenient starting material in the chemoenzymatic 
preparation a novel glycosidase inhibitor, A-hydroxypyrrolidine (53).56
OBn
OBrT ' Y  'H
OH 52a
53
Scheme 1.3.9: Synthesis of TV-hydroxypyrrolidine 53 using a) transketolase, TPP, Mg2", pH 7.0
The synthetic and commercial usefulness o f TK biotransformations are best 
demonstrated by the potential scale up o f Li-hydroxypyruvate (HPA) lc  as the pyruvate 
donor (Scheme 1.3.10), with achiral glycolaldehyde 42a as the aldehyde acceptor. This 
reaction with wild-type E. coli transketolase is known to have the fastest reaction rate57 
when compared with other aldehyde acceptors58 and the resulting product, L-erythulose 
44a is formed with the irreversible concomitant release of carbon dioxide.
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Scheme 1.3.10: Synthesis o f L-erythulose
The limitation of scaling these reactions, at present, is the high cost of hydroxypyruvic 
acid la , or its salt lc, due to the difficulty in its synthesis and isolation. 59,60,61 Progress 
has been made in improving the efficacy o f TK bioconversions by immobilizing E. coli 
TK onto two commercial supports Eupergit-C and Amberlite XAD-7. E. coli TK 
biotransformed Li-HPA lc  and glycolaldehyde 42a, which produced ketotriol, L- 
erythulose (44a). This was with an 80 to 100-fold improvement in the half-life of the 
immobilized TK preparations.62 Such improvements may avoid the need for reactant 
feeding strategies in subsequent reactor designs.
The synthesis of the chiral a-hydroxyketone functionality in ketotriols by TK was 
usually successful and performed in a single step biotransformation. The chemical 
synthesis of asymmetric a-hydroxyketones was also possible and is shown.
1.4 Chemical Synthesis of a -
hydroxyketones: TK alternatives
a-Hydroxyketones, whether in ketodiols or ketotriols, as discussed in the previous 
section are an important structural feature o f many biologically active molecules (See
63section 1.3). If it is possible to establish the chiral centre of an a-hydroxyketones as R 
or S , before subjecting it to chemical reductive amination or a TA bioconversion, the 
dual enzymatic or chemoenzymatic process heading towards chiral aminodiols 4 can be 
realised. Syntheses of a-hydroxyketones via other chemical routes are usually step­
intensive and challenging. The use o f organometallic reagents64,65 to produce racemic a - 
hydroxyketones is, however, known.
Bulman-Page et al., reported an asymmetric route to a-hydroxyketones using DiThiane 
OXide (DiTOX) methodology, which did not require symmetrical a-diketones as a 
precursor.66 A predecessor to this methodology used a chiral mono-dithioacetal 
sulfoxide as the enantiocontrol element in a diastereoselective reduction, but could only
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be used with symmetrical a-diketones as a precursor.67 The DiTOX methodology, 
shown in Scheme 1.4.1, relied upon hydrolysis of the dithiane 1-oxide moieties, 
produced in 3 steps, o f phenyl derivatives (54) and (55). Hydrolysis of these derivatives 
was achieved using A-bromosuccinimide (NBS)/acetone/water mixtures and gave a- 
hydroxyketones (56) and (57) with high enantioselectivities. Unfortunately the diketone 
side product (58) also resulted due to oxidation under these conditions.66
O' OH J Ph 
.St ”
54
OH
NBS Ph
3% H20/acetone
OH
55
O
56, 84% 
OH
NBS Ph
3% H20/acetone
O
57, 76%
58, 12%
58. 22%
Scheme 1.4.1: Preparation of chiral a-hydroxyketones 56 and 57
Having seen a limited synthetic method for the preparation o f chiral a-hydroxyketones 
in a relatively short number of steps, the use of TK to produce such molecules in one 
step outweigh a potentially lengthy asymmetric chemical synthesis. The formation of 
chiral a-hydroxyketones can be implemented using TK or asymmetric synthesis as 
seen, but the next section focuses on the asymmetric introduction o f nitrogen by 
transamination at the carbonyl centre of a-hydroxyketones.
1.5 Transaminase (TA)
The asymmetric synthesis of chiral amines via prochiral precursors as a strategy is
usually favoured over kinetic resolution o f enantiomers, as the theoretical yield is 
68  • •100%. The majority o f the enzymatic syntheses of chiral amines utilize hydrolases in 
kinetic resolutions.69 Amino acid dehydrogenases70, amine dehydrogenases71 or
72aminotransferases may act as biocatalysts for the synthesis of chiral aminoalcohols 
from keto alcohols. All o f these enzymes are known to convert a carbonyl group to an 
amino group, but would require genetic engineering to accept substrates other than keto 
acids or ketones. Recently, Ito et al. described an aminoalcohol dehydrogenase73 from 
genera Streptomyces, Pseudomononas, Burkholderia, and Arthobacter. In particular, a 
purified aminoalcohol dehydrogenase from Streptomyces virginiae IFO 12827 showed
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promise as a potential biocatalyst, by converting a wide range o f ketols and amines, but 
no information was available on the stereoselectivity of the reaction. Furthermore, this 
biocatalyst required cofactor recycling, a disadvantage in an industrial processes due to 
the additional cost.
Transaminases (TAs) catalyse the enzymatic amino transfer by a ping-pong bi-bi 
mechanism .72 In the first half of the reaction (Scheme 1.5.1), the amine donor is bound 
to the enzyme and the pyridoxal 5'-phosphate (PLP) coenzyme is aminated to 
pyridoxamine 5' phosphate (PMP).
Enz-PLP Schiff base -  General diamine intermediate ,  Amino acid-PLP
aldimine
Scheme 1.5.1: Transaminase mechanism I
In the second half of the reaction (Scheme 1.5.2), the transamination cycle is complete 
by transferring the amino group from the enzyme-bound PMP to the acceptor.
H
Amino acid-PLP 
aldimine Ketimine Pyridoxamine
Scheme 1.5.2: Transaminase mechanism II
TAs such as the (S)-specific co-transaminase (co-TA) from Vibrio fluvialis JS17 is 
known to catalyse the asymmetric synthesis o f chiral amines from prochiral ketones .4 
Whilst the use of an co-TA possesses advantages over a kinetic resolution, the co-TA 
reaction has an unfavourable thermodynamic equilibrium and could suffer from severe 
product inhibition. If these problems are overcome by in situ product removal4 or by 
enzyme membrane reactors , 74 TA promises to be a useful enzyme in the production of
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chiral amines and/or amino acids, as it has a broad chemoselectivity and no external 
cofactor regeneration requirements.2 This is an important issue in evaluating the cost o f 
industrial processes. 5
A report by Shin et al., shows that co-TA, using L-alanine (59, 300 mM) as an amine 
donor with acetophenone (60, 30 mM), gives (S)-a-methylbenzylamine (Y)-a-(MBA) 
11a and pyruvate 22 (Scheme 1.5.3). Yet, the concentration of (S)-a-MBA 11a formed 
is only 2.7 mM (9% of the theoretical concentration) . 74
(S)- TAm
60 11a
Scheme 1.5.3: Synthesis of (5)-a-methylbenzylamine 11a
Shin et a l , addresses this problem by the removal o f pyruvate 22 using lactate 
dehydrogenase (LDH) in a cell free extract and by using whole cells for the 
biotransformation. The whole cell reaction results in 90% and 92% reaction yields for 
formation o f (S)-a-MBA 11a, with enantiomeric excesses >99% . 4 Since this report, the 
value o f V fluvialis TA for biotechnological applications has been recognised, and 
several studies published on single step biotransformations4'74'7 ^  and multi-step 
biotransformations involving co-TAs.2'76,77
The synthesis o f enantiomerically pure trans-(\R,2R)- and cis-(\S,2R)-l-amino-2- 
indanol (Al) (61a and 61b) were afforded using lipase and co-TA as part of a 
chemoenzymatic strategy (Scheme I.5.4 . ) 77
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(1) Asymmetric Synthesis
LipaseMn(OAc)3
Amination
....mOH
Ethyl Pyruvate
(2) Kinetic Resolution
Scheme 1.5.4: Synthesis of trans-{\R,2R) and c«-(lS',2/?)-l-amino-2-indanol by lipase and co-TA
Treatment o f 1-indanone (62) and manganese(III) acetate gives 2-acetoxy indanone (63) 
in high yield. The enantioselective hydrolysis of racemic 63 is performed using Amano 
Pseudomonas lipase, yielding ketoalcohol (64). This is then subjected to an asymmetric 
transamination using V. fluvialis TA in organic solvents with ethyl pyruvate as the
• 7 7ammo acceptor and (<S)-a-MBA 11a as the amino donor. Studies of the amino donors 
are extended to include (5)-l-aminoindan, (S)-l-aminotetralin, (5)-1-methyl-3- 
phenylpropylamine and alanine 59. It was found that in non-aqueous media (S)-1- 
aminoindan has the fastest rate of reaction and proceeds with 25% conversion, yielding 
trans- 61a, in the first example o f a transamination reaction in non-aqueous media.
Reductive amination o f 64 using ammonium acetate and sodium cyanoborohydride 
yields a 1:1 diastereomeric mixture o f cis- and trans-AI 62. V. fluvialis TA is shown to 
have some selectivity towards trans-61a, but the diastereoselectivity is low. This is 
expected as there is a precedent for poor selectivity where substrates bear other 
functional groups on their (3-carbons relative to the amino group, such as 
phenylglycinol.78 Additions of y-cyclodextrin improves the enantioselectivity from 4 to 
21% ee, (though the mechanism for this is not clearly understood), yielding cis- 61b.77
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The possible development of multienzyme reactions is one o f the aims o f our work, so 
work by Kim et al., identifies that V. fluvialis TAs appears to be good candidates for the 
preparation of chiral aminoalcohols. Unfortunately, due to V. fluvialis being a highly 
toxic bacterium, TA homologues in the genomes of fully sequenced bacteria, have to be 
used instead. These allow access to a range of V . fluvialis-like TAs through a published 
protein sequence.79 Other TA homologues have also been identified.
A P-alanine: pyruvate TA homologue from Pseudomonas aerouginosa PAOl is shown 
to aminate the aliphatic ketotriol L-erythulose 44a in a de novo TK and p-Alanine:
o n  #
Pyruvate-TA pathway by the cloning and expression of the p-alamne: pyruvate TA 
homologue from Pseudomonas aerouginosa PAOl into E. coli. This means that E. coli 
would express both TK and TA at the same time. This total enzymatic synthesis 
(Scheme 1.5.5) is performed by the established biotransformation of Li-HPA (lc) with 
glycolaldehyde (42a) in the presence of TK, to give L-erythulose (44a). This then 
underwent transamination with TA in the same reaction pot and affords 2-amino-1,3,4- 
butanetriol (ABT) (65), a key component in protease inhibitor drug Nelfinavir™ (66).
44a
42a
TK OH+
OH HO. HO'
OH
OH
Amine
Me
OH PLP, TA
Ketone
NH2
NH OH
OH
65
Scheme 1.5.5: Synthetic scheme towards 2-amino-1,3,4-butanetriol (65) as a component of Nelfinavir™
(66)
The TK/TA dual plasmid E. coli strain is able to process Li-HPA (lc) and achiral 
substrate, glycolaldehyde 42a and generates L-erythulose 44a. The synthesis of 
compound 44a was possible in a one-pot process using either a lysate of the dual 
plasmid strain or unlysed cells. Unfortunately, the TA efficiency is quite low and the 
best amine donor iss (S)-a-MBA 11a. The low efficiency is attributed to long reaction
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times and the reactivity of Li-HPA lc  with both TK and TA.80 Mutagenesis o f TA and 
screening using L-erythulose 44a could be key for developing high throughput 
protocols.
Prior to this development, Hwang et al., had studied high-throughput screening methods 
for the identification o f active and enantioselective co-TAs.3 A number of high 
throughput screens utilise immunoassays, conventional chromatography (HPLC, GC), 
mass spectrometry, NMR spectrometry and UV-Vis spectrometry. Using UV-Vis 
spectrometry, the conversion of amino donors into ketones can be monitored. Addition 
o f MeOH/CuSCL to the reaction mixture leads to formation of a blue complex and easy 
quantification, using a UV-Vis spectrophotometer, is possible (Scheme 1.5.6).
o
R3 \  / - V
Y  OH
n h 2
amino acid
C uS04 / MeOH
Blue colour, 595 nm
Scheme 1.5.6: TA-catalysed reaction and spectrophotometric assay
This method is particularly effective with aromatic amino donors. Unfortunately, cupric 
sulphate solution can generate coloured complexes with any amino acid and phosphate 
buffers make it less useful in a one-pot assay method.
The potential o f using a TK/TA enzymatic pathway, along with genetic engineering and 
potential high throughput protocols, provides the opportunity for access to a number of 
chiral aminodiol synthons. These are found in many bioactive molecules and are 
presently discussed.
Transaminase
amino donor amino acceptor Ketone
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Chapter 2
2.1 Synthetic strategies to aminoalcohol 
functionalities found in bioactive 
molecules
Chiral aminoalcohols and derivatized chiral aminoalcohol motifs are present in many
• •  81 89  • • o ibiologically active molecules including alkaloids , amino sugars , enzyme inhibitors 
and antibiotics.84 Chiral aminoalcohols are easily derivatized into a number of useful 
compounds, A-protected aminoalcohols (67), oxazolidinones (68), Zus-(oxazolines) (69) 
and phosphinooxazolines (70), some o f which may be directed towards the preparation 
of bioactive molecules or used as chiral ligands in asymmetric catalysis (Figure 2.1.1).85
NHFmoc
Ri
OH
67
NH,
O
68
OH
Ph,R
R14
69 70
Figure 2.1.1: Applications of chiral aminoalcohols
Chiral aminodiols 4 are also key functional motifs and are found in a range of natural 
products (Scheme 2.1.1), including chloramphenicol (71) and thiamphenicol (72) 
antibiotics, and sphingosines (73), which are important cell membrane components. As 
outlined in the aims of this project, we are interested in synthesising chiral aminodiols 4 
via chemical, enzymatic or chemoenzymatic strategies.
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Asymmetric
synthesisChemical
NHCOCHCI2
OH OH
C
NH2
73R = N 02, 71
R = M eS02 72
Scheme 2.1.1: Possible strategies to aminodiols as bioactive molecules
The synthetic routes to selected chiral aminodiol-containing bioactive molecules 71, 72 
and 73 are discussed below as key examples o f the arduous chemical syntheses often 
required for such bioactive molecules.
2.1.1 Chloramphenicol and thiamphenicol syntheses
(2i?,3S)-Chloramphenicol 71 was isolated from Streptomyces venezuelae in 1954 and is 
one o f the first antibiotics produced in an optically active form by chemical synthesis, 
rather than fermentation techniques.86 Thiamphenicol 72, a synthetic analogue of 
chloramphenicol 71 shows antimicrobial activity against both Gram-positive and Gram- 
negative bacteria. Currently 100 tons per year of thiamphenicol 72 are produced by 
kinetic resolution.87
Chloramphenicol 71 and thiamphenicol 72 have been produced by a number of 
synthetic protocols. A cyclic iminocarbonate rearrangement is utilised by Park et al. to 
afford 71 in six steps (Scheme 2.1.2).88 One of the main problems identified by Park et 
al., is that whilst asymmetric epoxidation (AE) and aminohydroxylation (AA) (covered 
in Section 2.2) could potentially provide access to 71, poor regio- and diastereocontrol 
hindered its access. The asymmetric dihydroxylation (AD) reaction, however, is 
usually more useful in the synthesis o f anti-aminoalcohol diastereoisomers, as an extra 
stereoinversion step is required for the synthesis of sy«-aminoalcohol diastereoisomers. 
Park et al., report a rearrangement protocol, allowing divergent regiocontrol with
S 'sraaLA
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cinnamate substrates, in a synthesis towards syw-aminodiols from syw-diols in one 
step.89
AD-mix-p 
98 % (>99% ee)
O2N
1. Bu2SnO 
2. PhCH2NCS,
3. Bu4NBr
Ti(0/Pr)4
OH INNaOH OH NaBH4
CI2CHC02Me 
74%
C 0 2Et
COzEt
OH
NHCOCHCI2
Scheme 2.1.2: Synthesis of Chloramphenicol 71
Ethyl /7-nitrocinnamate ester (74) is successfully converted into (2S,3R)-diol (75) in 
98% yield and >99% ee using the AD reaction. Through a short sequence using dibutyl 
tin oxide (reflux, 24 h with Dean-Stark removal of water), benzoyl isothicyanate (reflux, 
6 h) and finally reaction with tetrabutylammonium bromide, (2S,3i?)-diol 75, via a 
cyclic iminocarbonate rearrangement, gives the syn oxazolidinone (76). The remaining 
functional group transformations are straightforward: debenzoylation of 76 under 
transesterification conditions gives oxazolidinone ester (77). Reduction of 
oxazolidinone ester 77, using sodium borohydride then gives aminoalcohol (78), which 
by hydrolysis with sodium hydroxide, gives the (*S,i?)-aminodiol (79). This is amidated 
with dichloroacetonitrile and gives chloramphenicol 71 in 30% overall yield and in 
>99% ee.88
Since this reaction, synthetic sequences have been shortened and methods changed. 
Bhaskar et al., utilise an asymmetric epoxidation (AE) reaction, but despite the 
problems previously mentioned (poor regio- and diastereocontrol), this method affords
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chloramphenicol 71 (Scheme 2.1.3) and thiamphenicol 72 (Scheme 2.1.4) in three and 
four steps, respectively.
OH OH
.CHO
CHCI2 c h c i2
NH
OH
84
OH
OH
NHCOCHC^
71
Scheme 2.1.3: Reagents and conditions: (a) Divinyl zinc, THF, Et20 , -78 °C to rt, 10 h, 72%; (b) (-)- 
DIPT, Ti(OiPr)4, TBHP, CH2C12, -20 °C, 14 h, 45%; (c) NaH, dichloroacetonitrile, CH2C12, 0 °C to rt, 1 
h, then BF3OEt2, -78 °C to rt. 3 h, 71%
4-Nitrobenzaldehyde (80) is reacted with divinylzinc to give l-(4-nitrophenyl)allyl 
alcohol (81). Allyl alcohol 81 is subjected to AE conditions (kinetic resolution) using (- 
)-diisopropyl tartarate ((-)DIPT) to yield the chiral epoxy alcohol (82) in 45% yield and 
in 95% ee. Then epoxy alcohol 82 is directly converted to chloramphenicol 71 in a one- 
pot reaction. This is achieved by treatment of the chiral epoxy alcohol 82 with 
dichloroacetonitrile in the presence o f sodium hydride, followed by an in situ epoxide 
ring-opening reaction of the resulting epoxy dichloroimidate (83) using boron 
trifluoride etherate. Excess boron trifluoride etherate complexes with oxazoline (84), 
which when hydrolysed, yields chlroamphenicol 71 in 71% yield. In an analogous 
synthesis (Scheme 2.1.4), thiamphenicol 72 is prepared in an additional step.86
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,CHO
M eS'
85
OH OH
86 R = MeS
OH
CHCI2 CHCI2
NH
OH
MeC^S' M e02S'
90
OH
NHCOCHCI2
72
Scheme 2.1.4: Reagents and conditions: (a) Vinyl magnesium bromide, THF, 0 °C to rt, 2 h, 88%; (b) 
Oxone, MeOH-H20-THF (1:1:2), 0 °C to rt, 6 h, 87%; (c) (-)-DIPT, Ti(OiPr)4, TBHP, CH2C12, -20 °C, 24 
h, 42 %; (d) NaH, dichloroacetonitrile, CH2C12, 0 °C to rt, 4 h, then BF3OEt2, -78 °C to rt, 4 h, 64%
Commercially available 4-(methylthio)benzaldehyde (85) is converted to allyl alcohol 
(86) using vinyl magnesium bromide. Oxone is used to oxidise 86 to the sulphone (87). 
The ally lie alcohol is subjected to AE conditions using (-)-DIPT to give the chiral 
epoxyalcohol (88) in 42% yield (95% ee). Using the same protocol as in Scheme 2.1.3, 
thiamphenicol 72 is obtained in 64% yield by an in situ rearrangement of compound 
(89) and its hydrolysis to oxazoline (90).86
In a different synthethic strategy, utilised by Mateus and Coelho, chloramphenicol 71 
and thiamphenicol 72, are accessible via ene-carbamates (98) and (99).90 Reaction 
(Scheme 2.1.5) of methyl acrylate with 4-nitrobenzaldehyde 80 and 4-methyl- 
sulfonylbenzaldehyde (95), in the presence o f l,4-diazabicyclo[2.2.2]octane (DABCO) 
and ultrasound, gives the adducts 91 and 92, in 97% and 95% yields, respectively. To 
facilitate the Curtius rearrangement, adducts 91 and 92 are treated with tert- 
butyldimethylsilyl triflate in dichloromethane and triethylamine to yield the silylated 
ethers (93) and (94) in almost quantitative yield. Subsequent hydrolysis of silylated 
methyl esters 93 and 94 using lithium hydroxide in a mixture of acetonitrile and water 
(1:1) at 40-50°C gives the acids (96) and (97) in 96% and 90% yields, respectively.90
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,CHO
80 R = N02 
87 R = MeS02
91 R = N02
92 R = MeS02
b,c
c o 2c h 3
OTBS
93 R = N02 Ri = C 0 2CH3
94 R = MeS02 R-i = C 02CH3
95 R = N02 Ri = C 0 2H
96 R = MeS02 Ri = C 0 2H
Scheme 2.1.5: Preparation of Baylis-Hillman adducts and hydrolysis of the ester. Reagents and 
conditions: (a) DABCO, methyl acrylate; (b)TBSOTf, CH2C12, Et3N, 0 °C to rt, 4 h, 99% (for 93 and 94); 
(c) LiOH, CH3CN:H20  (1:1), 40-50 °C, 2-4 h, 96% (for 95) and 90% (for 96)
To insert nitrogen atoms into the acids 95 and 96, ethyl chloroformate and triethylamine 
is added for 15 min at 0 °C (Scheme 2.1.6). The corresponding anhydrides are not 
isolated and are then directly treated with sodium azide in water at 0 °C for 50 min. The 
resulting mixtures are then heated at reflux in toluene to give vinyl isocyanates. These 
are heated at reflux in fe/t-butanol and form the corresponding terf-butyloxycarbonyl 
ene-carbamates (98) and (100) . 9 0
OTBS OTBS
96 R = N02
97 R = MeS02
98 R = N02
99 R = MeS02
Scheme 2.1.6: Reagents and conditions: (d) i) ethyl chloroformate, acetone, Et3N, 0°C, 15 min.; ii).
NaN3, H20 , 0°C, 50 min, then toluene, reflux, lh; iii) r-BuOH, reflux, 18 h, 52% overall yield
The hydroboration o f ene-carbamates 98 and 99 is effected by treatment with two 
boranes (borane dimethyl sulfide and 9-borobicyclo[3.3.1]nonane (9-BBN)). This is in 
the anticipation that the size o f the borane has good effects on the diastereoselectivity of 
the reaction. Ene-carbamates 98 and 99 are independently treated with borane 
dimethylsulfide and 9-BBN (Scheme 2.1.7) in THF at 0 °C for 18 h. Then sodium 
hydroxide and hydrogen peroxide are used to yield the ^/-protected aminoalcohols syn- 
(100a) and s>w-(101a). The highest syn diastereoselectivities obtained from the 
carbamates 98 and 99 are approximately 2:1 with borane dimethylsulfide. Anti isomers 
are shown as (100b) and (101b), respectively .90
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OTBS OTBS OTBS
98 R = N 02
99 R = M eS02
NHBoc
100a (syn) R = N 02 
101a (syn) R = M eS02
100b (anti) R = N 02 
101b (anti) R = M eS02
Scheme 2.1.7: Reagents and conditions: (e) i) BH3.S(CH3)2, THF, 0 °C to rt, ii) 3N NaOH, H20 2, 0 °C-rt
S>??-100a and s>??-101a are then treated with HC1 in ethyl acetate (Scheme 2.1.8) at 
room temperature for 3 h. Purification by ion exchange chromatography yields the 
corresponding £>77-aminoalcohols (102) in 98% yield and (103) in 90% yield, 
respectively. Subsequent treatment o f £>7 7 - 1 0 2  and £>77-103 with methyl dichloroacetate 
yields chloramphenicol 71 in 79% yield and thiamphenicol 72 as a racemate in 65% 
yield, respectively.
OTBS OH OH
OH
NHBoc
f OHo h  g
NHCOCHCI2n h 2
syn-100a R = N 02 syn-102 R = N 02 71 R = N 02
syn-101a R = M eS02 syn-103 R = M eS02 72 (racemic) R = M eS02
Scheme 2.1.8: Reagents and conditions: (f) ethyl acetate: HC1 (6N) (1:1), rt, 3 h, 90%; (g) methyl 
dichloroacetate, reflux, 1 h, 65%
For relatively simple bioactive aminodiols 71 and 72, the number of synthetic strategies 
and the number o f synthetic steps within each strategy highlight the benefits of 
developing shorter and more versatile reaction sequences. Furthermore, when dealing 
with more than one bioactive enantiomer, facile stereodivergent routes are sought after. 
Considering the synthetic routes towards sphingosines illustrate this point further.
2.1.2 Sphingosines
D-e^/zro-Sphingosines 73 (Figure 2.1.2) are the backbone of D-er>tf/zr0 -sphingolipids 
104. Saturated sphingolipid derivatives are known and are called, D-erythro- 
sphinganines 105 91,92 The D-erythro conformation is that found in natural sphingosines. 
All sphingosine enantiomers, however, including L-threo-13 and resultant 
sphingolipids, L-threo-104 and/or L-//2reo-sphinganine-105 are reported as potent 
inhibitors of protein kinase, as well as stimulators of DNA synthesis and cell 
proliferation.
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Sphingolipids 104 may vary at the head group Ri, and in the structure of the TV-acyl 
group, R2 . It is also possible to produce sphingolipids 104 with variations at R3 . D- 
erp/Zzro-sphingolipids 104 are important membrane components and play crucial roles 
in cell recognition events, such as growth, differentiation, the immune response and as
receptors for HIV cells lacking the CD4 receptor.93
Sphingosine 
(D-erythro-73)
NH(CO)R2
Sphingolipid
(D -e /y f /ir o -1 0 4 )
OH
Sphinganine
(D -ery th ro -1 0 5 )
OH
Sphingosine
(L-threo-73)
NH(CO)R
Sphingolipid
(L -fh r e o -1 0 4 )
NH,
Sphinganine
(L-threo-lOS)
Figure 2.1.2: Sphingosines, sphingolipids and sphinganines “
Sphingosines 73 have been the targets o f synthetic interest for several decades, but most 
strategies have relied on the chiral pool for their production. There are few suitable 
asymmetric reactions that have been used and even fewer stereodivergent synthetic 
routes .94 The common theme in the synthesis of these molecules has been to establish 
stereochemistry early on in the synthesis and then attach or manipulate at R3 . It is 
crucial that the stereochemistry at C-2 and C-3 was carefully controlled, as there are 
four possible stereoisomers, each with different bioactivities.95 Furthermore, the 
attachment o f the tail group must be considered carefully as the trans stereochemistry is 
generally required.
Sphingolipids 104 may be directly isolated from cell membranes, but they are 
heterogeneous materials where Ri, R2 and R3 vary vastly. Epimerisation of the allylic 
alcohol during isolation or manipulation occurs readily, so synthetic chemical routes are 
highly sought after for these compounds.92
Davis and Reddy utilise an enantiopure aziridine, ds-V-(/?-toluenesulfinyl)-2- 
carbomethoxyaziridine (106) in a thiamphenicol 72 synthesis (Scheme 2.1.8), which is 
first transformed by a lithium aluminium hydride reduction to the corresponding 
aziridine-2-methanol (107). Subsequent regio- and stereospecific ring opening of 107
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with p-toluenesulfonic acid and water allow access to (l^,2^)-(-)-2-am ino-l-[(4- 
methylthio)phenyl]-1,3-propanediol (108a) in a 93% chemical yield (Scheme 2.1.9); 
already identified as a key intermediate in the synthesis o f thiamphenicol 72. 
Interestingly, no (l£,2R)-(108b) is observed (Scheme 2.1.9) . 93
Ar = 4-Me2SPh
n h 2
C 0 2Me Ar CH2OH
LAH. 87% TsOH/H2Oi 5h (1R2R)-108a
\  /  \  93%
| H H | H
H
p-Tolyl ^ 0  NH2
(2S,3S)-106 (2S,3S)-107 Arv. A . .OH
OH (1 S,2R)-108b
Scheme 2.1.9: Synthetic route to (l/?,27?)-108a and (IS1,2R)~ 108b
A similar approach is used to access the sphingosine D-ery/Tzro-sphingosine 73 (where 
R 3  =  C 1 3 H 2 7 )  (Figure 2 .1 .2 ). Sulfinimine 109 is treated with the lithium enolate of 
methyl bromoacetate (Scheme 2.1.10) at -78 °C and gives (2i?,37?)-(-)-aziridine 110, 
which acts as a common intermediate, allowing access to both D-erythro-(13) and L- 
threo-(73) . 9 3 '9 6
OMe
p-Tolyl
109
OLi
p-Tolyl
Scheme 2.1.10: Synthesis of aziridine 110
Treatment of 110 (Scheme 2.1.11) with acetone/TFA/water gives the (3-hydroxy-a- 
amino acid ester (111) as a single isomer in 72% yield. Reduction of 111 with lithium 
borohydride yields L-r/zreo-sphingosine-(73).
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p-Tolyl
(2R,3R)-110
CC^Me
NHC(0)CF3
C02Me
OH
112
OH L-threo-Ti
NHC(0)CF3
OH 115
OH D-erythro-73
Scheme 2.1.11: Reagents and conditions: (a) 50% aq. TFA/acetone, 0 °C, 24 h, 72%; (b) TFAA/CH2C12, 
35 °C, 15 min., radial chromatography, 59%; (c) LiBH4/MeOH, rt., 30 min, 80%; (d) LiBH4/MeOH, rt., 1 
h, 71%; (e) K2C 0 3/Et0H, 50 °C, 5 h, 75%
Treatment o f 110 with trifluoroacetic anhydride (Scheme 2.1.11) results in the 
unexpected formation of aminoalcohol (112) with 8 8 % erythro diastereoselectivity. 
Usually, formation of erythro-112 requires nucleophilic attack from the same side as the 
departing amino group. Rationalisation of this step is that an activated sulfoxide 
complex (113) is formed (Figure 2.1.3) and undergoes a stereospecific [3,3]-sigmatropic 
rearrangement of the trifluoromethyl acetoxy group to a developing carbocation of the 
ion pair (114). The aziridine ^/-activating group that promotes the ring opening is 
identified as the amino-sulfonium salt.93
113 114
Figure 2.1.3: Stereospecific [3,3]-sigmatropic rearrangement of the trifluoromethyl acetoxy group in 113
to a developing carbocation of the ion pair 114
Reduction o f 112 is achieved using lithium borohydride, as before (Scheme 2.1.11), 
yielding 115. Hydrolysis of A^-trifluoroacetyl group from aminoalcohol (115) is 
achieved using potassium carbonate in ethanol at 50 °C and gives D-erythro-13. So far, 
this covers only two sphingosine enantiomers, D-erythro-13 and L-Z/zreo-sphingosine- 
73.
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Olofsson and Somfai have developed a divergent strategy to produce all eight isomers 
o f sphingosines, 73 and their regioisomers ent-(13) (Figure 2.1.4) . 94
OHOHOH OHOH OH OHOH
|H;
NHNH.NH2 n h 2
Sphingosine
ent-(D-threo)-73
Sphingosine
ent-(L-erythro)-72
NH2NH- OHOHOH NH2 OH
13m27
OHOHOH OH
Sphingosine
ent-(D-erythro)-7Z
Figure 2.1.4: All possible regio- and stereoisomers of sphingosines
The synthetic strategy employed by Olofsson and Somfai starts from the commercially 
available tetradecanol (116) (Scheme 2.1.12). A 2-iodoxybenzoic acid (IBX) promoted 
oxidation of 116, followed by a modified Homer-Emmons reaction with triethyl 
phosphonocrotonate leads to diene ester (117). Reduction of this ester with DIBAL 
gives the dienol (118). This is then benzylated using sodium hydride, benzyl bromide 
and phase transfer reagent, tetrabutylammonium iodide and gives diene (119). Diene 
119 undergoes a Shi epoxidation using catalyst (120) to give common precursors, vinyl 
epoxides (121) and (122) in a 1:1 ratio. Selective ring-opening of 122 yields L-erythro- 
(123) and D -threo-(\23), benzyl protected versions of L-erythro-13  and D-threo-13 , 
respectively. Ring closure o f L-erythro-123  and D-threo-123  to aziridine (124), act as a 
common precursor for the selective ring-opening to D-erythro-(123) and L-threo-(123), 
benzyl protected versions o f D-erythro-13  and L-threo-13 , respectively.94
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C 1 3 H 2 7
C 13H27
’selective opening
OH
BnO'
NH-
OH
BnO'
BnO Cl3H27
BnO'
OH
BnO'
L-tfwso-123OH
Scheme 2.1.12: Reagents and conditions: (a) i) IBX/DMSO, 90 min rt; ii) LiOH.H20 , triethyl 
phosphonocrotonate, THF, 2.5 h; (b) DIBAL/CH2C12, -40 °C, 59%; (c) NaH, Bu4NI, BnBr, THF, reflux, 
80 min, 95%; (d) DMM, MeCN, Na2B4O7.10H2O, Bu4NHS04, cat. 120, Oxone in EDTA, K2C 03, H20 , 
90 min, 90%
Vinyl epoxide 122 is heated in ammonium hydroxide at 125 °C giving a 
diastereospecific (>20:1) and regiospeciflc opening at the allylic position in 98 % yield. 
Even though vinyl epoxides 121 and 122 are formed in a 1:1 ratio, separating the two 
diminishes the yield of L-ery/Ztro-aminoalcohol 123 and D-//?reo-aminoalcohol 123. 
Fortunately, the crude vinyl epoxides 121 and 122 can be reacted together, as only 122 
undergoes ring-opening. L-erythro-aminoa\coho\ 123 is achieved using an aminolysis 
protocol (Scheme 2.1.12) . 94
A Pd(0)-catalysed ring-opening (Scheme 2.1.13) of vinyl epoxide 122 in the presence of 
tosyl isocyanate, yields oxazolidinone 126.
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a
BnO'BnO'
122
NTs 126
0
BnO'
NH 127
NH2
BnO 'CnH27
OH L-tfueo-123
Scheme 2.1.13: Reagents and conditions: (a) Pd (0), TsNCO; (b) Na, naphthalene; (c) KOH, A
Detosylation o f 126 is achieved by titration at -78  °C of sodium naphthalide to yield 
oxazolidinone (127) in 8 8 % yield. Finally, basic hydrolysis with potassium hydroxide 
yields L-threo-122>, in 98 % yield. Even though 121 and 122 are vinyl epoxides formed 
in a 1:1 ratio, separating the two diminishes the yield. Fortunately, the crude vinyl 
epoxide 121 and 122 can be reacted together, as only 122 epoxidises forming the 
oxazolidinone 126, which allows ease of separation in the purification stage o f this
reaction 94
Benzyl-protected D-erythro-sphingosinQ  125 and benzyl-protected L-/7?reo-sphingosine 
125 (Scheme 2.1.12) are regioisomers o f the aminoalcohols L-erythro-123  and L-threo- 
123, respectively. These are accessible via  vinyl aziridine 124. The L-erythro- 
aminoalcohol 123 is ring closed under Mitsunobu conditions to yield vinyl aziridine 124 
(Scheme 2.1.14).94
C 13H27
OH \.-erythro-MZ 124 NH2 D-erythro-M3
Scheme 2.1.14: Reagents and conditions: (a) PPh3, DIAD; (b) TFA
Treatment of aziridine 124 with trifluoroacetic acid allow access to D-erythro-123  in 
high diastereo- and regioselectivity (>2 0 :1 ) in 62% yield.
Synthesis of benzyl-protected L-Z/zreo-sphingosine (123) is shown in Scheme 2.1.15.
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BnO C 1 3 H 2 7  ^
a
BnO
b
C 1 3 H 2 7
124 0 128
OH
BnO'
N,
V
,0 129  BnO
C
C 13H27
NHAc 130
OH
d
BnO C 1 3 H 2 7
n h 2 D -f/7reo-123
Scheme 2.1.15: Reagents and conditions: (a) reduced DIAD, Et3N, DMAP, -78 °C, Ac20 ; (b) BF3.OEt7; 
(c) H20 ; (d) H2S 04
Acetylation of aziridine 124 occurs in almost quantitative yield to give acetylated amino 
aziridine (128). This is then rearranged to oxazoline (129) using boron trifluoride 
etherate, followed by an in situ hydrolysis of 129 to hydroxyamide (130). A high 
diastereoselectivity (de >20:1) and regioselectivity (>20:1) is achieved. Hydroxyamide 
130 is hydrolysed with 5% aqueous sulphuric acid and gives the D-Z/zreo-aminoalcohol 
123 in good yield.94
All of the benzylated aminoalcohols of 123 are converted into their corresponding 
sphingosines 73 using sodium in liquid ammonia in excellent yields. The corresponding 
regioisomers (ent-73) could be obtained by starting with en t-l22 (Scheme 2.1.12).94
Enders et al., describes the asymmetric synthesis of 2-amino-1,3-diols and d-erythro- 
sphinganine 105 (Scheme 2.1.16) using RAMP-hydrazone methodology.97,98
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H3u  'CH3 (R)-131
c=> c=> c=> c=>
47%
(7steps)
rrr.
n h 3+ c f 3c o 2-
O h (2R,3S)-105 de > 96%, ee  >96%
n-Ci3H27
a, b 
96%
g, 87%
Ri R1 32
h3g ch3
c 63%
h 3c  c h 3
(
(R)-132 Rv R2 = 0 (2R,3S)-134R1 = H, R2 = N3
c, 98% f, 91%
(2R,3R)-133 R-| = OH , R2 =H (2R,3S)-135 R1 = H ,R 2 = NH2
Scheme 2.1.16: Reagents and conditions: (a) /BuLi, THF, -78 °C, then pentadecyl bromide, -100 °C; (b) 
aq. Oxalic acid; (c) L-selectride®, THF, -78 °C; (d) MsCl, CH2C12, Et3N, -0 °C -> rt.;(e) NaN3, 18-crown- 
6, DMF, 100 °C; (f) LAH, THF, rt.; (g) TFA, THF/H20 , rt.
In the first step, hydrazone (7?)-(131) is alkylated with pentadecyl bromide (Scheme 
2.1.16). Subsequently, the hydrazone is cleaved with a saturated solution of oxalic acid. 
From this, ketone (i?)-(132) is obtained in an excellent 96% yield and ee (>96%). 
Subsequent reduction with L-selectride® gives alcohol (2jR,37?)-(133) in a practically 
quantitative 98% yield and very high diastereoselectivity (de >96%). Treatment of 133 
with methanesulfonyl chloride yields the corresponding mesylate, which is then 
converted to the azide (2i?,3S)-(134) by nucleophilic substitution. Reduction of 134 
with LAH, yields amine (135), which followed by hydrolytic cleavage o f the acetonide 
group with TFA in THF/water affords the ammonium salt (2R,3S)-105 in an overall 
47% yield , a de of >96% and an ee o f >96%.
There is a possibility of simplifying the asymmetric synthesis of aminodiols seen above 
by introducing two chiral centres simultaneously, but this requires a separate discussion, 
as follows.
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2.2 Sharpless Asymmetric 
Aminohydroxyiation (AA)
Synthetic routes to aminoalcohols can require arduous protecting group strategies and 
require numerous synthetic steps, as previously discussed vide supra. The Sharpless 
asymmetric aminohydroxyiation (AA) has significant potential in synthesis due to its 
ability to set up two chiral centres in a single step.
The aminohydroxyiation of olefins dates back to the 1970s," but the Sharpless 
asymmetric aminohydroxyiation (AA) was not discovered until 1996100, when the same 
research group used osmium tetroxide, a chinchona alkaloid derived ligand, typically
l,4-£A(dihydroquinyl)phthalazine (DHQ)2PHAL 136a, or 1,4-
bis(dihydroquinidinyl)phthalazine (DHQD)2PHAL 136b and 1,4-
T>A(dihydroquinyl)anthraquinone (DHQ)2AQN 137a or 1,4-
h/s(dihydroquinidinyl)anthraquinone (DHQD)2AQN 137b with an oxidant and a
nitrogen source. These components would then convert /nms-alkenes to TV-protected 
aminoalcohols with good regio- and enantioselectivities. The typical reaction protocol 
used in the AA transformation is shown in Scheme 2.2.1.101
XNCINa or AcNBrLi
K20 s 0 2(0H )4 (4 mol %) ^HX QH OH
DHQ\D2PHALorDHQ\D2AQN (5 mol%) |  f  |
0 °C or room temp 
X = Ts, Ms, Cbz, Boc, TeOC, Ac
OAlk =
MeO.
DHQ (a)
-OMe
DHQD (b)
OAlk (a) or (b) OAlk (a) or (b)
PHAL 136a or b AQN 137a orb
OAlk (a) or (b) OAlk (a) or (b)
Scheme 2.2.1: Overview of the Sharpless asymmetric amino hydroxylation (AA).101
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It is by an appropriate choice of alkaloid ligands 136 or 137, that the regio- and 
enantioselectivity of this reaction could be controlled to a certain degree.101 The main 
problems with this reaction are identified as:
• Selectivities (chemo-, regio, and enantioselectivities);
• Substrate scope;
• Formation of an unwanted diol product and
• Activity of the catalyst.102
Despite these problems, the AA transformation plays a key role in the synthesis of many 
important biological molecules, including amino cyclitols, the Taxol™ side chain, p- 
amino-a-hydroxyphosphonic acid derivatives and a-amino acids.101,103
The following sections highlight how altering various components of this reaction have 
an effect on the regio- and enantioselectivities, and how the problems encountered have 
been overcome; but first a consideration of the mechanism is important in defining how 
the two chiral centres are established.
2.2.1 Mechanism
The predecessor to the AA transformation is the asymmetric dihydroxylation reaction 
(AD), which is similar to the AA mechanism, shown below in Scheme 2.2.2.101
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NHXHO
high ee SECONDARY CYCLE
NX
O s = 0
N-X 138CIN DX R 02C :os'Ar
PRIMARY CYCLE
142
143
/Os—O 
0 ^ \ \
I N-X 139
C 0 2R
Os,
140
Os
141
NHXHO
low ee
Scheme 2.2.2: AA catalytic cycles.
The formation of an imidotrioxoosmium(VIII) (138) species results from the reaction of 
osmium tetroxide with an appropriate nitrogen source.101 The chiral ligand L, is 
coordinated and forms the active complex (139). An osmaazetidine (140) is then 
afforded. This subsequently undergoes a 1,2-migration of the carbon-osmium bond and 
gives the azaglycolate adduct (141). Displacement of the chiral ligand L by another 
nitrogen reagent results in species (142). It is at this point that hydrolysis by solvents 
containing 50% water (v/v) can release the aminoalcohol with high enantioselectivities 
(primary cycle) and regenerate 138, or could result in the unwanted diol formation 
(Scheme 2.2.1). Often alcohol-water mixtures are used to reduce the hydrolysis and 
hence the diol product. Otherwise, the secondary catalytic cycle is initiated by reaction 
with another alkene, forming complex (143) and releasing the aminoalcohol with low 
enantioselectivity.101
The point of controversy is whether 142 is achieved through a [2+2] cycloaddition, or is 
directly achieved through a [3+2] cycloaddition (Scheme 2.2.2). Whilst weight is 
lended to the [3+2] cycloaddition, through kinetic isotope effects104 and theoretical 
calculations hypotheses104, the dual cycles represented (Scheme 2.2.2) give an overall 
account.105
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Effective AA reactions result from the suppression of the secondary catalytic cycle, 
which relies on the effective hydrolysis o f 142. The diol formation is problematic as 
although less water in the reaction decreases the formation of diol by-products, water is 
also required to speed the hydrolysis of 142 to aminoalcohols in high enantiomeric 
excesses.
The second catalytic cycle is, however, considered important by Wu et a l, to give 
aminohydroxyiation products with good to moderate enantioselectivities, without the 
need o f chiral cinchona ligands for a range o f substrates. By considering the osmium 
azaglycolate species (144) (Figure 2.2.1), through X-ray crystallography, the second 
catalytic cycle is exploited. This means no diol is formed, appreciably quicker 
turnovers occur, higher yields occur and lower osmium catalyst loadings are required.106
—N//(„
<  > NV 1 1% 144
Figure 2.2.1: Osmium 6/5(azaglycolate) complex 144105
Complex 144 has a greater steric hindrance along the path by which water is needed to 
approach the only open coordination site of osmium. This is to initiate the hydrolysis 
step. The hydrophobic pockets created by the two-tosyl groups may also slow the 
approach of water. The tosyl groups are pointing “down” and around the vacant 
coordination site. These features generally explain the observation that catalytic 
aminohydroxyiation (AA) is slower than its asymmetric dihydroxylation (AD) 
counterpart.
Janda et al., study the active catalytic species o f the AA reaction with cinchona derived 
ligands and confirm the possibility that a substrate-based method can be used to control 
the regioselectivity imposed on unsymmetrical alkenes. This is achieveable by having 
an understanding of the active species (145) (Scheme 2.2.3). For example, when 
considering the (DHDQ^PHAL 136b (Scheme 2.2.1), Janda et al., shows that the 
regioselectivity of the reaction could be inferred from the catalyst-substrate complex, 
and is termed either mode A  or B  (Scheme 2.2.3) depending on the substrate used.107
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146
MeO..OMe
'a , N
t - n
o
NHAc
N ---
mode A
ps
OH
NHAc
mode B
Ps
OH
Scheme 2.2.3: Proposed structure of the Ac-N =0s0 3-(DHQD)2PHAL catalyst.
Sharma et a l , investigates the steric, electronic and substrate-catalyst shape with a 
range of alkenes 146a-g to support the concept o f “pre-programming” the 
regioselectivity of the reaction (Table 2.2.1).107
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NHAc
R1
r 2 AA
146a-g
Entry
with (DHQD)2PHAL 136b
OH
R2
R1
OH
147a-g
R2
NHAc
148a-g
Alkene Regioselectivity (147a-g: 148a-g)
R 1 = H, R2 =fj’ti
\(S ,0—Si-
146a
Ri = Et, R2 =Ph
* ,0—Si-
R ,  = H, R2 = C 0 2Et 
R 1 = Me, R2 = C 0 2Et
R t = H, R2 =
o.
Ri = Me, R2 —
Ri -  Et, R2 —
146b
146c
146d
OMe
146e
OMe
146f
146g
> 20 .0:1
2 . 0:1
15.2:1
1.4:1
1 .2:1
1:3.2
1:3.5
Table 2.2.1: AA reaction with selected olefins
The sterically demanding olefins 146a and 146b are shown not to fit the relatively 
narrow U-shaped binding pocket of the catalyst and the preferred mode A. Whereas R2
groups from (147a) and (147b) are directed towards the solvent (Scheme 2.2.3). 107
The electronic influence on the regiochemistry is exhibited by the alkenes 146c and 
146d, where the nucleophilic nitrogen ligand o f the osmium complex prefers to add to 
the more electrophilic p-carbon o f the a,p-unsaturated ester and to the oxygen to the a - 
carbon atom. It is thought that the polar ester group would be more stable in the 
hydrophilic environment and lead to mode A (Scheme 2.2.3) products (147c-d).107
Finally, it is noted by Janda et a l, that the subtle interplay between substrate-catalyst 
bindings results in the regioselectivities seen when alkenes 146e-146g are reacted to 
give products (147e-g). Yet, if steric effects are the only issue, mode A would be 
preferred due to the large p-methoxyphenoxy moieties, but the regioselectivity favours
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mode B (148f-g), as aryl-aryl interactions between the substrate and catalyst-binding 
cleft may prevail over such steric interactions. Other examples are reported, but the 
problem of regioselective control is non-trivial and can sometimes be difficult to 
rationalise.107
Sharpless et al., performs an investigation using an anthraquinone core (AQN) 137 
(Scheme 2.2.1) and finds a reversal in the regioselectivities with various methyl 
cinnamate precursors. This is linked to the electronic effects displayed by varying the R 
groups on methyl cinnamate ester. The typical reaction protocol involves the
o
carbamate modification (Scheme 2.2.4).
,C 0 2Me
CbzNCINa 
cat. [Os] 
cat. L*
NHCbz
C 0 2Me
NHCbz
C 02Me
OAlk*
O OAlk*OAlk*
LIGAND AQN PHAL
A B
Scheme 2.2.4: AA of cinnamates [L* = dihydroquinyl (DHQ) or -dihydroquinidinyl (DHQD)]8
(DHQ)2PHAL 136a core gives the corresponding 3-phenylisoserine regiosisomers A. It 
is found that by using A-chloro-A-sodio benzylcarbamates as the nitrogen source, 3- 
phenylserine regioisomer B (Scheme 2.2.4) is favoured when the (DHQ/D)2AQN 
137a/b core are used (Table 2.2.2).8,108
Entry R B:A (DHQ)2AQN 137a 
Ee (yield)/% 
of (2R,3S)-B
(DHQD)2AQN 
137b Ee 
(yield)/% 
of (2S,3R)-B
1 H 79: 21 95 (58) 92 (62)
2 4-F 82: 18 91 (67) 92 (68)
3 4-CI 77: 23 91 (58) 92 (54)
4 4-Br 80: 20 89 (51) 89 (52)
5 4-M e 78: 22 93 (n. d.) 96 (52)
6 4-M eO 78: 22 94 (67) 93 (65)
7 2,6-(M eO)2 75: 25 91 (50) 91 (51)
8 4-BnO 66: 34 87 (40) 87 (40)
Table 2.2.2: AA of R-substituted methyl p-cinnamate esters using CbzNCINa.8
Sharpless et al., find from these results that cinnamates act as a good model for SAA 
reactions, with resulting high asymmetric inductions and a good reversal in
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regioselectivity from 3-phenylisoserine enantiomers A to 3-phenylserine enantiomers B 
(Table 2.2.2). The electronic ring effect, due to the nature of either electron donating or 
electron withdrawing substituents at the p-position o f cinnamate methyl ester, results in 
a variety o f 3-phenylserine enantiomers. The regioisomeric ratio is as high as 82:18 
(entry 2).
The reversal in regioselectivity is not fully explained, but it is theorized that the 
substrate orientation within the binding pockets of these ligands is altered in such a way 
that, whilst the regioselectivity was reversed, enantioselectivities o f the AA 
transformation remain high.8
A complete study on the electronic effects on the regio- and enantioselectivity of the 
AA of O-substituted 4-hydroxyl-2-butenoates is also known, in an attempt to 
understand the aromatic-aromatic interactions.107 These are crucial in achieving high 
regio- and enantioselectivities with this class of substrates and investigates a range of 
electron donating/withdrawing groups.109
Finally an analysis of the by-products may aid a further insight into understanding the 
reaction mechanism. Recently, Liu et al., describe the by-products from the reaction of 
cinnamates with tert-butoxy carbamate as the nitrogen source and with (DHQD^PFIAL 
136b.110 Cinnamate precursor (149) undergioes AA and gives the expected enantiomers 
(150) and (151) (Scheme 2.2.5). Careful analysis of this reaction mixture, however, lead 
to the identification of aldehyde (152), acid (153), and novel a ,a -d i-tert- 
butyloxycarbamoyl-p-ketone ester (154). The ratio of these compounds is found to be 
time dependent. Prolonged reaction times lead to increased formation of side products 
152-154.110
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OMe
OPr1
C02Me 149
5 mol% (DHQD)2PHAL 
137b
4 mol% K20 s0 2(0H)4 
nPrOH-H20, 10 °C, 1 h
OMe
.OPH
OMe OMe
152 R = H, 7%
153 R = OH, 2%
OPr'.OPr'.
+
BocHN,HO,
OHNHBoc
C02Me 1 5 1 ,1 1 %COzMe 150 ,70%
OMe
+
BocHN.
BocHN'
C02Me 154, 4%
OMe
OPH.
+
HO,
OH
Scheme 2.2.5: By-products analysis
The origin of the by-product 154 is elucidated by resubmitting aminoalcohols 150 and 
151 and the diol (155) back into the reaction. Transesterification o f the methyl ester to 
a propyl ester by the solvent results in the formation of 4 methoxy-3,5-diisopropyloxy 
benzoic acid 153 in all o f these reactions; but 4-methoxy-3,5- 
diisopropyloxybenzaldehyde 152 only results from the diol 155. Ketone ester 154 is 
only formed from p-hydroxy-a-amino ester 151 (Scheme 2.2.6).110
OMe
OPr'-
BocHN
COOMe 151
OMe
OPr1
fBuOCONNaCI 
5 mol% (DHQD)2PHAL
4 mol% K20 s0 2(0H )4 
nPrOH-H20 ,  10 °C, 3 h  
conversion: 30%
OPr1.
BocHN.
BocHN'
COOMe 154, 69%
Scheme 2.2.6: Formation of ketone ester 154
Mechanistic implications arising from these observations (Scheme 2.2.7) are that an 
oxidation of benzylic alcohol 151 followed by TV-chlorination of 154 gives intermediate 
(156). Deprotonation and elimination o f chloride from compound 156 lead to the 
formation o f imine (157). Nucleophilic addition of tert-buty\ carbamidate anion onto 
the resulting imine gives compound 153. Two possible accounts for this are that N- 
chloro, A-sodio carbamate acts as a chloronium ion, as a base and then as a nucleophile. 
Alternatively, the enolization of p-keto ester 154 followed by another AA reaction on
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the resultant enolate (158), leads to the intermediate (159), which on hydrolysis forms 
154.110
The overall process (Scheme 2.2.7), however, is attributed to oxidation o f the benzylic 
alcohol to the ketone, which is initiated by the complex formed between osmium 
tetroxide and JV-chloro-A-sodio tert-\mty\ carbamate. Though studies are complete with 
(DHQD)2PHAL 136b ligand, implications for the mechanism with ligands 
[(DHQ)2AQN 137a & (DHQD)2AQN) 137b] and the 3-phenylserine enantiomers
7 o
concur with the literature results, generally showing a lower yield. ’ The partial 
decomposition of the enantiomers following the pathway shown in Scheme 2.2.7 may 
account for this reduced yield.
OMe OMe
OPr'- OPr1. .OPr*
fBuOCONNaCI
HO. BocHN,
NHBoc
BocHN
COOMe COOMe
151 153
OPr'. .OPr* .OPr1
BocN. BocN.
COOMe COOMe
OMe OMe
OPr*. .OPr*.OPr*
154
OH
BocHN BocHN,
ONaONa
BocHN
COOMe COOMe
158 159
Scheme 2.2.7: Mechanistic implications of resubmitting 151 to Sharpless AA conditions
The nature o f the nitrogen source may have mechanistic implications itself, by its size 
and electronic effects, but none of these are mentioned in the above discussion. What 
follows now is a brief overview of the many nitrogen sources that have been used in the 
A A reaction.
2.2.2 Nitrogen sources
Sharpless AA reactions are successfully performed with a number of nitrogen sources 
and substrates. Such nitrogen sources include, aminoheterocycles111, carbamates112, 
primary amides113 and sulfonamides114. Each o f the following examples provides a way
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of controlling enantio- and regioselectivities in the final product by their size or 
electronic effects.
2.2.2.1 Aminoheterocycles
A-chloro-A-sodio salts o f adenine derivatives are found to be suitable nitrogen sources 
for the Sharpless AA transformation, achieving suprafacial, vicinal addition of adenine 
and a hydroxyl group, but unfortunately not in a regio- or enantioselective fashion.111 
Dress et al., report that the poor reactivity and side reactions, such as ring chlorination 
have prevented the use of heterocyclic compounds in the Sharpless AA, but good 
reactivity is found between three derivatized adenosine molecules. These are labelled 
Ri = A, B and C (below). Three alkenes, 1,2-dihydronapthalene (160), 2-methyl-1- 
phenyl- 1-propene (162) and 1,2-diphenyl ethene (164) are reacted with A, B and C, as 
summarized in Table 2.2.3.
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TBDMSO.TBDMSO.NHAd = NH2
,Ov /^w
NR.
alkene 160
1. f-BuOCI cat. K20 s 0 2(0H)4
alkenes 160,162 & 164
2. NaOH
162
NHAd
Products 162a-c, 
164a-c&  
165a-c.
164
NHAd NHAd
kOH NHAd
OH
OH
165A-C163A-C
AdNH2 Alkene product % yield
A 160 161A 79
B 160 161B 68
C 160 161C 71
A 162 163 A 75
B 162 163B 64
C 162 163C 58
A 164 165 A 83
B 164 165B 76
C 164 165C 65
Table 2.2.3: Aminohydroxylations with adenine derivatives.1
Dress et al., notes that the only regioisomer produced is where the N6-adenine nitrogen 
is in the benzylic position (161, 163 & 165). The Ri substituent on the adenine 
derivatives has no effects on the regio- or diastereoselectivities o f the reaction. The 
addition o f (DHQ^PHAL 136a does not result in any particular asymmetric induction 
in the products.111 Whilst this is a good nitrogen source for producing high 
regioselectivities, though these are not reported, the enantioselectivities are poor, and 
therefore other TV-chloro-A-sodio salts are investigated, as follows.
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2.2.2.2 N-chloro-N-sodio-carbamates
The use of carbamates in the Sharpless AA transformations of styrene (166) and 2- 
chlorostyrene (168) show that ter/-butyl carbamate formation results in fair yields, but 
with high enantioselectivities for the resulting phenylglycinols (167a-c) and (169a-c).115 
/-Butyl carbamate is compared to ethyl carbamate and benzyl carbamate. The main 
difficulty seen with this reaction protocol is that careful column chromatography is 
needed to separate the regioisomers from the excess carbamate used in the reaction. 
The resultant A-Boc protected aminoalcohols 167a-c and 169a-c have the advantage 
that A-deprotection is usually straightforward (Table 2.2.4).115
o
m ethods (a-c) RO2CNH2)
3 .05  eq NaOH, 3 .05  eq fBuOCI 
4 mol %
K20 s0 2(0H)4
Method ( a ) : 3:1 eq B n 0 2CNH2, 5 mol% ligand, 1:1
nPrOH-water, 0 °C, 1.5 - 4 .5  h
Method (b) 3:1 eq E t0 2CNH2, 5 mol% ligand, 1:1
nPrOH-water, 0 °C, 0.5  - 3.5  h
Method (c) 3:1 eq tB u 0 2CNH2, 5 mol% ligand, 1 :1
nPrOH-water, 0 °C, 1 h
Ar Alkene Method Ligand 
136a or 136b
R Product Yield
(%)
Ee
(%)
Ph 166 a (DHQ)2PHAL
136a
Bn (S)-167a 8 -
Ph 166 b (DHQD)2PHAL
136b
Et (R)-167b 44 88
Ph 166 c 136a fBu (S)-167c 58 94
2-CIC6H4 168 a 136b Bn (R)-169a 0 -
2-CIC6H4 168 b 136b Et (R)-169b 44 84
2-CIC6H4 168 c 136a fBu (S)-169c 41 92
Table 2.2.4: AA of styrenes using Benzyl, Ethyl and t-Butyl Carbamates."5
O’ Brien et al., conclude from these results (Table 2.2.4) that the regioselectivity o f the 
reaction is ligand dependent, with better regioselectivities and higher yields being 
obtained by using (DHQ)2PHAL 136a rather than (DHQD)2PHAL 136b. Yet, 
enantioselectivities are not ligand dependent for this nitrogen source with styrene 
precursors 166 and 168. A-chloro-A-sodio salts can induce high level o f asymmetric 
induction, where the size of the R group does not appear to have much effect. The next 
section shows carboxamide nitrogen sources, which usually form A-bromolithium salts 
and can act as both the oxidant and the nitrogen source in the Sharpless AA. This does 
not occur with A-halocarbamate salts, which require an external oxidant.115
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2.2.2.3 Carboxamide nitrogen sources
Alternative nitrogen sources include the primary amides. In particular, N- 
bromoacetamide is the only commercially available nitrogen source, but Sharpless et 
al., report the facile monobromination of a variety of primary amides and their 
subsequent use in the Sharpless AA transformation. This moves away from the use of 
tert-butyl hypochlorite, an oxidant used with A-halocarbamate nitrogen sources. The 
reason for this move is because tert-butyl hypocholorite is difficult to synthesize, 
difficult to store on a large scale and is photosensitive.113 Instead, Gottardi reports the 
use o f dibromoisocyanuric acid (DBI),116 which proves to be an efficient brominating 
agent (90-99% conversion), allowing the synthesis o f a multitude of amides. These 
amides subsequently act as nitrogen sources for the AA reaction with isopropyl 
cinnamate (170) and the results are summarized below in Table 2.2.5.
o
170 fBuOH:H20  2:3 
4.4% K20 s 0 4.2H20  
4.0  % (DHQ)2PHAL
OH 171a-f
Entry Bromoacetamide
Ra-f
T(°C) Conversion
(%)
Yield
171a-f
(%)
E e  (%) Regio­
selectivity
1 a) CH3CH2CH2 4 96 94 95 21: 1
2 b) CICH2 10 86 75 95 23: 1
3 c) Bn 4 81 76 93 12: 1
4 d) C6H12 4 84 71 80 20: 1
5 e) Ph 4 50 38 77 2.0: 1
6 f) 4-(M eO)Ph 0 70 42 43 2.5: 1
Table 2.2.5: AA of isopropyl cinnamate 170 using various amides as the nitrogen source." ’
Sharpless et al., report that aliphatic amides (entries 1-2) are good nitrogen sources with 
isopropyl cinnamate, resulting in >95% conversions to the corresponding p- 
hydroxyamides (171a-b). Steric hindrance by large amide nitrogen sources (entries 3 
and 4) has little effect on yields or enantioselectivities. Yet aromatic amides (entries 5 
and 6 give low yields, regioselectivities and enantioselectivities.
In an investigation of the stereoelectronic effects of the AA reaction, Sharpless et al., 
show that electron-deficient carboxamides react more slowly, but do not undergo 
Hoffman rearrangements. This means that higher temperatures could be used in the 
reaction. Unfortunately, the diol by-product contamination is considered a problem, as
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it is difficult to remove by column chromatography and becomes a major product when 
altering the chloro-group of the acetamide to more electron-deficient halogens. 
Electron-rich amides react faster, but decompose more readily and so lower 
temperatures are required to circumvent this problem. When isopropyl cinnamate 170 
is used, products are obtained in high regioselectivities, probably due to favourable 
aromatic interactions in the binding pocket. Styrene and styrene derivatives, however, 
react well, giving high enantioselectivities, but poor to moderate regioselectivities. This 
highlights again that the AA reaction is partly dependent on the substrate type.113
Despite some of the problems encountered with this nitrogen source, its ease of 
removal, using thiourea, was considered an attractive option for accessing amino 
alcohols.117
The above studies of primary amides include aliphatic, cyclic and aromatic groups, 
whilst the next section shows the use of an aliphatic sulfonamide. This has different 
stereoelectronic properties to the above carboxamide and warrantes a separate 
discussion, as its synthesis is non-trivial.
2.2.2.4 Sulfonamides
The synthesis of /crt-buty 1 sulfonamide (Scheme 2.2.8), as an efficient nitrogen source 
and terminal oxidant for the catalytic AA of alkenes is now described. Usually, alkyl or 
aryl sulfonyl groups require harsh deprotection conditions,118 but tert-butyl 
sulfonamide, which is difficult to synthesize (as the intermediates are explosive) is 
removed under fairly mild acidic conditions. This makes its use as an attractive reagent 
towards synthesising aminoalcohols.
o 9
f-Bu H20 2 /A cO H or f-Bu 11 S 0 2CI2
S^ S\  TBHP, VO(acac)2 cat. S S\  CH2CI2, 0 °C / S\ .
172 f‘Bu 173 r-Bu [- f-BuSCI] t-Bu Cl
O' O
174
0
_NH3 .  ,S+ [Ox] y KlL1 NaOH.f-BuOCI I I  .  ,
/  \  ---------------------------§ -----  2-------------------------- ► f-Bu----- S ----- N' Na
t- Bu NH2 || || \ _
O o Cl
175 176 177
Scheme 2.2.8: Synthesis of sulfonamide 177
Bis-tert-butyl disulfide (172) is reacted with hydrogen peroxide and is subsequently 
oxidized, forming compound (173). This is reacted with sulfonyl chloride and gives
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terZ-butylsulfinyl chloride (174), which when reacted with ammonia forms tert-
114butylsulfinylamine (175). Subsequent oxidation with a range o f oxidants lead 
directly to tert-buXylsulfonamide (176), which is treated with tert-butyl hypochlorite and 
sodium hydroxide yielding the corresponding chloramine salt, (177).
Sharpless et al., then uses nitrogen source 177 in an AA reaction involving a,p~ 
unsaturated amides. It is noted that this class of compound has the highest turnover 
rates, chemoselectivities, and yields than any other alkene used with the Sharpless AA. 
The results of this study are summarized in Table 2.2.6.
Bus-N‘CINa+
K20 s 0 2(0H )4 
(0.5 mol %) 
f-BuOH-H20  1:1 
r.t., 12 h
NHBus N'
OH
OH
+
NHBus
BusHN
Entry Starting Alkene, Rj & R2
R i  = Ph, R2 = OM e 
R : = H, R2 = Me 
Ri = Pr, R2 = Me 
R 1 = m-Xyl, R2 = Me 
R 1 = NQ2Ph, R2 = Me
Yield (%) Regioisomer ratio A:B
93 
84 
91 
82
94
3.3: 1 
A only 
2.5: 1 
4.5: 1 
1.5: 1.
Table 2.2.6: AA of a,P-Unsaturated Amides 114
The results show (Table 2.2.6) that all of the yields (82-94%), whether having electron- 
donating groups (entry 1-4) or electron-withdrawing groups (entry 5) are high. The 
regioselectivities of the reaction are moderate, except for where electron-withdrawing 
groups are used, (entry 5) which is low.
All o f the above reactions seen in this section are under homogeneous catalytic 
conditions. To improve the efficiency o f this reaction, solid support catalysis is now 
considered in terms of chemical yield, regioselectivities and enantioselectivities. A 
variety of nitrogen sources are seen here, but the most attractive nitrogen source appears 
to be the carboxamides and is presently discussed.
2.2.3 Solid Support Catalysis
Heterogenization of AA transformations allows for the separation o f chiral products, 
whilst using only small quantities of catalyst and thus presents an obvious industrial 
advantage.119 At present, homogeneous reactions using osmium tetroxide on a large
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scale are unfeasible due to its volatility and toxicity. Moreover, the use o f osmium and
120 121chiral alkaloid ligands are uneconomical in large scale processes. ’ In an attempt to 
overcome these problems, the use of solid-supported catalysts for Sharpless AA has 
been considered by a number of research groups. The first example envisages the use of 
a silica gel-supported (SGS) Zu's-chinchona alkaloid (Figure 2.2.2), [SGS-(QN)2PHAL 
(178)] to convert rrans-cinnamate derivatives.122
Silica
Figure 2.2.2: SGS Zus-chinchona alkaloid 178
When SGS-(QN)2PHAL, 178 is used with osmium tetroxide, excellent 
enantioselectivities are observed in the asymmetric dihydroxylation (AD) o f trans- 
cinnamate derivatives. When applied to the asymmetric aminohydroxylation (AA) 
transformation with the same cinnamate derivatives, using ethyl carbamate or acetamide 
and under homogeneous reaction conditions;123,124 all with SGS-(QN)2PHAL, 178, 
excellent enantioselectivities and yields are observed. The results o f these AA 
transformations are summarized in Table 2.2.7 for a variety o f cinnamates.
NH
Ligand 178 OR2
K20 s 0 2(0H )4 
R3C(0)NHX, [OH]- 
solvent
OH
R
OR2
R
170 Rt = H, R2 = /-Pr 179 R1 = H, R2 = /-Pr, R3 = Me
180 R, = N 02, R2 = /-Pr 181 Ri = n 0 2. R2 = /-pr. r 3 = Me
182 Rt = H, R2 = Me 188 R1 = H, R2 = Me, R3 = OEt
184 R, = OMe, R2 = Me 185 R1 = 0M e' R2 = Me' R3 = 0Et
186 R1 = N 02, R2 = Me 187 R1 = N0 2, R2 = Me, R3 = OEt
Table 2.2.7: Heterogeneous catalytic A A using SGS-(QN)2PHAL 178
Entry Substrate Oxidant Solvent t(h) Product
Yield
(%)
Ee
(%)
(2 R, 
3 S)
1 170 AcNBrLi t- BuOH- 
H20
7 179 (71) >99
2 180 AcNBrLi f-BuOH-
H20
7 181 (30) >99
3 182 EtOCONCINa /- PrOH- 
H20
12 183 (40) 88
4 184 EtOCONCINa /- PrOH- 
H20
12 185 (43) 92
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5 186 EtOCONCINa CH3CN- 12 187 (52) 92
_____________________________________________ H2O______________________________
Song et al. note that the use o f 7V-bromoacetamide as the nitrogen source (entries 1 and 
2) with cinnamate 170 gives amidoalcohol (179) in high yields and enantioselectivity. 
Electron withdrawing cinnamate (180) gives amidoalcohol (181) in low yield, but in 
high enantioselectivity. On changing to ethyl carbamate (entries 3-5), cinnamates with 
different electronic properties (182), where R = H, gives TV-protected aminoalcohol 
(183) in reasonable yield and high enantioselectivity. When electron-donating 
cinnamate (184) gives TV-protected aminoalcohol (185), it is in a lower yield than 184, 
which is suprising. Interestingly, methyl p-nitrocinnamate (186) gives TV-protected 
aminoalcohol (187) in a higher yield than both 185 and 186. Despite decreases in 
yields, all of the enantioselectivities are high.
The main advantage of this method is that the osmium complex 178 is recovered by 
filtration after each reaction. Unfortunately, when the catalyst was studied using XPS 
(X-Ray Photoelectron Spectroscopy), up to 50% of the catalyst has been lost to the
reaction mixture. The repeated use of the catalyst has seen reduced yields, but similarly
122high enantioselectivities, making the low yields a limitation to its use in industry.
A different approach to solid support catalysis involving osmium tetroxide (OSO4) in an
ion-exchange technique using (layered double hydroxide) LDH-supported OSO4 is
x+reported. LDH, a class o f layered material consists o f cationic M(II)i.xM(III)x(OH )2 
and anionic An'.zH2 0  layers. Mgi_xAlx(OH)2(Cl)x.zH2 0  is synthesised and has been 
used in the Sharpless AA reaction using various substrates, resulting in moderate yields 
and enantioselectivities. These results are summarized below in Table 2.2.8.119
LDH-0s0 4, OH
(DHQ)2PHAL, f
R2 Chloramine- T 1. r 2
Ri ~ Rf
NHTs
Table 2.2.8: AA of alkenes with LDH-0s04
Entry Substrate Isolated yield
(%)
E e  (%)
1 R1 = Ph, R" = C 0 2Me 55 78
2 R1 = CH3, R2 = C 0 2Me 50 72
3 r 1 =  ph, R2 = Ph 45 60
4 C yclohexene 50 40
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Unfortunately this method is not particularly successful (Table 2.2.8), mainly due to the 
diol-by-product being formed in significant quantities, thus lowering the isolated yield 
o f the products (entries 1-4). Furthermore, osmium leaching occurs. Choudary et al., 
find that adding the oxidant slowly did not improve the ability to recycle this catalyst.119
Finally, Song et al, show promising results using osmylated macroporous resins which 
they had previous used in the asymmetric dihydroxylation of alkenes. These are more 
effective than any of the solid-supports outlined above.125 By immobilizing osmium 
tetroxide onto resins bearing vinyl groups such as Amberlite™ XAD-4, XAD-7 and 
XAD-16 (Scheme 2.2.9), osmium exists as both an Os(VI) monoglycolate and 
Os(IV)/}fsglycolate. This makes the osmium non-volatile, air stable and easier to handle 
compared with solid osmium tetroxide.120
0s04
fBuOH/HzO (v/v=1:1)
XAD-4 or XAD-16 
(white resin)
X A D-4-0S04 or X A D -16-0s04 
(black resin)
Scheme 2.2.9: Osmylated macroporous resin
The main problem, that has hindered the development of all the solid-supports, is 
osmium leaching. This example, unfortunately, is no exception. Nevertheless, the 
catalyst is recovered easily by filtration, but when the osmylated resins are recovered, 
osmium leaching results in decreased turnover rates after three successive uses. The 
results are summarized in Table 2.2.9 where 1,2-diphenyl ethene 164, styrene 166 and 
isopropyl cinnamate 170 are used as substrates.120
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Entry Resin- Substrates Products Time Regio- Ee Yield 
Os   (h) selectivity (%) (%)
XAD-4 TFFTPh"
164
24 88 48
XAD-16 PhPh"
164
188
NHAc 24 90 41
XAD-4
XAD-16
XAD-4
166
166
h/ ^ " c°2'Pr
170
pit"
188
189
189
NHAc
5.6:1
5.2:1
> 20:1
84 39
84 40
>99 93
XAD-16
170
190
NHAc
190
> 20:1 >99 90
Table 2.2.9: Acetamide-based AA of various alkenes using XAD-4 or XAD-16-Os complex3
The results (Table 2.2.9), using various osmylated resins, works well with all o f the 
substrates. 1,2-Diphenyl ethene 164 (entries 1 & 2) is converted to amidoalcohol (188) 
in moderate yields, moderate regioselectivites and high enantioselectivities. Styrene 
166 (entries 3 & 4) give amidoalcohol (189) in moderate yields, but with high 
enantioselectivities. Isopropyl cinnamate 170 (entries 5 and 6 ), however, performs the 
best and gives amidoalcohol (190) in excellent yields, regio- and enantioselectivities
Song et a l, hypothesise that the osmium anchored to the resins is highly exposed to the 
oxidant and as a result, it reacts more readily with the substrate and (DHQ^PHAL 136a 
in solution. Once the alkenes are consumed, the residual osmium is then trapped back 
on to the less accessible resin-bound vinyl groups. Unfortunately, osmium leaching is a 
problem in this reaction, but Song et al., state that future optimisation o f these reaction 
conditions should overcome this caveat, in what is otherwise, the most successful form 
o f solid-support catalysis for the Sharpless AA transformation seen thus far.
3 All reactions were performed on a 1 mmol scale using 4 mol% o f  Amberlte X AD-4.O s04 or Amberlite X A D -1 6 .0 s0 4, 5 mol% o f  
(DHQ)2PHAL,136a AcNHBr (1.1 mmol) and LiOH (1.02 mmol) in t-BuOH-H?0 (v/v = 1 : 1 ) .
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Results and Discussion 
Chapter 3
3.1 Transketolase Donor Synthesis
This chapter describes the synthesis o f the transketolase donor, shown in (Figure 3.1.1), 
hydroxypyruvate (1) and the methods used heading towards the synthesis of a series of 
novel nitrogen-containing pyruvate donors, 3-azidopyruvate 5a, 3-aminopyruvate 5b, 3- 
cyanopyruvate 5c and 3-phthalimido
o
0
Tk donors
Figure 3.1.1: TK donors
3.1.1 Hydroxypyruvate (HPA)
Hydroxypyruvate (HPA) 1 has been used in the past as a TK donor, but more recently, 
other donors including 3-halopyruvates have been tested for chemoselectivity with TK, 
as part o f the collaboration between chemistry and biochemical engineering. Whilst TK 
accepts a range of substituted alkyl aldehydes, particularly a-hydroxylated aldehyde 
acceptors, the donor substrates are still limited to HPA-1. Previously, HPA (la-c) has 
been employed in three forms in the TK biotransformations as:
1. Hydroxypyruvic acid HPA la; This was obtained via an ion exchange column 
from the lithium salt lc . 57
2. Potassium (K)-HPA (lb ); This was obtained from the reaction o f potassium 
hydroxide with bromopyruvic acid.49
3. Lithium (Li)-HPA lc; This was obtained from the reaction o f lithium hydroxide
with bromopyruvic acid.54
(Phth-) pyruvate 5d.
' >
X = 1a OH; free acid
b K+ salt
c Li+ salt
5a N3
5b NH2 0
5c CN
5d Phth — ►
w
0
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Whilst hydroxypyruvic acid HPA la  and Li-HPA lc  are commercially available, the 
cost is high for large-scale investigaions (£36.80 per gram for hydroxypyruvic acid la  
and £30.20 per gram for Li-HPA lc). Moreover, the commercial supply is not always 
reliable.5 The K-HPA lb  and Li-HPA lc  salts are therefore prepared, as they could be 
readily converted to the free acid l a  by ion exchange, if required.
We initially direct our attempts towards the synthesis of K-HPA lb, as better yields 
(36%; >95% purity) and solubilities (39g/L of reaction volume for K-HPA lb  c/T8 g/L 
for lithium Li-HPA lc) are reported for K-HPA lb . 4 9
Potassium hydroxide is added to bromopyruvic acid (191) and then reacts (Scheme 
3.1.1) until a steady pH of 9 is obtained using an autotitrator. Subsequent addition o f 
acetic acid to adjust the pH to 5.0 and removal o f the aqueous layer at 50 °C by rotary 
evaporation should yield pure K-HPA lb. Yet, *H NMR spectroscopic and HPLC 
analyses show this protocol to be ineffective and low yielding. A large-scale (20-30 g) 
preparation of K-HPA lb  leads to the formation of potassium bromopyruvate (192a), as 
identified by HPLCC (ret. time 9.1 min)d when compared with an authentic sample o f K- 
HPA lb  (ret. time (8.3 min).e lH NMR spectroscopic analysis also shows the tendancy 
of K-HPA lb  to exist in equilibrium with the potassium gem -diol (Id). The methylene 
protons of lb  resonate at 8 3.71 ppm and those of the potassium gem -diol at 8 4.61 ppm.
(i) KOH (5M), pH = 9.0 
or LiOH (1M), pH = 9.0 
by autotitration
(ii) AcOH pH = 5.0
OM
192a K+ 
192b Li+
O 1b K
OM OM
M = K+ or Li+
1d K+
1e Li+
Scheme 3.1.1: Synthesis of hydroxypyruvate salt lb  and lc  
Despite the significant precedent of the use o f Li-HPA lc  in TK biotransformations, a
f
protocol for its synthesis is developed due to the lack of experimental details 
available.49,55’56,57,62 This is attempted in our lab and the reaction is followed by HPLC.a 
After each hour, an aliquot of reaction mixture is removed and frozen. It is found that
b Fluka chemicals made this on a supply and demand basis only 
c HPLC analysis courtesy of Sean Costello, Biochemical engineering 
d Aminex 87H (300 x 7.8mm), 0.1%TFA (0.6mL min'1) 
e Sample obtained from Fluka chemicals 
Dr M.E.B Smith (Postdoctorate within our collaboration)
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after 3 h, there is no evidence of bromopyruvic acid 191 present, even though the
autotitrator has not reached a steady pH of 9.0. Beyond 4 h, significant levels o f lithium 
bromopyruvate (192b) are formed and so the optimal time is between 3-3.5 h 
maximum. Heat is considered as possibly aiding the formation o f 192b and
accelerating decarboxylation. Hence, the aqueous solution is concentrated in vacuo 
using a high-vacuum Buchi® until crystals are seeded. The concentrated reaction 
mixture is left to crystallise overnight and crystals are collected by vacuum filtration, 
yielding lithium HPA lc  in 30% yield and 95% purity. The lithium gem -diol version 
(le) is also identified by *H NMR spectroscopic analysis. Further attempts to obtain 
crystals from the mother liquor are unsuccessful.
In an attempt to improve upon this protocol, it is envisaged that protection of the 
carboxyl group of bromopyruvic acid 191 by esterification could prevent
decarboxylation and may also serve as a common precursor for the synthesis o f other 
nitrogen-containing pyruvate donors, namely azidopyruvate (5a) and aminopyruvate 
(5b). This could be achieved by nucleophilic substitution (Scheme 3.1.2) and 
subsequent ester hydrolysis. Fischer esterification conditions are reported by Noguchi 
for acid catalysed esterification of 191, but these fail to yield the methyl ester (193).126 
This is likely to be due to the increased rate of decarboxylation versus the formation of 
gem -diol Id.
o
o
1c X = OH, R = Li+ 
5a X = N3, R = Li+
5b X = NH2, R = H
Scheme 3.1.2: Reagents and conditions (a): Me0H/H2S04, rt and reflux; (b) Br2, N2
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Another pathway includes the reaction of methyl pyruvate (194) with molecular 
bromine at room temperature and yield 193 (and 193a) in 77% yield and a 1:1 ratio, as 
shown by lH NMR spectroscopic analysis. Subsequent nucleophilic substitution with 
lithium hydroxide fails to yield Li-HPA lc. It is likely that the base sensitivity o f this 
compound encourages polymerisation as a side reaction.
3.1.2 Azidopyruvate
Two main methods were explored for the synthesis of azidopyruvate 5a (Scheme 3.1.2). 
These included nucleophilic substitution and oxidation of a secondary alcohol 
precursor. Azidopyruvate 5a was a synthetic precursor to aminopyruvate 5b, but could 
potentially be an interesting donor for TK and/or its mutants. Azide compounds are 
known to have rich reaction chemistry (Figure 3.1.2) and can give clean high yielding
• 197reactions usually with few side products.
RNCO
isocyan ates triazoles
RCOCItetrazoles RCN
RX
R nh2 am inesHN
hydrolysis
R N = P ( C 6H5)3 ____
im inophosphoranes
h2n Azidoamines
H0 Azidoalcohols
Figure 3.1.2: Azide reactions
3.1.2.1 Substitution methodology
The reactions between bromopyruvic acid 191 and its methyl ester 193 with sodium 
azide are initially explored in a variety o f solvents and at different temperatures (Table 
3.1.1).
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o
see table for conditions
0 0
191 R = H 5a R = H
193 R = Me 195 R = Me
Entry Temperature (°C) Solvent
1 -78 EtOH/H20
2 0 EtOH/H20
3 +4 EtOH/H20
4 R oom  te m p e ra tu re 1 EtOH/H20
5 +4 DMF
6 R oom  te m p e ra tu re 1 DMF
7 +4 DMF/CH2CI22
8 Room  te m p e ra tu re 1 d m f /c h 2c i22
9 + 4 MeOH
10 Room  te m p e ra tu re 1 MeOH
1Room temperature (20 °C), 2CH2CI2/DMF (1:1) v/v; 31 mmol sc a le  
Table 3.1.1: Reaction conditions for attempted synthesis of azidopyruvate 5a
Bromopyruvic acid 191 is subjected to sodium azide at a range of temperatures (-78 °C 
to room temperature, entries 1-4). At these reaction temperatures and in ethanol/water 
(a common mixed solvent used for azide substitution, 128,129’130,131,132 no reaction is 
observed by TLC analysis. Mass spectrometry and !H NMR spectroscopic analyses are 
also used on both occasions, but no molecular ions or discernible product signals are 
observed from the crude reaction mixture. Using the ethanol/water mixture as a 
reaction solvent may cause formation of hydrazoic acid (HN3). In all reactions (entries 
1-4), a polymerisation may have occurred due to the high molecular ion peaks [M+ = 
456] being observed. Ester 193, is reacted under the same reaction conditions (entries 
1-4), but did not yield methyl azidopyruvate ester (195).
Attempts to investigate solvent effects on the reaction with bromopyruvic acid 191 or its 
methyl ester 193 are then conducted. N ,N -dimethylformamide (DMF) (entries 5 & 6 ) 
and a mixture of DMF/CH2CI2 solvents are used (entries 7 & 8 ), as these solvents have 
also been used in azide substitution reactions. 133,134 Finally, methanol is used135 (entries 
9 & 10), but unfortunately the change of solvent systems has no effect on the outcome 
of the reaction and no azidopyruvate 5a or its methyl ester 195 is achieved under these 
reaction conditions.
Nucleophilic substitution is successful when the carbonyl centre of eythl bromopyruvate 
(196) (commercially available) is reduced to the bromohydroxy ethyl ester (197) in 65%
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yield (Scheme 3.1.3). This is achieved using sodium cyanoborohydride in a methanol-
i T/r
hydrochloric acid mixture.
ba
OEtOEtOEt
OHOHO
196 197 198
Scheme 3.1.3: Reagents and conditions (a) NaCNBH3, MeOH-HCl, pH 4, bromocresol green, 65%; (b) 
NaN3, H20/EtOH (1:1, v/v), reflux, 44%
A reduction is also attempted using sodium borohydride with 196, but interestingly 
reduction of both carbonyl groups occurs. Bromohydroxy 197 is then treated with 
sodium azide to give the hydroxyazido ethyl ester (198) in 44% yield. This serves as a 
secondary alcohol precursor for the oxidation to an a-keto ester.
3.1.2.2 Oxidation of secondary alcohol precursors
Hydroxyazido ethyl ester 198 is subjected to a number o f suitable oxidation methods 
(Table 3.1.2) in the presence of the azide functionality, in an attempt to synthesise the 
azido a-keto ethyl ester (199).
o o
OH O
198 199
Entry Oxidants and conditions Reaction outcome
1 TEMPO, trichloroisocyanuric acid, NO REACTION
Me2CO, N aH C 0 3
2 PCC, EtOAc, (rt and reflux) NO REACTION
3 Swern: DMSO, Et3N, NO REACTION
Oxalyl chloride, CH2CI2
4 C r0 3, H2S 0 4, M e2CO, 60  °C NO REACTION
Table 3.1.2: Oxidations attempted with a-hydroxyester 198
The first attempt (entry 1) at this oxidation is with trichlorocyanuric acid/TEMPO under 
mild reaction conditions. This method was previously reported for the conversion 
(Scheme 3.1.4) of diol (200) into the a-keto acid (201).137 No reaction is observed by 
TLC analysis and by NMR spectroscopic analysis.
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0H TEMPO,
trichlorisocyanuric acid) 
NaHC03 
NaBr,
Me2CO
.OH
201
Scheme 3.1.4: TEMPO Oxidation
The use o f a pyridinium chlorochromate (PCC) oxidation (entry 2), known to convert a - 
hydroxyesters to a-ketoesters138 is attempted, but no reaction is observed. Similarly, no 
reaction is observed when Swem139 conditions (entry 3) are used. Finally, Kayser et al., 
report using chromic acid at 60 °C (Scheme 3.1.5) for converting a-hydroxyester (202) 
to a-ketoester (203), which has a similar carbon framework (highlighted) to yield the 
desired azidopyruvate ethyl ester 199.
OH
202 203
Scheme 3.1.5: Chromic acid oxidation
A reaction is observed by TLC analysis and a change o f colour associated with Cr(VI) 
to Cr(III) reduction (orange to green) is also observed when we react hydroxyazido 199 
under these conditions. NMR spectroscopic analysis also shows a singlet signal at 5 
3.93 ppm, which is consistent with the methylene protons of 199. Disappointingly, only 
one carbonyl group for the ethyl ester is observed in the 13C NMR spectrum at 6 172 
ppm. In order to simplify the number of signals in the ]H NMR spectroscopic analysis, 
a change of the hydroxyazido ethyl ester 198 to the methyl ester is sought after, so that 
some o f these oxidation protocols could be repeated.
As previously seen (Scheme 3.1.3), it is possible to obtain the ethyl ester 198 in 44% 
yield by a substitution method. Yet, a number of oxidation protocols followed are 
previously reported for reactions involving a-hydroxy methylesters to a-keto 
methylesters. Epoxidation of methyl acrylate (204)140,141 and ring-opening reactions 
involves epoxide methyl ester (205) and are used to access hydroxyazido methyl ester 
(206) (Scheme 3.1.6).142
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o o o
Scheme 3.1.6: Reagents and conditions (a) NaOCl (7%), NaHC03 (aq), C 0 2(s), 13%; (b) NaN3, MeOH, 
NH4C1, reflux, 56%
Methyl acrylate 204 is successfully converted to epoxide 205 using sodium hypochlorite 
and sodium bicarbonate, albeit in a low 13% yield. Methyl acrylate 204, however, is 
cheap and the reaction is carried out on a large scale (20-25 g). Nucleophilic oxidants 
are normally required for the epoxidation o f electron-deficient olefins and hydrogen 
peroxide with bases such as sodium hydroxide, sodium carbonate and potassium 
hydroxide are often used.143 This protocol is favoured over a Jacobsen-type 
epoxidation,144 which we also utilise (though on a smaller scale ca 1 g), mainly due to 
cost of the transition metal catalyst (manganese trimethyl 1,4,7-triazacyclononane). 
Despite being a high yielding reaction (85% yield), scale up reactions would be too 
costly and yields may not be as reliable.
The ring-opening of epoxide 205 (Scheme 3.1.6) is attempted using eerie ammonium 
nitrate (CAN) in f-butyl alcohol with sodium azide at 50 °C, as reported in the 
literature.142 The yield of this reaction, however, is only 15% after purification. 
Therefore, a different reaction protocol is explored. Epoxide 205 is treated with sodium 
azide and ammonium chloride in methanol. The reaction mixture is heated at reflux. 
After purification by column chromatography, hydroxyazido methyl ester 206 is 
obtained in 56% yield.
Azido alcohol methyl ester 206 is subjected to Jones’ reagent in sulphuric acid at 60 °C 
in acetone, but no reaction is observed by TLC analysis and no colour change occurs. It 
is likely that in the previous case, ethyl ester 199 may have contained a minor unknown 
impurity, which results in the signal being observed from the !H NMR spectroscopic 
analysis. Finally, a Dess-Martin periodinane reaction is attempted with 206 to yield the 
azidopyruvate methylester 195 (Table 3.1.1), but no reaction is observed by TLC 
analysis.145 At this point an enzymatic oxidation method is explored to access 195.
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3.1.2.3 Biotransformation using a reversed equilibrium lactate 
dehydrogenase (LDH) with alcohol dehydrogenase
Lactate dehydrogenase (LDH) is a key enzyme used in energy metabolism which 
catalyses the reversible oxidation o f lactate (207) to pyruvate 22 (Scheme 3.1.7), with 
the concomitant reduction o f NAD+. In muscles (when oxygen levels are low) pyruvate 
22 from glycolysis is converted by LDH to lactate 207. This is then secreted into the 
blood and transported to the liver where LDH converts lactate 207 back to pyruvate 22. 
Pyruvate 22 is mainly converted back to glucose via gluconeogenesis. This cycle 
allows the muscle to keep producing energy (via glycolysis) under high load.
NAD+ NADH + H+
lactate 207 NAD+ NADH + H+ pyruvate 22
Scheme 3.1.7: Reversible oxidation of pyruvate to lactate
In an attempt to favour the oxidation equilibrium, a dual enzyme system is envisaged 
using lactate dehydrogenase and alcohol dehydrogenase in a one-pot biotransformation. 
Alcohol dehydrogenases are commonly used in biotransformations to reduce ketones to 
chiral alcohols and to regenerate NAD+.52 We attempt to set up a cofactor recycling 
system (Scheme 3.1.8), whereby NAD+ could be regenerated. Ester hydrolysis of 
methyl ester 206 with lithium hydroxide affords azido a-hydroxyacid (208) in 60% 
yield. Oxidation of a-hydroxyacid 208 with lactate dehydrogenase LDH in a synthesis 
towards azidopyruvate 5a is attempted.
OH
alcohol
dehydrogenase 210209
NAD+ NADH + H+O
i) LiOH/MeOH
 0°C r
ii) citric acid, pH 3.0 
60%
OMe OHOH
Lactate dehydrogenase
OH 206 OH 208
Scheme 3.1.8: Enzyme cofactor regeneration
3-Azido-2-hydroxy-propionic acid 208 in water/acetone at pH 7 (adjusted using sodium 
hydroxide) is added to a dehydrogenase mixture consisting of lactate dehydrogenase 
(LDH) (2.18 mg, 2000U), alcohol dehydrogenase (4.43 mg, 2000U) and NADH (20 
mg) in tris(hydroxymethyl)aminomethane (TRIS) (50 mM, pH 7.0, 2 mL). The 
dehydrogenase mix is added to the stirred solution and the reaction mixture is
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maintained at pH 7.0 using a pH stat autotitrator. Alcohol dehydrogenase is added to 
convert acetone (209) to isopropyl alcohol (210), whilst regenerating a source of NAD+. 
After 3 h, a small aliquot was taken (5 mL) into ethyl acetate, dried and evaporated in 
vacuo. Unfortunately, !H NMR spectroscopic analysis shows the quantitative recovery 
of starting material 208.
In order to explain these observations, an oxidation reaction is sought after from the 
literature with a similar carbon framework in mind. Hoffman et al., describe the 
substitution of nosylate ester (211) with sodium azide, which results in the formation of 
the gem-diol (212), but no azide substitution occurs (Scheme 3.1.9) to give a-ketoester 
(213).146
Ns = p-nitrobenzenesulfonyl
ONs ONs
Ph Ph
OEt
HO' OH
211 212NaN3 N 
Me2CO 
anhydrous 
77% Ph
OEt
O
OEt
HO 'OH
213
Scheme 3.1.9: Formation of ge/w-diol instead of azide substitution
Trace water present in the acetone solvent is believed to react faster at the carbonyl 
center than the sodium azide is able displace the nosylate group. When the reaction is 
repeated in dry acetone, Hofmann et al., access the desired a-azido ketoester 213 in 
77% yield. The inherent instability of 213 is noted and reaction times are critical. After 
7 h, the extent of conversion of the starting material 211 to the product 213 versus 
decomposition pathways is optimal. Whereas, after 4 h, only half o f 211 is converted to 
213, over 11 h complete consumption o f the starting material 2 1 1  is observed. 
Evidence of the decomposition products (not described) after 11 h superseded the 
formation of 213.146 Hoffman’s et al., observations support the idea that reactions 
toward azidopyruvate 5a and/or its esters 195 and 199 result in unknown polymerisation 
reactions.
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3.1.3 Aminopyruvate
Bromopyruvic acid 191 is treated with sodium azide in ethanol and then 
triphenylphosphine is added for an attempted in situ Staudinger reduction of 3- 
azidopyruvate 5a. Although the reaction temperature increases, aminopyruvate 5b is 
not observed (Scheme 3.1.10). It is likely that the rate of nucleophilic substitution and 
its polymerisation pathways occur more rapidly than the reduction o f azidopyruvate 5a 
to aminopyruvate 5b.
NaN3, 
EtOH, 
PPh3, 
Water (cat)
Scheme 3.1.10: Attempted in situ Staudinger reduction of azidopyruvate 5a
Different methods are explored to synthesise aminopyruvate 5b. Cooper and Meister 
previously report its formation in an investigation of co-transaminases.147 A reaction 
(Scheme 3.1.11) between L-albizziin (L-a-amino-p-ureidopropionic acid) (214), a 
glutamine analogue and sodium glyoxylate (215) in the presence o f co-transaminases, 
amide (216) is formed. This is then treated with co-amidase, but does not yield the 
expected product, p-A-carboxy derivative (217). Instead, a spontaneous 
decarboxylation reaction occurs resulting in the formation of aminopyruvate 5b . 147
co-transaminase co-amidase 
n h 2 ---------------►
Scheme 3.1.11: Enzymatic route to aminopyruvate 5b
Although no characterisation data is provided for 5b, the following inference supports 
its formation. Cooper and Meister describe a number of control experiments, which 
show no reaction when selectively omitting any component. Treatment o f albizziin 214 
in the presence of pyruvate 22 with glutamine transaminase and co-amidase form 5b 
directly. This is supported by the fact that after incubation, the reaction mixture is
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adjusted to pH 4.0 and is then treated with hydrogen peroxide (1M). An aliquot is then 
subjected to paper chromatography which shows the formation o f glycine (the expected 
product between aminopyruvate 5b and hydrogen peroxide), but no glycine is formed in
3.1.3.1 Oxidation of secondary alcohols
3-Amino-1,2-propane diol (218) is reacted (Scheme 3.1.12) with benzyl carbamate to 
give A-Cbz-protected (219) in 37% yield. An attempt to utilise TEMPO oxidation, 
known to convert a similar 1,2 propane diol directly to the a-keto ester, is utilised 
(Scheme 3.1.4) in attempt to obtain a-ketoester (220), but only provides carboxylic acid 
(221) in 10% yield.
Scheme 3.1.12: TEMPO Oxidation
This route is abandoned and the oxidation of a-hydroxy acid 221 is not attempted due to 
the low 10 % yield obtained.
In an attempt to utilise hydroxyazido ethyl ester 198 and methyl ester 206 further, a 
Staudinger reduction (Scheme 3.1.13) followed by hydrogenation over a 
palladium/carbon catalyst is attempted. Unfortunately, the Staudinger reduction is 
unsuccessful and aminohydroxy ethyl ester (222) and methyl ester (223), for oxidation 
to aminopyruvate 5a remain inaccessible. This means a different method is sought, one 
capable o f protecting the highly reactive functional groups in aminopyruvate 5b, but 
also allowing ease of their removal.
control studies with reaction mixtures lacking the co-amidase.147
CbzCI,
NaOH,
TEMPO, 
trichlorisocyanuric acid
CbzHN CbzHN.
NaHCOs
NaBr,
Me2CO o 220 , 0%
+
OH
CbzHN,
O 221,10%
O O
OH OH
198 R = Et 
206 R = Me
222 R = Et
223 R = Me
Scheme 3.1.13: Staudinger reduction of azide using triphenylphosphine
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3 . 1 . 3 . 2  C a r b e n e  m e t h o d  t o w a r d s  a m i n o p y r u v a t e
A method for protecting all the reactive functional groups is provided by Nandra et al., 
after their reactions (Scheme 3.1.14) using rhodium(II)-catalysed olefination of tertiary 
formamides (224) with a silylated diazoester (225). These provide vinylogous
carbamates (226) instead of anticipated ring expanded products. 148
H NRtRz
224
N2j r
T E S " X 0 2Et
225
Rh(ll)acetate,
PhCH3
reflux
58%
R2RiN
C 0 2Et deprotection
H2N
COzH
OTES
226
O
5b
Scheme 3.1.14: Conversion of formamides to vinylogous carbamates
As seen (Scheme 3.1.14), the vinylogous carbamate 226 is essentially a “protected” 3- 
aminopyruvate 5b. By selective deprotection of the TES group, favourable ketol-enol 
tautomerisation equilibrium should favour the a-keto functionality, seen in 5b. The 
deprotection (R1R2) on the nitrogen atom of 226, should then allow access to the amino 
functionality in 5b. Finally, hydrolysis of the ester 226 should provide the carboxylic 
acid functionality seen in 5b.
Using this approach (Scheme 3.1.15), dibenzylamine (227) is reacted with ethyl formate 
(228) and heated at reflux to yield N J f  -dibenzyl formamide (229) in an excellent 90% 
yield. Diazoester (230) is treated with triethylsilyl triflate and N yN r- 
diisopropylethylamine at -78 °C to give the silylated diazoester 225 in 79% yield. 
Silylated diazoester 225 is reacted with N J f  -dibenzyl formamide 229 in the presence of 
rhodium(II) acetate, heating at reflux. This gives the vinylogous carbamate (231) in 
58% yield.148
NH(Bn)2
227
COjEt
230
0
h A j b
228
0  229
1
H N(Bn)2reflux, 90%
TESOTf, +
iPr2NEt, N2
1! 225
-78°C, Et20  
79%
II
TES COjEt
Rh(ll)Ac,
PhCH3
reflux
58%
XOzEt
(BnfeN'
OTES
231
Scheme 3.1.15: Synthesis o f vinylogous carbamate 231
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The mechanism for the formation of vinylogous carbamate 231 is postulated by Nandra 
et al., and is seen below (Scheme 3.1.16).
SiEt3
(Bn)2N ^ °  .  |Rh|^ \ c02B - < B ^ ^ O _ C 0 2E,
229 232 233 |
SiEt3
   / V "
235 (Bn)2N/  234 S,Et3
Scheme 3.1.16: Proposed course of the olefination reaction
Reaction of diazo species 225 with the metal catalyst formed a rhodium carbene species 
(232), which is transferred the carbene moiety to the carbonyl group of 229. This gives 
the carbonyl ylid (233). An intramolecular reaction forms epoxide (234), which is ring- 
opened to give zwitteriton (235). Finally the silyl group migrates from carbon to 
oxygen to give the vinylogous carbamate 231.148
In our reactions (Scheme 3.1.17), we attempt the removal of the triethylsilyl group from 
231 using acetic acid in a water-THF mixture to obtain the a-ketoester (236). Instead of 
forming 236, however, a retroaldol reaction forms AyV-di benzyl formamide 229. This 
is inferred from the ^  NMR spectroscopic analysis, which shows a singlet signal at 5 
8.42 ppm. Similarly, an attempted ethyl ester hydrolysis (lithium hydroxide in a 
THF/water mixture)149 does not give the enolic acid (237), but also results in the 
retroaldol reaction and gives NJSf -dibenzylformamide 229. This is also confirmed by 
NMR spectroscopic analysis. In a method, which involves neither acid nor base, ’H 
NMR spectroscopic experiments are conducted using tetrabutylammonium fluoride in 
methanol to investigate the nature of the retroaldol reaction. From this, the formation of 
enol (238) is observed. !H NMR spectroscopy is used to monitor the reaction over 24 h 
and shows a complete retroaldol reaction, which gives AyV-dibenzylformamide 229.
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(Bn)2N
CO,Et
236
AcOH/THF/H20  
3:1:1, rt
 X —
retroaldol
(Bn)2N
C 02Et
1) LiOH, H20/THF 
2) pH 3, HCI
 X — - (Bn)2N
TES 231
c o 2h
TES 237
NH4F, MeOH
N(Bn)2
229
Slow retroaldol (Bn^N
CO?Et
H2, Pd/C 
MeOH,
X
100 PSI, 
H 238 40°C
in situ
H,N
C 0 2Et
239
Scheme 3.1.17: Deprotection strategies towards aminopyruvate 5b
In an attempt to suppress this retroaldol reaction, by changing the stereoelectronic 
properties o f 238, removal of the dibenzyl groups by hydrogenation (Scheme 3.1.17), 
under atmospheric pressure and using 100-psi pressure at 40 °C is attempted. This 
would have given aminopyruvate ethyl ester (239), but no reaction results with either 
palladium/carbon catalyst or platinum oxide.150,151
A mechanism for the retroaldol reaction in aqueous media is shown (Scheme 3.1.18).
OSiEt3 OSiEt3 OSiEt3
(BnfcN^ ^ O E t  H+ transfer /O E t  (Bn)2Nk ^OEt
(,H ,0 O 231
OSiEt-
(Bn)2N.
O 229
OEt
OH 242
OH OH 240
OSiEt3
OEt
O 241
O 243
Scheme 3.1.18: Mechanism of retroaldol reaction
The retroaldol reaction occurs in both acid and alkali conditions and seems plausible 
that the nucleophilic addition o f water on the vinylogous carbamate 231 allows the 
formation o f species (240). It is possible that only catalytic amounts o f water are 
required to initiate the retroaldol, which would also explain when tetrabutylammonium 
fluoride (TBAF) was used in methanol, the same retroaldol occurring more slowly. 
Subsequent keto-enol tautomerisation favour formation o f species (241). The retroaldol 
reaction yields formamide 229 and keto-enol tautomerisation o f enol (242) gives ester 
(243).
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3.1.3.3 Biotransformations with lactate oxidase (LAO) and pyruvate 
oxidase (PAO)
A previous attempt to utilise lactate dehydrogenase and alcohol dehydrogenase (section 
3.1.2.3) to regenerate NAD+ to access azidopyruvate 5a is unsuccessful. It is 
considered that such enzyme systems are too complicated, as two substrates, two 
products, and the coenzyme (NAD+, which is expensive) are required for the recycling
1S2reaction.
The use of lactate oxidase is deemed more useful on a preparative scale as it may
directly convert a-hydroxy acid lactate 207 to a-ketoacid pyruvate 22 in one step.
Furthermore, a by-product of the lactate oxidase (from Lactococcus and Aeriococcus)
biotransformation of L-lactate 207 (a much cheaper precursor) to pyruvate 22 is
hydrogen peroxide (Scheme 3.1.19).153 Studies on Streptococcus pyogenes show the
involvement of lactate oxidase with lactate and coupling with aerobic utilisation, the
generation of copious amounts of hydrogen peroxide, useful for a colorimetric screen, 
o o
Lactate oxidase
OH + 0 2 »  OH + H20 2
OH 207 O 22
Scheme 3.1.19: Reversible lactate oxidase equilibrium
Hydrogen peroxide is deemed deleterious to the formation of pyruvate 22 (Scheme 
3.1.19), as it results in breakdown products, acetate, carbon dioxide and water. Despite 
this, generation o f an assay method using hydrogen peroxide as a colorimetric marker 
for the formation of pyruvate 22 is known, using a Trinder reagent, A-Ethyl-A-(2- 
hydroxy-3-sulfopropyl)-3-methylaniline sodium salt dihydrate (TOOS) (244) with 
horseradish peroxidase and 4-aminoantipyrine (4-AA) (245). The oxidised 
condensation product (246) results from this oxidative coupling (Scheme 3.1.20).154
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S 0 3 Na+
OH 244
+
245
H20 2/peroxidase
S 0 3Na
e 2 .2 5 x  104
value of 630 nm
Scheme 3.1.20: Oxidative coupling of 244 and 245
The amount of hydrogen peroxide formed corresponds to the substrate concentration 
and hence, the amount of substrate converted can be determined by the colour 
development of this oxidative coupling reaction.
We utilise this protocol in an attempt to bioconvert DL-isoserine (247) with lactate 
oxidase, initially and then with pyruvate oxidase using the colorimetric assay vide supra 
to give aminopyruvate 5b (Scheme 3.1.21).
OH 247
/ .y  . r\ Lactate oxidase
2 Phosphate buffer H2^ 
pH 7.0  
NaCI
OH + H20 2
O 5b
Horseradish peroxidase  
TOOS (244)
4-AA (245)
S 0 3Na
Scheme 3.1.21: Colorimetric assaying method for potential aminopyruvate formation
A 56-microwell-plate assay format was developed and tested with both lactate oxidase 
and pyruvate oxidase with DL-isoserine 247. The results of these biotransformations are 
shown below (Figure 3.1.3).
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#  A •
•
C air
D
Pyruvate Oxidase 
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[Enz] !! • *  
•  W
KEY FOR BOTH ENZYME REACTIONS
BLUE = DL-ISOSERINE (1 & 7)
RED = DL-ISOSERINE + LACTATE (2)
= DL-ISOSERINE + PYRUVATE (8 )
GREEN = LACTATE (3)
= PYRUVATE (8 )
BLACK = NO SUBSTRATE (CONTROL) (4 & 10)
PINK = CONTROL (BLANK) 5
= PYUVATE IN LACTATE OXIDASE (11)
ORANGE = H20 2 IN DECREASING CONCENTRATION A-H
Figure 3.13: 56 microwell plate format with DL-isoserine 247, lactate 207 and pyruvate 22 substrates 
with lactate oxidase and pyruvate oxidase, respectively
Each microwell contains horseradish peroxidase 8 U/ml, with TOOS 245 (0.4 mg/ml) 
and 4-AA 245 (0.27 mg/mL), which is responsible for not only providing a binary 
response as to whether any of the substrates are bioconverted, but could give a 
quantitative measure o f substrate concentration using a microwell plate reader. 
Cofactors considered important to lactate and pyruvate oxidase experiments are added 
to the wells, where appropriate. These include TPP (0.6 mM), flavin adenine 
dinucleotide (FADH) (0.02 mM) and magnesium chloride (5 mM).
Reading from right to left (Figure 3.1.3), the orange columns 6 and 12 show the 
increase of hydrogen peroxide from 0 to 1 mM and provide a calibration curve (Figure 
3.1.4). The sensitivity of the colorimetric assay to the concentration of hydrogen 
peroxide (H2O2) is as low as 0.03 mM.
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Figure 3.1.4: Calibration curve for concentration of hydrogen peroxide versus concentration found from
micro well plate reader
The pink column (5) is a control and contains only water and buffer. Lactate oxidase 
(pink column (11)) is tested with pyruvate 22 and lactate 207 in increasing enzyme 
concentration from well (H ll)  to well (E ll) . Some reaction is observed in well (F ll)  
to well (E ll) , as revealed by the purple colouration, so neither substrate inhibit lactate 
oxidase.
Negative controls, for lactate oxidase (black column (4)) and pyruvate oxidase (black 
column (10)) have no substrates added, and as expected no colours develop.
Lactate oxidase in decreasing concentration (green column (3)) (2 to 0 U m L'1) with 
lactate 207 in well (A3) to well (D3) and pyruvate oxidase with pyruvate 22 in 
decreasing concentration (2 to 0 U m l'1) in wells (E3 to F3) are tested. Lactate oxidase 
with lactate 207 is successfully bioconverted to pyruvatem, as shown by the increasing 
purple colouration produced by the colorimetric screen, seen in well (C3) to well (A3), 
with the increasing concentration of lactate oxidase. Pyruvate 22 is also successfully 
converted to acetate with increasing concentrations of pyruvate oxidase (0 U/mL) to 
(2U/ mL) as seen by the increasing purple colouration in well (H9) to well (E9).
As DL-isoserine 247 (the desired test substrate for conversion to aminopyruvate 5a) has 
no inhibitory effects on the natural substrates, lactate 207 with lactate oxidase and 
pyruvate 22 with pyruvate oxidase, DL-isoserine 247 is added. Red columns 2 and 8
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indicate this and these inferences are based on comparison of the purple colouration 
observed with the natural substrates.
Unfortunately though, in the final sets of experiments with DL-isoserine 2 4 7  (blue 
columns 1  and 7 )  with lactate oxidase, no purple colouration is observed in wells ( D l )  
to ( A l ) .  Hence, no reaction occurs. The same result is also recorded for DL-isoserine 
with pyruvate oxidase in well ( H 7 )  to ( E 7 ) .  The likelihood is that the amino group of 
DL-isoserine 2 4 7  may react with other amino acid residues in both lactate oxidase and 
pyruvate oxidase that are not necessarily linked to the active site, rendering the DL- 
isoserine as an inactive substrate. This is supported by the fact that it displays no clear 
inhibitory behaviour with the natural substrates of these enzymes. If it did act as an 
inhibitor, it would have to be in the active site to compete with the natural substrates.
3.1.4 Cyanopyruvate
A literature procedure155 in which an ethanolic/ether mixture o f sodium is treated with 
diethyl oxalate ( 2 4 8 )  at 0 °C in the presence of acetonitrile is adopted and the 
precipitated solid is collected. This is thought to be cyanopyruvate ethyl ester ( 2 4 9 ) ,  but 
NMR spectroscopic analysis shows an enolic signal at 5 4.89 ppm, which might be 
attributed to the sodium enolate ( 2 4 9 a )  (Scheme 3.1.22). Deuterium exchange shows 
how labile the enolic proton is, as after 3 h, the signal is no longer visible.
Under slightly different reaction conditions (Scheme 3.1.22) using potassium ethoxide, 
instead o f potassium or sodium metals in ethanol, an almost quantitative yield results 
for what is thought to be cyanopyruvate ethyl ester 2 4 9 .  'H NMR spectroscopic 
analysis in d6-DMSO (to prevent deuterium exchange), however, indicates presence of 
the potassium enolate ( 2 4 9 b )  by a signal at 8  4.19 ppm with 1H integration. The main 
problem is that the coupling constant J h-c expected is 140 Hz. Instead, the observed 
value for J h-c is 170 Hz, which is more consistent with potassium epoxide structure 
( 2 4 9 c ) .
An ethanolic contaminant is present in the ] H  NMR spectrum of 2 4 9  and by diffusion 
] H  NMR spectroscopic analysis is found to be a lower molecular weight than 2 4 9 .  The 
chief concern is that enol 2 4 9 b  or potassium epoxide 2 4 9 c  (Scheme 3.1.11) did not 
correlate with the 13C NMR analysis. This shows all of the key signals, including the 
cyano group (CN) at 8  125 ppm, methyl signals at 8  18 ppm (CH3) and ethyl signals at 8
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56 ppm (OCH2X but shows the 1,2-dicarbonyl signals at 6 166 and 6 170 ppm. These 
are more akin to the desired cyanopyruvate ethyl ester 249. No enolic carbon signals 
are observed for structures 249a-b and no epoxide carbon signals are observed for 
structure 249c.
Whilst uncertainty about the keto-enol form remains, some attempts are made to trap the 
enol by alkylation with methyl iodide. Unfortunately, these experiments are 
unsuccessful, thus lending little support to the formation of the enolic structure 249b 
(Scheme 3.1.22).
After this, hydrolysis of the ethyl ester 249 is attempted, first with lithium hydroxide, 
which by NMR and 13C NMR spectroscopic analyses shows the complete 
degradation of 249. Then, a milder form of hydrolysis with an esterase is considered. 
Two experiments are performed; one as a control, only containing phosphate buffer and 
the substrate 249. The other contains the phosphate buffer, esterase and the substrate 
249. Interestingly, hydrolysis of the ethyl ester occurs in both and the ethanolic 
contaminant is still present. From this observation and previous diffusion 'H  NMR 
experiments, it is realised that some potassium ethoxide is present in the sample of ethyl 
ester 249.
In order to overcome this oversight, reverse-phase column chromatography is employed 
to purify 249. After this, ab initio modelling8 of the carbon positions are compared with 
the carbon-proton coupled NMR and 13C NMR spectra and show that the 
cyanopyruvate ethyl ester exists as a carbanionic potassium salt (249e) at the methylene 
position (Figure 3.1.5), as is described in the literature.156
JH.C 170 Hz
MOEt
Ethanol/Ethec
MeCN
0°C
M = Na+ or K+
Not observed Observed
Scheme 3.1.22: *H NMR analysis of 249
Courtesy of Dr. Abil Aliev.
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Figure 3.1.5: Cyanopyruvate ethyl ester carbanionic salt 249e and its 13C NMR predicted peaks
Attempts to hydrolyse ester 249e are attempted and appear successful, as the ethyl 
groups by ]H NMR and 13CNMR spectroscopic analyses, are no longer visible. New 
proton signals for cyanopyruvic acid 5c at 8 3.20 ppm suggest possible inequivalence o f 
the methylene group in 5c, which is exemplified by a roofing effect o f two doublets (J  
7.0 Hz). The reason for this inequivalence remains unclear. Attempts to remove trace 
phosphate buffers in 5c by reverse phase chromatography fail and so yields for the 
formation of 3-cyanopyruvic acid 5c cannot be determined accurately. The presence of 
trace phosphate in 5c is identified using 31P NMR spectroscopic analysis and mass 
spectrometry further aid our analyses of this compound.
To make further use of the cyano functional group in 249e (Scheme 3.1.23), the 
possibility o f its reduction to an amino group is realised. If this is successful, then 
esterase hydrolysis could be used on the resultant 4-amino-2-oxo-butyric acid ethyl 
ester (250) and would give 4-amino-2-oxo-butyric acid (251), already known from the 
literature.1''7 4-Amino-2-oxo-butyric acid 251 would have an additional methylene 
group compared to aminopyruvate 5b and may act as a potential TK donor itself.
Our initial attempt to give 251 involves treatment of the cyanopyruvate ethyl ester 
carbanionic salt 249e with hydrogen over a Raney nickel catalyst at atmospheric 
pressure and room temperature, though no reaction is observed. The same reaction is 
repeated at 40 °C and 100 psi to no avail.
esterase
Scheme 3.1.23: Attempted reductions of cyano group
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Other reduction attempts are deemed too harsh and would reduce all o f the functionality 
in 249e, so a short synthetic route (Scheme 3.1.24) towards 4-amino-2-oxo-butyric acid 
methyl ester (252) is considered via the synthesis of a sulfinyl group. Subsequent 
acidic treatment may then give 4-amino-2-oxo-butyric acid 251.
p-Alanine methyl ester (253) is treated with triethylamine and Cbz-chloride to yield A- 
Cbz (254) in 74% yield from an adopted literature procedure.158 Attempts to convert A- 
Cbz 254 to A-Cbz-4-amino-l-methylsulfinyl-2-butanone (255) as described by 
Iriuchijima are tried, but are unsuccessful.158 The basis for the rest o f this synthesis 
would have involved the conversion o f the sulfinyl group 255 to an a-bromo sulfinyl 
group (256), using A-bromosuccinimide and acetone.159 This then could have been 
converted by acidic hydrolysis to A-Cbz-4-amino-2-oxo-butyric acid methyl ester (257). 
Removal of the N-Cbz group by hydrogenation would have yielded 4-amino-2-oxo- 
butyric acid methyl ester 252, and in no more than 6 steps.
CbzNH CbzHN
CbzHN CbzHN
O
Scheme 3.1.24: Reagents and conditions: (a) Et3N, CbzCl, CHC13, 74%; (b) NaH, DMSO, THF 70-75 °C, 
Ar, 0%; (c) NBS, acetone, 5 min, HC1, MeOH; (d) aq. HC1 (e) hydrogenolysis
3.1.5 Phthalimidopyruvate
Synthesis of pthalimidopyruvate 5d are reported by Williams et al.,138 and Newton et 
a l m  We utilise the Williams et al., route first as they have successfully oxidised an a- 
hydroxyester group to an a-ketoester.138 The second route utilises Newton’s route, using 
A-bromosuccinimide to remove a dithiane protecting group and also yields an a- 
ketoester. Both routes are adapted for comparison and to yield 5d in the shortest 
number o f steps possible.
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We adapt the Williams et al., route, which involves the synthesis o f a useful precursor, 
now described (Scheme 3.1.25). A protocol by Petit et al., is used to achieve this 
precursor, as it is absent from the experimental details of Williams et al. The precursor 
synthesis starts with L-serine (258) and is reacted in the presence o f sodium nitrite and 
hydrobromic acid to give bromoamino acid (259), in 88% yield. This is then reacted 
with potassium hydroxide and results in the ring closure to potassium glycidate (260), 
formed in 76% yield. This is subsequently converted to ethyl glycidate (261) using 
ethyl bromide in the presence o f triethylbutylammonium chloride (a phase transfer 
regent). The reaction temperature of this reaction is critical, as degradation of epoxide 
261 occurs above this temperature. Isolation by distillation affords epoxide 261 in 54% 
yield.161
x o 2h
NH2 258
1) KBr, HBr, H ,0  
2) NaN02 
-13 °C to rt 
stir 
88%
Br 259
KOH
Em
-20 °C overnight 
stir 
76%
ko2c
OH 262
PCC
NaOAc
DCM
38%
260
EtBr 
DCM 
50 °C 
TEBA 
54%
Potassium Phthalimide
 Phthalimide______
DMF 
90 “C 
30% Et02C 261
Pigs liver esterase 
Phosphate buffer 
pH 7 
50%
C 02H
Scheme 3.1.25: Adapted route to phthalimido pyruvate 5d
Using the synthetic route (Scheme 3.1.25) given by Williams et al., we achieve ring 
opening of epoxide 261 by using catalytic potassium phthalimide and phthalimide in 
DMF heated at reflux. This gives a-hydroxyester (262) in 30% yield. Pyridinium 
chlorochromate (PCC) oxidation of 262 affords a-ketoester (263) in 38% yield, but only 
on a 1 mmol scale reaction, as detailed by Williams et al.138 An individual 5 mmol scale 
reaction is attempted and confirms Williams et al. finding, that 1 mmol is the optimal 
scale for this oxidation. Successful esterase hydrolysis of a-ketoester 257 gives 3- 
phthalimidopyruvate 5d in 50% yield. We find that the hydrolysis of the ethyl ester 263
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using acid, reported by Williams et al. does not yield 3-phthalimido pyruvate 5 d ,  but 
forms a degraded product that we are unable to identify.
The main disadvantage of this route is the oxidation step, as it could not be successfully 
scaled above 1-mmol. Whilst Williams et a l, reports a number of methods to oxidise 
a-hydroxyester 2 6 2  to a-ketoester 2 6 3 ,  including an oxidation with potassium 
permanganate and copper sulfate in benzene; this is capricious, as yields range from 0 to 
80% and so is avoided. Williams et al., subject a number of secondary TV-protected 
ethyl esters of isoserine (Figure 3.1.6) to a range of oxidation conditions without any 
success, including the successful PCC oxidation and highlights the difficulty o f this 
transformation.
In order to scale up the reaction towards synthesis of a-ketoester 2 6 3 ,  a different 
method (Scheme 3.1.26) was adopted from Newton et al., which shortens the number of 
steps significantly and is readily scalable.160
Alkylation of ethyl l,3-dithiane-2-carboxylate ( 2 6 4 )  with bromomethyl phthalimide 
( 2 6 5 )  gives dithiane protected a-keto ester ( 2 6 6 )  in 39% yield. Subsequent treatment of 
2 6 6  with A-bromosuccinimide in aqueous acetone yields the desired a-ketoester 2 6 3  in 
55% yield. Unfortunately, attempted repeats of esterase hydrolysis on 2 6 3  from this 
route to afford 3-phthalimido pyruvate 5 d  are unsuccessful on a larger scale (1-2 g). 
Despite numerous recrystallisation attempts o f 2 6 3  and subsequent repeat of the esterase 
hydrolysis reaction on a 1-mmol scale; as before, these reactions are unsuccessful. 
Nonetheless, from the sample o f 2 6 3  obtained by the oxidation method, enough is 
available for a biomimetic reaction. It is hypothesised that a contaminant from the latter 
route involving the dithiane, however minor, is affecting the efficacy of the esterase.
PhOCHN
OH OH OH
Figure 3.1.6: a-hydroxyesters subjected to various oxidation attempts
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O 265S
NaH, DMF-C6H6l 39%
266
NBS, aqueous acetone 
55%
esterase
O 263O 5d
Scheme 3.1.26: Alternative synthesis of 263
3.1.6 Biomimetic reaction of phthalimidopyruvate with 
propionaldehyde
Reactions between Li- HP A lc  and propionaldehyde (267) with TK mutants are carried 
out and a range of buffers are evaluated for maintaining the pH at 7.0. Interestingly, 
Smith et al, observe that some control experiments (omitting the TK enzyme) form a 
ketodiol product, l,3-dihydroxypentan-2-one (268), from reactions containing buffers 3- 
(-morpholino)propanesulfonic acid (MOPS) (269) and A-methylmorpholine NMM
(270).
The mechanistic involvement of TPP 20 and the formation of a thiazolium ylid 21 are 
ruled out, as other control reactions, utilising rra(hydroxymethyl)aminomethane (TRIS)
(271) or glycylglyine (gly-gly) (272) do not yield any ketodiol 268. Tests with 
benzaldehyde 30, however, are also conducted, yielding ketodiol (273), but in a low 25 
% yield. (Scheme 3.1.27).6
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R = C2H5 267 
R = Ph 30
Li+ -0. OH buffer (see  choices),
H20 , rt R
R = C2H5 268 
R = Ph 273
buffer choice OH
h o 3S.
HO
■OH 271270269
OH
272
Scheme 3.1.27: Biomimetic reaction with various buffers 269-272
A reaction mechanism is postulated, which involve an enolic intermediate and is 
presented in Scheme 3.1.28.
268 R = C2H5
H 267 R = C2H5
Scheme 3.1.28: Proposed mechanism of the formation of 268 using NMM 270
It is proposed that in alkaline media, lc  is known to undergo enolization to enol (If) and 
tautomerisation to tartonate semialdehyde (lg), which could then undergo subsequent 
addition to NMM 270, generating enolate (274). Addition of propionaldehyde 267 to
109
______________________________________Results and Discussion: Chapter 3
enolate 274, followed by proton transfer gives species (275). Finally, decarboxylation 
o f species (276), yields keto diol 268 and regenerates NMM 270 in the catalytic cycle.
Following the successful synthesis of phthalimidopyruvate 5d, no enolization is 
observed by solution NMR spectroscopic analysis, but it is still possible for it to 
occur in aqueous media. A small-scale reaction (Scheme 3.1.29) is conducted between 
phthalimidopyruvate 5d and propionaldehyde 267 in the presence of NMM 270 and a 
product spot is observed by TLC analysis.
OH 277
+
NMM 270
5d
Scheme 3.1.29: Biomimetic reaction toward ketoalcohol 277
Preparative TLC is used to purify what appear to be two bands. Though 1HNMR 
spectroscopic analysis appear promising, not enough ketoalcohol 277 is available for 
13C NMR analysis (ca 5-6 mg) and contains propionaldehyde contaminants, despite 
columning. Fortunately, high-resolution mass spectrometry does provide a molecular 
ion peak (MFI+) 248.09187, which is 1.97 ppm different to the theoretical mass (MH+) 
248.09228 (well within the accepted error limit of for both bands). Both bands, on this 
basis, are identified as the same product. Unfortunately, it is not possible to conduct 
tests with phthalimidopyruvate 5d with TK or its mutants, as there is not enough of this 
substrate.
Attempts to make more o f phthalimido pyruvate 5d have been futile, despite repeating a 
number o f ester hydrolyses on ethyl ester 263 (Scheme 3.1.26). Methods on a larger 
scale include: basic hydrolysis with lithium hydroxide, acidic hydrolysis with 1M and 
6M HC1 and numerous repeats of the esterase hydrolysis.
3.2 Conclusion
In conclusion, despite numerous attempts to obtain novel nitrogen containing pyruvate 
donors, a number o f important factors are highlighted by this research. Firstly, the 
preference of enol forms over a-ketoester highlights the difficulty in synthesising these 
small and highly reactive molecules. This is prevalent, even in Li- HP A lc , which has a 
rigorous synthetic protocol; albeit only 30-40% yields are obtainable (Scheme 3.1.1).
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Having a number of reactive functional groups in a small molecule makes synthetic 
manipulation and functional group conversion a challenging task. This has clearly been 
highlighted in terms of substitution of bromopyruvic acid 191 or its ester 193 with 
azide, which undergoes unidentifiable polymerisation pathways (Table 3.1.1).
Attempts to obtain the a-ketoesters from a-hydroxyesters by oxidation (Table 3.1.2) are 
only successful with phthalimidopyruvate 5d, synthesised using a PCC oxidation route 
(Scheme 3.1.25). In addition to oxidation protocols utilised by Williams et a l we 
apply a rigorous set of oxidation conditions aimed toward the synthesis of 
azidopyruvate 5a and aminopyruvate 5b, but these are unsuccessful. Moreover, two 
enzymatic oxidation protocols, one involving lactate dehydrogenase and the other, 
lactate and pyruvate oxidases are used in a reversed equilibrium and forward reaction, 
respectively (Scheme 3.1.7, Scheme 3.1.8 & Scheme 3.1.19).
Nandra et al., provide a unique carbene methodology, which allow the protection o f the 
highly reactive functionalities in aminopyruvate 5b (Scheme 3.1.15). From this, we 
discover the preference of enol formation over the desired a-ketoester (Scheme 3.1.17) 
and the ease at which pyruvate donors can undergo retroaldol reactions. This is deemed 
important for biomimetic reactions because they utilise basic amine buffers to mimic 
TK reactions.
Further attempts to lengthen the methylene chain length o f a pyruvate donor and thus 
decrease the proximity of reactive functional groups is attempted by the synthesis of 
cyanopyruvate 5c and 4-amino-2-oxo-butyric acid (251). Though this is unsuccessful, 
we demonstrate a wide-range of chemical strategies that could be employed for this 
synthesis (Scheme 3.1.22 & Scheme 3.1.23).
Phthalimidopyruvate 5d is obtained in a six-step synthesis (Scheme 3.1.26). 
Unfortunately, synthesis of more of this material is unobtainable despite numerous 
attempts. Therefore, instead of subjecting 5d directly to TK and its mutants, we decide 
to utilise the mimetic TK reaction (Scheme 3.1.28). It is anticipated that the racemic 
ketoalcohol 277 from this reaction could be used as a standard for determining any 
enantioselectivity that might arise from TK or its mutant’s bioconversion. Despite low 
conversion of 3-phthalimido pyruvate 5d into ketoalcohol 277, phthalimido pyruvate 5b
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has been identified as a nitrogen containing pyruvate donor with potential uses in TK 
reactions.
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Chapter 4
4.1 Syntheses towards syn-aromatic 
aminodiol and syn-aromatic diol 
HPLC standards
Recently, Hailes et al., show that Li-HPA lc  with aldehydic substrates 2 reacted in the 
presence of TK generate an (S)-ketodiol 3h. Furthermore, it is known that TA can be 
used to accept (S)-ketodiols 3 and that some mutants may eventually accept (R)- 
ketodiols, ultimately favouring a syn stereochemistry in the final aminodiol product 4. 
Attempts have been made to extend this method to include aromatic aldehydes 2, R = 
Ar and this meant that chiral HPLC standards were required to aid elucidation of the 
stereoselectivities of 4 from the overall reaction scheme (Scheme 4.1.1).
Reductive Amination
Asymmetric
synthesis
OH OH
TK, Mg2+. TPP ? TA -
0 Li+ -     /  \  \  _
R OH /  \  R ^  0H
0 3  amine donor ketone 4
Scheme 4.1.1: Asymmetric synthesis of syw-aminodiols 4, where R = Ph
Carrying out the Sharpless asymmetric aminohydroxylation (AA) reaction (Scheme
4.1.2) with isopropyl cinnamate ester substrates (278) will give rise to four possible syn- 
stereoisomers, depending on the choice of chiral ligand, either as (DHQ)2PHAL 136a or 
(DHQ)2AQN 137a (Scheme 4.1.2).
If an osmium(VIII) species with (DHQ)2PHAL 136a is used, two possible syn- 
stereoisomers result. These are the (2i?,3S)-A-protected 3-phenylisoserine enantiomer 
(279a), obtained as the major enantiomer and (25,3i?)-A-protected 3-phenylisoserine 
enantiomer (279b), obtained as the minor enantiomer.124,162 The enantioselectivities are 
reversed when (DHQD)2PHAL 136b is used.
h Hailes, H.C., Smith, M.E.B., Smithies, K. Unpublished results
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When (DHQ)2AQN 137a is used, the major enantiomers produced are (2R,3S)-N- 
protected 3-phenylserine (280a), whilst (2S,3^)-Ar-protected 3-phenylserine (280b), 
results from the use of (DHQD)2AQN 137b.7,8
This means that the regioselectivity and enantioselectivity can be controlled by the 
choice of chiral ligands 136 and 137, and thus presents an attractive one-pot method for 
establishing a syn relationship. This is considered as the lead synthetic route toward 
aromatic sy/z-aminodiols (281) via this short reaction sequence (Scheme 4.1.2).
ZNCINa or AcNBrLi 
K20 s 0 2(0H)4 or 
0 s 0 4 
or Osmylated resin 
C° 2/Pr DHQUDzPHAL or 
DHQMJzAQN (5 mol%).
nPrOH or fBuOH/ H20  
0°C or  
room temp 
Z = Cbz, or 
Ac
(DHQ^PHAL
promoted
products
279a oh 279b OH
(DHQJjAQN
promoted
products
depending on conditions
OH
280a n h z 280b n h z
Short reaction sequence
OR
OH
DHQ (a) DHQD (b)
OAlk (a) or (b) O OALK (a) or
OALK (a) or (b) O OALK (a) or 
AON 137 a o rbPHAL 136a orb
Scheme 4.1.2: Sharpless AA as a route to aminodiol 281
We focus on the use o f (DHQ)2PHAL 136a and (DHQ)2AQN 137a chiral ligands, to 
give (2R,3S) syn stereoselectivity, as at the time of the work by Hailes et al., the 
stereochemistry of aminodiols 4, are unknown (Scheme 4.1.1).
The regioselectivity o f the reaction can be reversed from (2/?,35)-A-protected 3- 
phenylisoserine 279a to (2/?,3S)-A-protected 3-phenylserine 280a using either 136 or 
137; but through the use of 137, the regioselective ratios o f 279a:280a can range 
anywhere between 1:4 to 1:2 for the desired (2i?,31S)-Ar-protected 3-phenylserine 280a.8 
This means that a significant amount of unwanted (2/?,3*S)-A-protected 3- 
phenylisoserine 279a is present from the synthesis of (2/?,35')-A-protected 3-
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phenylserine 279a; which, when heading towards syn aromatic aminodiol 281 needs 
removal by careful column chromatography. Furthermore, should it not be possible to 
remove unwanted regioisomers from the Sharpless AA reactions, they will complicate 
the chiral HPLC interpretation of the final mixture.
A synthetic route that gave exclusively s>w-/V-protected 3-phenylserine regioisomers 
280 as chiral HPLC standards is developed. The attempted syntheses take advantage of 
known condensation reactions between non para-substituted and para-substituted (R = 
OBn, OH and OMethoxymethyl (OMOM)) aromatic aldehydes with glycine (282). 
Then, through a short reaction sequence to access syn-3 -phenylserine 280, these 
compounds could subsequently be used as test substrates for a synthesis heading 
towards sjw-aminodiols 281.
4.1.1 Synthesis of syn-serine regioisomers as chiral HPLC 
standards
Erlenmeyer first identifies that the sodium hydroxide mediated condensation of 
benzaldehyde 30 with glycine 282 affords the benzylidene salt (283).163 This is acidified 
and gives syn - 3 -phenyl serine (284). The syn diastereoselectivity is confirmed by 
Carrara and Weitnauer,164 who relates the compound to chloramphenicol 71, already 
discussed in section 2.1.1. Vogler, who performs resolution of 284, (though the 
experimental details are not given), reach a similar conclusion.165
Our aims are to selectively synthesise syn- and/or anti- amino alcohol esters, based on 
the general structure 281 (Scheme 4.1.2). These will assist chiral HPLC analysis of the 
Sharpless AA reaction (discussed in Chapter 5), and provide syn- and/or anti- 
aminodiols for applications in other screening activities of the BiCE project. 
Erlenmeyer’s method is repeated in our lab, by the reaction o f benzaldehyde 30 with 
glycine 282 in the presence of potassium hydroxide (Scheme 4.1.3). Syn-284 is obtained 
in 16% yield and is confirmed by *H NMR spectroscopic analysis against a 
commercially available sample.
115
Results and Discussion: Chapter 4
OHOH
H2N
OH OHH 282
MOH, Ethanol nh2 284, 16%
a ) NaOH, 
acetic 
anhydride 
or
b) NaHC03,
'' CbzCI
30
OH O0OH
OHO/Pr 1 ) C sC 03, water
2) 2-iodopropane, 
toluene
NHZ
285 Z = Ac, 68% 
287 Z = Cbz, 94%
NHZ
286 Z = Ac, 42% 
288 Z = Cbz, 65%
Scheme 4.1.3: Synthetic route towards j^n-diastereoselective HPLC standards 286 and 288
In order to test the amide and carbamate nitrogen sources in the Sharpless AA (Scheme
4.1.2), both A-acetyl and A-Cbz analogues are formed using standard Schotten- 
Baumann reaction conditions. Reacting acetic anhydride or benzyl chloroformate with 
283 under basic conditions yields syn-A-acetyl aminoacid (285) in 68% yield, and syn- 
N -Cbz aminoacid (287) in 94% yield, respectively. As we have elected to use the 
isopropyl cinnamate ester 170 in the Sharpless AA reactions (Scheme 4.1.2), cinnamic 
A-Cbz-protected aminoacids 285 and 287 are converted to the corresponding isopropyl 
cinnamate esters, with A-acetyl (Ac)-(286) obtained in 42% yield and A-Cbz-(288) in 
65% yield. This is achieved by formation of their corresponding caesium salts and 
alkylation of these with 2-iodopropane (Scheme 4.1.3).
Syn-286 and syn-288 are then analysed by chiral HPLC and a 1:1 ratio o f peaks show 
both syn enantiomers are present. It is anticipated that co-injecting these syn standards 
286 and 288 against the corresponding Sharpless AA adducts, the identity o f each chiral 
HPLC peak produced could be confirmed as the peak retention times for unsubstituted 
cinnamate substrates with Sharpless AA had been reported for the (2R,3S) isomer when 
using chiral ligand (DHQ)2AQN 137a563’124,162,166
One of the by-products of the Sharpless AA reaction is a diol (section 2.2, Scheme 
2.2.1).166 So to ensure as many expected products are identified before doing any 
Sharpless AA work, we synthesise a vyn-diol for chiral HPLC elucidation by reaction of 
isopropyl cinnamate ester 170 with A-morpholine oxide in the presence of osmium 
tetroxide. This affords syn-diol 289 in a yield of 61% (Scheme 4.1.4).
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C02/Pr.C02/Pr
acetone
61%
Scheme 4.1.4 Synthesis of diol product 289
Fortunately, the retention times of the expected Sharpless adducts N-Ac 286 and iV-Cbz 
288 is different enough to allow identification of each product enantiomers. They are 
also different in retention times to the peaks generated by the diol by-product 289. The 
deconvolution is shown in Table 4.1.1.
Enty Retention time/ mina Z if applicable Compound
1 14.55 Ac (2R,3S)-286a
2 15.36 Ac (2S,3R)-286b
3 16.74 C bz (2R,3S)-288a
4 18.00 Cbz (2S,3R)-288b
5 20.22 N/A Syn-2B9b
6 21.98 N/A Syn-2B9b
aChirapak AD : (0.6 ml min"1), 210  nm, 85:15 (hexane:/PrOH); °Absolute configuration not m easured  
Table 4.1.1: Retention times of chiral HPLC standards
We assume, based on earlier literature reports, that the N-Ac-(2R,3S) 286a enantiomer 
(entry 1) elutes first from our chiral HPLC trace when compared with the (2S,3R)~ 
enantiomer 286b (entry 2). The N-Cbz-(2S,3R)-2$8a and (2R,3S)-288b enantiomers are 
reported to elute at slightly later retention times (entries 3 and 4).166 Both enantiomers 
o f the s>?2-diol 289 (entries 5 and 6) are identified as much later peaks on the chiral 
HPLC trace, at retention times 20.22 and 21.98 min, respectively. This is however, 
only one Sharpless AA reaction and so we decide to explore the synthesis of p- 
substituted 3-phenylserine syn-HPLC standards for any other system under 
investiagtion. This is because we want to confirm the absolute stereochemistry of other 
p-substituted WCbz-3-phenylserine enantiomers as (2R,3S)-288a when (DHQ^AQN 
137a is used in later Sharpless AA reactions. This would be achieved, hopefully by 
comparison to a known standard.
From the literature, we are aware of how some (27?,3S)-3-phenylisoserine enantiomers 
280a and (2iS',37?)-3-phenylisoserine enantiomers 280b will elute by chiral HPLC. This 
aids the deconvolution process for a few o f the N -Ac and N-Cbz products.124,162 Having 
identfied a good chiral HPLC system, we turn our attention to the synthesis of the syn- 
aminodiol (291), seen in the next section.
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4.1.2 Synthesis of a syn-aminodiol
Using the syn-N-Cbz 3-phenylserine regioisomer 288 (prepared in section 4.1.1) as a
test substrate, a short synthesis is developed towards the corresponding sy/7-aminodiol
291 (Scheme 4.1.5). This could then be used to optimise the chiral HPLC purification
(a labour intensive process) of Sharpless AA generated enantiomers.
9H QH QH
,C 02'Pr LiBH4 10o/o Pd/c
THF/EtOH (v/v = 1/9)  ^ Ph OH cvclohexene t Ph OH
= 0°C to room temp,stir |  EtOH |
NHCbz 80% NHCbz reflux ^H,
74% 2
syn-288 syn-290 + syn-291
OH
Ph Y  OH 
NH2
Both enantiomers are commercially available!
Scheme 4.1.5: Short step reaction sequence to sjw-aminodiol 291
Initially sodium borohydride was used to reduce syw-ester 288 as Merlo and Fernandes 
use it to reduce a similar phenylalanine ester, but this is problematic.167 Increasing the 
number of equivalents of sodium borohydride is ineffective for the reduction of syn- 
288, as determined by TLC and NMR spectroscopic analyses. Instead, lithium 
borohydride in a mixed solvent system (THF/ethanol) is used, as Gershon and Rodin 
shows its effectiveness on a similar benzoyl tyrosine ester.168 The vy 77-ester 288 is 
reduced to the syn-N-Cbz aminodiol-290 in 80% yield. This then undergoes an 
attempted hydrogenation using a palladium catalyst at room temperature in ethanol to 
remove the A-Cbz protecting group. This is ineffective, so we use a catalytic transfer 
hydrogenation method. A palladium catalyst in ethanol with cyclohexene is heated at 
reflux with A-Cbz aminodiol 290 and results in the hydrogenolysis of the A-Cbz group, 
giving the syw-aminodiol 291 in 74% yield. It is anticipated that this method could be 
extended towards the synthesis of a number of p-substituted aromatic aminodiols, 
similar to compound 281 (Scheme 4.1.2).
4.1.3 Synthesis of syn p-substituted phenylserine chiral HPLC 
standards
A range of isopropyl p-substituted cinnamate substrates 278a-g (Scheme 4.1.6) is 
investigated with the Sharpless AA reaction, as seen in the next chapter. These 
cinnamates are chosen to investigate how varying the chain lengths or having other 
bulky aromatic groups at the p-position will affect regio- and enantioselectivities of
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Sharpless AA reactions, under both homogeneous and heterogeneous reaction 
conditions.
OH
293a nh.
OH OH
,C 0 2H
Cbz protection
,C 0 2h isopropyl
Removal of 
R group
OH
293b-g nh2
'  Cbz 
Protection
RX
295a NHCbz294a-g NHCbz
Isopropyl estenfication
C 0 2/Pr
a R = H, 
b R = Bn 
c R = Me 
d R = C6H13 
e R = C16H33 
f R = CH2OCH3 
g R = TBDPS
C 0 2/Pr
Glycine 282, 
basic alcohol
295b-g NHCbz
Sharpless AA 
reaction
,C 0 2/Pr
Wittig Reaction
292b-g 278a-g
Scheme 4.1.6: Diastereoselective syntheses towards ^-^-substituted 3-phenylserine HPLC standards 
295a-g
Reacting glycine 282 with ^-substituted aldehydes (293b-g) is thought to lead to the 
successful synthesis (Scheme 4.1.6) of sy«-(p-substituted-3-phenyl)serines) (293b-g). 
We are aware that hydroxybenzaldehyde (292a) would not be suitable for this type of 
condensation, but may be required in the synthesis of other aldehydes 292b-g. Syn-ip- 
hydroxy-3-phenyl)serine (293a) is of particular interest and is believed to be readily 
accessible by deprotection of the R groups o f (293b-g) should there be any problem in 
the latter stages of the synthesis.
If no problems result, sy«-(p-substituted-3-phenyl)serines 293b-g could be A-Cbz 
protected to give sy«-jV-Cbz-(p-substituted-3-phenyl)serines-(294b-g). Subsequent 
isopropyl esterification of syn-294b-g should give sjw-A-Cbz-(/?-substituted-3- 
phenyl)serine isopropyl esters (295b-g). Sy«-A-Cbz-(/?-hydroxy-3-phenyl)serine 
(294a), however, is potentially useful as alkylation of the phenolic group should give 
access to any of the syw-HPLC standards 295b-g. No chiral HPLC data are reported in 
the literature for (2^,3S)-295b-g resulting from the use of (DHQ^AQN 137a in the 
Sharpless AA transformations. Having access to all of the syn HPLC standards 295a-g
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could be useful for identifying the syn-(2R,3S) enantiomers of the subsequent Sharpless 
AA reactions.
Literature data are only available for synthetic routes to syw-(/?-substituted-3- 
phenyl)serines 293a, 293b and 293f (Scheme 4.1.6) and is a good place to start the 
subsequent investigations.
Bolhofer report that the condensation reaction (Scheme 4.1.7) of glycine 282 with p- 
benzyloxybenzaldehyde (292b) in alcoholic potassium hydroxide solution gives 
exclusively the sy«-(/?-benzyloxy-3-phenyl)serine (293b) in 77% yield. This is 
achieved via acidic hydrolysis o f the isolated p-benzyloxy benzylidene salt (296) in 
95% yield.169 Bolhofer also report a method to remove the benzyl ether from s>??-293b 
to give 5>7?-293a, thus providing a good lead synthesis to the two desired sy^-amino 
acids, 293a and 293b.
We repeat the condensation reaction (Scheme 4.1.7) and sy«-293b is obtained in 77% 
yield, via the successful isolation and acidic hydrolysis of 296, obtained in 63% yield. 
!H NMR spectroscopic analysis show that syn-293b is formed in a 60:40 de. Cable et 
al., note the same diastereoselectivities by NMR spectroscopic analysis even after a 
number of recrystallised samples are obtained from the mother liquor.170 Bolhofer has 
relied on the absence of a specific IR band (11.90 p), to show that the anti compound is 
absent from the condensation reaction, which is not the case.169'170 A series o f repeats 
using Cable’s method o f collecting crops of crystals are carried out, but the de remained 
constant at 60:40 (syn:anti), as determined by 'H NMR spectroscopic analyses.
Attempts to remove the benzyl ether by hydrogenation as described by both Bolhofer 
and Cable et al.,169,110 (sodium hydroxide & Pd/C or hydrochloric acid/methanol & 
Pd/C) are unsuccessful, as determined by TLC and NMR spectroscopic analyses.
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OH
H2N
OHH 282
KOH, Ethanol 296292b
BnO'BnO'
Ph-4-(OBn)
NH, 293b
hydrogenolysis
BnO
OH
OH
NH2 293a
HO'
Scheme 4.1.7: Synthetic protocol towards 5>w-(p-hydroxy-3-phenyl)serine 293a
Even though we have a 60:40 de (syn’.anti), we attempt to convert 293b to vV-Cbz- 
(294b) using the methods shown in Table 4.1.2. This is because the anti isomer present 
may still prove useful in the chiral HPLC analysis o f products formed using dual 
enzymatic pathways (Scheme 4.1.1). This could be achieved by derivatisation o f the 
corresponding aromatic aminodiols 4, in other screening activities of the BiCE project.
NH2 293b
OH
OHSee Table
NHCbz 294b
BnO'
Entry Reaction conditions
1 N aH C 03 (aq)/0°C/CbzCI
2 NaOH/0°C /pH 9,/CbzCI
3 MgO/EtOAc/reflux/CbzCI
Table 4.1.2: Reaction conditions for the conversion of 293b to /V-Cbz-294b
We initially try WCbz protection of 5y«-(/7-benzyloxy-3-phenyl)serine 293b under basic 
conditions (entry 1), as this method has previously been used on the analogous syn~3- 
phenylserine 284.171 .Sy«-(p-benzyloxy-3-phenyl)serine 293b is not fully soluble in the 
aqueous solution. The reaction is repeated with a small amount of TE1F added to ensure 
homogeneity, but still no reaction results. Next we use a method in which the pH is 
maintained at pH 9 by drop wise addition o f sodium hydroxide (entry 2). The substrate 
is fully soluble in this mixture, but once again, no reaction results. We hypothesise that 
using an organic solvent might drive the reaction to completion. Therefore, magnesium 
oxide and benzyl chloroformate are reacted with 293b in ethyl acetate and are heated at 
reflux for 24 h (entry 3), a method adapted from the literature.172 This reaction also does 
not proceed and it is concluded that the amphiphilic and zwitterionic nature of 293b is 
responsible for its inability to undergo this transformation. We therefore modify the 
synthesis so that the (p-benzyloxy-3-phenyl)serine isopropyl ester (297) is synthesised.
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This functional group transformation should increase the solubility of 293b in organic 
solvents by reducing the amphiphilic nature of the molecule, allowing the subsequent 
carbonylation reaction (Scheme 4.1.8).
BnO
C02H
1)SOCI2, /PrOH 
0°C ,
2) 40°C 24 h
293b 60:40 d e  
syn.anti
OH
BnO
C02/pr CbzQ| Et3N, 
_pH2C^ _ ^
NH2 
297, 10%
NHCbz
BnO'
295b
.C02/Pr
BnO'
298
Scheme 4.1.8: Synthesis of isopropyl ester 297 and subsequent N-Cbz protection to 295b
A number of routine esterification protocols on 293b are attempted, including 
dicyclohexylcarbodiimide/4-dimethylaminopyridine (DCC/DMAP), N-{ 3-
dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) and Fischer esterification, but 
without success. It is, however, seen from the lH NMR spectroscopic analysis o f 293b, 
that trace water is present in the sample and so, as a hydrate, the carboxylate reactivity 
may be reduced. Thionyl chloride mediated esterification does work, albeit in low yield 
(10%) to give 297, but NMR spectroscopic analysis shows the presence of only one 
diastereoisomer.
Since the starting material has a 60:40 de, we are only isolating either anti-(29T) or syn- 
(297) only. To complete the analysis, we anticipate that conversion of either anti-291 
or syn-291 to 295b by A-Cbz protection and subsequent ring closure to oxazolidinone 
298 should allow for the positive identification of syn or anti-291, by J  couplings, using 
NMR spectroscopic analysis. The protection o f 297 with a benzyloxycarbonyl group 
to give 295b (Scheme 4.1.8) using benzyl chloroformate, however, is unsuccessful.
Shigematsu et al report that the reaction of p-hydroxybenzaldehyde (292a) with 
methoxymethylchloride yields p-methoxymethylbenzaldehyde (292f). This aldehyde 
reacts with glycine 282 in the presence of ethanolic potassium hydroxide and results in 
the formation of a 1:1 diastereomeric mixture of syn- and anti- (p-methoxymethyl-3 - 
phenyl)serine (293f) in 20% yield (Scheme 4.1.9). Subsequent N -Cbz protection is 
possible.173
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OHOH
H d and e
NHCbzNHR
MOMO'MOMO'
I  292a R = OH
1-----► 292f R = OMOM c 293f R = H 1:1 antilsyn 295f, 54%, 2:3 antllsynchiral HPLC purification and derivitisation 294f R = Cbz 2:3 diasteromeric mix
a) Dimethoxymethane, p-toluenesulphonic acid, CH2CI2, soxhlet containing molecular sieves (3A), reflux, 23%; b) 
glycine 282, KOH, ethanol, 11%, c) NaHC03 (aq), CbzCI, 71%; d) K2C 03, BTEAC, 2-iodopropane, DMA, 55°C, .e) chiral 
HPLC purification
Scheme 4.1.9: Synthetic route towards chiral HPLC standard 295f
By modification of the protocol developed by Shigematsu et al, p-hydroxybenzaldehyde 
292a is reacted (Scheme 4.1.9) with /7-toluenesulphonic acid in dimethoxymethane. 
The mixture is heated to reflux using a soxhlet adaptor containing molecular sieves, p- 
Methoxymethylbenzaldehyde (292f) is obtained in 23% yield, which when compared to 
the literature yield of 60% appears poor. Despite numerous attempts, the literature yield 
is not achievable.174 This method is, however, better than using methoxymethyl chloride 
itself in the synthesis, as methoxymethyl chloride is difficult to obtain commercially and 
this modification reduces the number of steps.
As with the synthesis (Scheme 4.1.9) developed by Shigematsu et al., glycine 282 is 
reacts with the p-methoxymethylbenzaldehyde 292f in the presence of alcoholic 
potassium hydroxide (Scheme 4.1.9). This yields a 1:1 diastereomeric mixture of syn- 
and anti- (p-methoxymethyl-3-phenyl)serine 293f in 11% yield.173 Attempts are made to 
improve upon this yield, but are not successful. A-Cbz protection of 293f in the 
presence of aqueous sodium hydrogencarbonate with benzyl chloroformate afford a 1:1 
diastereomeric mixture of syn:anti-294i. This shows that steric hindrance may be 
preventing the A-Cbz protection of 293b (Table 4.1.2) or 297 (Scheme 4.1.8).
A number of standard routes to the isopropyl ester 295f (Scheme 4.1.9) are explored, 
but are unsuccessful (caesium carbonate/2-iodopropane/r.t. and potassium carbonate/2- 
iodopropane/DMF/r.t.). The reaction of 294f with benzyltriethylammonium chloride 
(BTEAC), potassium carbonate (26 equiv.) and 2-iodopropane (48 equiv.) gives 295f in 
54% yield. This is adapted from a literature precedent.175
Isopropyl ester 295f is then reacted with potassium carbonate (26 equiv.) in 
dimethylacetamide, to see if the diastereoisomeric ratio changes from 1:1 (,symanti), to
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favour more of the syw-product by epimerisation. /^-Methoxymethyl (MOM)- 
benzaldehyde 292f results from this reaction and is identified by !H NMR spectroscopic 
analysis. This suggests that 295f, instead of epimerisation, undergoes a retroaldol 
reaction. It is postulated that the high excess of 2-iodopropane (48 equiv.) is required to 
achieve ester formation, due to its volatility or possible elimination reactions.
A set o f trial reactions (Scheme 4.1.10) are then carried out with the 1:1 
diastereoisomeric mixture of 295f to ensure that derivatization to a ring closed product 
allows the relative stereochemistry to be deduced. This is done in preparation for 295f s 
purification into 4 diasteroisomers using preparative chiral HPLC. Successful 
hydrogenolysis on the 1:1 diastereisomeric mixture of 295f using hydrogen over a Pd/C 
catalyst ensures the synthesis of /?-(MOM-3-phenyl)serine isopropyl ester (298) in 81% 
yield. Subsequent ring closure of the diastereomeric mixture 298 using triphosgene with 
triethylamine ensures the synthesis of syn and awfi-oxazolidinones (299) in 94% yield 
(Scheme 4.1.10), which are readily separable by column chromatography.
OH OH
NH
NHCbz
295f
NH2
MOMO' MOMO'
MOMO'
+298a-d syn  and anti diastereoisomers ,0
= 9 Hz (anti 299a and d) Jtrans = 5 Hz (syn  299 and c)
NH
C02/Pr
MOMO'
Scheme 4.1.10: Determination of the relative syn and anti stereocenters of 295f by derivatization to 
oxazolidinones 299a-d for *H NMR spectroscopic analyses. Reagents and conditions: a) Pd/C (5%), H2, 
room temperature, methanol (46% for 298a-d); b) triphosgene, Et3N, Ar, THF, -10 °C to room temp,
(42% yield for 299a-d)
Having ensured the synthesis of oxazolidinones 299, preparative chiral HPLC is used to 
separate all 4 diastereoisomers of 295f and these syntheses are repeated on each 
diastereoisomer obtained (Scheme 4.1.10) to access syn- and anti-(298a-d). This leads 
to syn- and anti- oxazolidinones 299a-d.
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The trace chromatogram (Figure 4.1.1) shows that each isolated enantiomer o f 294f 
corresponds to a separate peak A-D (Table 4.1.3). 1HNMR spectroscopic J  coupling 
analysis of chirally pure oxazolidinones 299a-d (Scheme 4.1.10) allows correlation of 
the HPLC peaks (A-D) to the identities of 295f diastereoisomers (Table 4.1.3).
Compound
(Peak
entry)
Retention
time
(min)
Oxazolidinone JsynlJanti
(Hz)
295f(A) 34.7 299a 8.8 Hz ( a n t i )
295f(B) 38.7 299b 5.4 Hz ( s y n )
295f(C) 40.8 299c 5.4 Hz ( s y n )
295f (D) 44.2 299d 9.0 Hz ( a n t i )
Table 4.1.3: Identification of syn/anti products by chiral HPLC
Figure 4.1.1: HPLC trace for 295f
Anti-295i (peaks A and D) are separable, but syn-295f (peak B) and syn-295f (peak C) 
are more difficult to separate. On increasing the column loading from 2.5 mg ml"1 to 5 
mg ml"1 to obtain more of the syn enantiomers 295f (peak B) and 295f (peak C), the 
separation becomes even worse.
So that the desired sy«-(p-hydroxy-3-phenyl)serine isopropyl ester 295a is obtained via 
syn-295i (Scheme 4.1.6), preparative chiral HPLC is used to isolate peaks B and C 
simultaneously. Alkylation of the resultant sy«-295a should provide access to any syn- 
/?-substituted 3-phenylserine standard 295b-g for comparison with enantiomers 
produced by subsequent Sharpless AA reaction. For this protocol to be effective, the p- 
MOM group from the diastereomeric mixture of 295f has to be removed without 
removal of other protecting groups (i.e. the isopropyl ester or the A-Cbz group).
Compound 295f is reacted (Scheme 4.1.11) with 1-butanethiol and magnesium bromide 
and the /?-MOM group is successfully removed in 51% yield, to give 295a.176 As this 
method could be extended by simple alkylation procedures, we next turn our attention
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to isolating one sy«-enantiomer (peak B) using preparative chiral HPLC (Figure 4.1.1) 
for comparison with the corresponding Sharpless adduct.
OH
+ nBuSCH2SBun
OH
MgBr2, nBuSH, 
Et20 NHCbz
NHCbz
syn-295f
HO'
syn-295a, 51%
Scheme 4.1.11: Selective cleavage ofp-methoxymethyl group using a thioacetal protocol
4.1.4 Determination of absolute stereochemistry
It is thought that the absolute stereochemistry of syn 295f could be determined by using 
optical rotation data for a known derivative. The known derivative could be formed in 
one step (Scheme 4.1.12) using 6M HC1 to remove the />-MOM group, N-Cbz group and 
hydrolyse the isopropyl ester from the enantiomer syn-295f (peak B), which would be 
obtained by chiral HPLC purification (Figure 4.1.1). This should give pure syn-3-(4- 
hydroxyphenyl)serine enantiomer 300a as a hydrochloric acid (Scheme 4.1.12). An 
Amberlite IRA-97 resin could then be used (Scheme 4.1.12) to remove the hydrochloric 
acid from 300a and give syn-3 -(4-hydroxypheny l)serine enantiomer as the amino acid 
293a with unknown configuration. This could then be compared with the optical 
rotation data supplied by Herbert et al for known sy«-3-(4-hydroxyphenyl)serine 
(2/?,3S)-(300c) and (2S,3i?)-(300d) enantiomers (Scheme 4.1.12). From this data, the 
absolute configuration, deduced by optical measurements of 293a, should identify the 
stereochemistry of the original ^ -en an tio m er 295f, isolated as peak B (Figure
4.1.1).177
The synthesis is tested (Scheme 4.1.12) by conversion of L-tyrosine (301a) to L-tyrosine 
hydrochloric acid salt (301b) under acidic conditions. Lyophilisation of the aqueous 
mixture, maintaining the pH at 4.0 using a pH meter and the bead-wise addition of 
Amberlite IRA-97 resin provide 301a for comparison to known melting points. 
Isolation is simple, as the resin is removed by filtration and the aqueous mixture is dried 
by lyophilisation. The optical rotation is measured for 301a ([a]o =-11.8°) and found to 
be within acceptable error limits for the observed optical rotation of [a]o =-10.9°, seen 
in the literature for 301c.178 It iss found however, that the reliability of this result is 
dependent on the concentration being greater than 0.1 g/100 mL for this measurement.
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OH
,C 0 2/Pr
6HCI,stir 3d
NHCbz
'O' 'O'
syn-295f (unknown configuration in peak B)
Optical Rotation data
R
, C 0 2H
|  (2R3S)-300b R =OH
nh2 [a]D = +38° = 0.1g/100mL
_c o 2h
(2S,3R)-300c R =OH 
[a]o = -36° = 0.1g/100mL
301c R = H
[a]D = -10.9° = 5 g/100mL
,C 0 2h 
n h 2.hci
syn-300a R= OH (unknown configuration) 
301a R = H
Amberlite™ IRA-97 
pH 4.0 
water
,C 0 2h
n h 2
syn-293a R= OH (unknown configuration) 
301b R = H
Scheme 4.1.12: Derivatization to known standards 300c and 300d for determining the absolute 
stereochemistry of 293f
As only milligrams of syn-295f enantiomer (peak B) are obtained by chiral HPLC, a 
reliable optical rotation is too difficult to obtain. Also purification issues may arise if 
acidic hydrolysis does not cleave all the groups. Instead, a safer option is considered, 
using a Mosher’s ester route. The small amount of sy«-enantiomer 295f (obtained by 
chiral HPLC (peak B)) is kept for comparison with the corresponding Sharpless adduct 
as synthesised in chapter 5.
4 .2 Synthesis of Cinnamate 
precursors for Sharpless 
Asymmetric aminohydroxylation
The selected isopropyl cinnamate ester substrates 278a-g (Scheme 4.2.1) for preparation 
o f Sharpless AA A-Cbz 3-(p-substituted phenyl)serines 295a-g are identified in Scheme 
4.1.6. The required isopropyl cinnamate ester substrates 278a-g can be obtained using a 
number of routes. This section describes the synthesis of 278a-g using traditional 
Wittig reactions in organic, an organic/aqueous mixture and aqueous solvents. The 
Wittig methods are applied to the substrates (278a, 278b and 278f), which are not 
readily prepared by phenolic alkylation or carboxylate addition/esterification routes.
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C 02iPr
302
292a, 292b & 292f
Wittig 
(organic/aqueous) 
R, = OH
Wittig
(organic/aqueous)
,C 0 2iPr
278a 278b-g
Phenolic
alkylation
Sharpless
AA
(DHQ)2AQN
137a
carboxylate 
alkylation R' 
or esterification
OH
,C02/Pr
NHCbz
(2fl,3S)-295b-g
„C 02H
303b-g
a R = OH 
b R = OBn 
c R = OMe 
d R = OC6H13 
e R = OC16H33 
f R = OCH2OCH3 
g R = OTBDPS
Scheme 4.2.1: Retrosynthetic scheme for the synthesis of cinnamate substrates 278a-g
4.2.1 Wittig Methodology
The Wittig reaction is used to access cinnamate substrates 278a, 278b and 278f, as high 
E:Z ratios can be obtained using this approach. High E:Z ratios are required for 
Sharpless AA reactions to occur due to the nature of osmium binding. Aldehydes 292a 
(R = OH) and 292b (R =OBn) are commercially available, whilst the synthesis of 292f 
(R =OMOM) has previously been described (Scheme 4.1.9).
The phosphorous ylid 302 is generated from the phosphonium salt 304 and is used in its 
crude form in organic reactions, or is made in situ in aqueous reactions (Scheme 4.2.2). 
This is due to the inherent instability o f 302.179 The salt 304 is obtained in 95% yield 
from the reaction between isopropyl bromoacetate 305 with triphenylphosphine.
PPh3, 
toluene
'O /Pr  f j  ^  Ph3P + / ^ C 0 2,Pr P h j P ^ ^ ^ C O j / P r
305 940/0 304 NaOH (aq) 3Q2
Scheme 4.2.2: Synthesis of ylid 302
Phosphonium salt 304 is dissolved in dichloromethane and vigorously stirred with a 
sodium hydroxide solution. Separation o f the aqueous layer yields the crude 
phosphorous ylid 302. Addition o f aldehydes 292a (R = OH), 29b (R = OBn) and 292f 
(R = OMOM) in dichloromethane to the crude ylid 304 lead to the selected isopropyl
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cinnamate esters 278a (R = OH), 278b (R = OBn) and 278f (R = OMOM) as shown in 
Table 4.2.1 in good yields and with high E:Z selectivities.
^  / C 0 2,Pr
Ph3P'^ C 0 2/Pr
 302________
c h 2ci2
292a R = H
292b R = Bn
292f R = CH2OCH3
278a R = H 
278b R = Bn
278f R = CH2OCH3
Entry Aldehyde Product E:Z
__________________ (% yield) ratio3
1 292a 278a (90) 26:1
2 292b 278b (96) 25:1
3 292f 278f (75) 6:1
aAs determined by H NMR spectroscopic analysis
Table 4.2.1: Wittig reactions in dichloromethane
One disadvantage of using chlorinated organic solvents is that it costs four times as 
much to dispose of chlorinated waste than it does for non-chlorinated waste. Therefore, 
performing these reactions an aqueous environment may make the process more 
environmentally benign. In addition, the development of a one-pot reaction for forming 
Sharpless AA adducts directly from the in situ formation of cinnamates 278a, 278b, 
278d (R = C6H 13), 278e (R = C 16H33) and 278f may be possible.
Test reactions are initially carried out to see what effects a water-THF mixture (5:1 v/v) 
has on yields and E:Z  selectivities with the aldehydic substrates 292a (R = OH), 292b 
(R = OBn) and 292f (R = OMOM). These results are shown in Table 4.2.2.
/ C 0 2/Pr
Ph3P'^ C 0 2/Pr
 302________
in situ 
THF/water (5:1)
292a R = H 
292b R = Bn 
292f R = CH2OCH3
278a R = H 
278b R = Bn
278f R = CH2OCH3
Entry Aldehyde Product E:Z ratio3 
___________________(% yield)___________
1 292a 278a (83) 26:1
2 292b 278b (90) 56:1
3 292f 278f (93) 14:1
aAs determined by H NMR spectroscopic analysis
Table 4.2.2: Wittig reactions in THF/water
Wittig reactions in water/THF (5:1 v/v) using substrates 292a, 292b and 292f with 
phosphorus ylid 302 give improved E:Z ratios for cinnamates 278a, 278b and 278f 
compared to the reactions in dichloromethane (Table 4.2.1). The yields, however,
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decrease slightly for cinnamates 278a and 278b (entries 1 and 2), but increase from 
75% to 93% for cinnamate 278f (R = OCH2OCH3; entry 3).
With the substantial improvement in E:Z  selectivities on going from dichloromethane to 
aqueous THF, it is decided to test a wider range of substrates in water. Wu et a l, report 
reactions o f triethyl phosphonoacetate and diethyl 2-oxoalkanephosphonates with 
aldehydes in a Homer-Wadsworth-Emmons reaction in an aqueous environment, but 
decomposition of the phosphonium salts and phosphoms ylids caused by aqueous bases
1 OA
are observed. They also report that nitrobenzaldehyde 80 with 
(carbethoxymethylene)triphenylphosphorane (306), in the presence of aqueous lithium 
chloride, heated to reflux (Scheme 4.2.3) affords cinnamate (307) in 97% yield and with 
a 91:9, E:Z  selectivity. Wu et a l, investigates a wide range of aldehydes but they have 
to have a boiling point higher than that o f water, due to volatility issues. The order of 
reactivity o f the ^ -substituted aromatic aldehydes follows the expected pattern:
Electron withdrawing g ro u p s»  unsubstituted > electron donating groups.
All o f the yields are high (72-98%) and good E.Z  selectivities (85:15 to 95:5) are 
observed.
,C02Et
307
OEt
Water
reflux
LiCI306 O
Scheme 4.2.3: Synthesis of cinnamate 307 under aqueous conditions
Based on our previous observations, we decide to investigate a range o f aldehydes 
under aqueous conditions, without heating or with the addition of additives. These 
results are shown in Table 4.2.3. Triphenylphosphine oxide, a by-product o f the Wittig 
reaction should not be soluble in water and would be removed by filtration at the end of 
the reaction. Unfortunately, this is not the case and a chlorinated solvent has to be used 
for the workup as we are concerned that ether may not dissolve all o f the cinnamate 
products; whilst ethyl acetate has the potential to react unreacted triphenylphosphine 
forming ethyl crotonate and thus makes chromatographic separation o f the desired 
product difficult to perform.
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P h js P ^ ^ ^ C C ty P r
302________
in situ 
water
X 0 2/Pr
292a R = H 278a R = H
292b R = Bn 278b R = Bn
292d Rt = C6H13 278d R = C6H13
292e R-| = CigH33 278e R = C-|gH33
292f R = CH2OCH3 278f R = CH2OCH3
Entry Aldehyde Product 
(% yield)
E:Z ratio3
1 292a 278a (47) 26:1
2 292b 278b (67) 2:1
3 292d 278d (80) 30:1
4 292e 278e (80) 30:1
5 292f
1_ 11 1
278f (65) 15:1
Table 4.2.3: Wittig reactions in water
Aldehyde 292a (entry 1) gives the cinnamate 278a, but the reaction yield is low (47%). 
The E:Z ratio is maintained at 26:1 from the previous reaction (Table 4.2.2). Aldehyde 
292b (entry 2) gives the cinnamate 278b 67% yield (Table 4.2.3), which is lower than 
both reactions in dichloromethane (Table 4.2.1) or with aqueous THF (Table 4.2.2). 
Also the E:Z ratio is substantially lowered by using aqueous THF from 26:1 to 2:1 when 
compared with water. Aldehyde 292d is commercially available, but 292e requires 
synthesis (Scheme 4.2.4) and is readily prepared in 80% yield.
'O
292a
k2c o 3
Br(CH2)15CH3
DMF
Ar
80%
C 1 6 H 3 3 O
Scheme 4.2.4: Synthesis of 292e
Both aldehydes 292d and 292e (entries 3 and 4) give cinnamates 278d and 278e in high 
80% yields, with excellent E:Z  selectivities (30:1). This is not expected. We postulate 
that these aldehydes form reaction pockets in the aqueous media, whereby micelles 
envelope the ylid 302 and keep water out o f the reaction pocket. Moreover, creating 
localised areas of high concentration causes the reaction to be driven to completion and 
one face of the aldehyde is more readily available to the ylid. Finally, the use of 
aldehyde 292f (entry 5) gives cinnamate 278f and is obtained in good yields, in all 
solvents (65%-93% yields). The E:Z  selectivity improves slightly from 14:1 in 
dichloromethane (Table 4.2.1) when compared with 15:1 in aqueous THF (Table 4.2.2) 
and water. The water based Wittig reactions performs better than the Wittig reactions in
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dichloromethane. Furthermore, we find that additives (lithium chloride) and the need to 
reflux at high temperatures are unnecessary for these syntheses.
4.2.2 Other methods towards the synthesis of cinnamates
Standard esterification methods, carboxylate additions and phenolic alkylations are also 
used to access the desired isopropyl cinnamate esters 278a-g, all using commercially 
available compounds. The results of these syntheses are reported in this section.
Commercially available 4-hydroxycinnamic acid (303a) is alkylated at the phenolic 
position with benzyl bromide in alcoholic sodium hydroxide solution (Scheme 4.2.5), 
yielding 4-benzyloxycinnamic acid (303b) in 33% yield.
NaOH Acetyl chloride
isopropanol
reflux
86%
Scheme 4.2.5: Synthesis of 278b
Esterification of 303b (Scheme 4.2.5) is achieved using acetyl chloride with 
concentrated sulphuric acid in isopropanol heated at reflux and affords 4-benzyloxy 
isopropyl cinnamate (278b) in 86% yield. The overall yield for this route is 60%, which 
compared to the Wittig routes (even in water) is generally lower yielding (67%-96%) 
and requires more steps.
Fischer esterification (Scheme 4.2.6) o f commercially available 4-methoxycinnamic 
acid (303c) in isopropanol, heated to reflux with an acid catalyst, leads to the successful 
synthesis of 4-methoxy isopropyl cinnamate ester (278c) in 98% yield, thus providing 
the most direct route.
isopropanol
■C02h cone H2SQ4
reflux
98%
Scheme 4.2.6: Fischer esterification of 4-methoxycinnamic acid 303c
Commercially available 4-hydroxycinnamic acid (303a) is alkylated at the phenolic 
position with 1 -hexyl bromide and 1 -hexadecyl bromide in an alcohol/water mixture of 
potassium hydroxide (Scheme 4.2.5), yielding 4-hexyloxycinnamic acid (303d) in 43 % 
yield and 4-hexadecyloxycinnamic acid (303e) in 20% yield, respectively.
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, c o 2h KOHBcB..
303a
EtOH/water
(75:25)
43%
H2S 0 4 
,CQ2H isopropanol. 
reflux
303d R = C6H13, 43% 
303e R = C16H33, 20%
,C 0 2/Pr
278d R = C6H13, 50% 
278e R = C16H33i 20%
Scheme 4.2.7: Synthesis of 278d and 278e
A typical Fischer esterification protocol o f 303d and 303e (Scheme 4.2.7) affords 
cinnamates 278d in 50% yield and 278e in 20% yield, respectively. The overall yields 
for these reactions are 47% and 20% yields, which compared to the aqueous Wittig 
route are far more inefficient.
Cinnamate 278a (R = OH) is converted by conventional alkylation methods, as shown 
(Scheme 4.2.8).
C 0 2/Pr
Scheme 4.2.8: Reagents and conditions: (a) MOMC1, DIPEA, CH2CI2 -» 278f (24%); (b) imidazole, 
TBDPSiCl, DMF -► 278g (65%);
Cinnamate 278a in both instances are successfully alkylated at the phenolic position to 
give cinnamates 278f and 278g. As expected, the single Wittig reaction provides a 
better yield of 278g than using a two-step reaction.
4.3 Conclusion
A simple one-pot reaction (Scheme 4.1.3) of benzaldehyde 30 with glycine 282 under 
basic conditions yields the sy/7-3-phenylserine 284. Subsequent acetamide or 
benzyloxycarbonyl protection yields 285 and 287 (Scheme 4.1.3), respectively. 
Isopropyl ester formation by alkylation o f an in situ caesium salt of 285 and 287, yields 
desired syn chiral HPLC standards 286 and 288 (Scheme 4.1.3). The syn-diol by­
product 289, associated with the Sharpless reaction, is also readily synthesised (Scheme 
4.1.4). A short reaction sequence (Scheme 4.1.5) involving the reduction of isopropyl 
ester 288 and removal of the benzyloxycarbonyl group of 290 yields the desired syn 
aminodiol 291 and could be readily applied to the synthesis of other syn-3-N-Cbz-(p- 
substituted phenyl)serines substrates, 295a-g.
An investigation into the synthesis o f a range of 5p«-3-(p-substituted phenyl)serines 
using glycine 282 is attempted. First benzyloxybenzaldehyde (292b) is reacted with
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glycine 282 and this leads to the formation of 3-(p-benzyloxypheny l)serine 293b 
(Scheme 4.1.7) in a 60:40 syn!anti ratio. Subsequent hydrogenolysis methods fails to 
yield a desired 3 -(p-hydroxyphenyl)serine (293a). Attempts to form a chiral HPLC 
standard by benzyloxycarbonyl protection of 293b fail (Table 4.1.2). This is due to its 
amphiphilic nature. Isopropyl ester formation using 293b (Scheme 4.1.8) in the 
presence o f acetyl chloride with isopropanol is successful and affords 297, but only in 
10% yield. Attempts to synthesise A-Cbz-294b using 297 are unsuccessful.
Then glycine 282 is reacted under basic conditions with p -MOM benzaldehyde (292f) 
and provides a divergent route (Scheme 4.1.9), allowing access to a 1:1 diastereomeric 
mixture o f 3 -(p-methoxymethylphenyl)serine (293f). Subsequent N-Cbz protection and 
isopropyl ester formation, as before, gives chiral HPLC standard 295f. Chiral HPLC 
separation of the 4 peaks and derivatization o f each peak collected (peaks A-D) to give 
oxazolidinones 299a-d (Table 4.1.3) allow elucidation of the relative stereochemistry in 
peaks A-D of 295f. Syn products of 295f (peaks B and C) are collected as one product 
using preparative chiral HPLC and removal of the p-MOM group using «-butane thiol 
in the presence of magnesium bromide afford 295a (Scheme 4.1.11), which could be 
alkylated to give any other sy«-p-substituted alkoxy Sharpless adduct.
The determination of the absolute stereochemistry o f 295f is defined in the next chapter 
by comparison against Mosher’s ester formation. This is achievable using the Sharpless 
AA reaction, as not enough purified chiral HPLC 295f is available for the tentative 
route outlined in Scheme 4.1.12.
Three main routes are investigated towards the formation of cinnamate substrates used 
in the Sharpless AA reaction. The Wittig reactions of p-hydroxybenzaldehyde (292a), 
p-benzyloxybenzaldehyde (292b) and p-methoxymethylbenzaldehyde (292f) with the 
phosphorous ylid 302 in dichloromethane (Table 4.2.1), aqueous THF mixture (Table
4.2.2) and in water (Table 4.2.3) are investigated. There are no major differences 
between the three reaction media, with yields ranging from 47%-96%. The lower yields 
are observed generally in aqueous media, but the E:Z selectivities improve on going 
from dichloromethane to aqueous solvents.
Other methods, including esterification and phenolic alkylation, are used with 
commercially available cinnamic acid to access a variety of cinnamates (Scheme 4.2.6,
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Scheme 4.2.7 and Scheme 4.2.8). Those cinnamic acids that are not commercially 
available are readily synthesised by phenolic alkylation. Fisher esterification protocols 
are used to access cinnamates 278b-g. On the whole, the Wittig route is superior in 
terms of yields and is performed in one step. This provides all the selected test 
substrates for the Sharpless AA.
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Chapter 5
5. 1 Sharpless Asymmetr
Aminohydroxylation 
cinnamates
As shown previously (Scheme 5.1.1) the products generated using cinnamates 278 with 
chiral ligand (DHQ)2AQN 137a are 3-phenylserine enantiomers 280a and 280b and are 
now used as part of a synthetic strategy towards the desired chiral aminodiols 281.
ZNCINa or AcNBrLi 
K20 s0 2(0H)4 or 
0 s 0 4 
or Osmylated resin 
DHQ\D2PHALor 
DHQVDzAQN (5 mol%)i 
I I 27g nPrOH or fBuOH/ H2o ’
0 °C or 
room temp 
Z = Cbz, or
Ac (DHQJzAQN
promoted
products
depending on conditions
OH OH
280a nhz 280b n h z
Short reaction sequence
.OMe
OR
OH
DHQ (a) DHQD (b)
OAlk (a) or (b) O OAlk (a) or (b)
OALK (a) or (b) O OAlk (a) or (b) 
AON 137a o rbPHAL 136a o rb
Scheme 5.1.1: N-protected aminoalcohol esters generated from cinnamates 278 by Sharpless AA
The isopropyl cinnamate esters 170 (Ri = H) and 278b-g (Rj = Alkoxy group), as seen 
in Figure 5.1.1, were synthesised and are detailed in section 4.2. The isopropyl 
cinnamate esters 278b-g are elected to investigate the size effects of various p- 
substituted alkoxy groups on the yields, regio- and enantioselectivities in the Sharpless 
AA reaction. A one-pot synthesis provides a route towards syn chiral HPLC standards 
286 and 288, whereas 295f is only accessible in a 1:1 diastereomeric ratio (Figure
5.1.1). These standards are for the purposes of chiral HPLC elucidation and to test the 
synthetic methods towards syn-(S,S)-aminodio\s 281. The Sharpless AA reaction is
(DHQ)2PHAL
promoted
productsNHZ NHZ
279a OH 279b OH
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employed to synthesise either (2R,3S)-N-Cbz 3-phenylserine enantiomer 280a or 
(2S,3R)-N-Cbz 3-phenylserine enantiomer 280b. These can be achieved using chiral 
ligands (DHQ^AQN 137a or (DHQD^AQN 137b, respectively. We elect to use 
(DHQ)2AQN 137a in the Sharpless AA reaction to yield (2R,3S)-N-Cbz 3-phenylserine 
enantiomer 280a. (2S,3R)-N~Cbz 3-phenylserine enantiomer 280a could be isolated 
using preparative chiral HPLC and then converted to the (S^-am inodiols 281 (as 
previously detailed in section 4.1.2).
OHOH
278b-g
286 NHAc NHCbz
288
295f R, = OCH2OCH3
Cinnamates
Syn HPLC standards 
OH
278b R, = OBn 
278c Rt = OMe 
278d R, = OC6H13 
278e Ri = OC16H33 
278f R, = OCH2OCH; 
278g R, = OTBDPS 289 OH
Figure 5.1.1: Cinnamates and sy«-HPLC standards previously synthesised for comparison to Sharpless
adducts
Notwithstanding, the isopropyl cinnamate esters 170 and 278b-g resemble some of the 
desired aromatic aldehydes 2 that may be used in the dual TK/TA (Scheme 5.1.2) in 
terms of the alkoxy groups at the /^-position of the aromatic ring.
Reaction of lithium hydroxypyruvate lc  with aliphatic aldehydes 2 in the presence of 
TK recently confirm1 that (*S)-keto diols 3 are generated. TA is also recently shown to 
preferentially accept (S)-ketodiols 3. This would give rise to syn-(R,R) aminodiols 4. 
Nonetheless, through genetic engineering o f TA, it may be possible to accept aromatic 
keto diols with (i?)-stereochemistry, giving rise to aminodiols with syn-(S,S)~ 
stereochemistry. In terms of asymmetric synthesis, the Sharpless AA route provides the 
most direct route in establishing the syn-(2R,3S) stereocenters in the N-Cbz 3- 
phenylserine enantiomers.
1 Unpublished results, Hailes, H.C., Smith, M.E.B.
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Asymmetric 1
synthesis 1
Chemical
or
amine donor ketone
Scheme 5.1.2: Synthesis of aminodiols using TK/TA dual enzyme or chemoenzymatic route
Homogeneous and heterogeneous catalytic Sharpless AA reactions are performed using 
the (DHQ)2AQN ligand 137a and the results are presently discussed.
5.1.1 Homogeneous catalysis
There is a large literature precedent for the use of (DHQ)2PHAL 136a in Sharpless A A 
reactions,' o ^ 102’103*105’110’124’16 2 ,i8 U 8 2 ,i8 3  v a r j o u s  jSOpropyl cinnamates 170 (Ri = H)
and 278b-g (Ri = Alkoxy), ethyl cinnamates 308 and methyl cinnamates 182. These 
yield the expected (2R,3S)-3-phenylisoserine enantiomers 279a. The corresponding 
(DHQD)2PHAL 136b give rise to (2S,3R)-3-phenylisoserine enantiomer 279b (Scheme
5.1.1). Sharpless AA reactions with 170 (Ri = H) and 278b-g (Rj = Alkoxy) in the 
presence of (DHQ)2PHAL 136a under homogeneous catalytic conditions are undertaken 
for the main purpose of determining regioselectivities and enantioselectivities when 
compared with the analogous reactions using (DHQ)2AQN 137a, giving (2R,3S)-3- 
phenylserine enantiomers 280a.
Chiral HPLC elucidation of the semi-purified product mixtures resulting from Sharpless 
AA reactions using (DHQ)2AQN 137a would still contain the (2R,3S)-3- 
phenylisoserine enantiomer 279a and so these HPLC peaks need to be identified against 
the desired (2R,3iS)-3-phenylserine enantiomers 280a (Scheme 5.1.1). The synthesis of 
(2R,35)-3-phenylserine enantiomer 280a heading to .syu-(S,S)-aminodiols 281 (Scheme
7 85.1.1), ’ warrants an investigation into improving the regio- and enantioselectivities of 
the Sharpless AA reaction. This is done so that the final yield of syn-(S,S)-28\ would 
be increased by minimizing the formation of undesired by-products. This, we thought 
could be achieved by either homogeneous or heterogeneous catalysis.
Morgan et al. and Tao et al., previously report that yields and regioselectivities of 
(2R,3S)-3-phenylisoserine enantiomers 279a, formed using (DHQ)2PHAL 136a exceed
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those from the analogous Sharpless AA reactions using (DHQ^AQN 137a, which 
would yield (2^,3S)-3-phenylserine enantiomer 280a (Scheme 5.1.1).7,8 For example, 
O’Brien reports a direct comparison of the Sharpless AA with a Cbz-carbamate nitrogen 
source with methyl cinnamate 182 in the presence of both 136a and 137a, yielding 
(2^,3.S)-3-phenylisoserine enantiomer (309) and (2i?,3S)-3-phenylserine enantiomer 
310, respectively (Scheme 5.1.3).183
NHCbz
C 0 2Me
(DHQ)2PHAL
137a 309 OH
65%; 7:1 regioselection; 
94% ee
.C 0 2Me
AA %  
(DHQ)2AQN 
138a
,C 0 2Me
310 NHCbz
58%; 4:1 regioselection;
95%
Scheme 5.1.3: Sharpless AA reaction with methyl cinnamate in the presence of either (DHQ)2PHAL 
136a and (DHQ)2AQN 137a
A number of nitrogen sources are used in the Sharpless AA reaction and are discussed 
in the introduction. Several of these nitrogen sources (certain carboxamides,181 
aminohetereocycles111 and sulfonamides118) require synthesis. Therefore these nitrogen 
sources are not explored, so as to achieve the shortest possible synthetic route to 
(2R, 3S)-280a. The most successfully used nitrogen sources giving (2R,3S)-3- 
phenylisoserine enantiomers 279a (Scheme 5.1.1) are A-bromoacetamides124 and A- 
halocarbamates.162 Adopting this strategy, unsubstituted isopropyl cinnamate ester 170 
and p -substituted isopropyl cinnamate esters (278b-g) are used with A-bromoacetamide 
or benzyl carbamate in the presence of (DHQ^PHAL 136a under homogeneous 
Sharpless AA conditions.
Many Sharpless AA reactions utilise isopropyl cinnamate ester 170 with an A- 
bromoacetamide nitrogen source and (DHQ^PHAL 136a, but methyl and ethyl 
cinnamate esters when A-halocarbamates are used.63,124,166 Sharpless AA reactions with 
A-bromoacetamide and A-halocarbamates with (DHQ^AQN 137a are performed, as 
this type of comparison has not been reported with electron rich cinnamates - known to 
be good substrates for the Sharpless AA reaction.7,8
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The use o f styrenes though, are reported, both using chiral ligands 136a and 137a, in the 
presence of A-bromoacetamide and with some //-halocarbamates. These reports show 
varying levels o f success. Tao et al., for instance finds the amide-based A A preference 
is to place the nitrogen on the terminal non-benzylic carbon and is accentuated using 
(DHQ)2 AQN 137a. This is to our advantage.184’115
Therefore, we rationalise that a similar effect may occur with isopropyl cinnamate esters 
170 and 278b-g, owing to some of the successes reported by O’Brien (Scheme 5.1.3), 
but we decide to use benzyl carbamate as the nitrogen source in these transformations. 
This is after considering the following advantages and disadvantages o f each nitrogen 
source and then trialling them with isopropyl cinnamate.183
A-Bromoacetamide acts as both the oxidant for osmium and as the nitrogen source, 
whereas carbamates require an external oxidant.166 For, A-bromoacetamide, it is 
observed that the stereochemical outcome o f Sharpless AA reactions (irrespective of the 
regiochemical outcome) is analogous to the asymmetric dihydroxylation (AD) reaction. 
The empirical rule states that dihydroquinyl ligands (DHQ)-136a or 137a, should give 
rise to oxidation predominantly at the a-side of the olefin and exhibit (2R,3S) product 
stereochemistry, exemplified by 279a (Scheme 5 .1 .1 )102’106’185’186 The outocme has not 
been established in detail for carbamate nitrogen sources, but was assumed to be 
similar.124 It is also known that higher yields and enantioselectivities could be obtained 
when a less sterically demanding substituent is placed at the nitrogen atom of the 
aminoalcohol, so favouring the use of A-bromoacetamide. Furthermore, 
chromatographic separation o f the A-Ac-3-phenylserines is reported as easier than with 
A-Cbz-3-phenylserines.162
Nevertheless, removal of A-acetamide groups is not as easy as with A-Cbz groups, 
which are cleaved by hydrogenolysis.162 Additionally, A-bromoacetamide reactions are 
conducted at 4 °C to minimize the formation of Hoffman rearranged products;124 but t-
butyl hypochlorite, an oxidant used with the carbamate nitrogen source in Sharpless AA
• 162reactions could be problematic due to its light sensitivity, difficulty o f synthesis and 
short shelf life.187 Barta et al. however, detail the use of two solid oxidants which could 
be substituted for /-butyl hypochlorite and claim that they have no deleterious effects on 
yields, regio and enantioselectivities.176 These are l,3-dichloro-5,5-dimethylhydantoin 
(311) or dichloroisocyanuric acid (312), both commercially available (Figure 5.1.2).
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Neither oxidant have been used in homogeneous Sharpless AA reactions with 
cinnamates in the presence of (DHQ^AQN 137a.
311 312
Figure 5.1.2: l,3-dichloro-5,5-dimethyl hydantoin (311) and dichloroisocyanuric acid (312) oxidants
Moreover, Barta et al also states that by using a small excess of base, chromatographic 
separation o f A-carbamate Sharpless AA adducts could be simplified by using an in situ 
conversion to oxazolidinones (313) (Scheme 5.1.4).
Scheme 5.1.4: Synthesis of oxazolidinone from using a nitrogen carbamate source
Taking into account these facts, we perform a series of reactions with unsubstituted 
cinnamate esters.
5.1.1.1 Homogeneous Sharpless AA reactions with unsubstituted 
cinnamate esters and M-halocarbamates or M-bromoacetamide
The results of Sharpless AA reactions (Scheme 5.1.5) are shown for various 
unsubstituted cinnamate esters (Table 5.1.1). Regioselective ratios (A:B) are for A, the 
3-phenylisoserine enantiomer, the product generally formed using (DHQ^PHAL 136a. 
Whilst, B represents the desired 3-phenylserine enantiomer formed using (DHQ^AQN 
137a.
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OH
,C 0 2R
170 R = /Pr 
308 R = Et 
182 R = Me
AA (a) or AA (b)
„c o 2r
OH
(2R,3S)-3-phenylisoserine regisomer 
179 Z = Ac, R = /Pr 
316 Z = Cbz, R = /Pr
AA(a) for NaN(Cbz)CI and NaN(COo)EtCI: 
K2[0 s(0 H2)4].2 H20  (4 mol %)
NaOH and (DHQ)2PHAL (5 mol %) in fBuOH:H20  (1:1) or 
(DHQ)2AQN (5 mol %) in nPrOH:H20  (2:1) 
oxidants 311 or 312 
AA(b1 for AcNLiBr:
0 s 0 4 (4.5 mol %)
LiOH and (DHQ)2PHAL (5 mol %) in fBuOH:H20  (1:1) or 
(DHQ)2AQN (5 mol %) in nPrOH:H20  (2:1)
„C 02R
NHZ
(2R,3S)-3-phenylserine regioisomer
286 Z = Ac, R = /Pr 
288 Z = Cbz, R = /Pr
314 Z = Ac, R = Et
315 Z = Ac, R = Me
317 Z = C 02Et, R = Et
318 Z = Cbz, R = Et
Scheme 5.1.5: Sharpless AA reactions with unsubstituted cinnamate esters
Entry Nitrogen
Source
Cinnamate Ligand ( 2 R , Z S )  
Product 
(% yield)
(lit. Yield, 
R = e s te r  
group, if 
avail)
A:Ba
(A:B from 
literature, 
if avail)
E e  (%) 
(2R.3S)
(Lit Ee, 
If avail)
1 AcLiNBr 170 (DHQ)2AQN 286, 15d, 
11e 
179, 79d, 
(72, 
/Pr)124
1:3c’2:5d 17c
2 AcLiNBr 170 (DHQ)2PHAL 15:1 
(>20:1, 
/P r )124
90c, (99)124
3 AcLiNBr 308 (DHQ)2AQN 314, 20d 1:1 12c
4 AcLiNBr 182 (DHQ)2AQN 315, 16d 1:1 30°
5 NaNCbzCI 170 (DHQ)2AQN 288, 66d, 
(58, Me)8
2:3 (1:4, 
Me)8
94b(95)8
6 NaNCbzCI 170 (DHQ)2PHAL 316,
80,df 
(65, 
M e)162
18:1
(7:1,
M e)162
94c, (94)162
7 N aN C 02EtCI 308 (DHQ)2AQN 317,
(48)f'g,
3:2 n/a
8
a * _ j  „
NaNCbzCI
.. 1. . i . .
182 (DHQ)2AQN
. . . .  .
318,
48d’9,
16dh,
1:1
2:3e
n/a
aAs determined by 'H NMR spectroscopic analysis, BChiralpak AD, 80:20 (hexane:/PrOH), 0.6 mL mirf1; cChiralpak 
ODH, 60:40 (hexane:/PrOH), 0.5 mL min-1; d1 mmol scale; e5 mmol scale; f6.5 mmol scale; 91,3-dichloro-5,5-dimethyl
hydantoin (311); hdichloroisocyanuric acid (312);
Table 5.1.1: Results of Sharpless AA reactions with unsubstituted cinnamate esters using differing
nitrogen carbamate and amide sources
O’Brien states that the enantioselectivity would not be affected by altering the ligand 
from 136a to 137a with the same nitrogen source, which proves true for N-Cbz 
carbamate sources.183 Contrary to this observation, however, are the levels of 
asymmetric induction seen by changing the nitrogen source to A^-bromoacetamide. N- 
bromoacetamide (Table 5.1.1) with isopropyl cinnamate ester 170 under homogeneous
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conditions (entry 1) gives (2i?,3«S)-iV-Ac-3-phenylserine enantiomer-286 in 15% yield. 
This is worse than the analogous (2i?,3‘5)-Ar-Cbz-3-phenylserine enantiomer-288, which 
is obtained in 66% yield (entry 5). The regioselectivity of (27?,3‘5)-A-Ac-3-phenylserine 
enantiomer 286 is 1:3, whilst the enantioselectivity is poor, 17% ee.
Yet, a switch to (DHQ)2PHAL 137a (entry 2) gives 3-phenylisoserine enantiomer 
(2R,2S)-\19 (as expected) in high yield 79%, with excellent regioselectivities (15:1) and 
excellent enantioselectivities, 90% ee. Our results are directly comparable to the 
literature results available for (2R,3S) -A-Ac-3-phenyl serine regioisomer 179, though 
we observe a small drop in ee. It is rationalised that the drop in enantioselectivity to 
17% ee observed with (1R,35)-286 from 90% ee, observed with (2R,3S)-119 is a result 
of changing the chiral ligand from 136a to 137a. It is likely that unfavourable 
stereoelectronic effects and unfavourable binding interactions in the pocket of the chiral 
ligand were responsible for such a decrease in enantioselectivity.
To ensure this behaviour is not being affected by the size of the ester group alone, the 
corresponding ethyl ester (27?,3S)-314 (entry 3) and methyl ester (2R,3S)-315 (entry 4) 
A-Ac-3-phenylserine enantiomers are synthesised using (DHQ)2AQN 137. These are 
obtained in 20% and 16% yields, respectively. The regioselectivity is affected, going 
from 1:3 observed with the isopropyl ester (entry 1) to 1:1 with both (2R,3S)-314 and 
315. The enantioselectivities are poor, 12% ee for (2i?,3S)-314, but an improvement is 
noted for 315, obtained in 30% ee.
From these results, it is decided that A-halocarbamates (Table 5.1.1) urethane (ethyl 
carbamate) and Cbz-carbamate are to be used as nitrogen sources in the following 
Sharpless AA reactions. Isopropyl cinnamate ester 170 (Table 5.1.1) using 
(DHQ)2AQN 137a with Cbz carbamate (entry 5), provides (2^,3S)-A-Cbz-3- 
phenylserine enantiomer-288 in 66% yield and in a 2:3 regioselective ratio. The 
enantiomeric purity o f (2R,3S)-2HH is 94% ee and our result is comparable to the 
literature result available for the corresponding methyl ester. A change o f ligand from 
(DHQ)2AQN 137a to (DHQ)2PHAL 136a (entry 6 ) gives (2R,3S)-N-Cbz-3- 
phenylisoserine enantiomer 316 in excellent yields, regio- and enantioselectivities. 
Again this result is comparable to the available literature result for the corresponding 
methyl ester. The (2R,3S) absolute configuration is assigned by analogy to 3- 
phenylserine enantiomers formed in the literature, where (DHQ)2AQN 137a is used
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(Scheme 5.1.3).8 This assumes that oxidation was occurring predominantly at the a-face 
of the cinnamate, as previously detailed.124
Ethyl cinnamate 308 is reacted with urethane (entry 7), a smaller nitrogen source than 
Cbz-carbamate (entry 8). Both reactions give similar yields and regioselectivities. To 
establish whether oxidants l,3-dichloro-5,5-dimethylhydantoin (311) and 
dichloroisocyanuric acid (312) would improve yields or regioselectivities, assuming that 
similar enantioselectivities are achieved, ethyl cinnamate 308 is reacted under 
homogeneous Sharpless AA conditions. As shown in Table 5.1.1 (entry 8), oxidant 311 
gives a yield o f 48% for 3-phenylserine enantiomer (2/?,3S)-317. This is reduced to 
16% when oxidant 312 is used, but a slight improvement in regioselectivity is observed 
for (2£,3S)-A-Cbz-318.
From these results (Table 5.1.1), further investigations are then performed with Cbz 
carbamate and ^-substituted isopropyl cinnamates 278b-g due to the reasonable yields, 
regio- and enantioselectivities observed (entry 5).
5.1.1.2 Homogeneous Sharpless AA reactions with p-substituted 
isopropyl cinnamate esters with N -Cbz carbamate
Electron poor cinnamates are described as non-ideal substrates with A-Cbz carbamates 
from previous studies.8 Therefore, electron-rich p-substituted isopropyl cinnamate esters 
278a-g (Figure 5.1.3) with (DHQ)2PHAL 136a are reacted under homogeneous 
conditions to give various (27?,35)-3-phenylisoserine enatiomers-279a (Scheme 5.1.1), 
aiding HPLC elucidation as before.
■CO 2/Pr
b R = OBn 
c R = OMe 
d R — OC6H13 
e R = OC16H33 
f R = OCH2OCH3 
g R = OTBDPS
Figure 5.1.3: p-substituted cinnamate esters
The results of these homogeneous Sharpless AA reactions are shown first for 
homogeneous Sharpless AA reactions with (DHQ)2PHAL 136a (Table 5.1.2) and then 
with (DHQ)2AQN 137a (Table 5.1.3), which forms part of the synthetic strategy 
towards 5y,«-(1S',S)-aminodiols 281 (Scheme 5.1.1). The regioselective ratio A:B is where 
A is the (2i?,3S>3-phenyisoserine enantiomer (319b-g) formed using (DHQ)2PHAL
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136a. Whilst, B is the desired (2^,35)-3-phenylserine (295b-g) enantiomer formed 
using (DHQ)2AQN 137a.
A
NHCbz
B
OH
, C 0 2/Pr
278b-g
C 0 2/Pr
, C 0 2/Pr
NHCbz
(2R,3S)-3-phenylisosenne regioisomers (2R, 3S)-3-phenylserine regioisomers 
319b-g 295b-g
AA(a) for NaNCbzCI:
K2[0 s(0 H2)4].2H20  (4 mol %)
NaOH and (DHQ)2PHAL (5 mol %) in 'BuOH:H20  (1:1) or 
(DHQ)2AQN (5 mol %) in nPrOH:H20  (2:1) 
oxidant 311
Entry R (2R,ZS) Product 
(% yield ) 3
A:Bb Ee (%) 
(2R,3S)C
1 OBn 319b, 80 18:1 94
2 OMe 319c, 48 28:1 96
3 OCeH13 319d, 65 5:3 90
4 O C 16H33 319e, 6 4:1 87
5 OMOM 319f, 15 19:1 94
6 OTBDPS 319g 49
"K" -1 1_11 1 niirT
3:1 95
__I
(hexane:/PrOH), 1 mL min'
Table 5.1.2: Results of the homogeneous Sharpless AA reactions with the (DHQ)2PHAL 136a ligand
No literature results are available for 3-phenylisoserine enantiomers (2/?,3S)-319b-g as 
these are novel compounds (Table 5.1.2). The additional benzyl group on cinnamate 
278b results in 3-phenylisoserine enantiomer (2R,3»S)-319b (entry 1) and is thought to 
be responsible for favourable n-n stacking interactions within the binding pocket of 
either chiral ligand 136a and 137a. This is exemplified by having the highest (80% 
yield) of this reaction series, giving excellent regioselectivities (18:1) and having 
excellent enantioselectivities (94% ee). The smallest substituent at the />-alkoxy 
position, R = OMe of cinnamate 278c (entry 2) gives 3-phenylisoserine enantiomer 
(2R,3S)-319c in a moderate 48% yield, but has the highest regio- and 
enantioselectivities for this reaction series.
Aliphatic olefins do not show high levels of regioselectivities or high levels of 
asymmetric induction with either chiral ligand 136a or (DHQ)2AQN 137a.105 p-Alkoxy 
groups (R = OC6Hj3 and R = OC16H33) attached to cinnamates 278d and 278e (entries 3 
and 4) are reacted to see if the favourable 71-71; stacking interactions within the binding 
pocket of (DHQ)2PHAL 136a are interrupted by these alkyl chains. 3-Phenylisoserine 
enantiomer (2R,3S)-319d with a p-hexyloxy side chain (entry 3) is given in 65% yield,
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but the regioselectivities is 5:3. This effect is observed also with the longer alkyl 
substituent (OC16H33) and gives 3-phenylisoserine enantiomer (2/?,3iS)-319e, isolated in 
6% yield. The regioselectivity for (2R,3S)-319e was 4:1, but both (2jR,3*S)-319d and 
(2R,3S)-319e are formed in lower enantioselectivities, 90% and 87% ee’s, respectively 
when compared with (2i?,35)-319b (entry 1) or (2R,3S)-319c (entry 2).
A / 7-methoxymethyl isopropyl cinnamate 278f gives 3-phenylisoserine enantiomer 
(2i?,3S)-319f in 15% yield (entry 5), in high regioselectivity (19:1) and 
enantioselectivity (94% ee).
The “bulkiest” group used on cinnamate 278g (R = OTBDPS) gives 3-phenylisoserine 
enantiomer (2^,3S)-(319g) and interesting results (entry 6 ). The yield achieved is 49%, 
but the regioselectivities are low (3:1), without having a detrimental effect on the 
enantiomeric purity, 95% ee.
Using the same cinnamates 278b-g, homogeneous Sharpless AA conditions are 
repeated, but with chiral ligand (DHQ)2AQN 137a (Table 5.1.3).
Entry R (2R,ZS) Product/ 
(% yield) 3
aTb6 Ee (%) 
(2f?,3S)cd
1 OBn 295b (76) 3:4 93
2 OMe 295c (60) 1:5 95
3 OCeH1 3 295d (75) 5:7 91
4 OCI6 H3 3 295e (34) 1:1 86
5 OMOM 295f (76) 1:1 93e
6 OTBDPS 295g (40)bA_i x  _i 1_- 1. ■ 111 1 1:8 95
(hexane:/PrOH), 1 mL mirf ;°By analogy to previous literature data, eA d iscussion  in the text follows 
Table 5.1.3: Results of the homogeneous Sharpless AA reactions with (DHQ)2AQN 137a
As before, an additional benzyl group on cinnamate 278b (entry 1) is thought to 
improve the favourable n-n stacking interactions within the binding pocket of 137a, 
affording 3-phenylserine enantiomer (2i?,3*S)-295b in 76% yield. This yield is 
comparable to (2^,3S)-319b (entry 1, Table 5.1.2), but a large decrease in 
regioselectivity for 3-phenylserine enantiomer (27?,3»S)-295b (nearly 1:1) is observed 
when compared with 3-phenylisoserine enantiomer (2R,3S)-319b (Table 5.1.2, entry 2). 
The enantioselectivities are unaffected, with a 93 % ee observed for 3-phenylserine 
enantiomer (2R,3S)-295b. Cinnamate 278c (entry 2) with the smallest substituent at the 
^-alkoxy position gives 3-phenylserine enantiomer (2R,3S)-295c in 60% yield. This is 
unexpected, as generally yields for Sharpless AA reactions with (DHQ)2PHAL 136a
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(48%, entry 2, Table 5.1.3) are higher than those with (DHQ^AQN 137a. The 
regioselectivities, however, decrease to 1:5 for 3-phenylserine enantiomer (2R,3S)-295c 
from 3-phenylisoserine regioisomer (2i?,3S)-319c (28:1). The enantioselectivities 
remain unaffected by changing from (DHQ^PHAL 136a to (DHQ^AQN 137a and are 
high (95% ee) for (2i?,3S)-295c.
With large alkyl groups at the /7-alkoxy position of cinnamates 278d and 278e, the 
corresponding 3-phenylserine enantiomers (27 ,^3.S)-295d and (2i?,3»S)-295e (entries 3 
and 4) are obtained. Yields are comparable with 3-phenylisoserine enantiomers (2R,3S)~ 
319d (75% yield) and (2i?,3S)-319e (34% yield), as shown in Table 5.1.2. The trend in 
regioselectivities and enantioselectivities follow the traits already seen thus far.
p-Methoxymethyl cinnamate 278f (entry 5, Table 5.1.3) gives 3-phenylserine 
enantiomer (2i?,35)-(295f) in a 76% yield. This is compared to the 15% yield obtained 
for the 3-phenylisoserine enantiomer (2J?,3«S)-319f, seen in Table 5.1.2. The 
regioselectivities are affected significantly when (DHQ^PHAL 136a (entry 5, Table
5.1.2) are compared to the regioselectivities of reactions involving (DHQ^AQN 137a 
(Table 5.1.3). Little effects on the enantioselectivities are observed when either ligand 
136a or 137a are used. The only major difference observed is when cinnamate 278g is 
used. This has a bulky OTBDPS group. The yield of 3-phenylserine enantiomer 
(27?,3S)-(295g) (entry 6 , Table 5.1.3) is similar to 3-phenylisoserine enantiomer 
(2i£,3S)-319g (entry 6 , Table 5.1.2) being in the 40-50% region. The regioselectivity, 
however, improves to 1:8 for the 3-phenylserine enantiomer (2R,3S)-295g from 3:1 for 
the 3-phenylisoserine enantiomer (2-fl,3S)-319g. This is also achieved without having 
any deleterious effects on enantioselectivities of (27?,3S)-295g, which is obtained in 
95% ee.
Co-injecting an analytical sample of previously obtained 295f (via a diastereoselective 
synthesis, see section 4.1.4) by chiral HPLC separation confirms the identity of 
Sharpless AA product 295f. Sharpless AA product (2R,3S)-295i is isolated and is 
converted to a Mosher’s («S)-MTPA ester 320 (Scheme 5.1.6) for confirmation of the 
absolute configuration as (2R,3S).
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o
.C 0 2/Pr.C 0 2/Pr
DCC, (S)-MTPA, CH?CI?, 
53%
NHCbzNHCbz
MOMO'
Scheme 5.1.6: Synthesis of Mosher’s ester 320
A DCC coupling of the secondary alcohol 295f with (S)-(+)-a-methoxy-a-
trifluoromethylphenylacetylacid (5)-MTPA gives the Mosher’s ester 320 in 53% yield.
• 188The use o f Mosher’s esters to assign chiral centres is well known from the literature 
and useful conformation correlation models exist, which are used with 320a (Figure 
5.1.4) and aid the confirmation of the absolute configuration of the alcohol as a (35)- 
stereocenter.
OMOM
,OMOM
NHCbz
OMpH(NHCbz)C02/Pr
320a 320b
Figure 5.1.4: Conformational correlation model 320a and 320b for (S)-MTPA 320
Our model, in accordance with the literature,188 places the a-trifluoromethyl group and 
carbonyl oxygen eclipsed.189 Ha is eclipsed by the carbonyl group. Assuming a trans- 
ester conformation is present, shown as the extended Newman projection 320b, the 4- 
(MOM)Ph group would be close to the shielding influence of the magnetically 
anisotropic aromatic group and is expected to resonate at higher fields (typically ASh =
0.04 ppm). In our result, the OMOM group has A8h = 0.07 ppm, supporting the first 
part of this model.
In the second part of the literature model, the OMe group of (5)-MTPA (Figure 5.1.5) is 
oriented towards the anisotropic carbonyl group and means ASh should be > 0.04 ppm 
for Ha. In our case, this is observed for Ha and it has a ASh = 0.1 ppm, indicating that 
the 5,5 diasteroisomer is present in 320b (Figure 5.1.4).188
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Figure 5.1.5: Extended NMR region of (5)-Mosher’s esters 320
Confirmation of the stereocenter as (35) in 320, gave the second stereocenter as (2R), 
because a syn product always resulted from the Sharpless AA reaction. Furthermore, 
ring closing to the oxazolidinone 299b (Scheme 5.1.7), as seen from section 4.1.4, 
determined the relative stereochemistry of this peak as syn , by measuring the J  coupling 
of the hydrogens in this oxazolidinone. This aided the assignment o f the (2R,3S) 
absolute configuration, which was fortunately consistent with the literature and the 
analogous Sharpless asymmetric dihydroxylation rule in assigning absolute 
configurations using dihydroquinyl chiral ligands (DHQ^PHAL 136a and (DHQ^AQN 
137a.
OH OH
C 02/'Pr NH
NHCbz
295
NH2
MOMO' MOMO'
MOMO'
+298a-d syn and anti diastereoisomers ,0
J c i s  =  9  Hz (anti 299a and d) Jtrans = 5 Hz (syn  299b and c)
NH
MOMO'
Scheme 5.1.7: Confirmation of syn stereochemistry by ring closure to oxazolidinone 299b
5.1.2 Heterogeneous catalysis
The use of a solid supported catalysis is also investigated to establish whether improved 
regioselectivities could be obtained and compared to those from homogeneous catalysis. 
As described in the introduction (section 2.2.3), some precedent for work on
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heterogeneous Sharpless AA reactions already exists, but using an A-bromoacetamide
nitrogen source with (DHQ^PHAL 136a chiral ligand and an osmylated macroporous
120resin to access 3-phenylisoserine enantiomers (2i?,3*S)-279a (Scheme 5.1.1). The 
advantages o f investigating this method includ isolating osmium tetroxide onto a resin, 
making it less volatile and less toxic. Jo et al., determine through X-ray photoelectron 
spectroscopy (XPS) the oxidation state of osmium in osmylated resins bearing residual 
vinyl groups, such as Amberlite™ XAD-4, XAD-7 and XAD-16 resins. The oxidation 
state varies between an Os(VI) monoglycolate and an Os(IV)bisglycolate species.185
No work has been previously been reported in the literature to access 3-phenylserine 
enantiomers (27?,35)-279a (Scheme 5.1.1) with the (DHQ^AQN 138a ligand. We 
investigate our chosen nitrogen sources (A-bromoacetamide and A-Cbz carbamate) with 
isopropyl cinnamate ester 170 and p -substituted isopropyl cinnamate esters 278b-g for 
comparison with the homogeneous Sharpless AA reactions.
5.1.2.1 A comparative study of osmium anchored Amberlite XAD resins 
with homogeneous methodology.
Preparation of a number of Amberlite XAD-osmylated resins is undertaken to 
investigate the effects of resins bearing different vinyl residues. Amberlite XAD-4 is a 
polystyrene-based resin, whilst XAD-7 is a polyacrylate-based resin. XAD-16 is 
similar to XAD-4, but has a higher surface area.J These are synthetic non-ionic 
adsorbents and are highly cross-linked macroporous resins bearing residual vinyl groups 
(from 0.2 to over 0.4 mol of vinyl groups per mole of polymer repeating unit).185
The use of this method for Sharpless AA reactions is interesting because A- 
bromoacetamide acts as both the nitrogen source and in-situ oxidant. On reaction, 
osmium(VI) and osmium(IV) species could be released by the oxidant from the resin 
and once utilised, are trapped by other vinyl groups on the resin. This immobilises the 
active osmium species and makes the resin potentially available for reuse.120 
Furthermore, synthesis o f the osmylated resins is a facile process (Scheme 5.1.8).
j From Sigma-Aldrich Catalogue 2005-2006
150
Results and Discussion: Chapter 5
0 s 0 4
'BuOH/H20  (v / v = 1:1)
XAD-4 or XAD-16 
(white resin)
XAD-4-0s0 4 orXAD-16-Os04 
(black resin)
R = CO,R
OsO.
fBuOH/H20  (v/v= 1:1)
XAD-4 or XAD-16 
(white resin)
XAD-7-0s0 4 
(midnight blue resin)
Scheme 5.1.8: Synthesis of osmylated macroporous resins
XAD-4, XAD-7 and XAD-16 are reacted with osmium tetroxide in a tert-butyl alcohol 
and water mixture and give the corresponding osmylated resins. Isolation is by 
filtration and the osmylated resin is believed to contain 3.5-4.0 mol% of the equivalent 
osmium tetroxide per gram of resin, as described for XAD-4 and XAD-16 osmylated
• 120 1RSresins. ’ Initially, experiments are conducted with XAD-4 and XAD-7 osmylated 
resins with isopropyl cinnamate 170 to compare the yields, regio- and 
enantioselectivities o f the corresponding (2^,35)-phenylisoserine enantiomers 179 and 
(2j?,3S)-3-phenylserine regiosisomers 286 with those from the homogeneous Sharpless 
AA reactions. This is achieved using chiral ligands (DHQ^PHAL 136a and 
(DHQ)2AQN 137a with an A-bromoacetamide nitrogen source (Table 5.1.4).
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A
NHAc
B
OH
,C 0 2/Pr ,C 0 2/Pr
,C 0 2/Pr
AA (a)
170 OH V
AA (a) for NaNAcNLiBr:
XAD4/7- Os Resin ( ca 4 mol %)
Li OH and (DHQ)2PHAL (5 mol %) in fBu0H:H20  (1:1) or 
(DHQ)2AQN (5 mol %) in nPrOH:H20  (2:1)
(2S,3R)-3-phenylisoserine
179
(2S,3R)-3-phenylserine
286
Entry XAD-Os
resin
Chiral
Ligand
(2A?,3S)a Product 
(% yield)
(lit. Yield %, R = 
e s te r  group, w here 
avail)
A:Bb
(A:B from 
literature, 
w here 
avail)
£e(%)
( 2 R , Z S )
(Ee from 
literature 
%, w here 
avail)
1 XAD-4-Os (DHQ)2AQN 286, 9 3:7 34
2 XAD-4-Os (DHQ)2PHAL 179, 79 (93)120 7:3 
(>20:1)120
Q3
(>99)120
3 XAD-7-Os (DHQ)2AQN 286, 9 5:9 46
4 XAD-7-Os (DHQ)2PHAL 179, 32 4:5 >99
aYields isolated as both regioisomers; DAs determined by nH NMR spectroscopic analysis, cChirapak AD, 80:20 
(hexane:/PrOH), 1 mL min ‘;dEe’s based upon analogy with current literature
Table 5.1.4: Heterogeneous Sharpless A A reactions with XAD osmylated resins in the presence of chiral 
ligands 136a and 137a using an isopropyl cinnamate ester substrate 170
Using (DHQ)2AQN 137a with the osmylated resin XAD-4-Os and substrate 170, the 
behaviour observed is analogous to the homogeneous reaction (Table 5.1.1), whereby 
yields and moderate regioselectivitiesare similar (entry 1, Table 5.1.4). The 
enantioselectivities, however, are improved by the use of osmylated resin XAD-4 with 
chiral ligand 137a. In agreement with the literature (Table 5.1.4), a heterogeneous 
Sharpless AA reaction using chiral ligand 136 with the isopropyl cinnamate ester 170 
affords (2/J,35)-179 in 79% yield (entry 2).120
We next compare the use of polystyrene resin XAD4-Os with polyacrylate resin XAD 
7-Os. XAD-7-Os resin, which has not been used by Jo et al., in heterogeneous 
Sharpless AA reactions.120 XAD-7-Os resin has been used in a Sharpless asymmetric 
dihydroxylation reaction.125 The reaction is performed using (DHQ^AQN 137a (entry 
3, Table 5.1.4) with XAD-7-Os and gives (2R,3S)-286 in 9% yield, which is comparable 
to the yield obtained with XAD-4-Os resin (entry 2, Table 5.1.4). No improvements in 
regioselectivity or enantioselectivity occur with either osmylated resin. However, the 
use of (DHQ)2PHAL 136a reverses the regioselectivity of (27?,35)-179, giving a 1:1 
ratio of (2R,3S)-119:(2R,3S)-286 (A:B), where B is the 3-phenylserine regioisomer.
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The yield for this reaction, however, is a poor 32% yield. Although interestingly, the 
enantioselectivity o f (2R,3S)-\19 is high (90% ee).
On the basis of these results, we are able to discount the use of A-bromoacetamide as a 
nitrogen source to access of 3-phenylserine enantiomer (27?,3<S)-286. We are still 
interested in the possibility of using the osmylated resins, but with a carbamate nitrogen 
source. An oxidant is required to release the active osmium(VIII) species from the resin 
and A-bromoacetamide seems the perfect choice for this, as it acts as an in situ oxidant 
and as the nitrogen source. Yet, the use of A-Cbz with l,3-dichloro-5,5- 
dimethylhydantoin (311) as the oxidant could perform the same role.
Experiments are conducted using isopropyl cinnamate ester 170 (Table 5.1.5) in the first 
instance; and also include the XAD-16 Os resin. No comparable literature results are 
available for comparison with these results as these are novel compounds.
A B
. CC>2/PrCO2/Pr.C02/Pr
NHCbz
(2R,3S)-3-phenylisoserine (2R,3S)-3-phenylserine
316 288
AA (a) for NaNCbzCI:
XAD-4, XAD-7 and XAD-16- Os Resin (ca 4 mol %)
NaOH and (DHQ)2PHAL (5 mol %) in fBuOH:H20  (1:1) or 
(DHQ)2AQN (5 mol %) in nPrOH:H20  (2:1)
Oxidant (311)
Entry XAD-Os
resin
Chiral
ligand
(2/?,3S)a Product 
(% yield)
A:Bb E e  (%) 
(2f?,3S)cd
2 XAD-4-Os (DHQ)2AQN 288 (62) 5:7 >99
3 XAD-7-Os (DHQ)2AQN 288 (88) 5:9 95
4 XAD-16-Os (DHQ)2AQN 288 (50) 2:3 87
1 XAD-7-Os (DHQ)2PHAL 316 (43) 9:1 87
C/-v l. : _____A r \  o
(hexane:/PrOH), 1 mL min ‘;dEe’s based upon analogy with current literature
Table 5.1.5: Heterogeneous Sharpless AA reactions with XAD-4, XAD-7 and XAD-16-osmylated resins 
in the presence of chiral ligands 136a and 137a using an isopropyl cinnamate substrate 170
XAD-4-Os (polystyrene) resin and XAD-7-Os (polyacrylate) resin are reacted with 170 
using (DHQ)2AQN 137a (entry 1 and 2, Table 5.1.5) to give 3-phenylserine enantiomer 
(2R,3S)-2HH. The XAD-7-Os resin slightly outperforms the XAD-4-Os resin in terms of 
an 88% yield and a 5:9 regioselectivity. The enantioselectivity is 95% ee, but gives 
more of the desired 3-phenylserine enantiomer. The XAD-16-Os resin (entry 3) has a
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greater surface area than XAD-4, but performs worst out of all three osmylated resins 
when used with (DHQ)2AQN 137a. Overall, the homogeneous reaction conditions are 
slightly more successful (Table 5.1.1). Due to the unexpected reversal of 
regioselectivity observed with A-bromoacetamide and isopropyl cinnamate 170 (entry 
4, Table 5.1.4) with the (DHQ)2PHAL 136a chiral ligand, the same experiment is 
repeated, this time using the A-CBz carbamate nitrogen source with (DHQ)2PHAL 
136a. Under these reaction conditions (entry 4, Table 5.1.5), the normal regioselectivity 
favouring the 3-phenylisoserine enantiomer (2i?,3*S)-316 results in a 9:1 regioisomeric 
ratio. A moderate 43% yield of 3-phenylisoserine enantiomer (27?,35)-316 is observed 
with a good enantioselectivity o f 87% ee.
We then decide to investigate a couple o f the cinnamate substrates 278b (R = OBn) and 
278d (R = OC6H 13) with the osmylated resins to determine whether yields, regio and 
enantioselectivities could be improved by switching from homogeneous to 
heterogeneous Sharpless AA reaction conditions with benzyl carbamate, using 
(DHQ)2AQN 137a (Table 5.1.6) to favour the 3-phenylserine regioisomer B in the 
regioisomeric ratio (A:B).
A
NHCbz
B
OH
X 0 2/Pr
AA (a)
, C 0 2/Pr
, C 0 2/Pr
278b (R = OBn) 
278d (R = OC6H13)
OH
(2R,3S)-3-phenylisoserine 
319b (R = OBn)
 319d (R = OC6H13)
AA (a) for NaNCbzCI:
XAD-4, XAD-7 and XAD-16- Os Resin (ca 4 mol %) 
NaOH and (D H Q ^Q N  (5 mol %) in '7PrOH:H20  (2:1) 
Oxidant (311)____________________________________
NHCbz
(2R,3S)-3-phenylserine 
295b (R = OBn) 
295d (R = OC6H13)
Entry R XAD-Os
resin
(2R,ZS)a Product 
(% yield)
A:Bb Ee<%)
(2R,ZS)
1 OBn XAD4-OS 295b (62) 5:6 72
2 OBn XAD7-OS 295b (8 8 ) 2:3 70
3 OBn XAD 16-Os 295b (50) 5:6 75
4 OCeH1 3 XAD4-OS 295d (37) 5:6 75
5 OC6 H-i3 XAD7-OS 295d (33) 2:3 76
6 o c 6 h 1 3 XAD16-OS
__ __  D a  x :
295d (44)
J  I l l  L lf tf ll-k  _
5:6 80
1. . • C/*M- • 1. A
(hexane:/PrOH), 1 mL min ‘;dEe’s based upon analogy with current literature
Table 5.1.6: Heterogeneous Sharpless AA reactions with XAD-4, XAD-7 and XAD-16-osmylated resins 
using (DHQ)2AQN 137a with isopropyl cinnamate esters 278b and 278d
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Based on the results (Table 5.1.6) o f using isopropyl cinnamate ester 278b (entry 1-3) to 
access the 3-phenylserine enantiomer (2R,3S)-295b, the best results are obtained in 
entry 2 using XAD 7-Os. Despite having the lowest enantioselectivity (70% ee), this is 
outweighed by having the highest 8 8 % yield and 2:3 regioselectivity for the 3- 
phenylserine emantiomer. Similar results are observed using isopropyl cinnamate ester 
278d (entry 4-6) to access 3-phenylserine enantiomer (2R,3S)-295d.
Having selected the XAD-7-Os resin as having the best overall performance, it is tested 
under the same heterogeneous Sharpless AA conditions with the remainder o f the 
isopropyl cinnamate esters, 278c (R = OMe), 278e (R = OC16H33), 278f (R = 
OCH2OCH3) and 278g (R = OTBDPS) (Table 5.1.7).
A
NHCbz
B
OH
X 0 2/Pr
AA (a)
X 0 2/Pr
278c (R = OMe)
278e (R = OC16H33)
278f (R = OCH2OCH3) 
278g ( R = OTBDPS)
AA for NaNCbzCI:
XAD-7- Os Resin (ca 4 mol %)
NaOH, (DHQ)2AQN (5 mol %) in nPrOH:H20  (2:1) 
Oxidant (311)
OH
(2S,3R)-3-phenylisoserine 
319b (R = OMe)
319e (R = OC6H13)
319f (R = OCH2OCH3) 
319g (R = OTBDPS)
, C 0 2/P
NHCbz
(2S,3/?)-3-phenylserine 
295c (R = OMe) 
295e (R = OC6H13) 
295f (R = OCH2OCH3) 
295g (R = OTBDPS)
Entry R {2R,ZS)a Product 
(% yield)
AiB* Ee (%) 
(2R,3S)cd
1 OMe 295c (67) 1 : 1 89
2 OC1 6 H3 3 295e (35) 1 : 1 90
3 OCH2 OCH3 295f (62) 1 : 1 91
4 OTBDPS
^  . bA-
295g (41) 1 : 1 89
(hexane:/PrOH), 1 mL min ‘;dEe’s based upon analogy with current literature
Table 5.1.7: Reaction of isopropyl cinnamate cinnamate esters with XAD-7-Os resin
Unfortunately, despite yields (Table 5.1.7, entries 1-4) being comparable with 
homogeneous reactions (Table 5.1.3) and to other heterogeneous resin results (Table 
5.1.5 and Table 5.1.6), not much o f an improvement is observed. This observation is 
based on regio- and enantioselectivities going from homogeneous to heterogeneous 
Sharpless AA reactions. Overall, it appears that the homogeneous reaction performs 
better than the heterogeneous reactions, with higher regio- and generally 
enantioselectivities observed, when (DHQ^AQN 137a is employed. Nevertheless, 
heterogeneous catalysis is a safer option and more environmentally benign.
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5.1.2.2 Mechanistic Considerations
The mechanism postulated for these results is based upon a known literature 
mechanism, which typifies the (DHQ^PHAL 136a ligand (Scheme 5.1.9), but is 
adapted to give (2R,3S)-3 -phenylserine enantiomers.105
ORHO NHX H20
resin vinyl grouphigh ee
NX
>*JI .<£>'
N-X 138CIN DX
C 02R
PRIMARY CYCLE 322
323
SECONDARY CYCLE./Os— O 
I N-X 139
Os.Ar
320
Arv
.ps:
278b-g 321
Ar
HO NHX
low ee
Scheme 5.1.9: Sharpless AA mechanism with the (DHQ)2AQN chiral ligand 137
As discussed in the literature, the formation of an imidotrioxoosmium(VIII) complex
138, (section 2.2.1) with a nitrogen source occurs. Following this, coordination with a 
chiral ligand, in this case (DHQ^AQN 137a leads to the formation of an active complex
139, which is ready to react with cinnamate substrates 278b-g. On reaction with these 
alkenes, subsequent rearrangement of 320 to 321 should occur. In the Sharpless AA 
reaction using the (DHQ^PHAL 136a chiral ligand, the mechanism is based on 
electronic effects and the nitrogen is introduced at the p-position to an electron- 
withdrawing group in the alkene, simultaneously coordinating the electrophilic osmium 
centre at the a-position.
The reversal of regioselectivity observed by use of the (DHQ^AQN 137a chiral ligand 
from the literature7,8 and from our own homogeneous and heterogeneous Sharpless AA 
reactions cast doubts on this explanation. It is clear that the complexes observed 320 
and 321 occur not only by stereoelectronic effects, but rather by the substrate orientation 
within the binding pocket of the (DHQ)2AQN 137a chiral ligand.101 Whilst this appears 
to be the only explanation available for the homogeneous Sharpless AA, lending credit
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to the [3+2] cycloaddition, the behaviour observed from our results also require 
explanation. The most important complex within this mechanism is 322. It is at this 
point that hydrolysis could result in ^-protected amino alcohols with high ee’s. It is 
also at this point where a second cinnamate 278b-g can complex with osmium, forming 
323.
It is possible that the different sizes o f resin, particularly XAD 4-Os (polystyrene) and 
XAD-7-Os (polyacrylate) have no deleterious effects on enantioselectivity (as seen), but 
there are effects on regioselectivity which affects the substrate-ligand orientation. It is 
also likely that, should a vinylic group from the osmylated resins be bound on the 
formation of 323, the second cinnamate 278b-g cannot be bound. From this 
observation, hydrolysis at this point would not have deleterious effects on 
enantioselectivities, but the regioselectivities observed from our results can be 
rationalised by subtle interplay between the size of the group attached to cinnamates 
278b-g and the size of the groups on the vinyl resins {i.e. polystyrene or polyacrylate 
groups) and how well they bind to complex 322.
XAD-7-Os resins, even with (DHQ^PHAL 136a, give 1:1 mixtures of i-phenylserine 
enantiomers (entry 4, Table 5.1.4). Therefore, it is even more probable that the size of 
the groups attached at the p-alkoxy position and the vinylic groups within the resin are 
closely related in affecting the regioselective outcome, but not the enantioselectivities.
One notable observation from our studies is the loss of enantioselectivity when using an 
A-bromoacetamide nitrogen source with (DHQ^AQN 137a. From our investigations, 
either using homogeneous or heterogeneous Sharpless AA conditions, a behavioural 
trait that is common is the number o f factors that could determine the yield, 
regioselectivity, and enantioselectivity o f the reaction. By this, it appears that 
cinnamates bearing p-alkoxy groups that are electron-donating work well with this 
reaction. These are the stereoelectronic factors. Notable, is having a TBDPS group at 
p-alkoxy position of cinnamate 278g. Furthermore, n-n stacking interaction also 
appears favourable, as exemplified by both cinnamates bearing a TBDPS group 278g or 
an OBn group 278b. These are steric factors that affect substrate binding within the 
chiral ligands “U-shaped binding pocket”.
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5.2Sharpless Asymmetric 
Aminohydroxylation (AA) using 
methyl 1 -trans-2-octenoate
We decide to extend the methodology to the alkyl olefin methyl /ra«s-2-octenoate (R = 
C5H11) (324) to increase the versatility of the Sharpless AA reaction. This serves as a 
model for the short step synthesis towards aliphatic aminodiols 4 through ester 
reduction of pentylserine regioisomer (325), followed by the catalytic hydrogenolysis o f 
(326) (Scheme 5.2.1). There is also some literature precedent for this substrate being 
used with (DHQ^AQN 137a in a homogeneous reaction, giving the desired 
pentylserine enantiomer 325 in 3:1 regioselectivity and 93% ee, though no yield is 
cited.8
OH
Sharpless AA, (DHQ)2AQN
137a R'
,C 0 2Me
324
u b h 4
THF/EtOH (v/v = 1/9) ^  
0°C to room temp,stir
NHCbz
syn -325
OH OH
NHCbz 
syn -326
10% Pd/C 
cvclohexene,
' b o h '"
reflux
n h 2 
syn -4
Scheme 5.2.1: Short step synthesis to (S',S)-aliphatic aminodiol 4
We react this substrate 324 under homogeneous conditions with both chiral ligands 
136a and 137a. The XAD-7-Os resin is used with 137a for the heterogeneous reaction 
and the results are shown below (Table 5.2.1).
A
NHCbz
/ / % ^ C 0 2Me
5h 11
AA (a)
,C 0 2Me
324
AA (a) for NaNCbzCI:
K2[Os(OH2)4].2H20  (4 mol %) (Homogeneous)
XAD-7-Os (Heterogeneous)
NaOH and (DHQ)2PHAL (5 mol %) in fBu0H:H20  (1:1) or 
(DHQ)2AQN (5 mol %) in nPrOH:H20  (2:1) 
oxidant (311)
OH
(2 R, 3S)-pentylisoserine 
327
B
OH
, C 02Me
NHCbz
(2R,3S)-pentylserine
325
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Entry Ligand (2R,ZS) Product/ A:BD 
(% yield)3
Ee (%) 
(2R,ZSf
1 (DHQ)2AQN 325,37 1:1 26
2 (DHQ)2PHAL 327,35 1:1 64
3 (DHQ)AQNd 325,30 1:1. . . ... 1. , nun____ ___
45
__________ _i. /
(hexane:/PrOH), 1 mL min'1; dHeterogeneous reaction with XAD-7-Os resin
Table 5.2.1: Results of the homogeneous and heterogeneous Sharpless A A reactions with (DHQ)2PHAL
136a and (DHQ)2 AQN 137a
The results (Table 5.2.1) show that regardless of the ligand choice (136a or 137b) and 
whether the reaction is performed under homogeneous or heterogeneous Sharpless AA 
conditions (entries 1-3), ester 324 is not a suitable substrate for the Sharpless AA 
reaction. These results contradict those of Tao et al., and our results may need to be
• • R •optimised. Disappointing yields, regioselectivities and ees resulted from this reaction, 
but also suggested that the substrate was influential in determining these factors, rather 
than yield optimisations.
5.3 Conclusions
The homogeneous Sharpless AA reactions utilises the (DHQ^PHAL 136a chiral ligand 
and is useful for the synthesis of (2i?,35)-3-phenylisoserine enantiomers 279a (Scheme 
5.1.1). These products are used for chiral HPLC elucidation. As expected, the yields, 
regio and enantioselectivities for unsubstituted 170 and ^-substituted 278b-g isopropyl 
cinnamate esters work well (Table 5.1.1 and Table 5.1.2) with 136a and conform to the 
literature results, where available.
Homogeneous Sharpless AA reactions using the chiral ligand (DHQ^AQN 137a with 
isopropyl cinnamate ester 170 show deleterious effects on enantioselectivities when 
combined with A-bromoacetamide (Table 5.1.3). This is addressed by swapping to an 
A-Cbz carbamate source (Table 5.1.3). Oxidant l,3-dichloro-5,5-dimethylhydantoin 
(311) works well with isopropyl cinnamate ester 170, but reaction of 170 with 
dichloroisocyanuric acid (312), proved otherwise (Table 5.1.3). This is despite claims 
that neither oxidant would have deleterious effects on yields, regio and 
enantioselectivities.182. Size effects are deemed important at the p-alkoxy position of 
the isopropyl cinnamate esters 278b-g, with bulky benzylic groups (278b, R = OBn) 
and (278g, R = OTBDPS) having considerable effects on the regioselectivities (Table
5.1.3).
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HPLC standard 295f is compared with the Sharpless AA product 295f by chiral HPLC 
and corresponds as the same HPLC peak. This allows us to confirm that the leading 
enantiomer from chiral HPLC is (2R,3S). Isolation of the Sharpless AA product 295f 
using preparative chiral HPLC and subsequent synthesis of Mosher’s ester 320 (Scheme 
5.1.6) confirming the absolute configuration as (2R,3S)-295f by *H NMR spectroscopic 
analysis and uses a pre-existing conformational model (Figure 5.1.4). This is consistent 
with the Sharpless asymmetric dihydroxylation prediction of stereochemistry for 
dihydroquinyl chiral ligands 136a and 137a.8,162
Heterogeneous Sharpless AA reactions are then investigated using, XAD-4, XAD-16 
and XAD-7-osmylated resins. Both jV-bromoacetamide and vV-Cbz carbamate nitrogen 
sources are tested with isopropyl cinnamate 170 and with both chiral ligands 
(DHQ)2PHAL 136a and (DHQ^AQN 137a (Table 5.1.4). Poor levels of asymmetric 
induction are observed with the A-bromoacetamide source with the (DHQ^AQN 137a 
chiral ligand, similar to the poor enantioselectivities observed in the homogeneous 
Sharpless AA reactions. Interestingly, XAD-7-Os when used with N-Ac and 
(DHQ)2PHAL 136a gives 179 (Table 5.1.4) in a 1:1 regioselectivity, without any effects 
on the enantioselectivity of the reaction. On moving to /?-alkoxy substituted 
cinnamates, with A^-Cbz carabamate, the same behaviour is not observed. To test which 
resin has the best overall performance, determined by yields, regioselective ratios and 
enantioselectivities, a couple of representative isopropyl cinnamate esters (278b, R = 
OBn and 278d, R = OC6H 13) are reacted with XAD-4, XAD-16 and XAD-7-Os resins. 
Overall, from these results (Table 5.1.6), the XAD 7-Os resin is chosen for the 
remaining /^-substituted isopropyl cinnamate esters (Table 5.1.7). Unfortunately, the 
yields and regioselectivities are not particularly high, making the homogeneous 
Sharpless AA an attractive alternative. From these results, it is hypothesised that the 
mechanism (Scheme 5.1.9) is affected by having other vinyl residues present on an 
osmylated resin. In terms of providing a useful methodology towards (SLS)-aromatic 
aminodiols 281, the Sharpless AA reaction is a powerful method that is worth further 
investigation. We attempt to extend the Sharpless AA methodology to include alkyl 
olefin 324, under homogeneous and heterogeneous catalytic conditions to access 
pentylserine regioisomer 325, but this is not very successful (Table 5.2.1).
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Summary & Future 
Work 
Chapter 6
In Chapter 3 several attempts to synthesise novel nitrogen containing pyruvate donors 
are investigated and phthalimidopyruvate 5 d  is prepared in seven steps (Scheme 6.1.3) 
from L-serine 2 5 8 .
NH2 258
1) KBr, HBr, H ,0  
2) NaN02 
-13 °C tort 
stir 
88%
Br 259
KOH 
EK5TH 
-20 °C overnight 
stir 
76%
ko2c 260
EtBr 
DCM 
50 °C 
TEBA 
54%
OH 262
Potassium Phthalimide
 Phthalimide_____
DMF 
90 °C 
30% EtOoC 261
PCC
NaOAc
DCM
38%
C 02Et
N
O
263
Pigs liver esterase
Phosphate buffer 
pH 7 
50%
.C02H
N
O
5d
Scheme 6.1.1: Adapted route to phthalimido pyruvate 5d
Synthesis and isolation of more of this material is unsuccessful and therefore, instead of 
subjecting this substrate 5 d  directly to TK or its mutants, it is decided to utilise it in the 
mimetic TK reaction (Scheme 6.1.2).
267
+
NMM 270
OH 277
Scheme 6.1.2: Biomimetic reaction toward ketoalcohol 277
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It is anticipated that the racemic ketoalcohol (277) from this reaction could be used as a 
standard for determining any enantioselectivity that might be achieved from future TK 
or TK mutant bioconversions.
Despite the low conversion of phthalimidopyruvate 5d into ketoalcohol 277, 
phthalimidopyruvate 5d is an exciting novel nitrogen containing pyruvate donor. 
Future work would see that the synthesis of this molecule is optimised, allowing future 
studies and investigating the biomimetic reaction (discussed in section 3.1.6) with this 
substrate and an array of aldehydic acceptors. Furthermore, the removal of the 
phthalimido group from 5d could give access to aminopyruvate 5b, which may also be 
used in the TK mimetic screen or for activity with TK and its mutants, providing 
racemic 5d or 5b from the mimetic TK reaction or chiral 6d or 6b from a TK 
bioconversion (Scheme 6.1.3).
OH
NMM 2 7 0 , orTK
5d  X = NPhth
hydrazine
NMM 2 7 0 , or TK
R H
0
Scheme 6.1.3: Biomimetic reactions with amine catalysts, such as NMM 270
If chiral ketoalcohols 6d and 6b were inaccessible from TK or its mutants, a chiral 
amine catalyst, such as L-proline may give access to ketoalcohols, as it is known from 
the literature to catalyse asymmetric carbon-carbon bond forming reactions.190
A one-pot reaction of benzaldehyde 30 with glycine 282, under basic conditions gives 
access to syn-3-phenylserine 284 and is presented in chapter 4. The subsequent 
acetamide or benzyloxycarbonyl protection yields 285 and 287 (Scheme 6.1.4), 
respectively.
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OHOH
H2N.
OH OHH 282
MOH, Ethanol NH2 284, 16%
a ) NaOH, 
acetic 
anhydride 
or
b) NaHC03,
'' CbzCI
% 28330
oOHOH O
OHO/Pr 1 ) CsC03, water
2) 2-iodopropane, 
toluene
NHZNHZ
285 Z = Ac, 68% 
287 Z = Cbz, 94%
286 Z = Ac, 42% 
288 Z = Cbz, 65%
Scheme 6.1.4: Synthetic route towards syw-diastereoselective HPLC standards 286 and 288
Following this, isopropyl ester formation by alkylation of an in situ caesium salt of 285 
and 287, yields syn chiral HPLC standards 286 and 288 (Scheme 6.1.4) for use in the 
chiral HPLC elucidation of Sharpless AA adducts formed in Chapter 5. The sy«-diol 
by-product 289 also associated with the Sharpless reaction is readily synthesised.
A short reaction sequence (Scheme 6.1.5) involving the reduction of isopropyl ester 288 
and the removal of the benzyloxycarbonyl group in 290 yields the desired syn aminodiol 
291 and could be readily applied to other sy«-(p-substituted-3-phenyl)serines 281.
OH OHOH
,C 0 2'Pr LiBH4 1Qo/o pd/c
THF/EtOH (v/v — 1/9)  ^ Pb q |_| cvclohexene
1 0°C to room temp,stir = EtOH
NHCbz 80% ^HCbz reflux = H
74% " n2
syn-288 syn-290 + syn-291
OH
Ph Y  0H 
NH2
Both enantiomers are commercially available!
Scheme 6.1.5: Short step reaction sequence to .syw-aminodiol 291
Glycine 282 with p-methoxymethyl benzaldehyde 292f provides a divergent route 
(Scheme 4.1.9), allowing access to a 1:1 diastereomeric mixture of (p-methoxymethyl- 
3-phenyl)serine 293f. Subsequent A^-Cbz protection of 293f and isopropyl ester 
formation, as before, gives chiral HPLC standard 295f. Chiral HPLC separation of the 
4 peaks and derivatization of each peak collected (peaks A-D) to oxazolidinones 299a-d 
(Table 4.1.3) allows the elucidation of the relative stereochemistry in peaks A-D of 
295f. Syn products of 295f (peaks B and C) are collected as one product using
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preparative chiral HPLC. Removal of the p-methoxymethyl group of crude 295f using 
«-butane thiol in the presence o f magnesium bromide affords 295a (Scheme 4.1.11), 
which can be alkylated to give any other /^-substituted alkoxy Sharpless adduct (295b- 
g). Also described in chapter 4 is the formation of the cinnamate substrates used in the 
Sharpless AA reaction.
The Wittig reactions o f p-hydroxybenzaldehyde 292a, p-benzyoxybenzaldehyde 292b 
and /7-methylmethoxybenzaldehyde 292f with phosphorous ylid 302 in dichloromethane 
(Table 4.2.1), aqueous THF mixture (Table 4.2.2) and in water (Table 4.2.3) are 
investigated and allow access to the corresponding cinnamate. Surprisingly water 
works really well in this reaction, providing an environmentally benign route to 
cinnamate substrates 278a, 278b and 278f. Other methods are also used to provide 
cinnamates 278b-g, but the Wittig reaction is the most successful reaction where 
comparisons are available.
Aqueous Wittig reactions (discussed in section 4.2.1), through a mixture of solvents, 
may in future be used to directly access enantiomeric syn-3-phenylserine 280a in a one- 
pot reaction (Scheme 6.1.6). This is either through homogeneous Sharpless AA 
reactions or using osmylated macroporous resins as seen in sections 5.1.1 and 5.1.2. 
Water dilutions and filtration of triphenylphosphine oxide may be possible by 
controlling the solvent concentrations and would also feature as part of any future work.
CbzNCINa or 
K20 s 0 2(0H )4 or 
Osmylated resin
.CC>2/Pr .C 02/Pr(DHQ)2AQN (5 mol%) 
nPrOH / H20  
room temp
280a NHCfcc
302
water
R-i
Scheme 6.1.6: Potential one-pot reaction to generate 280a
Once all o f the cinnamates are synthesised, they are then subjected to a range of 
Sharpless AA reactions, as described in chapter 5. The regioselectivity o f the reaction is 
explored by swapping the chiral ligand from (DHQ)2PHAL 136a to (DHQ)2AQN 137a.
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Both homogeneous and heterogeneous Sharpless AA reactions with two different 
nitrogen sources (A-bromoacetamide and A-Cbz carbamate) are investigated. 
Homogeneous Sharpless AA reactions utilises the (DHQ)2PHAL 136a chiral ligand and 
is useful for the synthesis of (2R,3S)-279a (Scheme 5.1.1). These compounds are then 
used for chiral HPLC elucidations.
Homogeneous Sharpless AA reactions using the chiral ligand (DHQ)2AQN 137a with 
isopropyl cinnamate ester shows deleterious effects on the enantioselectivities when 
combined with A-bromoacteamide (Table 5.1.3), which are addressed by swapping to 
an A-Cbz carbamate source (Table 5.1.3). The oxidant l,3-dichloro-5,5- 
dimethylhydantoin 311 works well with isopropyl cinnamate ester 170, but the 
Sharpless AA reaction o f 170 with dichloroisocyanuric acid (312) is poor (Table 5.1.3). 
Size effects were deemed important at the /?-alkoxy position of the isopropyl cinnamate 
esters 278b-g, with bulky benzylic groups (278b, R = OBn) and (278g, R = OTBDPS) 
having considerable effects on the regioselectivities (Table 5.1.3). At this point, 
through homogeneous Sharpless AA conditions, HPLC standard 295f (from chapter 4) 
is elucidated by the synthesis of a Mosher’s ester 320.
Heterogeneous Sharpless AA reactions are then investigated using, XAD-4, XAD-16 
and XAD-7-osmylated resins. Both A-bromoacetamide and A-Cbz carbamate nitrogen 
sources are tested with isopropyl cinnamate ester 170 and with both chiral ligands 
(DHQ)2PHAL 136a and (DHQ)2AQN 137a (Table 5.1.4). Poor levels of asymmetric 
induction are observed with the A-bromoacetamide source with (DHQ)2AQN 137a. To 
test which resin has the best overall performance, measureble by yields, regioselective 
ratios and enantioselectivities, a couple o f representative isopropyl cinnamate esters 
(278b, R = OBn and 278d, R = OC6H 13) are reacted with XAD-4, XAD-16 and XAD- 
7-Os resins. Overall, from these results (Table 5.1.6), the XAD-7-Os resin is selected 
for use with the remaining ^-substituted cinnamates (Table 5.1.7). Unfortunately, the 
yields and regioselectivities are not outstanding, making the homogeneous Sharpless 
AA an attractive alternative. From these results, it is hypothesised that the mechanism 
(Scheme 5.1.9) is affected by having other vinyl residues present on an osmylated resin. 
We attempt to extend the Sharpless A A methodology to include alkyl olefin 321, under 
homogeneous and heterogeneous catalytic conditions to access pentylserine enantiomer 
325.
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Finally, once a generic one-step reaction is possible towards 5y«-(27?,35)-3-phenylserine 
enantiomer 280a, optimisation studies on the Sharpless AA reaction or by a different 
methodology could be used to access the shortest reaction sequence to aminodiols 
(discussed in section 4.1.2). This would then be implemented to produce any desired 
chiral HPLC standard for comparison with those generated from the TK/TA screens. 
The work carried out in this thesis has seen syn-(2R,3S) or (2S,3R) enantiomers as the 
focal point of discussion, ^tez'-aminodiols may be accessed if the SAA conditions are 
optimised. One such method to achieve stereoinversion may include an adapted route 
used to access (-)-cytoxazone, presented in Scheme 6.1.7.191
,C 0 2Me C 0 2Me
0=="
C
C 0 2Me
NH3+Cr
Scheme 6.1.7: Reagents and conditions: (a) SAA conditions, 137a; (b) Tf20 , DMAP, CH2C12; (c) LiBH4 
reduction; (d) 12% HC1, heat
Failing the ability to access anti-aminodiols via this route, another route, already 
mentioned in section 2.1.2 may also be used. This involves the RAMP-hydrazone 
method, which Enders uses to access D-er^/zro-sphinganine 105 (Scheme 6.1.8).98
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CH3 (R)-131h 3c
a, b 
96%
47%
(7steps)
c, 98%
63%
(R)-132 Rh R2 = 0  
(2R,3R)-133 R, = OH , R2 =H
^h3+ cf3co2-
.✓''"'s. ^ n-C13H27
OH OH (2R,3S)-105 de > 96%, ee  >96%
g, 87%
f, 91%
(2R,3S)-134 R, = H, R2 = N3 
(2R,3S)-135 Rt = H , R2 = NH2
Scheme 6.1.8: Reagents and conditions: (a) 7BuLi, THF, -78 °C, then pentadecyl bromide, -100 °C; (b) 
aq. Oxalic acid; (c) L-selectride®, THF, -78 °C; (d) MsCl, CH2C12, Et3N, -0 °C -> rt.;(e) NaN3, 18-crown- 
6, DMF, 100 °C; (f) LAH, THF, rt.; (g) TFA, THF/H20 , rt.
The only problem with this route is the lengthy synthetic protocol, but it is more 
versatile in that the lipid chain can be substituted for aryl groups of other alkyl groups 
and may be adequately scaled.
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Chapter 7
7.1 General Experimental Procedures
Unless otherwise stated, all reagents were obtained from Sigma-Aldrich Co Ltd., BDH 
laboratory supplies, Fischer Scientific UK and Lancaster synthesis and are used without 
any further purification.
Dry solvents, where used were obtained from a Sharpe dry column system (using 
activated alumina; bead size 1-2 mm) and were stored under nitrogen, or were bought in 
from commercial suppliers and then used immediately. Ether refers to diethyl ether, 
ethanol refers to absolute ethanol (>99.7%) and brine refers to a saturated solution of 
sodium chloride. For all air and moisture sensitive reactions, glassware was dried in a 
hot oven (120 °C) and a nitrogen atmosphere was used.
The term in vacuo refers to the removal of solvents by means of evaporation at a 
reduced pressure, which was provided by the in-house vacuum or an oil pump, using a 
Buchi® rotary evaporator.
Thin layer chromatography (TLC) was performed on plastic backed, precoated Merck 
6 O - F 2 5 4  silica plate with 0.25 mm thickness. Visualisation was achieved through 
absorption of U. V. light or by staining with potassium permanganate solution [KMnCL 
(1.25 g), Na2CC>3 (6.25 g), water (250 mL)] or phosphomolybdic acid (PMA) solution 
[PMA hydrate (12 g), conc. sulphuric acid (10 mL), ethanol (250 mL). Normal phase 
flash column chromatography was carried out using silica gel (40-63 pm). Preparative 
TLC was carried out on Whatman preparative TLC plates (silica gel 60 A ,  1000 pm 
thickness, 20 x 20 cm).
Normai phase high performance liquid chromatography (HPLC) was carried out using a 
Varian Prostar machine with hexane//PrOH mixtures. Preparative HPLC was achieved 
using the same machine with an attached fraction collector.
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Melting points (m.p.) were determined using a Gallenkemp instrument and are 
uncorrected.
I.R. spectra were recorded on Shimadzu FTIR-8700 spectrophotometers for solutions in 
chloroform (with a KBr cell) unless otherwise stated.
lH NMR and 13C spectra were recorded using B raker® AMX300, AMX400 and 
AVANCE500 machines. All samples were dissolved in deuterated chloroform 
(CDCI3), unless otherwise stated. The chemical shifts (8 ) were given in units ppm 
relative to tetramethylsilane (TMS). Couplings constants (J) were measured in hertz 
(Hz). Multiplicities for ]H were shown as s (singlet), d (doublet), t (triplet), q (quartet), 
quint (quintet), dd (doublet of doublets), bt (broad triplets), m (complex multiplet). 13C 
chemical shifts were listed where characterisation o f peaks were carried out from 
experiments described in parentheses following the “8 c”. The term “oz” in front of a
1 3 C chemical shift indicates an approximate value for two or three signals for the same 
carbon that were indistinguishable (regioisomers and/or diastereoisomers) and 13C 
chemical shifts expressed as (X + Y) indicated two distinct diastereomeric carbon 
signals.
Mass spectra were recorded on a VG-7070 instrument, available for low mass range El 
methods. Ionisation methods include electron impact (El), positive and negative and 
desorptional chemical ionisation (Cl). Fast atom bombardment (FAB) was recorded on 
a UG70FE. In addition, (+ES and -ES) were recorded on a Micromass Quattro LC 
spectrospray (MassLynx software) on a MAT 900XP spectrometer. The same 
spectrometer was used for (+HRFAB and +HRES) for accurate mass spectrometry. 
Major peaks were reported with intensities quoted as percentages of the base peak.
Microanalyses were determined, using a Perkin Elmer 2400 Elemental Analyser (CHN) 
and Perkin Elmer 240 Elemental Analyser (S, halogen).
Optical rotations were recorded on Optical Activity: polAAR2001 polarimeter at 589 
nm in chloroform solutions (unless otherwise indicated) quoted in 1 0 ’ 1 deg cm2 g '1. 
Concentrations (c) were in g/100 mL.
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7.2 Transketolase Donor Synthesis
7.2.1 Hydroxy pyruvate (HPA)
Lithium hydroxide monohydrate (8.39 g, 200 mmol) was dissolved in water (200 mL). 
H alf o f this solution was added to bromopyruvic acid (1.67 g, 10.0 mmol) in 100 mL 
water, by autotitration (radiometer ABU91), with the pH not exceeding 9.5. The
mixture was concentrated in vacuo at room temperature until crystals started to appear. 
At this point, the concentrated solution was cooled to 0 °C for 16 h and the product was 
precipitated and collected by filtration, to give the title compound as a colourless solid 
(1.18 g, 32%).
vmax (K B rycm '1: 3433br (OH), 1751s, (C=0), 1635s (C=0);
'H NMR (400 MHz, D2 0): 8  3.40 (2H, s, CH2OH);
13C NM R(100 MHz, D2 0): 8  66.5 (CH2OH), 177.0 (C 0 2H), 203.0 (CO C02H); 
m/z (+ES): 104 (M+, 100%);.
HPLC (reverse phase): Column: Aminex 87H (300 x 7.8 mm) (Bio-Rad Laboratories) 
Mobile Phase: Isocratic, 0.1% TFA in water, 0.6 mL/min, Electrochemical Detector 
(Dionex), HPA lc  8.38 min.
7.2.1.2 Methyl 3-Bromo-2-oxo-propionate (193)
The reaction was carried out under anhydrous conditions. To methyl pyruvate (5.00 g,
48.9 mmol) was added bromine (7.28 g, 45.6 mmol) over 1 h. Nitrogen was bubbled 
through the reaction mixture to remove any hydrogen bromide. The product was 
purified by distillation under reduced pressure (110 mmHg; 82-84 °C) to yield the title 
compound as a gold oil (6.93 g, 77%). 
vmax (neat)/cm‘: 1736s (C=0), 671s (C-Br);
7.2.1.1 Lithium hydroxy-2-oxo-propionate (1c)
o
OH
reaction was stopped after 3 h and the pH adjusted to 5.0 using dilute acetic acid. The
o
Me02C
Br
H NMR (400 MHz): 8  3.87 (3H, s, OMe), 4.30 (2H, s, C77>Br);
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13C NMR (100 MHz): 8  30.73 (OCH3), 53.96 (CH2Br), 158.28 ((CO)CH2Br), 177.93 
(C 0 2Me);
m/z (Cl): 180 (M+, 25%), 165(M+ -[CH3]+, 8 ), 150 ([BrCH2COCOH]+, 76), 123 
([BrCH2COH]+, 85).
7.2.2 Azidopyruvate
7.2.2.1 Ethyl 3-Bromo-2-hydroxy-propionate (197)
Ethyl 3-bromopyruvate (2.80 g, 14.4 mmol) dissolved in methanol (4 mL) was added to 
a stirring solution of NaCNBH3 (0.39 g, 6.21 mmol) and a trace of bromocresol green in 
methanol (4 mL). HC1 (1M) was added dropwise to maintain the pH at 4, as indicated 
by the yellow colour o f the solution over 90 min. The solvent was removed in vacuo 
and the residue dissolved in sat. ammonium sulfate (10 mL). The aqueous layer was 
then extracted with ether (5 x 20 mL). The organic layers were combined, dried 
(MgSCL) and then evaporated in vacuo. The crude was purified by flash column 
chromatography ( 1 0 0 % dichloromethane), which yielded the title compound as an oil
dt, J 6.5, 3.2 Hz, C//(OH));
l3C NMR (100 MHz): 8  14.1 (OCH2CH3), 35.1 (CH2Br), 62.5 (OCH2CH3), 69.7 
(CH(OH)), 171.4 (C 0 2Et);
m/z (El): 199 (M + 81Br, 38%), 197 (M + 79Br, 38), 125 ([79BrCH2CH2OH]+, 100).
7 .2 . 2 . 2  Ethyl 3-Azido-2-hydroxypropionate (197)
3-Bromo-2-hydroxypropionic acid ethyl ester (1.82 g, 9 . 1 0  mmol) was dissolved in 
water/ethanol (1:1 v/v, 100 mL). Sodium azide (0.86 g, 13.1 mmol) was added and the 
mixture heated to reflux for 24 h. The solvent was removed in vacuo and the residue
OH
197
Br
(1.82 g, 65%).
Vmax (neat)/cm '1: 3358br (C-OH), 3019s, 2926m, 2854m, 1716 (C=0);
*H NMR (400 MHz): 8  1.33 (3H, t, J7 .1  Hz, OCH2Ctf3), 3.22 (1H, d, J  6.6 Hz, OH), 
3.70 (2H, dt, J7 .2 , 3.5 Hz, CH2B t), 4.29 (2H, dq, J7 .1 , 3.2 Hz, (OCH2CU3), 4.50 (1H,
OH
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taken up in water (30 mL). The aqueous layer was extracted with dichloromethane (5 x 
30 mL) and the organic layers were combined, dried (NaiSCL) and the solvent was 
removed in vacuo, yielding an oil that was purified by flash column chromatography 
(3:7, EtOAc: hexane). This gave the title compound as an oil (503 mg, 34%). 
vmax (KBr)/cm'‘: 3415br, (C-OH), 2956s, 2108s (N3), 1743s (C=0);
'H NMR (400 MHz): 5 1.30 (3H, t, J  7.0 Hz, OCH2C773), 3.51 (1H, d, J  4.4 Hz, 
CH //N 3), 3.64, (1H, d, J 4 .4  Hz, CHHN3), 4.28 (2H, q, .11.0 Hz, OCH2CH3), 4.34 (1H, 
m, C//(OH));
13C NMR (100 MHz): 6  14.0 (OCH2CH3), 53.7 (CH2N3), 62.4 (CH(OH)), 69.7 
(OCH2CH3);
m/z (FAB): 160 (MH+, 45%).
7.2.2.3 Methyl Oxirane-2-carboxylate (205)
° \  C 0 2Me
205
Sodium hypochlorite (6 .8 % wt/v; 176.5 mL) was added to a stirred solution of sodium 
carbonate (16.00 g in 40 mL water) and methyl acrylate (12.26 mL, 136.1 mmol) at 10 
°C. Stirring was continued for 1 h, whilst a stream of CO2 (8.00 g) was passed through 
the solution. The mixture was extracted with dichloromethane (4 x 150 mL), dried 
(Na2SC>4) and the solvent was removed in vacuo. The product was purified by 
fractional distillation under vacuum (20 mmHg; 45-49 °C) to give the title compound as 
yellow oil (1.84 g, 13%).
V m a x  (neatycm 1: 2986s (C-H), 1736 (C=0), 1203 (C-O);
'H NMR (500 MHz): 6  2.98 (2H dt, J 4 .0 , 2.5 Hz, CH2CO), 3.42 (1H, dd, J  4.0. 2.5 
Hz), 3.77 (3H, s, OMe);
,3C NMR (125 MHz): 8  46.2 (CH20 ), 47.1 (CHO), 53.0 (OCH3), 169.6 (C 0 2Me); 
m/z (C l): 103 (MH+, 46%).
7.2.2.4 Methyl 3-Azido-2-hydroxy-propionate (206)
OH
.N 3
MeOoC
206
The reaction was carried out under anhydrous conditions. To a stirred solution of 
oxirane-2-carboxylic acid methyl ester (1.50 g, 14.7 mmol) in methanol (70 mL) was
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added sodium azide (2.35 g, 36.2 mmol) and ammonium chloride (1.41 g, 26.3 mmol). 
The mixture was stirred and heated at reflux. The reaction was monitored by TLC and 
stopped after 24 h. The solvent was removed in vacuo and the residue was extracted 
with hot CHCI3 (3 x 150 mL). The combined organic extracts were dried (Na2S0 4 ) and 
the solvent was then removed in vacuo. The crude mixture was purified by flash 
column chromatography (1:1, EtOAc: petroleum ether 40-60 °C), yielding the title 
compound (1.70 g, 80%).
13c  NMR (100 MHz): 8  53.5 (CH2N3), 53.9 (OCH3), 70.0 (CH(OH)), 172.9 (C 0 2Me); 
m/z (E l): 144 (M+, 30%), 126 (M -  [OH]', 28).
7.2.2.5 Azido-2-hydroxy-propionic acid (208)
3-Azido-2-hydroxy-propionic acid methyl ester (300 mg, 2.07 mmol) was dissolved in 
methanol, with stirring and cooled to 0 °C. Lithium hydroxide (51 mg, 2.1 mmol) was 
added. The mixture was stirred for 24 h and warmed to room temperature. The mixture 
was then diluted with water (10 mL) and extracted with EtOAc (3 x 100 mL) to remove 
any unreacted starting material. The aqueous layer was acidified to pH 3 with citric 
acid solution (10% w/v), then extracted with EtOAc (3 x 100 mL), dried (Na2S0 4 ) and 
evaporated in vacuo to give the title compound as an orange oil. No further purification 
was required (163 mg, 60%).
vmax (neat)/cm 'r: 3358br (C-OH), 2920s, 2112 (N3), 1702m (C=0), 1265 (C-O);
‘H NMR (400 MHz): 8  3.43 (1H, d, J 4 .4  Hz, CHHN3) 3.73 (1H, d, J4 .4  Hz, CHHN3), 
4.44 (1H, t, J3 .5  Hz, CH{OH));
13C NMR(100 MHz): 8  53.5 (CH2N 3), 70.1 (CH(OH)) 175.4 (C 0 2H); 
m/z (Cl): 132 (MH+, 75%), 118 (M+ - N, 90).
vmax (K Br)/cm '!: 3420br (OH), 2111 (N3), 1740 (C=0), 1220 (C-O);
'H NMR (400 MHz): 8  3.41 (1H, d, J 4 .3  Hz, OH), 3.50 (1H, d, J  4 . 4  Hz, CH(OH)), 
3.60 (1H, d, J4 .4  Hz, C7/HN3), 3.80 (3H, s, OMe), 4.36 (2H, d, J3 .5  Hz, C //2N3);
OH
208
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7.2.3 Aminopyruvate
7.2.3.1 Benzyl (2,3-Dihydroxy-propyl)-carbamate (219)
OH
HO CbzNH
219
3-Amino-l, 2-propane diol (1.00 g, 11.0 mmol) was dissolved in water (50 mL). The 
reaction mixture was cooled to 0 °C and sodium hydroxide (1M) added to increase the 
basicity to pH 10. Benzyl chloroformate (1.4 mL, 10 mmol) was then added over a 10
The product was extracted into dichloromethane (3 x 40 mL) and dried (MgSCL). The 
solvent was removed in vacuo and the product was then purified by recrystallisation 
using dichloromethane. This gave the title compound as colourless crystals (0.83 g, 
37%).
H)\
n C NMR (100 MHz): 8  43.2 (CH2NH), 63.7 (CH2OH), 67.2 (OCH2Ph), 71.2
(CH(OH)), 128.1, 128.2, 128.5, 136.0 (Ar-C), 157.1 (N C02Bn);
m/z (C l): 226 (MH+, 35%), 118 (M -  [C6H5CH20 ] +, 60), 107 ([C6H5CH20 ]+, ), 91
([C6H5CH2]+,100).
7.2.3.2 Ethyl Diazo-triethylsilanyl-acetate (225)
Triethylsilyl trifluoromethanesulfonate (8 . 6  mL, 38 mmol) was added to a stirring 
solution at -78  °C of ethyl diazoacetate (4.0 mL, 38 mmol) and N,N'~ 
diisopropylethylamine (6 . 6  mL, 38 mmol) in ether (50 mL). The reaction was stirred at
overnight. A white precipitate was filtered off and the solvent removed in vacuo. The
min period and the reaction was then warmed to room temperature and stirred for 24 h.
m.p. (°C): 62-63, Lit192 (60.5);
vmax (KBr)/cm *: 3340br (C-OH), 2931s, 1697s (C=0);
*H NMR (400 MHz): 6  2.29 (2H, m, C //2OH), 3.54 (2H, m, C/fcN), 3.75 (1H, quint, J
6.3 Hz, C//(OH)), 5.11 (2H, s, N C 0 2C //2Ph-), 5.25 (1H, br, OH). 7.31-7.36 (5H, m, Ar-
225
78 °C for 0.5 h and allowed to warm to room temperature. Stirring was continued
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crude product was purified by flash column chromatography (1:99 EtOAc: hexane) to
afford the title compound as a yellow oil (6.90 g, 79%).
vmax (neatycm1: 2987s, 2905s, 2877s, 2083s (N2), 1689s, (C=0), 1211s (C-O);
*H NMR (500 MHz): 6  0.69 (6 H, q, J  6.9 Hz, Si(C//2CH3)), 0.93 (9H, t, J  7.1 Hz, 
Si(CH2C //3)), 1.20 (3H, t, J7 .1  Hz, OCH2C7/3), 4.15 (2H, q, J l . \  Hz, O C//2CH3);
13C NMR (125 MHz): 6  2.9 (Si(CH2CH3), 6.7 (Si(CH2CH3), 14.3 (OCH2CH3), 42.3 
(CH(N2)), 60.5 (OCH2CH3), 169.4 (C 0 2Et);
7 . 2 . 3 . 3  A/,A/-Dibenzyl-formamide (229)
Dibenzylamine (1.0 mL, 52 mmol) was heated at reflux at 60 °C in ethyl formate (4.3 
mL, 53 mmol overnight. The solvent was removed in vacuo and the solid recrystallised 
from ether. This yielded the title compound as a crystalline solid (10.87 g, 93%) 
m.p. (°C): 53-54, Lit192 (53-54.5); 
vmax (KBr)/cm *: 3024s, 2931s, 1951s, 1651s (C=0);
m, Ar-H), 8.42 (1H, s COT/);
13C NMR (100 MHz): 6  44.9 (NCH2), 50.5 (NCH2), 127.9, 128.4, 128.8, 129.0, 129.2,
135.9, 136.3 (A r-Q , 163.1 (NCOH);
m/z (E l): 226 (MH+, 100%), .134 (M -  [C6H5CH2] f, 100), 91 ([C6H5CH2]+, 100).
7.2.3.4 3-Dibenzylamino-2-triethylsilanyloxy-acrylic acid ethyl ester (231)
A/,A-Dibenzyl-formamide (100 mg, 0.44 mmol) in dry toluene (4.0 mL) was added to a 
stirring solution of rhodium(II) acetate dimer (2.0 mg, 1.8 pmol) and ethyl 
diazo(triethylsilyl)acetate (105 mg, 0.46 mmol) in dry toluene (4.0 mL). The reaction 
mixture was heated at reflux for 12 h and monitored by TLC. The solvent was removed 
in vacuo, and purified by flash column chromatography (1:9, EtOAc: hexane). This 
yielded the title compound as an off-white solid (105 mg, 58%). 
vmax(f i lm ) /c m 3016s, 2954s, 2877s, 1728s (C=0), 1666s (C=C), 1218s (C-O);
o
229
H NMR (400 MHz): 6  4.26 (2H, s, NC7/2Ph), 4.41 (2H, s, N C//2Ph), 7.16-7.35 (10H,
OTES
231
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'H NMR (500 MHz): 5 0.64 (6 H, q, J  7.8 Hz, Si(Cff2CH3)), 0.90 (9H, t, J  7.8 Hz, 
Si(CH2CH })\ 1.27 (3H, t, y  5.7 Hz, OCH2CH3), 4.15 (2H, q, J5 .7  Hz, O C//2CH3), 4.42 
(4H, s, N C //2Ph), 6.94 (1H, s, NC//C(OTES)), 7.18-7.38 (10H, m, Ar-H  and 
NC//CH(OTES));
13C NMR (125 MHz): 5 5.7 (Si(CH2CH3)), 7.2 (Si(CH2CH3)), 14.8 (OCH2CH3), 54.3 
(NCH2Ph), 60.1 (OCH2CH3), 118.1 (NCHCH(OH)), 127.7 (NCHCH(OH)), 128.1, 
128.8, 129.2, 133.2, 138.0 (Ar-C), 167.5 (C 0 2Et); 
m/z (El): 425 (M+, 12%), 396 (M+ - [C2H5]+, 38), 91 ([C6H5CH2]+, 100).
7.2.3.5 Attempted Synthesis of aminopyruvate 5b using lactate oxidase 
(LAO) and pyruvate oxidase (PAO)
A 56-microwell titre plate format was used. Distilled water was used to make up 
solutions. Each well contained the following concentrations of reagents required for 
cofactor assay and colorimetric assay:
Cofactor assay (required cofactors and buffer):
Phosphate buffer (100 mM, pH 7.1);
Thiamine pyrophosphate (TPP), 0.6 mM;
Magnesium chloride (5 mM);
Flavin Adenine Dinucleotide (FAD), 0.02 mM.
Colorimetric Assay (required enzyme and colouring agents):
4-aminoantipyrine (4-AA), 0.27 mg m L'1;
7V-Ethyl-7Vr-(2-hydroxy-3-sulfopropyl)-3-methylaniline sodium salt dihydrate (TOOS), 
0.4 mg m L'1;
Horseradish Peroxidase (HRP), 8  U m L'1.
To the cofactor assay and colorimetric assay in each well, the enzymes (5.3 pL) in 
concentrations of 0 to 2 U mL ' 1 (A-D or E-H) were added (using serial dilution) for the 
unnatural substrate (i.e. DL-isoserine for either lactate oxidase and pyruvate oxidase). 
The enzyme concentration for the natural substrates (lactate for lactate oxidase and 
pyruvate for pyruvate oxidase) was added in 0 to 0.02 U mL ' 1 (A-D or E-H) using serial 
dilution. The concentration of substrates or hydrogen peroxide (0-0.1 mM, 75 pL) 
added is represented in Figure 7.2.1, Figure 7.2.2 and Figure 7.2.3 to show the positive 
and negative controls.
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Lactate Oxidase
A A
B
[Enz]
C 
D
1 2 3 4 5
1 2 3 4 5 S u b stra te
+  + - DL-lsoserine (10 mM, 120 juL)
-  +  + Lactate (0.5 mM, 120 |xL)
- - +  Pyruvate (0.5 mM, 120 ^L)
Figure 7.2.1: Lactate oxidase micro wells with natural and unnatural substrates
Column 1 contained the unnatural substrate DL-isoserine, as indicated by the *+’ in 
Figure 7.2.1. Column 2 was an inhibition test o f DL-isoserine and lactate with lactate 
oxidase. Column 3 was a positive control containing the natural lactate substrate. 
Column 4 was a negative control containing only the cofactor and colorimetric assays. 
Column 5 was a test to see if  pyruvate was accepted by lactate oxidase.
Pyruvate Oxidase 
7  8 9 10 11
E , • •  •
*  A[Enz] f f i A
4 - .V
7 8 9 10 11 S ubstra te
+  + - DL-lsoserine (10 mM, 120 fiL)
- - + Lactate (0.5 mM, 120 ^L)
-  +  + + Pyruvate (0.5 mM ,120 |d_)
Figure 7.2.2: Pyruvate oxidase micro wells with natural and unnatural substrates
Column 7 contained the unnatural substrate DL-isoserine, as indicated by the *+’ in 
Figure 7.2.2. Column 8  was an inhibition test of DL-isoserine and pyruvate with 
pyruvate oxidase. Column 9 was a positive control containing the natural pyruvate 
substrate. Column 10 was a negative control containing only the cofactor and 
colorimetric assays. Column 11 was a test to see if  pyruvate and lactate were accepted 
by pyruvate oxidase.
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peroxide
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Figure 7.23:  Calibration curve for concentration of hydrogen peroxide versus concentration found from 
micro well plate reader
7.2.4 Cyanopyruvate
7.2.4.1 Potassium 2-cyano-1-ethoxycarbonyl-ethenolate (249e)
o
. - L  ©  CN
E t02C C
H
249e
K+
This reaction was carried out under anhydrous conditions. Potassium ethoxide (2.94 g, 
0.03 mol) was dissolved in ethanol/ether (32/32 mL) and the mixture was cooled to 0 
°C. Diethyl oxalate (9.35 g, 0.06 mol) was dissolved in ether (3 mL) and added to the 
reaction mixture, which was thereafter stirred for 30 min. A solution of acetonitrile 
(2.63 g, 0.06 mol) in ether (3 mL) was added and the reaction mixture warmed to room 
temperature and then stirred for 1 h. The precipitated solid was collected by filtration 
and was dried over phosphorous pentoxide to yield the title compound as an orange 
solid. The crude material was purified by reverse phase chromatography (100% water 
to remove excess potassium ethoxide) to yield the title compound as an orange solid
(1.82 g, 16%).
vmax (KBrycm*1: 3394s (C-OH), 2176s (O N ), 1766s (C=0), 1635s (C=C), 1103 (C- 
O);
’H NMR (400 MHz, D20 ): 8  1.20 (3H, t, 77 .2  Hz, OCH2C i/3), 4.13 (2H, q, 77 .2  Hz, 
OC//2CH3);
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13C NMR (100 MHz, D2 0): 5 15.6 (OCH2CH3), 68.2 (OCH2CH3), 125.7 (C=N), 169.7
(CHCN), 172.3 (C 0 2Et);
m/z (-CI): 141 (M \ 5%), 122 (M' - [C2H5]+, 100).
7 . 2 A . 2  3-Cyano-2-oxo-propionic acid (5c)
A control experiment without pig liver esterase (PLE) was conducted by dissolving 
potassium 2-cyano-l-ethoxycarbonyl-ethenolate (300 mg, 1.67 mmol) in phosphate 
buffer solution (pH 7.0, 100 mM, 3 mL). 13C NMR was used to monitor the reaction 
over the course of 14 h. In phosphate buffer (pH 7.0, 100 mM, 3 mL), PLE (100 mg) 
was dissolved. To this was added potassium 2-cyano-l-ethoxycarbonyl-ethenolate (300
1 3mg, 1.67 mmol). The reaction was monitored over the course of 14 h by C NMR and 
by reverse phase TLC. The reaction mixture was filtered through a pad o f Cig silica and 
washed through with water (10 mL). The crude sample (100 mg) was purified using 
preparative reverse-phase chromatography (100% water). It was not possible to remove 
phosphate as shown by 31P NMR and so yields are unreliable. However, it was still 
possible to attempt characterisation.
vmax(KBr)/cm'1: 3294s (COOH), 2177s (CN), 1709s (C=0), 1564s
'H NMR (400 MHz, D2 0 )  inter alia: 8  3.10 (1H, d, J  17.0 Hz, CH7/CN), 3.16 (1H, d, J
17.0 Hz, C//HCN), See Appendix B;
l3C NMR (100 MHz, D2 0): 5 60.3 (CH(ONa)), 119.2 (O N ), 165.5 (CHCN), 175.0 
C 0 2H);
7.2.4.3 Methyl 3-Benzyloxycarbonylamino-propionate (254)
.CO2M6
CbzHN' 254
To a stirred solution of [3-alanine methyl ester (4.50 g, 32.3 mmol) and TEA (4.5 mL, 
33 mmol) in chloroform (70 mL) was added benzyl chloroformate (2.8 mL, 20 mmol). 
After a few minutes, TEA (5.4 mL, 39 mmol) was added and then after a few minutes 
again, was added benzyl chloroformate (2.8 mL, 20 mmol). The mixture was stirred for 
2h. The mixture was then washed with water (3 x 100 mL), dried (Na2S0 4 ) and 
concentrated in vacuo. The residue was purified by flash column chromatography (7:3, 
hexane:EtOAc) to yield the title compound as a colourless oil (6.54 g, 74 %).
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vmax (film)/cin'1:3353s> 2953s, 1750s (C=0) 1699s (NCO), 1211 (C-O);
'H NMR (500 MHz): 6  2.54 (2H, t, J  5.8 Hz, (C’H2C //2C 0 2Me)), 3.45 (2H, m, 
(C //2CH2C 0 2Me)), 3.65 (3H, s, CO2C //3), 5.02 (2H, s, C 0 2C //2Ph), 5.29 (1H, s, NH), 
7.23-7.38 (5H, m, Ar-H);
7.2.5 Phthalimido Pyruvate
7.2.5.1 Synthesis of Pyridinium chlorochromate
A 6 M HC1 solution (0.92 mmol) was added to a fully dissolved stirring solution of 
chromium trioxide (500 mg, 5.00 mmol) in water. This was cooled to 0 °C and to this 
was slowly added pyridine (0.39 mL, 5.00 mmol). The precipitated solution was 
recooled to 0 °C before suction filtration. The orange solid was dried in vacuo, to give 
the title compound (0.65 g, 65%).
7 .2 . 5 . 2  Ethyl (R)-(+)-2,3-epoxypropanoate (Ethyl glycidate) (261)
(S)-(-)-2-Bromo-3-hydroxypropanoic acid (259)
L-Serine (52.5 g, 0.50 mol) and potassium bromide, KBr, (200 g, 1.70 mol) were 
dissolved in water (400 mL). Hydrobromic acid (48%, 123 mL, 1.09 mol) was added at 
room temperature and the mixture was cooled to -13 °C with stirring. Nitrogen was 
bubbled through the solution and sodium nitrite (42.8 g, 0.62 mol) was slowly added in 
small portions (ca. 5 g every 15 min). After each addition, the reaction mixture turned 
brown and the colour slowly faded, but the solution did not decolourise entirely. The 
total time required for addition of all the sodium nitrite was approximately 2.5 h. The 
solution was then allowed to warm to 0°C and the nitrogen purge was stopped. The 
mixture was then stirred for 6  h. Excess nitrogen oxides were removed by bubbling 
nitrogen through the solution for 1 h. The pale green solution was then extracted with 
ether ( 6  x 300 mL). The combined organic extracts were concentrated to 0.5 L by rotary 
evaporation and dried over anhydrous (MgS0 4 ). The ether was then evaporated in
o 261
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vacuo. The pale yellow or green oil (82 g, 90%) was used immediately in the next 
reaction without further purification. 161
Potassium (R)-(+)-2,3-epoxypropanoate (260)
The crude acid from the preceding step (74.5 g, 0.44 mol) was dissolved in absolute 
ethanol (300 mL) and cooled to -20°C. Under nitrogen, a filtered solution of potassium 
hydroxide (55.5 g, 0.85 mol) in absolute ethanol (300 mL) was slowly added. After 2 h, 
the mixture was allowed to warm to 0°C and stirred at this temperature for 14 h. The 
solution was filtered to remove precipitated salts. Half of the solvent was removed by 
rotary evaporation without warming and an additional crop of salt (2-4 g) was isolated 
by filtration. The combined salts were dried under vacuum to give 105 g of a 1:1 
mixture o f KBr and potassium glycidate. 161
One third of this mixture (35 g) was extracted by refluxing in a mixture of 585 mL of 
absolute ethanol and 15 mL of water in a 1 L flask with good stirring for 45 min. After 
filtration of the hot suspension, the glycidate crystallized from the filtered solution to 
give 12-13 g of product. Another third of the 1:1 KBr: potassium glycidate mixture was 
heated at reflux with stirring in the mother liquors for 45 min. After the second batch of 
crystalline potassium glycidate was isolated by filtration, the procedure was repeated 
with the last portion of the KBr-glycidate mixture. The solids collected from the three 
hot filtrations were combined and extracted a fourth time with the same solution, then 
crystallized to give additional product. After drying, the total weight o f recrystallised 
potassium glycidate was 35.5 g . 161 
m.p. (°C): 136-138, Lit193 (135.5-137);
Vmax (mijol)/cm'': 2851s, 1614s (C=0);
'H NMR (400 MHz): 5 2.83 (2H, d, .76.3 Hz, CH20), 3.33 (1H d, J6 .3  Hz, C //C 0 2K); 
,3C NMR (100 MHz): 6  44.7 (CH20 ), 61.0 (CHO), 177.5 (C 0 2K); 
m/z (Cl): 103 (MH+, 46%).
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Ethyl (R)-(+)-2,3-epoxypropanoate (261)
A suspension of dry potassium glycidate (26.0 g of an 91:9 glycidate: KBr mixture, 0.19 
mol), benzyltriethylammonium chloride (42.4 g, 0.19 mol), and ethyl bromide (76.0 g, 
0.70 mmol) in dichloromethane (300 mL) was heated at reflux for 16 h with good 
stirring. The solvent and excess ethyl bromide was then slowly removed by rotary 
evaporation without warming, and the resulting viscous solid was triturated with 
anhydrous diethyl ether (3 x 100 mL) to extract the ethyl glycidate. The combined 
ethereal extracts were filtered and dried over anhydrous (MgSCL). The solvent was 
slowly removed by rotary evaporation (without warming) and the residue was then 
distilled (2.4 mmHg; 40 °C) with 0 °C water circulating through the condenser to afford 
the title compound. 161 (8.80 g, 40%);
vmax (neatycm'1: 2985s, 1750 (C=0), 1736 (C=0), 1203s (C-O);
lH  NMR (400 MHz, D2 0): 8  1.29 (3H, t, J  7.1 Hz, OCH2C//3), 2.94 (2H, t, J  6.5 Hz,
C //2CO), 3.42 (1H, d, J4 .1  Hz, CHCO), 4.25 (2H, q, J6 .5  Hz, OC/72CH3);
13C NMR (100 MHz, D2 0): 8  13.9 (OCH2CH3), 46.1 (CH2CO) 47.3 (CHCO), 61.6
(OCH2CH3), 169.1 (C 0 2Et)
m/z (Cl): 117 (MH+, 89%), 89 (M+ - [C2H5]+, 100);
m/z (+HRES): 117.055019, (MH+, C5H80 3 requires 117.05517).
7.2.S.3 Ethyl 3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-hydroxy-propionate
(262)
OH
EtOoC
262
O
Ethyl (i?)-(+)-2,3-epoxypropanoate (220 mg, 1.89 mmol) in DMF (2 mL) was added 
dropwise to a potassium phthalimide (40 mg, 0.22 mmol)/phthalimide (220 mg, 1.50 
mmol) mixture in DMF (50 mL). The reaction mixture was heated to 90 °C and stirred 
for 48 h. The reaction mixture was diluted with water (500 mL) and extracted with 
chloroform (3 x 100 mL). The organic layer was washed with water (50 mL), then 
brine (50 mL) and then dried (Na2SC>4). The solvent was removed in vacuo and the 
solid recrystallised from chloroform to yield the title compound as colourless crystals 
(440 mg, 89 %).
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m.p. (°C): 80-81, Lit138 (82-83);
vmax (KBr)/cm-1: 3472s (C-OH), 1750 (C O ), 1735 & 1730s (C O ), 1103 (C-O);
*H NMR (400 MHz): 5 1.26 (3H, t, J1 .2  Hz, OCH2C //3), 3,12 (1H, d, OH), 4.03 (2H, 
dt, J  8 .6 , 4.5 Hz, C //2NH), 4.21 (2H, dq, J  7.2, 2.3 Hz, OC//2CH3), 4.48 (1H, t, J  5.8 
Hz, C//(OH))
13C NMR (100 MHz): 8  13.9 (OCH2CH3), 41.0 (CH2N), 62.3 (OCH2CH3), 68.3 
(CH(OH)), 123.4, 131.3, 134.1 (Ar-C), 158 (NCO), 168.1 (C 02Et); 
m/z (FAB): 264 (MH+, 32%).
7.2.5.4 Ethyl 2-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-[1,3]dithiane-2- 
carboxylate (266)
O 266
Under dry conditions, sodium hydride (6.94 g, 173 mmol of a 60 % mineral dispersion) 
was washed with pentane (3 x 20 mL). In a second round bottom flask, bromomethyl 
phthalimide (50.0 g, 208 mmol) and ethyl l,3-dithiane-2-carboxylate (33.8 g, 173 
mmol) was dissolved in DMF (200 mL). This was transferred to a dropping funnel by 
cannula. Sodium hydride was suspended in dry benzene (250 mL) at 5 °C. The DMF 
mixture was added to the sodium hydride suspension with caution over 2 h. On 
completion, the reaction mixture was allowed to warm to room temperature and was 
stirred for 18 h. The mixture was poured into water (1 L) and extracted with ether (5 x 
500 mL). The combined extracts were dried (Na2S0 4 ) and were then evaporated in 
vacuo. The residue was purified by recrystallisation, using EtOAc-light petroleum (1:2) 
to yield the title compound (22.89 g, 3 9 %). 
m.p. (°C): 145-146, Lit160 (142-144); 
vmax (film)/cm'1: 2252s, 1776s (C=0), 1720s (C=0);
*H NMR (400 MHz): 8  1.29 (3H, t, J  7.2 Hz, OCH2CH3), 1.90 (2H, m, 
SCH2C //2CH2S), 2.84-3.01 (4H, m, -SC//2CH2C//2S), 4.23 (2H, q, J  1.2 Hz, 
O C//2CH3), 7.64 - 7.81 (4H, m, Ar-H);
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13C NMR (100 MHz): 8  13.8 (OCH2CH3), 27.2 (-SCH2CH2CH2S), 30.90 (- 
SCH2CH2CH2S), 55.1 (OCH2CH3), 62.8 (C(S(CH2)3S))), 123.5, 131.7, 134.1 (Ar-C),
167.9 (Ar(C=0)), 169.3 (C 0 2Et); 
m/z (+ES): 374 (MNa+, 100%).
7 .2 . 5 . 5  Ethyl 3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-oxo-propionate
(263)
263
O
2-(l,3-Dioxo-l,3-dihydro-isoindol-2-yl)-[l,3]dithiane-2-carboxylic acid ethyl ester 
(19.3 g, 55.5 mmol) was dissolved in acetone (190 mL) and added to N- 
bromosuccinimide (68.4 g, 384 mmol) in acetone/water (97:3, 900 mL), maintained 
between -5  to 5°C. After 45 min, the reaction mixture was poured into hexane: 
dichloromethane (1:1, 600 mL) and aqueous sat. sodium bisulfite (1.6 L). The aqueous 
phase was extracted with hexane: dichloromethane (1:1, 2 x 600 mL). The combined 
organic layers were dried (Na2S0 4 ) and the solvent then evaporated in vacuo. The 
residual phthalimide was removed by rinsing the residue with dichloromethane (70 mL) 
and concentrating the filtrate to give viscous oil. This was purified by flash column 
chromatography (100% CHCI3) to yield the title compound as colourless crystals (8.80 
g, 55 %).
m.p. (°C): 85-86, Lit160 (89-90);
vmax (KBrJ/tni1: 1778 (C=0), 1722 (C=0), 1103 (C-O);
‘H NMR (400 MHz): 8  1.37 (3H, t, J  8.0 Hz, OCH2Cf/3), 4.35 (2H, q, J  7.2 Hz, 
O C //2CH3), 4.41 (2H, s, C //2N), 7.74 (2H, m, Ar-/7). 7.87 (2H, m, Ar-H);
UC NMR (100 MHz): 8  13.9 (OCH2CH3), 44.8 (CH2N), 63.1 (OCH2CH3), 123.5, 
123.7, 131.9, 134.3-134.2 (Ar-C), 159.0 (N(CO)), 167.2 (C 0 2Et), 185.7
(E tC 02C0CH 2N);
m/z (+ES): 284 (M N a\ 21%), 262 (MH+, 10);
m/z (+HRES): 284.05372, (MNa+, Ci3HnNOsNa+ requires 284.05294).
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7.2.5.6 3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-oxo-propionic acid (5d)
(l,3-Dioxo-l,3-dihydro-isoindol-2-yl)-2-oxo-propionic acid ethyl ester (261 mg, 1 .0 0  
mmol) was dissolved in methyl tert butyl ether (MTBE; 15 mL). To this was added a 
solution o f pig liver esterase (PLE; 42 mg, 1000U) dissolved in phosphate buffer (pH 
7.0; 100 mM, 15 mL). The mixture was stirred and periodically monitored by TLC for 
the disappearance of starting material. The MTBE layer was separated and the aqueous 
layer was washed with MTBE (3 x 75 mL). The pH was adjusted to 3 by dropwise 
addition of HC1 and the aqueous layer was extracted with EtOAc (3 x 100 mL). The 
combined organic layers were dried (Na2S0 4 ) and then evaporated in vacuo. The 
mixture was recrystallised by layering with chloroform and hexane. White crystals 
emerged but were not the product, as determined by 1H NMR spectroscopy. The 
remaining oily residue was identified as the title compound and was sufficiently pure 
for use in further steps (100 mg, 40%).
Vmax (film j/crrf1: 3279br (C-OH), 3019s, 1776 (C=0), 1722 (C=0), 1616m, 1600m, 
1580m, 1469m;
'H NMR (400 MHz): 8  4.93 (2H, s, CH2N), 7.61 (2H, m, At-H), 7.83 (2H, m, Ar-H), 
9.39-9.86 (br, 2H);
l3C NMR (100 MHz): 5 44.7 (CH2N), 122.9, 132.6, 134.3 (Ar-C), 162.7 (Ar(C=0),
171.3 (C 0 2H), 188 (CO); 
m/z (Cl): 234 (MH+, 4%);
m/z (+HRES): 234.03912 (MH+, C i,H 7N 0 5 requires 234.04025).
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7.2.6 Phthalimido pyruvate: Biomimetic reaction with
propionaldehyde
7.2.6.1 2-(3-Hydroxy-2-oxo-pentyl)-isoindole-1,3-dione (277)
HO
277
3-(l,3-Dioxo-indan-2-ylamino)-2-oxo-propionic acid (54 mg, 0 . 2  mmol) and 
propionaldehyde was mixed with water (5 mL). The pH was adjusted to 7 with 
saturated NaHCC>3 . 7V-Methylmorpholine (25 pL, 0.2 mmol) was added and the pH was 
adjusted to pH 7 with 0.01 M HC1. The reaction was stirred for 48 h and the solvent ws 
then removed in vacuo. The residue was purified using preparative TLC (5:95 
MeOH/dichloromethane) to yield the title compound (23 mg, 46%). Attempts were 
made to record a *H NMR spectrum, but unreliable signals were observed from excess 
propionaldehyde.
vmaj[ (film ycm '1: 3323br (C-OH), 3019s, 2927s, 1711m (C=0); 
m/z (+CI): 248 (MH+, 95%);
m/z (+HRES): 248.09187, (MH+, Ci3H ,3N0 4  requires 248.09228).
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7.3 Chiral HPL C standard syntheses
Benzaldehyde (2.01 g, 18.9 mmol), glycine (706 mg, 9.40 mmol) and KOH (1.06 g,
temperature for 5 h. The Schiff s base product was hydrolysed using HC1 (2M), with 
warming (40-50 °C). The precipitate formed, on cooling, was collected by filtration and 
recrystallised from water/ethanol to yield the title compound as colourless crystals (557 
mg, 16%).
Ci/(OH)), 7.43-7.48 (5H, m, Ar-H );
UC NMR (125 MHz, TFA-d): 8  55.7 (CH(NH2)), 66.9 (CH(OH)), 120.4, 123.7, 124.8,
125.2, 130.0 (Ar-C), 169.6 (C 0 2H);
7.3.1.2 Syn-2-Acetylamino-3-hydroxy-3-phenyl-propionic acid (285)
DL-//2reo-3 -phenylserine (1.00 g, 5.51 mmol) was dissolved in water (10 mL). The pH 
was adjusted to 9, using NaOH (2M) and acetic anhydride (1.67 g, 16.2 mmol) was 
added. The pH of the solution was maintained at 9.0 by addition of NaOH (1M). The 
mixture was cooled after 1 h and slowly the aqueous layer was acidified using HC1 to 
pH 2. A white solid precipitated and was collected. The aqueous layer was extracted 
with EtOAc (3 x 30 mL). The combined organic layers were dried (Na2S0 4 ) and then 
evaporated in vacuo to yield a white solid. The white solids were rinsed with diethyl
7.3.1 Unsubstituted aromatic syn standards
7.3.1.1 Sy/i-2-Amino-3-hydroxy-3-phenyl-propionic acid (284)
OH
Ph
284  NH2
18.9 mmol) were dissolved in ethanol (70 mL) and the mixture was stirred at room
m.p. (°C): 177-180, Lit194 (175);
Vmax (nujol)/cm_1: 3614m (C-OH), 3371m (NH2), 1641m (C=0);
*H NMR (500 MHz, D2 0): 6  3.94 (1H, d, J 4 A  Hz, C/7(NH2)), 5.32 (1H, d, J  4.0 Hz,
OH
Ph
285 NHAc
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ether and dried in vacuo. No further purification was necessary, yielding the title 
compound as a colourless solid (1.23 g, 6 8 %). 
m.p. (°C): 177-178, Lit164 (177-178);
13C NMR (100 MHz): 6  23.8 (NCOCH3), 61.2 (CH(NHAc)), 75.1 (CH(OH)), 128.4,
130.6, 130.9, 142.1 (Ar-C), 175.8 (NCOCH3), 176.5 (C 0 2H); 
m /z (Cl): 224 (MH+, 35%), 206 (M+ - OH), 107 ([C6H5C(OH)]+).
7.3.1.3 Sy/7-2-Benzyloxycarbonylamino-3-hydroxy-3-phenyl-propionic 
acid (287)
DL-//?reo-3-phenylserine (1.00 g, 5.51 mmol) was dissolved in water (25 mL) and 
cooled to 0 °C. Sodium bicarbonate (1.15 g, 13.8 mmol) was added, before the dropwise 
addition o f benzyl chloroformate (0.94 mL, 6.61 mmol). The reaction mixture was 
allowed to come to room temperature and stirred for 2 h. The aqueous layer was 
extracted with ether (3 x 30 mL), before acidification of the aqueous layer to pH 3.0. 
The acidified aqueous layer was extracted with EtOAc (3 x 100 mL). The combined 
organic layers were dried (Na2S0 4 ) and then evaporated in vacuo to yield a white solid 
(1.58 g, 94%). No further purification was necessary as determined by *H NMR 
spectroscopic analysis.
m.p. (°C): 80-82, Lit195 (83-85);
vmax (KBr)/cm *: 3325s (C-OH), 3085br (C-OH), 1720s (C=0), 1226 (C-O);
*H NMR (400 MHz): 8  4.68 (1H, d, J  9.3 Hz, CH(NHCBz)), 4.76-5.00 (2H, m,
13C NMR (100 MHz): 8  59.8 (CH(NHCbz), 67.1 (OCH2Ph), 73.0 (CH(OH)), 125.9, 
128.0, 128.3 (overlap), 128.6, 139.3 (Ar-C), 156.9 (NC02Bn), 171.5 (C 0 2H); 
m/z (FAB): 328 (MNa+, 12%).
'H NMR (400 MHz): 8  1.82 (3H, s, NHCOCH3), 4.62 (1H, d, J  3.4 Hz, Ctf(NHAc)), 
5.24 (1H, d, J 3 A  Hz, C//(OH)), 7.22-7.34 (5H, m, Ai-H );
OH
Ph
287 NHCbz
C //2Ph), 5.39 (1H, s, C//(OH)), 6.00 (1H, d, J9 .3  Hz, NH), 7.18-7.35 (10H, m, Ar-H);
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7.3.1.4 Isopropyl Syn-acetylamino-3-hydroxy-3-phenyl-propionate (286) 
and Isopropyl syn-benzyloxycarbonylamino-3-hydroxy-3-phenyl- 
propionate (288)
OH OH
.C 0 2/Pr ^C 02/Pr
Ph Ph
286 NHAc 288 NHCbz
To a solution o f ethanol (100 mL) containing acid (1.09 g, 3.50 mmol) was added 
caesium carbonate (583 mg, 1.78 mmol) in water (30 mL). The resulting mixture was 
evaporated and azeotroped with toluene to remove the majority o f water from the 
reaction mixture. The resultant solid was dried in vacuo and dissolved in dry DMF (20 
mL). Under anhydrous conditions, 2-iodopropane (17.9 mL, 178 mmol) was added to 
the reaction mixture. The mixture was left to stir at room temperature for 24 h. DMF 
was evaporated in vacuo and the residue was purified by flash column chromatography 
(1:9, acetone:toluene) to yield 286 (390 mg, 42%) and 288 (800 mg, 65%).
HPLC (286): Chiracel AD-H, 4.6mm x 250 mm, hexane/z'PrOH, 85/15, 0.6 ml min'1, 
2 1 0  nm, 14.6 (2R,3S), 15.4 (2S,3R)
HPLC (288): Chiracel AD-H, 4.6mm x 250 mm, hexane/zPrOH, 85/15, 0.6 ml min'1, 
210 nm, 16.7 (2R,35), 18.0 (25,310.
Full characterisation vide infra.
7.3.1.5 Isopropyl s y n - 2,3-Dihydroxy-3-phenyl-propionate (289)
OH
^.C02/'Pr
Ph
289 OH
Isopropyl cinnamate (3.45 mmol) was dissolved in acetone (10 mL). To this was added, 
with stirring, A-methylmorpholine oxide hydrate (3.78 mmol) and osmium tetroxide 
(0.39 mmol). The reaction was monitored by TLC and quenched by adding sodium 
bisulfite (6 % wt/v, 10 mL). The mixture was extracted into ethyl acetate and 
magnesol® (5 g) was added with stirring for 10 min. The magnesol® was filtered and 
combined organic extracts were dried (Na2S0 4 ). Then the solvent removed in vacuo 
and the crude was purified by flash column chromatography (4:6 EtOAc:hexane) to 
yield the title compounds.
(407 mg, 61 %);
189
Experimental
Vmax (filmj/cm1: 3425br (C -O H ), 1729s (C=0), 1216 (C-O);
'H NMR (500 MHz): 6  1.15 (3H, d, J  6.3 Hz, OCH(C//3)2), 4.27 (1H, d, J  3.7 Hz, 
C//(OH))), 4.91 (1H, d, J  3.6 Hz, Cf/(OH)), 5.03 (1H, sept, J  6.5 Hz, OC//(CH3)2), 
7.18-7.39 (5H, m, Ai-H);
l3C NMR (125 MHz): 6  ca 21.5 (OCH(CH3)2), 69.8 (OCH(CH3)2), 74.6 (CH(OH)),
74.8 (CH(OH)), 126.3, 127.8, 128.2, 128.5, 139.3 (Ar-C), 172.1 (C 0 2 ;Pr); 
m/z (FAB): 244 (M+, 28%), 207 (M+ - [OH]).
HPLC: Chiracel AD-H, 2mm x 250 mm, hexane/iPrOH, 80/20, 0.6 ml m in'1, 210 nm, 
20.2, 21.9 (^ -p ro d u c ts )
7.3.1.6 Benzyl Syn-(2-Hydroxy-1-hydroxymethyl-2-phenyl-ethyl)-
carbamate (290)
OH
290 NHCbz
Lithium borohydride (1.40 g, 56.3 mmol) was added portionwise to a cooled solution of 
DL-//zreo-benzyloxycarbonylamino-3-hydroxy-3-phenyl-propionic acid isopropyl ester 
(4.64 g, 13.1 mmol) in THF/ethanol (1/9), with stirring. Once added, the reaction 
mixture was warmed to room temperature and left to stir for 48 h. To this mixture was 
added HC1 (0.5 M, 200 mL), with caution. The aqueous layer was extracted with 
EtOAc (2 x 100 mL) and the combined organic layers dried (Na2S0 4 ) and then 
evaporated in vacuo. The residue was purified by flash column chromatography (1:1, 
EtOAc:hexane) to yield the title compound as a colourless crystalline solid (3.25 g, 
80%).
m.p. (°C): 100-101, Lit196 (102-103);
vmax (film)/cm'‘: 3617s (C-OH), 3433br (C-OH), 3018s, 1706s (C=0), 1216s (C-O);
'H NMR (400 MHz): 5 3.23 (1H, br, OH), 3.63 (2H, m, C/AOH), 3.85 (1H, m, 
C/7(NHCBz)), 4.76 (N C //2Ph, s, 2H), 5.61 (1H, d. J8 .3  Hz, CH(OH)), 7.23-7.33 (10H, 
m, Ar-H)\
13C NMR (100 MHz): 6  57.6 (CH(NHCbz)), 63.4 (CH(OH)), 66.9 (OCH2Ph), 73.6 
(CH(OH)), 123.4, 125.6, 127.8, 128.3, 129.4, 134.1, 136.2, 140.8 (Ar-C), 157.0 
(N C 02Bn);
m/z (+ES): 302 (MH+, 100%), 284 (M - [H20]).
190
Experimental
7.3.1.7 Syr7-2-Amino-1-phenyl-propane-1,3-diol (291)
OH
A mixture o f Benzyl DL-/72r£o-(2-Hydroxy-1 -hydroxymethyl-2-phenyl-ethyl)-carbamate 
(3.05 g, 10.0 mmol), 10% Pd-C (1.18 g), cyclohexene (57 mL) and ethanol (114 mL) 
was heated at reflux with stirring for 3 h. The mixture was filtered through celite with 
ethanol (3 x 100 mL) and water (3 x 100 mL). The ethanol layer was evaporated in 
vacuo to yield the title compound as a white solid. No further purification was 
necessary. (1.25 g, 74%). 
m.p. (°C): 115-17, Lit197 (112-113);
vmal (KBr)/cm ':  3394s (C-OH), 3309s (C-OH) 3055s (NH2), 2862s, 2738s, 2669s, 
1581 (C-N);
'H NMR (400 MHz): 6  2.90 (1H, Ad, J 9.9 Hz, C//(NH2)), 3.50 (2H, dd, J  16.7, 5.0 Hz, 
CH2OH), 4.61 (1H, d, J  5.2 Hz, C7/(OH)), 7.13-7.43 (5H, m, Ar-Hy.
13C NMR (100 MHz): 5 58.1 (CH(NH2)), 64.6 (CH2OH), 74.7 (CH(OH)), 126.2 
(overlap), 127.7 (overlap), 128.5, 142.1 (Ar-C); 
m/z (+ES): 168 (MH+, 94%), 335 (M, dimer, 20).
7.3.2 p-Substituted aromatic syn standards
7.3.2.1 Sy/?-2-Amino-3-[4-(benzyloxy)phenyl]-3-hydroxy-propionic acid 
(293b)
293b NH2
BnO
To a solution of potassium hydroxide (5.61 g, 0.10 mol) and glycine (3.75 g, 0.05 mol) 
in ethanol (75 mL), was added a solution of/>-benzyloxybenaldehyde (21.2 g, 0.10 mol) 
in ethanol (50 mL). The mixture was warmed until it was absolutely clear (ca. 60 °C) 
and the solution was allowed to stand at room temperature. A crystalline solid 
precipitated, which was filtered after 5 h and washed thoroughly with alcohol and ether. 
This product was the potassium salt of TV-p-benzyloxybenzylidene-p-benzyloxyphenyl-
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3-serine (296) and was obtained as a white powder (15.6 g yield average, 60-63%), m.p. 
161-163 °C. The potassium salt 296 (41.6 g, 0.08 mole) was stirred vigorously with 1M 
HC1 (400 mL) and the mixture was filtered immediately. The solid p- 
benzyloxybenzaldehyde was washed with 0.5M HC1 (200 mL) and then with water (100 
mL). It weighed 37.10 g and probably contained some p-benzyloxy-3-phenylserine. The 
acid filtrates were combined and on neutralization the title compound was obtained. A 
sample was recrystallized from a mixture o f alcohol ( 6  parts), water ( 2  parts) and 
dimethylformamide (2 parts) to afford colourless crystals (17.7 g, 77.0%). 
m.p. (°C): 190-192, Lit169 (190-192);
Vmax (KBr)/cm -1: 3363br (C-OH), 3147s (NH2), 1666s (C=0); 
lH  NM R (400 M Hz, DMSO-d6 ): 6  2.24 (1H, s, OH), 3.27 (1H, d, J4 .0  Hz, C//(NH2)), 
4.87 (1H, d, J  3.6 Hz, C//(OH)), 4.94 (2H, s, C tf2Ph), 6.81 (2H, d, J  8.5 Hz, Ar-H), 
7.11-7.32 (7H, m, Ai-H);
13C NM R (100 M Hz, DM SO-d6 ): 5 59.2 (CH(NH2)), 69.2 (OCH2Ph)), 70.4 (CH(OH)),
114.3, 127.7 (overlap), 127.9, 128.5 (overlap), 137.3 (Ar-C), 157.6 (Ar (C-O)); 
m/z (+FAB): 289 (MH2+, 8 %).
7 .Z .2 .2  Isopropyl syn-2-Amino-3-[4-(benzyloxy)phenyl]-3-hydroxy- 
propionate (297)
OH
^  297 NH2
BnO
DL-threo-2-Amino-3- (4-benzyloxy-phenyl)-3-hydroxy-propionic acid (5.00 g, 17.4 
mmol) was suspended in 'PrOH (50 mL) and cooled to 0 °C. SOCl2 (1.4 mL, 19.2 
mmol) was added dropwise with stirring. The mixture was warmed to 40 °C. The 
reaction was monitored using TLC. The solvent was then removed in vacuo. An initial 
column ran in EtOAc removed all less polar organic components leaving behind 
unreacted carboxylic acid. A second column was run in (3:7 EtOAc ihexane) to yield 
the title compound (610 mg, 1 0  %).
*H NM R (400 MHz): 5 1.31 (6 H, d (overlap), .76.3 Hz, OCU(CH3)2), 4.21 (1H, d ,J5 .3  
Hz, C//(OH)), 5.08 (2H, s, C //2Ph), 5.14 (1H, sept, J  6.3 Hz, C//(OH)), 5.56 (d, J  5.2 
Hz, N //2), 7.01 (2H, d, J  8.7 Hz, Ar-H), 7.48-7.23 (7H, m, Ar-//);
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13C NMR (100 MHz): 8  21.6 (OCH(CH3)2), 61.0 (CH(NH2)), 68.4 (OCH2Ph), 69.0
(OCH(CH3)2), 72.3 (CH(OH)), 114.4, 127.5, 127.8, 128.1, 128.6, 129.6, 131.0, 133.9,
157.0 (Ar-C), 170.0 (C 0 2/Pr);
m/z (+ES): 330 (MH+, 24%), 312 (M -  [H20 ], 100);
m/z (+HRES): 330.16978, ([MH+], Ci9H24N 0 4 requires 330.17053).
7.3.2.3 4-(Methoxymethoxy)benzaldehyde (292f)
o
292f
MOMO"
The reaction was performed under an inert atmosphere. 4-Hydroxybenzaldehyde (32 g, 
0.25 mol) was dissolved in dichloromethane (500 mL). To this was added, p- 
toluenesulphonic acid monohydrate (250 mg) followed by dimethoxymethane (100 mL, 
1.13 mol) and the mixture was heated at reflux under a soxhlet containing 150 g of 
molecular sieves (3A) overnight. The solvent was removed in vacuo and the residue 
purified by vacuum distillation (0.5 Torr; 125-130 °C), yielding the title compound as 
an oil (10.31 g, 23%).
Vmax (neatycm  1: 1685s (C=0), 1110 (C-O);
'H NMR (400 MHz): 8  3.45 (3H, s, O C //3), 5.19 (2H, s, OC//2OCH3), 7.08 (2H, d, J
8 .8  Hz, Ar-H), 7.79 (2H, d , . / 8 .8  Hz, Ar-H), 9.87 ( 1H, s, CO//); 
l3C NMR (100 MHz): 5 56.6 (OCH3), 94.3 (OCH2OCH3), 116.5, 131.0, 132.2, 162.4 
(Ar-Q , 191.1 (COH);
7.3.2.4 2-Amino-3-hydroxy-3-[4-(methoxymethoxy)phenyl]propionic acid
(293f)
OH
,c o 2h
293f NH2
MO MO'
Glycine (10.28 g, 0.14 mol) and 4-(methoxymethoxy)benzaldehyde (33.00 g, 0.20 mol) 
were added to a suspension of potassium hydroxide (15.37 g, 0.27 mol) in ethanol (300 
mL) at room temperature, and the reaction mixture was stirred for 19 h. The solvent 
was evaporated, and the residue dissolved in water and acidified with HC1. The
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aqueous solution was washed with EtOAc and the pH adjusted to 6.0 with NaHC03. A 
white solid was precipitated and collected by filtration to give the title compound, after 
recrystallisation to remove excess173 glycine. The title compound was found to exist as 
a 1:1 (A: B) diastereomeric mixture (3.63 g, 11%). 
m.p. (°C): 162-163, Lit173 (164-166);
vmax (KBr)/cm *: 3454br (C-OH), 3070s (NH2), 2962s, 1635s (C-O), 1512s (C-N), 
1234s (Ar-O);
!H  NM R (500 MHz, D20): 5 3.47 (6 H, s, 6 H, A + B, OC//3), 3.89 (1H, d, J  5.5 Hz, A,
C//(NH2)), 4.06 (1H, d, J  5.3 Hz, B, C//(NH2)), 5.19 (4H, s, A + B, OC//2OCH3 &
C//(OH)), 7.11 (4H, m, A, Ar-//), 7.33 (4H, m, B, Ar-//);
m/z (+ES): 242 (MH+, 54), 180 (M+ - [MOM]+, 100%);
m/z (+HRES): 242.10302, (MH+, C nH 15N 0 5 requires 242.10285).
7.3.2.5 2-Benzyloxycarbonylamino-3-hydroxy-3-[4-(methoxymethoxy) 
phenyl]propionic acid (294f)
294f NHCbz
MOMO
To a solution o f 2-amino-3-hydroxy-3-[4-(methoxymethoxy)phenyl]propionic acid (935 
mg, 3.86 mmol) in sat N aH C 03 (100 mL) at 0 °C was added benzyl chloroformate (0.55 
mL, 3.86 mmol). Once added, the mixture was allowed to warm to room temperature 
and was stirred for 1 h. The aqueous layer was extracted with ether (4 x 20 mL) and 
acidified to pH 3.0. Once acidified the aqueous layer was extracted with EtOAc (3 x 
100 mL). The organic layers were combined, dried (Na2S0 4 ) and evaporated in vacuo. 
The crude product was subjected to flash column chromatography (5:95, 
methanol:CHC13), giving an inseparable 2:3 (A:B) diastereomeric mixture (1.04 g, 
71%).
*H NMR (500 MHz, CD3 OD): 6  3.30 (6 H, s, A + B, O C//3), 3.96 (1H, d, J  5.1 Hz, B, 
C//(NHCBz)), 4.42 (1H, d, J  9.1 Hz, A, C//(NCBz)), 4.99-5.02 (4H, m, A + B, 
O C //2OCH3). 5.43 (1H, d, J  5.1 Hz, B, C//(OH)), 5.62 (1H, d, J  9.3 Hz, 1H, A, 
C//(OH)), 6.75-7.29 (12H, m, Ar-//);
UC NMR (125 MHz, CD3 OD): 8  56.2 (OCH20CH 3), ca 62 (CH(NHCBz)), 67.3 
(OCH(CH3)2), 69.1 (N C02CH2Ph), 95.4 (OCH2OCH3), 116.9, 128.33, 128.6, 128.9, 
129.1,129.4, 138.2 (Ar-C), 158.0 (NC02Bn), 177.3 (C 0 2H);
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m/z (+ES): 398 (MNa+, 100%);
m/z (+HRES): 398.12211, ([MNa+], Ci9H2 iN 0 7Na requires 398.12157).
7.3.2.6 Isopropyl 2-Benzyloxycarbonylamino-3-hydroxy-3-[4- 
(methoxymethoxy)phenyl]propioniate (294f)
OH
,C02/Pr
^  294f NHCbz
MOMCT
2-Benzyloxycarbonylamino-3 -hydroxy-3, [4-(methoxymethoxy)phenyl]propionic acid 
(1.00 g, 4.10 mmol) and benzyltriethyl ammonium chloride (940 mg, 4.10 mmol) were 
dissolved in dimethylacelamide (DMA) (40 m'L). Potassium carbonate (14.9 g, 108 
mmol) was added to the stirred solution, followed by 2-iodopropane (19.9 ml,, 199 
mmol). The mixture was stirred at 55 °C for 24 h. The reaction was allowed to cool, 
poured into water (100 mL) and was extracted with EtOAc (3 x 50 mL). The combined 
organic extracts were dried (Na2S0 4 ) and then concentrated in vacuo to give a residue. 
The residue was purified by flash column chromatography (1:9, acetone: toluene), 
giving two inseparable diastereomers (syn-A+ anti-B) in a 1:1 ratio (604 mg, 54%). 
The mixture was further purified using preparative HPLC and derivatized (see 299) to 
determine relative stereochemistry, ((isolated syn-A): 52 mg). 
vmax (filmycm'1 (A+B): 3433s (C-OH), 3018s, 2927s, 1720 (C O );
Shs>7.-a  ( 5 0 0  MHz): 1 .1 5  (3H, d ,  J  6.3 Hz, OCH(C//3)), 1.22 (3H, d ,  J  6.2 Hz, 
O C H 3. 44 (3H, s, OC/V,), 4.49 (1H, d d ,  J  9.0, 4.3 Hz, C//(NHCBz)), 4.96-5.06 
(5H, m, O C//2OCH3, C f/2Ph & C7/(OH)). 5.58 (1H, d ,  J 9 .0  Hz, Nfl), 6.96 (2H, d ,  J  8 .8  
Hz, Ai-H), 7.21-7.35 (7H, m, Ar-77);
8cs,7,-A:a«/-R(125 MHz): ca 21 (OCH(CH3)2), 55.9 (OCH2Oa-I3), ca 60 (CH(NHCBz)), 
ca 6 6  (OCH2Ph), ca 69 (OCH(CH3)2), ca 73.5 (CH(OH)), 94.3 (OCH2OCH3), 115.9- 
116 (overlap), 124.1, 126.2, 127.8, 128.5, .128.6, 130.1, 131.6, 135.9 (Ar-C), 157.1 
(N H C02Bn), 170.0 (CXhJVr) 
nt-t (FAB): 440 (MNa+, 100%);
m/z (+HRFAB): 440.16995, (MNa+, C22H!7N0 7 Na requires 440.16851).
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/ZPrOH, 80/20, 20 ml min"1, 210 ran,
20.2 {anti-B), 23.4 (syn-A) and 24.1 (syn-A), 26.4 (anti-B).
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7.3.2.7 Isopropyl 2-Amino-3-hydroxy-3-[4-
(methoxymethoxy)phenyl]propionate (297)
OH
C02/Pr
297 NH2
MOMO'
Isopropyl 2-Benzyloxycarbonylamino-3 -hydroxy-3 - [4-
(methoxymethoxy)phenyl]propionate (50 mg, 0 .1  mmol) was dissolved in methanol (1  
mL). To this was added 5% Pd/C (10 mg). The mixture was hydrogenated at room 
temperature and pressure. The reaction was stirred over the weekend. The mixture was 
filtered through celite and was washed through with methanol (50 mL). The solvent 
was removed in vacuo and the residue purified using preparative TLC (95.5:2.5:2 
dichloromethane/methanol/TEA) to yield the title compound as a 1:1 diastereomeric 
(A:B) mixture (27.5 mg, 81%).
B A r-//);
13C NMR (A + B) (100 MHz): 6  21.7 (OCH(CH3)2), 56.2 (OCH2OCH3), 60.1 
(CH(NHCbz)), 69.3 (OCH(CH3)2), 74.1 (CH(OH)), 94.6 (OCH2OCH3), 116.3 (overlap),
127.6, 127.9, 128.0, 133.4, 134.4 (Ar-Q , 172.7 (C 0 2/Pr);
This reaction was performed under anhydrous conditions. Cooled to -10 to -15 °C, a 
solution of 2-Amino-3-hydroxy-3-(4-methoxymethoxy-phenyl)-propionic acid 
isopropyl ester (20.0 mg, 0.07 mmol) was dissolved in THF (1 mL) and TEA (28 pL,
H NMR (A + B) (400 MHz): 8  1.10 (3H, d, J6 .3  Hz, A, (OCH(C//3)2)), 1.15 (9H, m, A 
+ B, OCH(C//3)2)), 3.46 (6 H, s, O C//3), 3.52 (1H, d, J5 .5  Hz, A, C//(NH2)), 3.76 (1H, 
d, J  5.5 Hz, B, C/7(NH2)), 4.76 (1H, d, J  5.3 Hz, 1H, A, C//(OH)), 4.99 (3H, m, B, 
CH(OH) & A + B OC/7(CH3)2), 5.14 (4H, s, A + B, OC//2CH3), 6.93-7.26 (8 H, m, A +
7.3.2.8 Isopropyl 5-[4-(Methoxymethoxy)phenyl]-2-oxo-oxazolidine-4- 
carboxylate (299)
o
MOMO
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0.2 mmol). This mixture was added dropwise to a round bottom flask containing 
triphosgene (8.40 mg, 0.03 mmol) cooled to -10 to -15 °C. The reaction mixture was 
stirred for 1 h at low temp and was then stirred for 1.5 h at room temp. Triethylamine 
hydrochloride was filtered off and the filter cake washed with THF (10 mL). The
was washed with sat. NaHC0 3  ( 1 x 5  mL). The aqueous layer was then extracted with 
EtOAc ( 3 x 5  mL). The organic layers were combined, dried (Na2S0 4 ) and then 
evaporated in vacuo. The residue was then purified using preparative TLC (1:9, 
acetone: toluene). Two diastereomeric (syn-A) and {anti-B) products were separated and 
identified by lH NMR spectroscopic analysis (sy«-8.40 mg + anti-10.3 mg, 94 %).
d, J  5.2 Hz, C//(NHCO)), 5.10-5.17 (3H, m, OCH2OCU3 & OC//(CH3)2), 5.56 (1H, d,
To a suspension of magnesium bromide (65 mg, 0.36 mmol) in ether (5 mL) was added 
Isopropyl sy«-2-benzyloxycarbonylamino-3-hydroxy-3-[4-(methoxymethoxy)phenyl]- 
propionate (50 mg, 0.12 mmol), followed by 1-butanethiol (26 mg, 0.29 mmol). The 
reaction mixture was stirred and monitored by TLC. After 2 h, magnesium bromide 
was filtered and the solvent was then removed in vacuo. The residue was purified using 
preparative TLC (4:6 EtOAc: hexane), yielding the title compound as two inseparable 
(A: B, 1:1) diasteromers, (20 mg, 51%).
filtrate was evaporated in vacuo and the residue was dissolved in EtOAc (5 mL). This
8 hsyn -A  (400 MHz): 1.30 (6 H, d, J6 .2  Hz, OCH(C//3)2), 3.46 (3H, s, OCH3), 4.19 (1H,
J 5.2 Hz, Ctf(OH)), 7.06 (2H, d, J 8 . 8  Hz, Ar-H), 7.33 (2H, d, J 8 .8  Hz, Ar-H);
m/z (+ES): 310 (MNa+, 89%), 266 (M -  [CH(CH3)2]+, 100);
m/z (+HRES): 310.12778, (MNa+, Ci5Hi9N 0 6Na requires 310.12851).
7.3.2.9 Isopropyl 2-Benzyloxycarbonylamino-3-hydroxy-3-[4-
(hydroxyl)phenyl]-propionate (295a)
OH
C02/Pr
295a NHCbz
HO'
‘H NMR (500 MHz): 5 1.10 (12H, d, J  6.1 Hz, A + B, OCH(C//3)2), 4.49 (1H, dd, J
5.9, 3.15 Hz, A, Ctf(NHCBz)), 4.67 (1H, dd, J4 .0 , 3.9 Hz, B, C#(NHCBz)), 5.05 (4H, 
m, A + B, C //2Ph), 5.10 (2H, m, A + B, C//(OH)), 5.50 (1H, d ,./7 .3  Hz, A, NH), 5.60 
(1H, d, J9 .1  Hz, B, NH), 6.75-7.40 (16H, m, A + B, Ar-H);
m/z (FAB): 396 (MNa+, 100%);
m/z (+HRFAB): 396.14278, (MNa+, C2oH23N0 6Na requires 396.14230).
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7.3.2.10 2-Amino-3-[4-(hydroxyl)phenyl]propionic acid hydrochloride 
(301a)
301a nh2.hci
HO'
L-Tyrosine (100 mg) was dissolved in 2M HC1 (2 mL) and was stirred for 30 min. The 
reaction mixture was lyophilised yielding the title compound (116 mg, 96%). The 
melting point was the same as the literature value (242 °C).
7.3.2.11 Preparation of Amberlite IRA-97 and testing with 301b
Amberlite IRA-97 was washed with copious amounts of water until the pH was neutral. 
Once neutral, L-tyrosine hydrochloride (100 mg, 0.45 mmol) was dissolved in water (10 
mL). The Amberlite IRA-97 resin was added bead wise, until neutralisation was 
achieved. The mixture was lyophilised to regain L-tyrosine 300a (59.3 mg, 71%).
7.4 Synthesis of isopropyl cinnamate 
esters
7.4.1.1 Isopropoxycarbonylmethyl-triphenyl-phosphonium bromide (304)
Br ■'■ppfu^^^C^/Pr 
304
This reaction was carried out under inert conditions. Isopropyl bromoacetate (18.00 g,
67.3 mmol) was dissolved in toluene (200 mL). Triphenylphosphine (17.65 g, 67.3 
mmol) was added and the mixture was stirred for 7 d. The precipitate was filtered and 
washed with toluene (3 x 100 mL), followed by hexane (3 x 100 mL). The solid was 
collected was dried in vacuo over phosphorus pentoxide to yield the title compound as a 
colourless solid (27.20 g, 94%).
'H  NMR (400 MHz, DMSO-d6 ): 5 0.97 (6 H, d, J6 .3  Hz, OCH(C//3)2), 4.85 (1H, sept, 
J  6 . 2  Hz, OCH(CH3)2), 5.60 (2 H, d, J  14.5 Hz, CH2P), 7.72 - 7.91 (15H, m, Ar-H);
UC NMR (75.4 MHz): 5 2 1 . 2  (OCH(CH3)2), 33.3 (CH2P), 71.2 (OCH(CH3)2), 117.5,
126.7, 127.3,128.2,128.5, 135.1 (Ar-Q , 163.2 (C 0 2'Pr); 
m/z (FAB): 363 (M+, 100%);
m/z (+HRFAB): 363.15090, (M+, C23H24PO2 requires 363.15138).
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7.4.2 Wittig reactions in dichloromethane, aqueous THF and 
water: A general procedure
Isopropoxycarbonylmethyl-triphenyl-phosphonium bromide (1 equivalent) was 
dissolved either in dichloromethane (25 mL), aqueous THF (5:1, v/v, 25 mL), or water 
(25mL) and was gently shaken with NaOH (2M, 25 mL) in a separatory funnel for 5 
min when using dichloromethane. The organic layer was separated, dried (NaiSCL) and 
concentrated in vacuo, only for dichloromethane. The aldehyde (0.95 equiv) was 
dissolved in dichloromethane (50 mL) and added to the crude phosphorus ylid. The 
reaction mixture was stirred vigorously for 12 h and concentrated in vacuo for the 
reaction containing dichloromethane. The residues were purified by flash column 
chromatography or vacuum distillation, as indicated.
For reactions containing aqueous THF and water, the aldehyde was mixed with the 
solvent (25 mL) and the phosphorus ylid created in situ was added to the aldehyde (0.95 
equiv). These reaction mixtures were also stirred for 12 h and were monitored by TLC 
for the formation of cinnamate products. These reactions were extracted into 
dichloromethane (2 x 100 mL), dried (Na2S0 4 ) and the solvent removed in vacuo to 
yield the crude cinnamate, which was purified either by flash chromatography or by 
vacuum distillation, as indicated.
7.4.2.1 Isopropyl 3-[4-(hydroxyl)phenyl]acrylate (278a)
The residue was purified by flash column chromatography (2:1 EtOAc: hexane) to yield
the title compound as gold oil
(1.66 g, 96 %). From using dichloromethane.
(2.10 g, 88%). From using aqueous THF 
(2.01 g, 47%). From using water
Vmax (filmVcm'1: 3342br (C-OH), 3019s, 2984s, 1701 (C=0), 1653 (C=C), 1605s 
(Ar(C=C)), 1514s (Ar(C=C));
C02/Pr
278a
HO'
H NMR (500 MHz): 6 1.28 (1H, d, J  6.2 Hz, OCH(Ci/3)2), 5.12 (1H, sept, J  6.2 Hz, 
OCtf(CH3)2), 6.27 (1H, d, J  15.9 Hz, ArCHCT/COj/Pr), 6.88 (2H, d, J  8.5 Hz, Ar-fl), 
7.38 (2H, d, J  8.5 Hz, Ai-H), 7.61 (1H, d, J  15.9 Hz, ArC//CHC02/Pr);
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13C NMR (125 MHz): 6 22.2 (OCH(CH3)2), 68.4 (OCH(CH3)2), 116.3
(ArCHCHC02z'Pr), 127.0, 130.3 (Ar-C), 145.0 (ArCHCHC02zPr), 156.5 (Ar(C-O)),
168.0 (C 02z'Pr); 
m/z (FAB): 165 (MH+, 71%)
7.4.2.2 Isopropyl 3-[4-(benzyloxy)phenyl]acrylate (278b)
Purified by flash column chromatography (1:9, EtOAc: hexane) to yield the title
compound as colourless crystals
(1.41 g, 90%). From using dichloromethane
(1.41 g, 90%). From using aqueous THF
(2.43 g, 67%). From using water
(1H, sept, J  6.3 Hz, OC//(CH3)2), 6.32 (1H, d, J  15.9 Hz, ArCHC//C02zPr), 6.98 (2H,
13C NMR (100 MHz): 8 21.9 (OCH(CH3)2), 67.5 (OCH2Ph), 69.9 (OCH(CH3)2), 115.1
(ArCHCHC02iPr), 160.3 (Ar(C-O)), 166.7 (C 02;Pr);
m/z (FAB): 297 (MH+, 95%), 255 (MH+ - [CH3CHCH3]+, 100);
m/z (+HRFAB): 297.14942, (MNa+, Cl9H20O3 requires 297.14906).
7.4.2.3 Isopropyl 3-[4-(Hexyloxy)phenyl]acrylate by aqueous Wittig 
reaction (278d)
Purified by flash column chromatography (1:9, EtOAc: hexane) to yield the title 
compound as a colourless crystalline solid (2.80 g, 80%).
'H NMR (400 MHz): 5 0.90 (m, 3H, 0(CH 2)5C //3), 1.30 (6H, d, J  6.3 Hz, 
OCH(CH})2), 1.32 (4H, m, 0(CH2)2C //2C //2CH3), 1.45 (2H, m, 0(CH2)3C7/2CH2CH3), 
1.77 (2H, quint, J  7.9 Hz, OCH2C/72CH2(C//2)2CH3), 3.96 (2H, t, J  6.8 Hz, 
O C//2(CH2)4CH3), 5.13 (1H, sept, J  6.3 Hz, OC7/(CH,)2). 6.26 (1H, d, J  15.8 Hz,
BnO
C 0 2iPr
H NMR (400 MHz): 8 1.32 (6H, d, J6 .3  Hz, OCH(C//3)2), 5.11 (2H, s, CH2Ph), 5.16
d, J  8.8 Hz, Ai-H), 7.26-7.48 (7H, m, Ar-H), 7.65 (1H, d, J  16.0, ArC7/CHC02/Pr);
(ArCHCHC02/Pr), 116.3, 127.4, 1278.1, 128.6, 129.6, 136.4 (Ar-C), 143.8
C02/Pr
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ArCHC7/C02/Pr), 6.87 (2H, d, J  8.7 Hz, Ar-H), 7.45 (2H, d. J8 .7  Hz, Ar-H), 7.63 (1H,
d, 16.0 Hz, ArC//CHC02z'Pr);
l3C NMR (100 MHz): 5 14.0 (0(CH 2)5CH3), 22.1 (OCH(CH3)2), 22.8, 26.4, 30.6, 32.5 
((CH2)4CH3), 67.6 (OCH(CH3)2), 68.2 (OCH2(CH2)4CH3), 114.9, 128.8, 129.2 (Ar-C),
116.2 (ArCHCHC02;Pr), 144.2 (ArCHCHC02/Pr), 161.0 (Ar(C-O)), 167.0 (C 02iPr); 
m/z (+ES): 291 (MH+, 54%), 231 (MH+-  [(CH3)2CHOH]); 
m/z (+HRES): 291.19500, (MH+, CISH260 3 requires 291.19547).
7.4.2.4 Isopropyl 3-[4-(hexadecyloxy)phenyl]acrylate (278e) by aqueous 
Wittig reation
Purified by flash column chromatography (1:9 EtOAc: hexane) to yield the title 
compound as a colourless solid (2.50 g, 80 %);
vmax (film)/cm_1: 3019s, 2926s, 2854s, 1699 (C=0), 1634s (C=C), 1108 (C-O);
'H NMR (500 MHz): 6 0.86 (3H, m, 0(CH2)i5C773), 1.27-1.29 (31H, m, 
OCH2(C //2)i5CH3 & OCH(C//3)2), 1.41 (2H, m, O(CH2)4Ctf2(CH2)i0CH3), 1.45 (2H, m, 
0(C H 2)3C //2(CH2)iiCH3), 1.76 (2H, quint, J  7.5, 0(CH2C //2(CH2)i3CH3)), 3.95 (2H, t, 
J 6 .8  Hz, OC772(CH2)14CH3), 5.11 (1H, sept, .76.5 Hz, OC/7(CH3)2), 6.26 (1H, d ../  15.9 
Hz, ArCHC77C02iPr), 6.90 (2H, d, J  8.7 Hz, Ar-77), 7.43 (2H, d. J  8.7 Hz, Ar-H), 7.61 
(1H, d, J  16.0 Hz, A rC//CH C02/Pr);
13C NMR(125 MHz): 5 14.2 (0(CH 2)i5CH3), 21.9 (OCH(CH3)2), 22.6,25.9,29.1, 29.3
(overlap), 29.5 (overlap), 29.6 (overlap), 31.9 (OCH2(CH2),5CH3), 67.4 (OCH(CH3)2),
68.1 (OCH2(CH2)4CH3), 115.1, 127.0. 127.2 (overlap) (Ar-C), 116.0 (ArCHCHC02/Pr),
144.0 (ArCHCHC02/Pr), 160.8 (Ar(C-0)), 166.8 (C 02/Pr);
m/z (El): 430 (MH+, 25%), ([CH3(CH2)U]+, 100%);
m/z (+HRES):, 430.34494, (MH+, C^H ^O s requires 430.34415).
7.4.2.5 Isopropyl 3-[4-(methoxymethoxy)phenyl]acryate (278f)
MOMO
C02/Pr
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Purified by vacuum distillation (0.5 - 0.6 mmHg; 160 -  165 °C) to afford the title
compound as a yellow oil
(2.17 g, 75%). From using DCM
(2.80 g, 93%). From using aqueous THF
(1.56 g, 63%). From using water.
Vmax (neat)/cm_1: 2979s, 2937s, 1735s (C=0), 1708s, 1635s (C=C), 1109 (C-O);
'H NMR (400 MHz): 5 1.28 (6H, d, J  6.3 Hz, OCH(CH3)2), 3.46 (3H, s, OCH3), 5.11
(1H, sept, J  6.3 Hz, OCH(CH3)2), 5.18 (s, 2H, OCH2OCH3), 6.27 (1H, d, J  16.0 Hz,
(ArCHCHC02/Pr), 7.10 (2H. d, J  8.8 Hz, Ar-H), 7.45 (2H, d, J  8.8 Hz, Ar-H), 7.60 (1H, 
d, J  16.0 Hz, ArCHC’HCOjiPr);
l3C NMR (100 MHz): 5 22.3 (OCH(CH3)2), 56.5 (OCH2OCH3), 68.0 (OCH(CH3)2),
94.5 (OCH2OCH3), 116.9 (ArCHCHC02tPr), 116.7, 116.9, 117.1, 128.6, 129.9, 130.2 
(Ar-C), 144.2 (ArCHCHC02/Pr), 159.1 (Ar(C-O)), 167.2 (C 02/Pr); 
m/z (El): 250 (MH+, 100).
7.4.2.6 4-Hexadecyloxy-benzaldehyde (292e)
This reaction was carried out under an inert atmosphere. Potassium carbonate (28.3 g, 
205 mmol) was suspended in DMF (30 mL). This was treated with 4- 
hydroxybenzaldehyde (5.00 g, 40.9 mmol) and 1-bromohexadecane (12.5 mL, 40.9 
mmol). The suspension was stirred vigorously at room temperature for 30 min and was 
quenched with water (150 mL). The aqueous layer was extracted with dichloromethane 
(2 x 75mL) and organic layers were washed with water (2 x 75 mL). The organic layers 
were combined, dried (Na2S0 4 ) and were then evaporated in vacuo. The residue was 
purified by flash column chromatography (100% dichloromethane) to yield the title 
compound as a yellow solid (11.30 g, 80%)
m.p. (°C): 120-122, Lit198 (121-122);
vmax (KBr)/cm'': 2927s, 2854s, 1685 (C=0), 1600s;
'H NMR (500 MHz): 6 0.87 (3H, m, 0(CH2)15CH3), 1.33-1.38 (26H, m,
OCH2CH2CH2(CH2)i2CH3), 4.09 (2H, t, J  6.7 Hz, OCH2(CH2)14CH3), 6.94 (2H, d, J  8.7
o
292e
0 (C //2)15CH3), 1.40 (2H, m, OCH2CH2CH2C //2(CH2)iiCH3), 1.77 (2H, quint, J6 .8  Hz,
Hz, Ar-//), 7.79 (2H, d, J  8.8 Hz, Ar-H), 9.92 (1H, s, CO//);
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13C NMR (75.4 MHz): 5 14.0 (0(CH2)i5CH3), 22.5, 25.8, 28.9, 29.4, 29.6 (overlap),
31.8 (0(CH2)i5CH3), 68.2 (OCH2(CH2)i4CH3), 114.6-164.1 (Ar-C), 190.7 (COH); 
m/z (+ES): 347 (MH+, 100%).
7.4.3 Other methods towards the synthesis of cinnamates
7.4.3.1 3-[4-(Benzyloxy)phenyl]acrylic acid (303b)
3-[4-(Hydroxy)phenyl]acrylic acid (5.00 g, 30.0 mmol) was dissolved in an ethanolic 
solution (100 mL) of NaOH (62 mL, 1M). The reaction mixture was stirred for 5 min 
before the addition o f benzyl bromide (3.7 mL, 31 mmol). A precipitate was formed, 
but stirring was commenced for 48 h. The precipitate was filtered and recrystallised 
from methanol/water. The solid was dried in vacuo over phosphorus pentoxide for 48 
h, yielding the title compound as a colourless solid (2.56 g, 33%).
15.9 Hz, ArC//CHC02H);
13C NMR (100 MHz, THF-d8 ): 8 69.4 (OCH2Ph), 115.1 (ArCHCHC02H), 114. 
9, 127.8,128.0, 128.5, 129.5, 129.8, 131.8,136.8 (Ar-C), 136.8 (ArCHCHC02H; 
(C 02H);
m/z (El): 254 (M+, 100%).
7.4.3.2 Isopropyl 3-[4-(benzyloxy)phenyl]acrylate (278b)
3-[4-(Benzyloxy)phenyl]acrylic acid (1.00 g, 3.93 mmol) was suspended in 2-propanol. 
Acetyl chloride (0.3 mL, 0.3 equiv.) was added dropwise. Concentrated sulphuric acid 
(4 drops) was also added and the reaction mixture was then heated at reflux for 12 h. 
The residual solid was filtered and the filtrate evaporated in vacuo. The residue was 
taken up in EtOAc (100 mL) and washed with sat. NaHC03 (4 x 100 mL), water (100
BnO
m.p. (°C): 209-211, Lit199 (208-209);
vmax (nujoiycm'1: 2924s, 2853s, 1667 (C=0), 1624 (C=C);
*H NMR (400 MHz, THF-d8 ): 6 5.23 (2H, s, CH2Ph), 6.37 (1H, d, J  15.9 Hz, 
A rC H C//C02H), 7.06 (2H, d, J8 .7  Hz, Ar-H), 7.30-7.56 (7H, m, Ar-H), 7.63 (1H, d, J
BnO
C02/Pr
203
Experimental
mL) and brine (100 mL). The organic layer was collected, dried (MgSCL) and the 
solvent evaporated in vacuo. The residue was purified by flash column chromatography 
(5:95 EtOAc: hexane) to yield the title compound as a colourless solid (LOO g, 86%); 
Characterised vide supra
7.4.3.3 General procedure for Fischer esterification
Cinnamic acid (1 equiv) was suspended in 2-propanol (lOOmL). Sulfuric acid (4 drops) 
was also added and the reaction mixture was heated at reflux for 12 h. The residual 
solid was filtered and the filtrate evaporated in vacuo. The residue was taken up in 
EtOAc (2 x 100 mL) and washed with sat. NaHC0 3  (4 x 100 mL), water (100 mL) and 
brine (100 mL). The organic layer was collected, dried (MgS0 4 ) and the solvent 
evaporated in vacuo. The residues were purified by column chromatography (1:9 
ether:hexane) to yield the following compounds:
(1H, sept, J  6 3  Hz, OCtf(CH3)2), 6.29 (1H, d, J  15.9 Hz, ArCHC//C02zPr), 6.90 (2H,
A rC//CHC02/Pr);
l3C NMR (100 MHz): 6 21.1 (OCH(CH3)2), 55.3 (OCH3), 60.2 (OCH(CH3)2), 114.2, 
127.2, 129.6 (Ar-C), 115.7 (ArCHCHC02:Pr), 144.2 (ArCHCHC02/Pr), 161.3 (Ar (C- 
O)), 167.2 (C 02/Pr);
m/z (El): 221 (MH+, 82%), 205 (M -  [CH3]+), 161 (M+ - [HOCH(CH3)2]).
7.4.3.4 3-[4-(Methoxy)phenyl]acrylate (278c)
C02/Pr
Yield: 5.90 g, 98%;
Vmax/cm1 (KBr): 2977s, 2939s, 2839s, 1697s (C=0), 1621s (C=C);
‘H NMR (400 MHz): 5 1.30 (6H, d, J  6.3 Hz, OCH(C//3)2), 3.83 (3H, s, OAfo), 5.12
d, J  8.5 Hz, Ai-H), 7.45 (2H, d, J  8.5 Hz, Ai-H), 7.64 (1H, d, J  15.9 Hz,
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7.4.3.5 Isopropyl 3-[4-(hexyloxy)phenyl)acrylate (278d) by Fischer 
esterification
Yield: 585 mg, 50 %;
Characterised vide supra
7.4.3.6 Isopropyl 3-[4-(hexadecyloxy)phenyl]acrylate (278e) by Fischer 
esterification
Yield: 894 mg. 20 %;
Characterised vide supra
7.4.4 General procedure for phenolic alkylation of cinnamic
3-[4-(Hydroxy)phenyl]acrylic acid (5.00 g, 30.4 mmol), potassium iodide (57.2 mg. 
0.30 mmol) and potassium hydroxide (5.13 g. 91.4 mmol) were dissolved in 
ethanol/water (75/25 mL) and was then heated to reflux for 1 h. 1-Bromoalkane (30.4 
mmol) was then added and the reaction mixture was heated at reflux for 24 h. The 
solvent was removed in vacuo and the residue was stirred vigorously with HC1 (1M, 
100 mL). The crude material was filtered and recrystallised from dichloromethane to 
yield the following compounds.
7.4.4.1 3-[4-(Hexyloxy)phenyl]acrylic acid (303d)
c o 2h
3-[4-(Hydroxy)phenyl]acrylic acid (5.00 g, 30.4 mmol), potassium iodide (57.2 mg, 
0.30 mmol) and potassium hydroxide (5.13 g, 91.4 mmol) were dissolved in 
ethanol/water (75/25 mL) and were heated at reflux for 1 h. 1-Bromohexane (4.27 mL,
CCtyPr
acids
205
Experimental
30.4 mmol) was added and the reaction mixture was heated at reflux for 24 h. The
solvent was then removed in vacuo and the residue stirred vigorously with HC1 (1M, 
100 mL). The crude material was filtered and recrystallised from dichloromethane to 
yield the title compound as colourless crystals (3.25 g, 43%).
m.p. (°C): 150. Lit200 (150-151);
‘H NMR (400 MHz): 8 0.90 (m. 3H, 0 (C H 2)5CH3). 1.25 (8H. m. OCH2(CH2)4CH3), 
3.96 (2H. t. J 6 .8  Hz. OCH2(CH2)4CH3) . 6.32 (1H, d. J  15.8 Hz. A rCH CH C02H). 6.89 
(2H. d. J  8.7 Hz. Ar-H). 7.47 (2H. d. J  8.7 Hz, Ar-H). 7.63 (1H, d. 16.0 Hz. 
ArCHCHCOiH);
UC NMR (75.4 MHz, DMSO-d6 ): 8 13.8 ((CH2)5CH3), 21.6-30.8 (OCH2(CH2)4CH3).
67.5 (OCH2(CH2)4CH3). 114.7-129.8 (Ar-C), 114.7 (ArCHCHC02H), 143.4
(ArCHCHCOjH), 160.3 (Ar(C-O)), 168.9 (C 0 2H); 
m /z  (FAB): 249 (MH*. 25%);
m/z (+HRFAB): 249.14829. (MH+. C i5H20O3 requires 249.14906).
7.4.4.2 3-[4-(Hexadecyloxy)phenyl] acrylate (303e)
White solid (894 mg. 20 %). 
m.p. (°C): 120-121. Lit199 (118-119);
Vm«x (nujoll/cm 1: 3434br (C-OH). 2852s. (nujol). 2725s. 2670s. 1676s (C =0). 1633s 
(C=C). 1604s (C=C). 1556s. (C=C). 1110(C-O);
'H NMR (500 MHz): 8 0.86 (3H. m. (0(C H 2),5CH3)). 1.23 (26H. m.
OCH2CH2(CH2)i3CH3)). 1.41 (2H. m. OCH2CH2CH2CH2(CH2)n CH3). 1.45 (2H. m. 
OCH2CH2CH2CH2(CH2)nC H 3). 1.76 (quint. J  7.8 Hz. 2H, OCH2CH2 (CH2),3CH3)). 
3.95 (2H. t. J  6.5 Hz, OCH2(CH2),5CH3)), 6.27 (1H. d. J  15. 9 Hz, A rCH CH C02H). 
6.89 (2H, d. J  8.7 Hz. Ar-H), 7.46 (2H. d, J  8.7 Hz, Ar-H), 7.73 (1H, d. J  16.0 Hz. 
A rCH CH C02H);
,3C NMR (125 MHz): 8 14.2 ((CH2)5CH3), 22.6, 26.6 (overlap), 28.6 (overlap), 30.3 
(overlap), 31.9 (OCH2(CH2),5CH3), 68.1 (OCH2(CH2),4CH3), 114.8-129.6 (Ar-C).
114.2, 126.5. 130.0 (ArCHCHC02H). 146.7 (ArCHCHC02H), 161.3 (Ar(C-O)), 171.9 
(C 0 2H);
303e
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7.4.4.3 3-(4-Methoxymethoxy-phenyl)-acrylic acid isopropyl ester (278f)
1-Chloromethyl methyl ether (0.28 mL, 3.64 mmol) was added to a solution of 
Isopropyl 3-[4-(hydroxyl)phenyl] acrylate (500 mg, 2.42 mmol) and 
diisopropylethvlamine (DIPEA) (0.42 mL, 2.42 mmol) in dichloromethane (25 mL). 
The mixture was stirred overnight and the solvent removed in vacuo. The crude was 
partitioned between EtOAc (50 mL) and water (50 mL). The organic layer was washed 
with sat. NaHCOs (3 x 60 mL). The organic layers were combined, dried (MgS0 4 ) and 
then evaporated in vacuo. The residue was purified by flash column chromatography 
(2:8 EtOAc: hexane) to yield the title compound as a colourless oil (860 mg, 24%). 
Characterised vide supra
7.4.4.4 Isopropyl 3-[4-(tert-butyl-diphenyl-silanyloxy)phenyl]acrylate 
(278g) by phenolic silylation
This reaction was carried out under an inert atmosphere. Isopropyl 3-[4- 
(Hydroxy)phenyl]acrylate (3.00 g, 14.6 mmol) and imidazole (1.90 g, 16.0 mmol) were 
dissolved in DMF (60 mL). Once dissolved, tert-butyldiphenylchlorosilane (4.15 mL.
16.0 mmol) in DMF (25 mL) was added. The reaction mixture was left to stir for 48 h. 
before another 2 equiv o f tert-butyldiphenylchlorosilane (8.30 mL. 32.0 mmol) in DMF 
(25 mL) were added dropwise. The reaction mixture was stirred for another 48 h and 
analysis by TLC showed no further reaction. The reaction mixture was poured into 1M 
HC1 (60 mL) and extracted with EtOAc (3 x 60 mL). The combined organic layers 
were dried (Na^SCL) and then evaporated in vacuo. The residue was purified by flash 
column chromatography (1:1. dichloromethane: hexane) to yield the title compound as 
colourless cry stals (4.60 g, 65%).
Vmax (K B r)/cnT ': 3018s, 2932w. 1701m (C =0), 1635s (C=C), 1600s (C=C), 1108 (C- 
O);
'H NMR (500 MHz): 5 1.08 (9H, s, S i C ( C 1.29 (d, J 6 .3  Hz, O C H (C//3)2), 5.12 
(1H. sept, J  6.3 Hz, O C/flCH ,),). 6.22 (1H, d, J  16.0 Hz, ArCHCT/COjPr). 6.78 (2H.
MOMO
TBDPSO
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d, J  8.8 Hz, Ar-fl), 7.27 (2H, d, J  8.5 Hz, Ar-/7), 7.34-7.46 (6H, m, Ar-//), 7.54 (1H, d. 
J  16.0 Hz, A rC //C H C 02H), 7.68-7.73 (4H, m, Ar-tf);
13C NMR (125 MHz): 5 19.7 (SiC(CH3)3), 22.2 (OCH(CH3)2), 26.7 (SiC(CH3)3), 67.8 
(OCH(CH3)2), 116.7 (A rCH CH C02H), 120.4, 127.9, 128.2, 129.7, 128.2, 129.7, 130.4, 
132.8. 135.7 (Ar-C). 144.3 (A rCH CH C02H), 157.8 (ArC-O), 167.1 (C 0 2;Pr); 
m /z (FAB): 467 (MNa+, 18%), 387 (M+ - [C(CH3)]+, 100); 
m /z (+HRFAB): 467.20274, (M N a\ C28H32N a 0 3Si requires 467.20183).
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7.5Sharpless Asymmetric 
Aminohydroxylation reactions
aminohydroxylations with unsubstituted cinnamate esters
All yields cited within this section are quoted for both regioisomers and are not isolated 
yields.
7.5.1.1 General procedure for Sharpless asymmetric aminohydroxylations 
with M-bromoacetamide and (DHQ)2AQN under homogeneous 
conditions, with added acetamide and calculated reaction volumes 
(for isopropyl cinnamate, an example).
In 0.85 mL o f an aqueous solution o f LiOHLLO (42.8 mg. 1.02 mmol), a solution of 
osmium tetroxide was added (11.4 mg. 0.05 mmol, 1 mL), with stirring. After addition 
o f "PrOH (1.85 mL). (DHQ^AQN (42.8 mg, 0.05 mmol) was added, and the mixture 
was stirred for 10 min. After the chiral ligand was dissolved completely, the mixture 
was immersed in a cooling bath set to 4 °C. After addition o f trans-cinnamate (1.00 
mmol). A-bromoacetamide (165 mg, 1.20 mmol) and acetamide (59 mg. 1.0 mmol) 
were added in one portion (which resulted in an immediate colour change from yellow 
to green) and the mixture was vigorously stirred at the same temperature. After 
completion o f the reaction, the catalyst was filtered and was then washed with 
dichloromethane. Saturated aqueous sodium sulfite and IN HC1 were added to the 
filtrate and the mixture was stirred for an additional hour. The organic product was 
extracted with dichloromethane and after removing the solvent in vacuo, the crude 
product was purified by chromatography on silica gel with EtOAc/hexanes.
7.5.1.2 Isopropyl (2R,3S)-2-acetylamino-3-hydroxy-3-phenyl-propionate
287 NHAc
Purified using preparative TLC (dichloromethane: methanol, 98-90:2%—> 10%) to yield 
the title compound (40.3 mg, 15%).
7.5.1 Homogeneous Sharpless asymmetric
(287)
OH
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Vmax (nujol)/cm ':  3329br (C-OH), 1719s (C =0), 1650s (C=0);
'H NMR (400 MHz, CD3 OD): 6  1.07 (3H, d, J 1 2  Hz, OCH(CH})% 1.14 (3H, d, J6 .3
C //(N H A c», 5.19 (1H, d, J 3 .9  Hz, C77(OH)), 7.12-7.38 (5H, m, Ar-H);
,3C NMR (400 MHz, CD3OD): 5 16.8 (OCH2CH3), 24.5 (NCOCH3). 62.7 
(CH(NHAc), 64.8 (OCH2CH3), 76.6 (CH(OH)), 126.2, 127.8, 128.1, 128.5, 140.3 (Ar- 
Q .  174.2 (NCOCH3). 175.8 (C 0 2 /Pr);
m /z (Cl): 252 (MH+. 95%), 234 (M -  [OH]), 121 ([C6H5CH(OH)CH2]+).
7.5.1.3 Ethyl (2R,3S)-2-acetylamino-3-hydroxy-3-phenyl-propionate (314)
Purified using preparative TLC (6:4 hexaneiethyl actetate) to yield the title compound 
(47.1 mg. 20%):
vm,x (KBr)/cm ':  3454br (C-OH). 1699s (C=0);
'H NMR (400 MHz): 8  1.23 (t. J  7.1 Hz, 3H), 1.92 (3H, s, C O C//3), 4.81 ( 1 H, dd. J
4.7. 3.9 Hz. C//(NHAc)), 5.20 (1H, d, J 3 .9  Hz. C//(OH)), 7.25-7.40 (5H, m. Ar-H); 
l3C NMR (100 MHz): 8  21.7 (OCH(CH3)2). 23.1 (NCOCHj), 54.8 (CH(NHAc). 69.6 
(OCH(CH 3)2). 73.9 (CH(OH)). 129.7. 131.3. 131.5. 144.6 (Ar-C), 170.2 (NCOCH3).
172.4 (C 0 2 /Pr):
m /z (FAB): 252 (MNaT. 90%). 176 (M -  [H20 ], 100). 121 ([C6H5CH(OH)CH2]". 40).
7.5.1.4 Methyl (2R,3S)-2-acetylamino-3-hydroxy-3-phenyl-propionate (315)
QH
: C 0 2M e
Purified using preparative TLC (6:4 hexane:ethyl actetate) to yield the title compound 
as colourless cry stals (36.4 mg, 16%);
'H NMR (400 MHz, CD3 OD): 8  1.99 (3H, s, NHCOC7C). 4.01 (3H, s, OMe), 4.71 
(1H, dd, J 4 .7 , 3.9 Hz, C//(NHAc)), 5.19 (1H, d, J 3 .9  Hz, C//(OH)), 7.15-7.35 (5H, m. 
Ar-H):
Hz, OCH(CH3), 1.94 (3H, s, C O C //3), 4.69 (d, J  3.9 Hz, OH), 5.09 ( 1 H, q, J  6.3 Hz,
OH
314 N H A c
315 N H A c
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m /z ( C l ) :  237 (M+, 8 %);
7.5.1.5 General procedure for Sharpless asymmetric aminohydroxylations 
with M-bromoacetamide and (DHQ^ AQN under homogeneous 
conditions on a 5 mmol scale.
In 150 mL o f an aqueous solution o f LiOHELO (273 mg. 6.50 mmol), potassium 
osmate dihydrate was added (81 mg, 4.4 mol %), with stirring. A 1-propanol (100 mL) 
solution containing (DHQ^AQN (171 mg, 4 mol %) and trans isopropyl cinnamate 
(951 mg. 5.00 mmol). The two solutions were combined and the mixture was immersed 
in a cooling bath set at 4 °C. Ar-bromoacetamide (966 mg, 7.00 mmol was added in one 
portion (which resulted in an immediate colour change from brown to green) and the 
mixture was vigorously stirred at the same temperature. After completion o f the 
reaction, the catalyst was filtered and washed with dichloromethane. Saturated aqueous 
sodium sulfite and IN HC1 were added to the filtrate and the mixture was stirred for an 
additional hour. Organic product was extracted with dichloromethane. After removing 
the solvent, the crude product was purified by chromatography on silica gel with 
EtOAc/hexanes.
7.5.1.6 Isopropyl (2R,3S)-2-acetylamino-3-hydroxy-3-phenyl-propionate 
(287)
Product was purified by flash column chromatography (4:6, EtOAc: hexane) to yield the 
title compound (130 mg. 11%).
Characterised vide infra.
H P L C :  Chiracel AD-H. 20mm x 250 mm, hexane/z'PrOH. 80/20. 20 ml m in '1. 210 nm. 
8.84 and 9.74 (2R3S) & (2S3R).
7.5.1.7 General procedure for homogeneous Sharpless asymmetric 
aminohydroxylations with benzyl carbamate and (DHQ^ AQN 
under homogeneous conditions
A reaction flask was charged with NaOH (2.98 mL, 1.02 M) and diluted with water (4.5 
mL). Potassium osmate dihydrate (14.7 mg, 0.04 mmol) was dissolved in a separate 
vial with an aliquot o f the alkaline solution (0.5 mL). With vigorous stirring. 1- 
propanol (4 mL) was added, followed by benzyl carbamate (469 mg, 3.10 mmol). 1,3- 
dichloro-5,5'-dimethylhydantoin (300 mg, 1.52 mmol) was then added in small 
portions. Once added and completely dissolved, a 1-propanol solution (3.5 mL)
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containing cinnamate (1.00 mmol) and (DHQ^AQN (42.8 mg, 0.05 mmol) was added, 
followed by the aqueous solution o f potassium osmate dihydrate.
After 2 h. sodium bisulfite (500 mg) was added. The aqueous phase was separated and 
then extracted wih EtOAc (3 x 30 mL). The combined organic layers were dried 
(T^SC L) and evaporated. The residues were purified by flash column chromatography 
(1:9. acetone:toluene).
7.5.1.8 Isopropyl (2ft,3S)-2-benzyloxycarbonylamino-3-hydroxy-3-phenyl- 
propionate (288)
Yield: 239 mg. 6 6 %;
vm>s (film)/cm ': 3435s (C-OH). 3018s (C-H). 1713s (C=0);
'H NMR (500 MHz): 6  1.16 (3H. d, J  6.3 Hz, OCH(C//3)). 1.23 (3H. d. J  6 . 8  Hz. 
OCH(CHi)), 4.54 ( 1 H, dd. J  9.1, 2.5 Hz, Ctf(NHCbz)), 5.00 (2H, s. C //2Ph). 5.05 ( 1 H. 
sept. J  6.3 Hz. OCW(CH;,)2). 5.19 (1H. s, C//(OH)). 5.50 (1H, d, J  9.1 Hz. NH). 7.23- 
7.35 (10H. m. Ar-H):
13C NMR (125 MHz): 5 ca 21.6 (OCH(CH3)2), 58.4 (CH(NCbz). 66.9 (OCH 2Ph). 69.7 
(OCH(CH3)2). 73.5 (CH(OH)). 126.1. 127.9, 128.1 (overlap). 128.4 (overlap). 136.2.
139.6 (Ar-C). 155.6 (N C 0 2CH2Ph). 170.0 (C 0 2/Pr):
Elemental Analysis: Found C. 65.64. H. 6.41, N. 3.79. %. C2 iH27N 0 6 -MeOH requires 
C. 64.77. H. 6.99. N. 3.60. %.
m /z (Cl): 358 (M Ff. 42%). 340 (M -  [H20]), 314 (M+ - [CH(CH3)2]+). 107 
([C 6F fC (O H )f):
m/z (+HRES): 358.16476, ([M Ff]. C20H23NO 5. requires 358.16545
HPLC: Chiracel AD-H, 20mm x 250 mm. hexane/ZPrOH, 80/20, 20 ml m in '1, 210 nm,
34.6 (2R 3S).
[a ] D20 = + 35.6 (c 0.5. CHC13).
OH
Ph
C 0 2/Pr
2 8 8  N H C bz
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7.5.1.9 Synthesis of Isopropyl (2/?,3S)-3-acetylamino-2-hydroxy-3-phenyl- 
propionate (179) by M-bromoacetamide and (DHQ)2PHAL under 
homogeneous conditions on a 5 mmol scale.
N H A c
C02/Pr
In 150 mL o f an aqueous solution o f L i0 H H 20  (273 mg, 6.50 mmol), 
K2[ 0 s 0 2(0H4)].2H20  was added (81 mg, 4.4 mol %), with stirring. A 'BuOH (100 mL) 
solution containing (DHQ)2PHAL (156 mg, 4.00 mol %) and trans isopropyl cinnamate 
(951 mg. 5.00 mmol). The two solutions were combined and the mixture was immersed 
in a cooling bath set to 4 °C. A-bromoacetamide (966 mg, 7.00 mmol was added in one 
portion (which resulted in an immediate colour change from brown to green) and the 
mixture was vigorously stirred at the same temperature. After completion of the 
reaction, the catalyst was filtered and then washed with dichloromethane. Saturated 
aqueous sodium sulfite and IN HC1 were added to the filtrate and the mixture was 
stirred for an additional hour. The organic product was extracted with dichloromethane. 
After removing the solvent, the crude product was purified by column chromatography 
(4:6. EtOAc: hexane) to yield the title compound as a white solid (1.04 g, 79%). 
m.p. (°C): 111-112. Lit201 (108-109);
vmax (KBr)/cm ':  3332br (C-OH). 3019s. 2931s. 1712s (C=0), 1651s;
*H NMR (500 MHz): 6 1.26 (6H. d. J 7 .4  Hz. OCH(CH3)2). 1.98 (3H, s. COCH3). 3.19 
(1H. d. J  3.8 Hz. OH). 4.46 (1H. s. CH(OH)). 5.09 (1H. sept. J  6.3 Hz. OC//(CH3)2).
5.54 (1H. dd. J9 .3 . 2.2 Hz. CH(NHAc)). 7.24-7.38 (5H. m, Ai-H):
,3C NMR (125 MHz): 6 21.3 (OCH(CH3)2). 23.3 (NCOCH3). 54.7 (CH(NHAc)). 60.7 
(OCH(CH3)2). 74.9 (CH(OH)). 127.2. 128.1. 128.9. 139.2 (Ar-C), 169.8 (NCOCH3).
172.7 (CO: /Pr);
m /z (FAB): 288 (MNa+. 100%);
HPLC: Chiracel AD-H. 2 mm x 250 mm, hexane/zPrOH, 60/40, 20 ml min"1. 210 nm.
17.7 (2R.3S).
179 OH
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7.5.1.10 General procedure for homogeneous Sharpless asymmetric 
aminohydroxylations with benzyl carbamate and (DHQ)2PHAL.
A reaction flask was charged with NaOH (2.98 mL, 1.02 M) and diluted with water (4.5 
mL). Potassium osmate dihydrate (14.7 mg, 0.04 mmol) was dissolved in a separate 
vial with an aliquot o f the alkaline solution (0.5 mL). With vigorous stirring, 1- 
propanol (4 mL) was added, followed by benzyl carbamate (469 mg, 3.10 mmol). 1,3- 
dichloro-5,5'-dimethyl hydantoin (300 mg, 1.52 mmol) was added in small portions. 
Once added and completely dissolved, a 1-propanol solution (3.5 mL) containing 
cinnamate (1.00 mmol) and (DHQ^PHAL (38.9 mg, 0.05 mmol) was added, followed 
by the aqueous solution o f potassium osmate dihydrate.
After 2 h. sodium bisulfite (500 mg) was added. The aqueous phase was separated and 
then extracted with EtOAc (3 x 30 mL). The combined organic layers were dried 
(Na2SO_0 and evaporated. The residues were purified by flash column chromatography 
(1:9, acetone: toluene).
7.5.1.11 Isopropyl (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-3-(4- 
phenyl)-propionate (316)
C bzH N
Yield: 285 mg. 80%;
v max (KBr)/cm  ’: 3535s (C-OH). 3019s (C-H). 1717s (C=0):
'H NMR (500 MHz): 6  1.20 (3H. d, J  6.1 Hz. OCH(CH3)), 1.23 (3H. d. J  6.9 Hz. 
OCH(CH}). 3.29 (1H. d. J  3.9 Hz, OH). 3.76 (3H. s, OCH3). 4.65 (1H. s. CH(OH)).
4.99-5.09 (3H. m. OCH(CH3) 2 & CTCPh). 5.22 (1H. d. J 9 .2  Hz, CMNHCbz)). 5.70 (d, 
J  9.6 Hz, N H). 6 . 8 6  (2H, d, J  8 . 8  Hz. Ar-H), 7.26-7.30 (7H, m, Ar-H);
UC NMR (75.4 MHz): 8  21.6 (OCH(CH3)2), 55.2 (OCH3), 55.9 (CH(NHCbz)), 66.9 
(OCH(CH3)2). 70.7 (N C 0 2CH2Ph), 73.6 (CH(OH)), 113.9, 126.3, 127.1. 127.2, 127.8. 
128.6, 128.7, 129.8, 130.0, 136.5, 139.3 (Ar-C), 159 (N C 0 2Bn), 172.3 (C 0 2/Pr); 
Elemental Analysis: Found C, 66.64, H, 6.44, N, 3.83, %. C20H23NO 5 requires C, 
67.21, H, 6.49, N, 3.83 %; 
m /z (+ES): 388 (MET, 100 %), 370 (M -  OH);.
C02/Pr
316 OH
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m/z (+HRES): 410.15618, (MNa+, C2 iH2 5N 0 6Na requires 410.15741).
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane//PrOH, 80/20, 20 ml m in '1, 210 nm,
18.7 (2R3S).
[a ] D20 = + 32.8 (c 0.5, CHC13)
7.5.1.12 Large Scale synthesis of Ethyl (2R,3S)-2- 
ethoxycarbonylamino-3-hydroxy-3-phenyl-propionate (317)
OH
co2Et
Ph
317 N H C 0 2 Et
A reaction flask was charged with NaOH (794 mg in water (25 mL), 19.7 mmol). 
Potassium osmate dihydrate (23.9 mg. 0.07 mmol) was dissolved in a separate vial with 
an aliquot o f the alkaline solution (0.5 mL). With vigorous stirring, 1-propanol (12.5 
mL) was added, followed by ethyl carbamate (1.78 g, 20.0mmol) and l,3-dichloro-5,5'- 
dimethylhydantoin (1.94 g, 9.85 mmol) was added in small portions. Once added and 
completely dissolved, a 1-propanol solution (12.5 mL) containing cinnamate (6.50 
mmol) and (DHQ)2AQN (68.5 mg, 0.08 mmol) was added, followed by the aqueous 
solution o f potassium osmate dihydrate. After 2 h, sodium bisulfite (2 g) was added. 
The aqueous phase was separated and then extracted with EtOAc (3 x 100 mL). The 
combined organic layers were dried (Na2S0 4 ) and then evaporated. The residue was 
purified by flash column chromatography (6:4:1, hexane:dichloromethane:methanol) to 
yield the title compound as a colourless solid (250 mg. 14%). 
v max (film V cnf1: 3435br(C-OH). 3018s. 2983m. 2931m. 1720s (C=0);
'H NMR (400 MHz): 8  1.15 (3H. t, J  1 2  Hz. N C 0 2CH2C //3). 1.22 (3H. t. J  1 2  Hz. 
OCH2C //3). 4.02 (2H, q. J  7.1 Hz. O C //2CH3), 4.20 (2H. q. J  7.1 Hz. NCO2C //2CH,).
4.55 (1H. dd. J  4 .1 . 9.1 Hz. C //(N C 0 2Et)), 5.23 (1H. s. C//(OH)), 5.42 (1H. d. J  9.1 Hz. 
NH). 1 2 6 -1 2 1  (5H. m. Ar-H);
l3C N M R (100 MHz): 8  13.9 (NCO2CH 2C //3). 14.3 (OCH2C //3), 56.2 (NCCbC/ACH,).
59.8 (OCH2CH3), 61.6 (CH(NHC02Et)), 73.4 (CH(OH)), 125.9, 126.7, 127.8, 128.3,
128.5. 139.8 (Ar-C). 155.9 (N C 0 2Et), 170.7 (C 0 2Et);
m/z (ES): 282 (MH+, 20%).
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7.5.1.13 Ethyl (2R,3S)-2-benzyloxycarbonylamino-3-hydroxy-3-phenyl- 
propionate (318) by varying oxidants: 1,3-dichloro-5,5'-
dimethylhydantoin and dichloroisocyanuric acid
with water (4.5 mL). Potassium osmate dihydrate (14.7 mg, 0.04 mmol) was dissolved 
in a separate vial with an aliquot o f the alkaline solution (0.5 mL). With vigorous 
stirring, 1-propanol (4 mL) was added, followed by benzyl carbamate (469 mg, 3.10 
mmol) and L3-dichloro-5,5'-dimethyl hydantoin (300 mg, 1.52 mmol) or 
dichloroisocyanuric acid sodium salt (334 mg, 1.52 mmol), in small portions. Once 
added and completely dissolved, a 1-propanol solution (3.5 mL) containing cinnamate 
(1.00 mmol) and (DHQ^AQN (42.8 mg. 0.05 mmol) was added, followed by the 
aqueous solution o f potassium osmate dihydrate. After 2 h, sodium bisulfite (500 mg) 
was added. The aqueous phase was separated and then extracted with EtOAc (3 x 30 
mL). The combined organic layers were dried (T^SCL) and then evaporated. The 
residues were purified by flash column chromatography (6:4:1. 
hexane: dichloromethane: methanol).
Yield: 163 g. 48 %; (from l,3-dichloro-5.5-dimethylhydantoin);
Yield: 56 mg, 16 %: (from dichloroisocyanuric acid sodium salt): 
vmax (KBrVcm1: 3363br (C-OH). 2978s. 1723s (C=0):
'H NMR (500 MHz): 6  1.24 (3H. t. J  7.1 Hz. OCH2C //3). 4.21 (2H. q. J  6.9 Hz. 
O C //2CH3). 4.60 (1H. dd. J 8 .5 . 2.4 Hz. C//(NHCBz)), 5.02 (1H, s. C//(OH)). 5.26 (1H. 
s. N H). 7.21 - 7.42 (5H. m. Ar-H):
l3C NMR (125 MHz): 6  14.1 (OCH2CH3). 56.5 (CH(NHCBz)). 61.9 (N C 0 2CH2Ph).
67.1 (OCH2CH3). 73.5 (CH(OH)). 126.1, 126.9 (overlap). 128.1 (overlap), 128.2. 128.3.
128.5. 128.8. 136.3. 139.7 (Ar-C), 158.2 (N C 0 2CH2Ph). 170.7 (C 0 2Et); 
m /z  (FAB): 366 (MNa+. 31%).
OH
Ph
318 N H C bz
A reaction flask was charged with sodium hydroxide (2.98 mL, 1.02 M) and diluted
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7.5.2 Homogeneous Sharpless asymmetric
aminohydroxylations with p-substituted isopropyl
cinnamate esters
All yields cited within this section are quoted for both regioisomers and are not isolated 
yields. The general procedures 7.5.1.7 and 7.5.1.10 were used for (DHQ)2AQN 136a 
and (DHQ)2PHAL 137a, respectively.
7.5.2.1 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4-
(benzyloxy)phenyl]-3-hydroxy-propionate (295b)
OH
, C 0 2/Pr
295b N H C bz
B n O '
m.p. (°C): 85-86;
Yield: 353 mg. 76%;
v max (fUm)/cm*': 3435m (C-OH). 3019s. 1718s (C=0). 1611m (Ar(C=C)). 1585m 
(Ar(C=C)). 1454m (Ar(C=C)), 1104 (C-O);
'H NMR (400 MHz): 8 1.17 (3H, d. J  6.3 Hz. OCH(C//3)). 1.23 (3H. d. J  6.8 Hz. 
O CH (C//j)). 4.53 (1H. dd. J  9.0. 2.5 Hz. C//(NHCbz)), 5.00 (4H. m N C 02C7/2Ph & 
C //2Ph). 5.05 (1H. s e p t../6.3 Hz. O C//(CH 3)2), 5.19 (1H. s, Ctf(OH)), 5.56 (lH .d. J9 .0  
Hz. NH). 6.93 (2H. d. J 8 .6  Hz, Ar-H). 7.18-7.39 (12H. m. Ar-H):
,3C NMR (100 MHz): 8 ca 21.6 (OCH(CH3)2). 58.4 (CH(NCbz), 66.9 (OCH2Ph). 69.7 
(OCH(CH3)2). 70.0 (N C 02CH2Ph) 73.5 (CH(OH)). 114.9, 127.5. 128.1 (overlap).
128.5. 128.6. (overlap). 131.5. 136.4. 137.0 (Ar-C). 158.6 (N C 02CH2Ph). 170.0 
(C 0 2/Pr):
Elemental Analysis: Found C, 68.70. H, 6.28, N, 3.04, %. C27H29N06 
requires C. 69.96; H. 6.31; N, 3.02 %;
m /z (+ES): 486 (M N a+, 10%), 446 (M+ - OH, 20), 402 (MH+ - OHCH(CH3)2.100); 
m/z (+HRFAB): 486.18967, ([MNa+]. C27H29N06Na+, 486.18925);
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane//PrOH, 70/30, 20 ml m in '1, 210 nm,
25.7 (2R3S);
[o ]D20 = + 43.1 (c 0.5, CHC13).
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7 .5 .2 .2  Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4- 
(methoxy)phenyl]-3-hydroxy-propionate (295c)
HO
C 0 2/Pr
295c NHCbz
MeO'
Yield: 232 mg. 60%;
vmax (film )/cm ‘':3019s. 2400m, 1723 (C =0), 1623m (C=0), 1514s, 1216s (C-O);
'H NMR (500 MHz): 5 1.20 (3H, d, J  6.2 Hz, OCH(C//3)), 1.23 (3H, d, J  6.2 Hz, 
OCH(C7/3). 3.79 (3H. s, OCH}), 4.52 (1H, dd, J 9 .0 .  4.0 Hz, C//(NHCbz)). 4.99-5.12 
(3H, m. O C//(CH 3)2 & CH2Ph), 5.15 (1H, s, C//(OH)), 5.61 (d, J  9.0 Hz. N //). 6.86 
(2H, d, J 8 .8  Hz, Ar-H), 7.26-7.30 (7H, m, Ar-H );
UC NMR (75.4 MHz): 8 21.6 (OCH(CH3)2), 55.2 (OCH3), 55.9 (CH(NHCbz)). 66.9 
(OCH(CH3)2). 70.7 (N C 02CH2Ph), 73.6 (CH(OH)), 113.9. 127.9. 128.1, 128.5, 131.2.
136.4 (Ar-C). 159 (N C 02Bn). 172.3 (C 0 2/Pr); 
m /z (+FAB): 388 (M IT. 100 %), 370 (M -  OH);.
m /z (+HRFAB): 410.15858, ([MNa+], C2iH25N 0 6Na requires 410.15795);
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/iPrOH, 80/20, 20 ml m in '1, 210 nm.
24.4 (2R3S);
[a ]D:o = + 28.1 (c 0.5, CHC13)
7.5.2.3 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4-(hexyloxy)
phenyl]-3-hydroxy-propionate (295d)
Yield: 341 mg, 75%;
v max (film )/cm '': 3434s (C-OH), 3017s, 2933s, 1717s (C=0);
'H NMR (500 MHz): 8 0.86-0.91 (3H, m, 0 (C H 2)5C //3), 1.16 (3H, d, J  6.3 Hz, 
O CH (C//3)), 1.23 (3H, d, J6 .3  Hz, O CH(C//3)), 1.53 (6H, m, 0 (C H 2)2(C //2)3CH3), 1.81 
(2H, quint, J  6.2 Hz, OCH2C //2CH2(CH2)2CH3), 3.91 (2H, t, J  6.6 Hz.
O C //2(CH2)4CH3), 4.43 (1H, dd. J9 .0 . 4.1 Hz, C//(NHCBz)), 5.03 (2H, s, C //2Ph), 5.13
OH
C 0 2/Pr
295d NHCbz
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(1H, s, C H (O H )\ 5.50 (1H, d, J 9 .0  Hz, NH), 6.83 (2H, d, J 8 .8  Hz, 1H), 7.22-7.36 (m, 
1H);
,3C NMR (100 MHz): 8 14.0 (0 (C H 2)5CH3), 21.6 (OCH(CH3)2), 22.6, 26.1, 29.4, 29.7, 
(OCH2(CH2)4CH3). 59.1 (CH(NHCbz)), 66.9 (OCH(CH3)2), 68.0 (OCH2Ph). 69.5 
(CH(OH)), 73.6 (OCH2(CH2)4CH3), 114.4, 114.5, 127.2, 127.7, 128.4, 131.3, 155.4 
(Ar-C), 158.5 (N C 02Bn). 169.3 (C 0 2/Pr);
m /z  (+ES): 458 (M H \ 11%), 440 (M -  [OH],), 396 (M -  [iPrOH],), 307 (M -  [Cbz]+);. 
m/z (+HRFAB): 480.23718 (MNa+, C26H35N 0 6Na requires 480.23726);
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/ZPrOH, 85/15, 20 ml min"1, 210 nm,
26.9 (2R3S);
[a ]D20 = + 51.0 (c 0.5, CHC13)
7.5.2.4 Isopropyl (2/?,3S)-2-Benzyloxycarbonylamino-3-[4-(hexadecyloxy) 
phenyl]-3-hydroxy-propionate (295e);
Yield: 205 mg. 34 %;
'H NMR (400 MHz): 8 0.91 (3H, m. 0 (C H 2)i?C //3), 1.28-1.29 (31H.
OCH2(C //2) |5CH3 & OCH(C//3)2). 3.92 (2H. t. J  6.6 Hz. O Ctf2(CH2),4CH3). 4.52 (1H. 
dd. J  8.4. 3.5 Hz. C//(NHCbz)). 4.93-5.31 (4H, m. CH2Ph, OC//(CH3)2 & C//(OH)).
5.56 (1H. d. J8.2 Hz. NH). 6.85 (2H. d.78.4 Hz, Ar-H). 7.24-7.40 (7H. m, Ar-H):
13C NMR (75.4 MHz): 8 14.1 (0 (C H 2) ,5CH3). 21.6 (OCH(CH3)2). 21.6. 22.7. 26.1.
29.4. 29.7. 31.9 (overlap) (0 (C H 2) |5CH3). 55.6 (OCH2(CH2) 14CH3). 61.0
(CH(NH(Cbz)). 66.9 (OCH(CH3)2), 68.0 (OCH2Ph), 69.1 (CH(OH)). 114.4, 114.5.
127.3. 127.9. 128.0. 128.5. 131.5, 155.5 (Ar-C). 158.0 (N C 02Bn). 172.6 (C 0 2/Pr); 
m/z (FAB): 620 (M N a\ 100%);
m/z (+HRFAB): 620.39042, ([MNa+], C36Hj5N06Na+ requires 620.39269);
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane//PrOH, 80/20, 20 ml min"1, 210 nm,
8.1 (2R3S);
[a ]D20 = + 43.2 (c 0.5, CHC13)
OH
CC>2/Pr
295e NHCbz
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7.5.2.5 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-hydroxy-3-[4- 
(methoxymethoxy) phenyl]propionate (295f)
Yield: 353 mg, 76%;
Characterised vide supra
H PL C : Chiracel AD-H, 20mm x 250 mm, hexane/ZPrOH, 80/20, 20 ml m in '1, 210 nm,
25.9 (2R3S);
[a ]D20 = + 16.5 (c 0.5. CHC13)
7.5.2.6 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4-(fert-butyl- 
diphenyl-silanyloxy)-phenyl]-3-hydroxy-propionate (295g)
OH
294g NHCbz
TBDPSO
Yield: 246 mg. 40 %;
'H NMR (500 MHz): 5 1.09 (9H, s. SiC(C//3)3). 1.12 (3H. d. .7 6.2 Hz, OCH(C7/3)). 
1.20 (3H. d. J 6 .3  Hz. O CH (C//3)), 4.45 (1H, dd, J9 .1 , 4.9 Hz, C//(NHCbz)). 4.96-5.05 
(4H. m. O C//(CH 3)2. C//(O H ) & C //2Ph), 5.46 (1H, d , J9 .1  Hz, NH). 6.71 (2H, d , J 8.6 
Hz. A r-//). 7.07 (2H. d , J  8.6 Hz, Ar-//), 7.25-7.34 (9H, m. Ar-//), 7.36-7.44 (2H. m. 
Ar-H). 7.66-7.71 (2H. m, A r-//);
l3C NMR (75.4 MHz): 6 19.4 (SiC(CH3)3), 21.5 (OCH(CH3)2), 26.5 (SiC(CH3)3). 55.1 
(C7/(NHCbz)). 66.9 ((OCH (C//3)2)), 70.7 (N C 02C //2Ph). 73.4 (CH(OH)). 115.9. 119.6.
127.3 (overlap). 128.1. 128.4. 129.9. 132.0. 132.7. 135.5. 155.6 (Ar-C). 155.5 
(NCYCBn). 172.3 (C 0 2/Pr);
m/z (FAB): 634 (MNaC 100%)
m /z (+HRFAB): 634.25836, (M Na'. C36H4iN 0 6SiN a' requires 634.26007).
HPLC: Chiracel AD-H. 20mm x 250 mm, hexane/zPrOH. 80/20, 20 ml m in'1, 210 nm,
9.3 (2R.3S):
[a ]D20 = - 67.7 (c 0.5, CHC13).
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7 .5 .2 .7  Isopropyl (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-3-[4- 
(benzyloxy)phenyl]propionate (319b)
CbzHN
Yield: 371 mg, 80%;
'H NMR (500 MHz): S 1.20 (3H, d, J  6.1 Hz, OCH(C7/3)). 1.23 (3H, d, J  6.9 Hz,
4.99-5.09 (3H, m, OC//(CH3)2 & C //2Ph). 5.22 (1H, d, J 9 .2  Hz, C//(NHCbz)). 5.70 (d, 
J  9.6 Hz. N //). 6.86 (2H, d, J  8.8 Hz, A r-//), 7.26-7.30 (7H, m, A r-#);
UC NMR (75.4 MHz): 8 21.6 (OCH(CH3)2), 55.2 (OCH3), 55.9 (CH(NHCbz)), 66.9 
(OCH(CH3)2), 70.7 (N C 02CH2Ph), 73.6 (CH(OH)), 114.9. 127.4, 128.0. 128.5. 128.6.
131.5. 136.4. 136.9. (Ar-C), 159 (N C 02Bn), 172.3 (C 0 2/Pr); 
m/z (+ES): 486 (M N a+, 10%). 446 (M -  [H20 ], 20). 402 (MH+ - OHCH(CH3)2.100); 
m/z (+HRES): 486.18889, (MNa+, C27H29N 0 6Na+, 486.18871);
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/ZPrOH, 80/20, 20 ml min"1. 210 nm.
18.3 (2R3S):
[a ]D20 = + 54.1 (c 0.5. CHC13)
7.5.2.8 Isopropyl (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-3-[4- 
(methoxy)phenyl]propionate (319c)
Yield: 188 mg. 48%;
v mal (KBr)/cm"‘: 3434s (C-OH). 3019s. 2838w. 1724 (C=0);
'H NMR (500 MHz): 8 1.20 (3H, d. J  6.1 Hz, OCH(C7/3)). 1.23 (3H. d, J  6.9 Hz, 
O C H (C //3), 3.29 (1H, d, J  3.9 Hz, OH), 3.76 (3H, s, OCH}), 4.65 (1H, s, C//(OH)),
4.99-5.09 (3H, m, O C #(C H 3)2 & C # 2Ph), 5.22 (1H, d, J 9 .2  Hz, C#(NHCbz)), 5.70 (d. 
J 9.6 Hz, NH), 6.86 (2H, d, J 8 .8  Hz, Ar-//), 7.26-7.30 (7H, m, Ar-//);
BnO
C 0 2/Pr
319b OH
O C H (C //3), 3.29 (1H, d, J  3.9 Hz, OH), 3.76 (3H, s, OCH3), 4.65 (1H, s, C//(OH)),
CbzHN
MeO
C02/Pr
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13C NMR (75.4 MHz): 5 21.6 (OCH(CH3)2), 55.2 (OCH3), 55.9 (CH(NHCbz)), 66.9
(OCH(CH3)2), 70.7 (N C 02CH2Ph), 73.6 (CH(OH)), 113.9, 128.0, 128.1, 128.4, 131.2,
155.6, (Ar-C), 159 (N C 02Bn), 172.3 (C 0 2/Pr);
m/z (+ES): 388 (MH+, 100 %), 370 (M -  OH);.
m/z (+HRES): 410.15618, (MNa+, C2iH25N 0 6Na requires 410.15741).
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/z'PrOH, 80/20, 20 ml m in '1, 210 nm,
18.7 (2R,3S).
7.5.2.9 Isopropyl (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-3-[4-
(hexyloxy)phenyl]propionate (319d)
Yield: 300 mg. 65%;
vmax (film j/cm 1: 3433 br (C-OH). 3019s. 2985m, 2935m, 1718 (C=0), 1512s;
'H NMR (400 MHz); 8  0.85 (3H, m, 0(C H 2)5CH}), 1.14 (3H, d. J 6 .2  Hz, O CH(C//3)),
1.23 (3H. d. J  6.1 Hz, OCH(C//3)), 1.27 (4H, m, 0(C H 2)3(C //2)2CH3), 1.38 (2H. m. 
O (CH2)3CH iCH2CH3). 1.72 (2H, quint, J  7.1 Hz, OCH2C //2(CH2)3CH3), 3.88 (2H. t. J
6.8 Hz. O C //2(CH2)4CH3). 4.29 (1H. s. C7/(OH)). 4.75 (2H. s. C //2Ph), 5.03 (1H. m. 
O C //(C H 3)2). 5.14 (1H. d, J9 .1  Hz, C//(NHAc)). 5.84 (1H. d. J 9 .4  Hz. NH). 6.81 (2H. 
d. J 8 .8  Hz. Ar-//). 7.21-7.31 (7H, m. Ar-//); 
m /z (ES): 458 (MH*. 15%); 307 (MH+ - [NHCbz]+. 100);
HPLC: Chiracel AD-H. 20mm x 250 mm, hexane/ZPrOH. 80/20, 20 ml m in '1. 210 nm.
13.4 (2S3R):
[a ]D20 = + 44.4 (c 0.5, CHC13)
7.5.2.10 Isopropyl (2R,3S)-3-benzyloxycarbonylamino-3-[4- 
(hexadecyloxy)phenyl]-2-hydroxy-propionate (319e)
N H C bz
C02/Pr
319d OH
CeH-oO
C bzH N
C02/Pr
C 1 6 H 3 3 O '
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Yield: 34.2 g, 6 %;
vm>x (KBr)/cm'': 3359br (OH), 3024s (C-H), 1710 (C=0);
'H NMR (500 MHz): 5 0.88 (m, 3H 0 (C H 2)i5C //3), 1.19 (3H, d, J 5 .6  Hz, OCH(C//3)),
1.23 (23 H, m, OCH(CH3) & O(CH2)5(C //2) i0CH3), 1.41 (m, 2H.
0(C H 2)5C //2(CH2)9CH3), 1.46 (4H, m, O(CH2)3C //2C //2(CH2)10CH3), 1.73 (2H, m, 
0 (C H 2C //2(CH2)i3CH3), 3.91 (2H, t, J  6.5 Hz, O C //2(CH2)MCH3). 4.37 (1H, s, 
C//(OH)), 4.97-5.09 (3H, m, C //2Ph & O C //(C H 3)2), 5.20 (d, J  8.8 Hz, C//(NHCbz)),
5.57 (1H. d, J9 .1  Hz, N //), 6.84 (2H, d, J 8 .8  Hz, Ar-//), 7.21-7.34 (7H, m, Ar-//);
13C NMR (75.4 MHz): 6 14.1 (0(C H 2),5CH3), 21.8 (OCH(CH3)2), 22.7, 26.6, 29.2,
29.4, 29.7, 31.9 (0(CH 2)i5CH3), 55.6 (OCH2(CH2),4CH3), 61.0 (CH(NH(Cbz)), 67.4 
(OCH(CH3)2), 67.5 (OCH2Ph), 68.1 (CH(OH)), 114.0, 126.1, 126.3, 127.1, 128.2, 155.5 
(Ar-C), 158.0 (N C 02Bn), 172.8 (C 0 2/Pr); 
m/z (FAB): 620 (MNa+, 100%);
m /z (+HRFAB): 620.39042, (MNa+, C36H55N06Na requires 620.39269).
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/iPrOH, 80/20, 20 ml m in 1, 210 nm,
8.8 (25,3/f);
[a ]D20 = + 55.1 (c 0.5, CHC13)
7.5.2.11 Isopropyl (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-3-[4- 
(methoxymethoxy)phenyl]propionate (319f)
C bzH N
319f OH
MOMO
Yield: 62 mg, 15%;
'H NMR (500 MHz): 8 1.19 (3H, d. J  6.2 Hz, OCH(C//3)), 1.26 (3H, d, J  6.2 Hz, 
O C H (C//3)). 3.44 (s, OCH3), 4.39 (1H, s, CH(OH)) 4.97-5.06 (5H, m, OC//(CH3)2, 
O C //2OCH3 & N C //2Ph), 5.21 (1H, d, J  9 2  Hz, C//(NHCbz), 5.60 (d, J  9.2 Hz, N //), 
6.99 (2H, d, J  8.8 Hz, A r-//), 7.26-7.36 (7H, m, Ar-//);
IJC NMR (75.4 MHz): 8 21.4 (OCH(CH3)2), 56.9 (OCH2OCH3), 59.8 (CH(NHCBz)),
67.5 (OCH2Ph), 69.2 (OCH(CH3)2), 73.2 (CH(OH)), 94.5 (OCH2OCH3), 115.6, 116.3,
126.3, 127.2. 129.8, 144.4, 160.0 (Ar-C), 158.7. (N H C 02Bn), 167.1 (C 0 2;Pr) 
m/z (+ES): 418 (MH+, 26%), 357 (MH+ -  [(CH3)2CHO]‘) or (M+ - [OCH2OCH3]); 
m /z (+HRFAB): 440.16994, (MNa+, C22H27N 0 7 requires 440.16851).
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HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/z'PrOH, 80/20, 20 ml m in '1, 210 nm,
22.9 (2S,3R);
[a ]D20 = + 61.0 (c 0.5, CHC13)
7.5.2.12 Isopropyl (2/?,3S)-3-benzyloxycarbonylamino-3-[4-(ferf-butyl- 
diphenyl-silanyloxy)-phenyl]-2-hydroxy-propionate (319g)
C bzH N
319g o h
T B D P S O
Yield: 301 mg, 49 %;
vIB>I(lilm)/cm~l : 3435m (C-OH), 3016s, 2932s, 2859s, 1717 (0 = 0 ), 1106 (C-O);
'H NMR (400 MHz): S 1.09 (9H, s, SiC(C//3}3). 1.17 (3H, d . ./ 6.3 Hz, OCH(CH3)),
I.25 (3H, d, J  6.3 Hz, OCH(CH3) \  4.35 (1H, s.C7/(OH)). 4.96-5.10 (3H, m, C //2Ph & 
O C //(C H 3)2), 5.15 (1H, d, J  9.1 Hz, C//(NHCbz)), 5.54 (1H, d, J  9.8 Hz, N H), 6.72 
(2H. d. J  8.8 Hz, Ar-//), 7.05-7.75 (17H, m, Ar-//);
l3C NMR (75.4 MHz): 8 19.4 (SiC(CH3)3), 21.5 (OCH(CH3)2), 26.5 (SiC(CH3)3), 55.1
(CH(NHCbz)), 66.9 ((OCH(C//3)2)), 70.7 (N C 02C //2Ph), 73.4 {CH(OH)), 119.6-135.5
(Ar-C). 155.5 (NCYCBn), 172.3 (COdPr);
m /z (FAB): 634 (MNa+, 100%), 387 (M -  [HSi(Ph)2(C(CH3)2) f ) .
m /z (+HRFAB): 634.26121, ([MNa+], C36H4iN06SiNa+ requires 634.26007).
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/iPrOH, 80/20, 18 ml m in '1, 210 nm,
II .5 (2/J.3S);
[a ]D20 = - 40.8 (c 0.5. CHC13)
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7.5.3 Mosher’s Ester synthesis
7.5.3.1 (2R,3S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 2- 
benzyloxycarbonylamino-2-isopropoxycarbonyl-1-(4- 
methoxymethoxy-phenyl)-ethyl ester (320)
In a round bottomed flask was placed (2i?,35)-2-Benzyloxycarbonylamino-3-hydroxy- 
3-(4-methoxymethoxy-phenyl)-propionic acid isopropyl ester (33.0 mg, 0.08 mmol), 
DCC (18.0 mg, 0.08 mmol) and DMAP (0.76 mg, 6.20 pmol) in dichloromethane (1 
mL). This was stirred for a couple o f minutes before the (S)-MTPA (20.0 mg, 0.08 
mmol) was added to the reaction mixture. The reaction mixture was stirred for 48 h. 
The crude product was loaded directly onto silica and purified by flash chromatography 
(100% dichloromethane) to yield the title compound as an oil in (21 mg, 53%).
!H NMR (400 MHz): 6 1.12 (3H, J  6.3 Hz, (OCH(C//3)), 1.21 (3H, J  6.3 Hz, 
(O C H (C //3)) 3.46 (3H, s, O C //3), 3.48 (3H, s, O C //3), 4.73 (1H, dd, J  8.0, 5.1 Hz, 
C //(N H CBz)). 4.99-5.02 (3H, m, (OC//(CH3)2, O C //2OCH3), 5.12 (2H, s. CH2Ph), 5.39
m, A r-//);
m /z (+ES): 633 (MH+, 12%), 482 (MH+ - [Cbz], 100%);
m /z (+H RES):, 656.20857 (M N a\C 32H34F3N 0 9 requires 656.20779).
7.5.4 Heterogeneous Catalysis
7.5.4.1 General method for the preparation Amberlite XAD-4, XAD-7 & 
XAD-16-0s0 4 anchored resins
Amberlite XAD4, 16 and XAD7 (10.0 g) was weighed and pretreated by soxhlet
extraction for three days in refluxing methanol. The resins were dried under vacuum for
a further three days. To a suspension o f XAD4, 7 & 16 resins (5.00 g) in lBuOH/H20
(1:1 v/v, 95 mL) was added 0.98 wt % O s04 (50 mL). This was stirred for 24 h. When
the resins were filtered, the filtrate was clear, indicating the osmium had been
120successfully anchored. Each resin contains 0.35 mmol of O s04/g.
o
CCty'Pr
MOMO
NH Cbz
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(1H, d. J  12 Hz), 6.91 (2H, J  8.4 Hz, Ar-//), 7.00 (2H, J 8 .4  Hz, Ar-//), 7.23-7.39 (10H.
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7.5.4.2 General procedure for Sharpless asymmetric aminohydroxylations 
with M-bromoacetamide and (DHQ)2AQN or under heterogeneous 
conditions with XAD4 and 7-0s04 resins.
In 3 mL o f an aqueous solution o f LiOHLLO (42.8 mg, 1.02 mmol), XAD-4-Os 
complex (111 mg, 0.04 mmol) was suspended with stirring. After addition o f "PrOH ( 6  
mL), (DHQ)2AQN (42.8 mg, 0.05 mmol) was added, and the mixture was stirred for 10 
min. After chiral ligand was dissolved completely, water ( 6  mL) was added 
subsequently, and the mixture was immersed in a cooling bath set to 4 C. After addition 
o f trans-cinnamate (1.00 mmol), A-bromoacetamide (152 mg, 1.10 mmol) was added in 
one portion (which resulted in an immediate colour change from brown to green) and 
the mixture was vigorously stirred at the same temperature. After completion o f the 
reaction, the catalyst was filtered and washed with dichloromethane. Saturated aqueous 
sodium sulfite and IN HC1 were added to the filtrate and the mixture was stirred for an 
additional hour. The organic product was then extracted with dichloromethane. After 
removing the solvent, the crude product was purified by chromatography on silica gel 
(4:6 EtOAc: hexane).
7.5.4.3 Isopropyl (2R,3S)-2-acetylamino-3-hydroxy-3-phenyl-propionate 
(286)
Yield: 110 mg. 9 % (XAD4, 286);
Yield: 116 mg, 9 % (XAD7, 286);
Characterised vide supra.
7.5.4.4 General procedure for Sharpless asymmetric aminohydroxylations 
with M-bromoacetamide and (DHQ)2PHAL or under heterogeneous 
conditions with XAD4 and 7-0s04 resins.
In 3 mL o f an aqueous solution o f LiOHLLO (42.8 mg, 1.02 mmol), XAD-4-Os 
complex (111.1 mg, 0.04 mmol) was suspended with stirring. After addition o f 'BuOH 
( 6  mL), (DHQ)2PHAL (38.9 mg, 0.05 mmol) was added, and the mixture was stirred for 
10 min. After chiral ligand was dissolved completely, water ( 6  mL) was added 
subsequently, and the mixture was immersed in a cooling bath set to 4 °C. After 
addition o f /nms’-cinnamate (1.00 mmol), A-bromoacetamide (151.8 mg, 1.10 mmol) 
was added in one portion (which resulted in an immediate colour change to green) and 
the mixture was vigorously stirred at the same temperature. After completion of the
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reaction, the catalyst was filtered and washed with dichloromethane. Saturated aqueous 
sodium sulfite and IN  HC1 were added to the filtrate and the mixture was stirred for an 
additional hour. Organic product was extracted with dichloromethane. After removing 
the solvent, the crude product was purified by chromatography on silica gel (4:6 EtOAc: 
hexane)
7.5.4.5 Isopropyl 3-Acetylamino-2-hydroxy-3-phenyl-propionate
Yield: 126 mg, 47 % (X A D 4,179);
Yield: 1.04 g, 79 % (XAD4, 130, 5 mmol scale, 179);
Yield: 183 mg, 69 % (X A D 7,179);
Yield: 320 mg, 32 % (X A D 7,179);
Characterised vide supra.
7.5.4.6 General procedure for Sharpless asymmetric aminohydroxylations 
with benzyl carbamate and (DHQ)2AQN under heterogeneous 
conditions with XAD-4, XAD-7 and XAD-16-0s04 resins.
A reaction flask was charged with NaOH (2.98 mL, 1.02 M) and diluted with water (4.5 
mL). With vigorous stirring, 1-propanol (4 mL) was added, followed by benzyl 
carbamate (469 mg, 3.10 mmol). l,3-dichloro-5,5'-dimethyl hydantoin (300 mg, 1.52 
mmol) was added in small portions. Once added and completely dissolved, a 1- 
propanol solution (3.5 mL) containing cinnamate (1 mmol) and (DHQ^AQN (42.8 mg.
0.05 mmol) was added, followed by chosen XAD-OSO4 resin (115 mg, 0.05 mmol). 
After 2 h, sodium bisulfite (500 mg) was added. The XAD-OSO4 resin was filtered and 
washed with EtOAc (20 to 30 mL). The aqueous phase was separated and then 
extracted with EtOAc (3 x 30 mL). The combined organic layers were dried (Na2S0 4 ) 
and evaporated. The residues were purified by flash column chromatography (1:9. 
acetone: toluene).
7.5.4.7 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-hydroxy-3-phenyl- 
propionate from XAD-4-Os04, XAD-7-Os04-& XAD-16-0s04 
Sharpless AA
Yield: 220 mg, 62%; (X A D -4-0s04, 288);
Yield: 311 mg, 88%; (X A D -7-0s04, 288);
Yield: 189 mg, 50%; (XAD-16-Os04, 288).
Characterised vide supra.
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7.5.4.8 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4-(benzyloxy) 
phenyl]-3-hydroxy-propionate (295b) from XAD4-0s04, XAD7- 
0 s0 4-& XAD16-0s04 Sharpless AA.
Yield: 220 mg, 62%; (X A D 4-0s04, 295b );
Yield: 311 mg, 88%; (X A D 7-0s04, 295b);
Yield: 189 mg, 50%; (X A D 16-0s04, 295b).
Characterised vide supra.
7.5.4.9 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4- 
(methoxy)phenyl]-3-hydroxy-propionate (295c)
Yield: 254 mg, 67%; (X A D 7-0s04, 295c);
Characterised vide supra.
7.5.4.10 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4-(hexyloxy)
phenyl]-3-hydroxy-propionate (295d) from XAD4-Os04, XAD7- 
0 s0 4-& XAD16-Os04 Sharpless AA.
Yield: 170 mg, 37 %; (X A D 4-0s04, 295d);
Yield: 150 mg, 33 %; (X A D 7-0s04, 295d);
Yield: 200 mg, 44 %; (XAD16-Os04, 295d).
Characterised vide supra.
7.5.4.11 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4-
(hexadecyloxy)phenyl]-3-hydroxy-propionate (295e) by XAD-7- 
0 s0 4 Sharpless AA
Yield: 204 mg, 35 %; (X A D -7-O s04, 295e);
Characterised vide supra.
7.5.4.12 Isopropyl (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-3-[4-
(methoxymethoxy)phenyl]propionate (295f)
Yield: 258 mg, 62 %; (X A D 7-0s04, 295f);
Characterised vide supra.
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7.5.4.13 Isopropyl (2R,3S)-2-benzyloxycarbonylamino-3-[4-(ferf-butyl- 
diphenyl-silanyloxy)-phenyl]-3-hydroxy-propionate (295g)
Yield: 251mg, 41%; (X A D 7-0s04, 295g);
Characterised vide supra.
7.5.5 Sharpless Asymmetric Aminohydroxylation (AA) using 
methyl trans-2-octenoate
This section used both homogeneous and hetereogenous Sharpless AA reactions, as 
before and the methods used are stated in the yield.
7.5.5.1 Methyl (2R,3S)-2-benzyloxycarbonylamino-3-hydroxy-octanate
Yield: 113 mg, 35 % (using homogeneous method 7.5.1.7);
vmax (film)/cm *: 3435s (C-OH), 3019s, 2956m, 2931m, 1734s (C=0);
*H NMR (500 MHz): 5 0.88 (3H, m, (CH2)4C //3)), 1.29 (6 H, m, CH2(C //2)3CH3), 1.38
5.0 Hz, C //(NHCbz)), 4.39 (1H, d, J  9.1 Hz, C//(OH)), 5.14 (2H, s, C //2Ph). 5.49 (1H. 
d. J9 .1  Hz. N //), 7.29-7.39 (5H, m, Ar-//);
13C NMR (75.4 MHz): 5 13.9 ((CH2)4CH3), 22.5-33.6 ((CH2)4CH3), 52.4 (OCH3), 58.7 
(CH(NHCbz)). 66.7 (OCH2Ph), 71.8 (CH(OH)), 127.9-138.1 (Ar-C), 155.3 (N C 0 2Bn),
171.2 (C 0 2Me);
m /z (Cl): 325 (MH+, 48%), 280 (M+ - [CH3CH2CH2]+).
m /z (+HRES): 324.18064, (MH+, C i7H25N 0 5 requires 324.18109).
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/zPrOH, 80/20, 20 ml min"1, 210 nm, 
11.8(2^,35).
(325)
HO
C 0 2M e
C bzH N
(2H, m, C //2(CH2)3CH3), 3.03 (1H, d, J 4.6 Hz, OH)), 3.77 (3H, s, O C //3), 4.12 (1H, t. J
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7.5.5.2 Methyl (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-octanate
(327)
C bzH N
OH
Y ield: 188 mg, 58 % (using homogeneous method 7.5.1.10);
'H NMR (500 MHz): S 0.88 (3H, m, (CH2)4CHi), 1.30 (6H, m, CH2(C //2)3CH,). 1.38 
(2H, m, C //2(CH2)3CH3), 3.03 (1H, d, J 4 .6  Hz, OH), 3.74 (3H, s, O C //3), 4.05 (1H, dt, 
.78.6, 6.5 Hz, C//(NHCbz)), 4.18 (1H, d, J 4 .6  Hz, C//(OH)), 5.06 (2H, s, C7/,Ph). 7.29- 
7.38 (5H, m, A r-//);
13C NMR (75.4 MHz): 8 13.9 ((CH2)4CH3), 22.5-33.6 ((CH2)4CH3), 52.5 (OCH3), 58.2 
(CH(NHCbz)), 66.7 (OCH2Ph), 71.8 (CH(OH)), 127.9-138.1 (Ar-C), 155 (N C 02Bn),
171.2 (C 0 2Me);
m /z  (Cl): 325 (MH+, 48%), 280 (M+ - [CH3CH2CH2]+).
m/z (+HRES): 324.18117, (MH+, C I7H25N 0 5 requires 324.18109).
HPLC: Chiracel AD-H, 20mm x 250 mm, hexane/z'PrOH, 80/20, 20 ml min’1, 210 nm,
20.8 (2R3S).
7.5.5.3 Methyl (2R,3S)-2-benzyloxycarbonylamino-3-hydroxy-octanoate by 
XAD7-0s0 4 Sharpless AA (325)
Yield: 113 mg, 335 % (using hetereogenous method 7.5.4.6);
Characterised vide supra.
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Appendix
H NM R o f Li-HPA lc  and its gem-diol I d
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Base: 350.00 Int: 177387 Sample: VG70-SE Positive Cl-Methane
248
0%
Biomimetic Ketoalcohol 277 
Instrument Resolution: 8000 
Theroetical Mass (M+H) 248.09228 
M easured Mass: (M+H) 248.09187 
Error: 1.65 ppm
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Appendix D
Appendix
4.205 4.200 4.195 4.190 4.185 4.180 4.175
1H NM R for syw-oxazolidinone 299d J 5.5 Hz
C02/Pr
NHCbz
295f MOMO' MOMO
298a-d syn and anti diastereoisomers
'trans
MOMO'
syn-299b 
syn-299c
Determination o f the relative syn and anti stereocenters of 295f by derivatization to 
oxazolidinones 299a-d for NMR spectroscopic analyses. Reagents and conditions: 
a) Pd/C (5%), H2, room temperature, methanol (46% for 298a-d); b) triphosgene, Et3N, 
Ar, THF, -10 °C to room temp, (avg 42% yield for 299a-d)
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1:1 diasteroisomeric HPLC trace for product 295f
OH
NHCbz
295fMOMO
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Error: 1.21 ppm
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I I 1 1T T i r'
H NMR for SAA HPLC-purified product 288
OH
C 0 2/Pr
NHCbz 288
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Chiral HPLC trace for homogeneous reaction mixture with (DHQ^AQN 137a to give
(2/?,3S)-3-phenylserine 288
OH
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Appendix K
Chiral HPLC trace for homogeneous reaction mixture with (DHQ^PHAL 136a to give
(2i?,35)-3-phenylserine 316
CbzH N
